-- Table structure for table `groups`
--

DROP TABLE IF EXISTS `groups`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `groups` (
  `id_group` int(11) NOT NULL AUTO_INCREMENT,
  `group` varchar(60) NOT NULL,
  PRIMARY KEY (`id_group`)
) ENGINE=InnoDB AUTO_INCREMENT=74 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `groups`
--

LOCK TABLES `groups` WRITE;
/*!40000 ALTER TABLE `groups` DISABLE KEYS */;
INSERT INTO `groups` VALUES (1,'ACTIVATOR'),(2,'ADHESION'),(3,'AGONIST'),(4,'ANTAGONIST'),(5,'ANTIBIOTIC'),(6,'ANTIGEN'),(7,'ANTIMICROBIAL'),(8,'ANTITUMOR'),(9,'APOPTOSIS'),(10,'BINDING'),(11,'BIOSYNTHETIC'),(12,'BIOTIN'),(13,'BLOOD'),(14,'BUNDLE'),(15,'CALCIUM'),(16,'CELL'),(17,'CHAPERONE'),(18,'CLOTTING'),(19,'COAGULATION'),(20,'COMPLEX'),(21,'CONTRACTILE'),(22,'CYCLE'),(23,'DE NOVO PROTEIN'),(24,'DNA'),(25,'ELECTRON'),(26,'ENDOCYTOSIS'),(27,'EXOCYTOSIS'),(28,'FACTOR'),(29,'FIBRIL'),(30,'FUNCTION'),(31,'GENE'),(32,'GROWTH'),(33,'HELIX'),(34,'HISTOCOMPATIBILITY'),(35,'HORMONE'),(36,'HYDROLASE'),(37,'IMMUNE SYSTEM'),(38,'IMMUNOSUPPRESSANT'),(39,'INHIBITOR'),(40,'INVASION'),(41,'ISOMERASE'),(42,'LIGASE'),(43,'LYASE'),(44,'MEMBRANE'),(45,'METAL'),(46,'MHC'),(47,'MOTOR'),(48,'NUCLEAR'),(49,'OXIDOREDUCTASE'),(50,'PEPTIDE'),(51,'PHOTOSYNTHESIS'),(52,'PLANT'),(53,'PROTEASE'),(54,'PROTEINASE'),(55,'RECEPTOR'),(56,'RECOMBINATION'),(57,'REGULATION'),(58,'REGULATOR'),(59,'REPLICATION'),(60,'RNA'),(61,'SERINE'),(62,'SIGNALING'),(63,'STRUCTURAL'),(64,'SUBSTRATE'),(65,'SUGAR'),(66,'TOXIN'),(67,'TRANSCRIPTION'),(68,'TRANSFERASE'),(69,'TRANSLATION'),(70,'TRANSPORT'),(71,'UNKNOWN'),(72,'VIRAL'),(73,'OTHERS');
/*!40000 ALTER TABLE `groups` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `organism`
--

DROP TABLE IF EXISTS `organism`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `organism` (
  `id_organism` int(11) NOT NULL AUTO_INCREMENT,
  `organism` varchar(100) NOT NULL DEFAULT '',
  PRIMARY KEY (`id_organism`)
) ENGINE=InnoDB AUTO_INCREMENT=559 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `organism`
--

LOCK TABLES `organism` WRITE;
/*!40000 ALTER TABLE `organism` DISABLE KEYS */;
INSERT INTO `organism` VALUES (0,'-'),(1,'Acanthamoeba castellanii'),(2,'Acidovorax sp. MR-S7'),(3,'Acinetobacter baumannii'),(4,'Actinobacteria'),(5,'Actinomyces'),(6,'Aeromonas caviae'),(7,'Aeropyrum pernix'),(8,'African swine fever virus'),(9,'Agarophyton chilense'),(10,'Agrobacterium fabrum'),(11,'Agrobacterium tumefaciens'),(12,'Aichivirus C'),(13,'Alicyclobacillus sendaiensis'),(14,'Aliivibrio fischeri'),(15,'Alphacoronavirus 1'),(16,'Alphainfluenzavirus'),(17,'Alphamesonivirus 1'),(18,'Alphapapillomavirus 5'),(19,'Alphapapillomavirus 7'),(20,'Alphapapillomavirus 9'),(21,'Amaranthus hypochondriacus'),(22,'Amblyomma variegatum'),(23,'Ambrosia artemisiifolia'),(24,'Amycolatopsis orientalis'),(25,'Anas platyrhynchos'),(26,'Ancylostoma caninum'),(27,'Ancylostoma ceylanicum'),(28,'Anopheles albimanus'),(29,'Anopheles gambiae'),(30,'Apis mellifera'),(31,'Aplysia californica'),(32,'Aquifex aeolicus'),(33,'Arabidopsis thaliana'),(34,'Arabidopsis'),(35,'Archaeoglobus fulgidus'),(36,'Artocarpus heterophyllus'),(37,'Artocarpus hirsutus'),(38,'Artocarpus integer'),(39,'Ascaris suum'),(40,'Aspergillus fumigatus'),(41,'Aspergillus nidulans'),(42,'Aspergillus niger'),(43,'Aspergillus oryzae'),(44,'Astacus astacus'),(45,'Astacus leptodactylus'),(46,'Asticcacaulis excentricus'),(47,'Avena sativa'),(48,'Avian coronavirus'),(49,'Azotobacter vinelandii'),(50,'Bacillus amyloliquefaciens'),(51,'Bacillus anthracis'),(52,'Bacillus cereus'),(53,'Bacillus halmapalus'),(54,'Bacillus lentus'),(55,'Bacillus licheniformis'),(56,'Bacillus phage SPP1'),(57,'Bacillus phage phi3T'),(58,'Bacillus sp. MN-32'),(59,'Bacillus subtilis'),(60,'Bacillus thermoproteolyticus'),(61,'Bacillus thuringiensis'),(62,'Bacillus virus SPbeta'),(63,'Bacillus virus phi29'),(64,'Bacteroides thetaiotaomicron'),(65,'Bartonella birtlesii'),(66,'Bartonella quintana'),(67,'Bauhinia forficata'),(68,'Bdellovibrio bacteriovorus'),(69,'Bifidobacterium longum'),(70,'Biomphalaria glabrata'),(71,'Bipolaris zeicola'),(72,'Bombina maxima'),(73,'Bombus pascuorum'),(74,'Borreliella burgdorferi'),(75,'Bos taurus'),(76,'Bothrops insularis'),(77,'Bothrops leucurus'),(78,'Bradyrhizobium diazoefficiens'),(79,'Brassica napus'),(80,'Brevibacillus brevis'),(81,'Brugia malayi'),(82,'Bubalus bubalis'),(83,'Bungarus multicinctus'),(84,'Burkholderia pseudomallei'),(85,'Caenorhabditis elegans'),(86,'Cali mammarenavirus'),(87,'Camelus dromedarius'),(88,'Campylobacter jejuni'),(89,'Canarypox virus'),(90,'Canavalia cathartica'),(91,'Canavalia ensiformis'),(92,'Candida albicans'),(93,'Candida parapsilosis'),(94,'Candida tropicalis'),(95,'Canis lupus'),(96,'Capparis masaikai'),(97,'Capsicum annuum'),(98,'Cardiovirus B'),(99,'Carica papaya'),(100,'Carp sprivivirus'),(101,'Caulobacter vibrioides'),(102,'Ceratogyrus marshalli'),(103,'Chaetomium thermophilum'),(104,'Chikungunya virus'),(105,'Chlamydia trachomatis'),(106,'Chlamydomonas reinhardtii'),(107,'Chlamys nipponensis'),(108,'Chlorocebus aethiops'),(109,'Chromobacterium violaceum'),(110,'Citrobacter freundii'),(111,'Citrus sinensis'),(112,'Clonostachys'),(113,'Clostridioides difficile'),(114,'Clostridium botulinum'),(115,'Clostridium butyricum'),(116,'Clostridium perfringens'),(117,'Clostridium tetani'),(118,'Conus bullatus'),(119,'Conus geographus'),(120,'Conus imperialis'),(121,'Conus pennaceus'),(122,'Conus pergrandis'),(123,'Conus regius'),(124,'Conus textile'),(125,'Coreopsis grandiflora'),(126,'Corynebacterium glutamicum'),(127,'Cowpox virus'),(128,'Cricetulus griseus'),(129,'Crotalus durissus'),(130,'Cryphonectria parasitica'),(131,'Cryptococcus neoformans'),(132,'Cryptosporidium parvum'),(133,'Ctenopharyngodon idella'),(134,'Cucumis melo'),(135,'Cucurbita maxima'),(136,'Cucurbita pepo'),(137,'Cupriavidus metallidurans'),(138,'Cyanidioschyzon merolae'),(139,'Cyanobacteria'),(140,'Cylindrocarpon lucidum'),(141,'Cytomegalovirus'),(142,'Daboia russelii'),(143,'Daboia siamensis'),(144,'Danio rerio'),(145,'Daucus carota'),(146,'Deinagkistrodon acutus'),(147,'Deinococcus radiodurans'),(148,'Deinococcus'),(149,'Delftia acidovorans'),(150,'Dengue virus'),(151,'Desulfococcus multivorans'),(152,'Dickeya chrysanthemi'),(153,'Dickeya dadantii'),(154,'Dictyostelium discoideum'),(155,'Drosophila melanogaster'),(156,'Ebola virus sp.'),(157,'Ecballium elaterium'),(158,'Eimeria tenella'),(159,'Eisenia fetida'),(160,'Encephalitozoon cuniculi'),(161,'Endothia gyrosa'),(162,'Entamoeba histolytica'),(163,'Enterobacteria phage fd'),(164,'Enterococcus faecalis'),(165,'Enterococcus faecium'),(166,'Enterovirus A'),(167,'Enterovirus B'),(168,'Enterovirus C'),(169,'Enterovirus D'),(170,'Enterovirus E'),(171,'Enterovirus F'),(172,'Eptatretus burgeri'),(173,'Equine infectious anemia virus'),(174,'Equus caballus'),(175,'Eremothecium gossypii'),(176,'Erinaceus europaeus'),(177,'Escherichia coli'),(178,'Escherichia virus M13'),(179,'Escherichia virus P1'),(180,'Escherichia virus T4'),(181,'Escherichia virus T7'),(182,'Feline immunodeficiency virus'),(183,'Felis catus'),(184,'Fervidobacterium nodosum'),(185,'Finegoldia magna'),(186,'Flavobacterium johnsoniae'),(187,'Flexibacter sp.'),(188,'Foot-and-mouth disease virus'),(189,'Fowlpox virus'),(190,'Francisella tularensis'),(191,'Fusarium oxysporum'),(192,'Galerina marginata'),(193,'Galleria mellonella'),(194,'Gallus gallus'),(195,'Geobacillus stearothermophilus'),(196,'Geodia cydonium'),(197,'Gloydius blomhoffii'),(198,'Glycine max'),(199,'Griffithsia monilis'),(200,'Gypsophila vaccaria'),(201,'Haemaphysalis longicornis'),(202,'Haemophilus influenzae'),(203,'Haloarcula marismortui'),(204,'Haloferax volcanii'),(205,'Halomonas sp.'),(206,'Hathewaya histolytica'),(207,'Helianthus annuus'),(208,'Helicobacter pylori'),(209,'Helicoma ambiens'),(210,'Helicoverpa armigera stunt virus'),(211,'Heliobacterium modesticaldum'),(212,'Heliothis virescens'),(213,'Helleborus purpurascens'),(214,'Heloderma suspectum'),(215,'Hemicentrotus pulcherrimus'),(216,'Hendra henipavirus'),(217,'Hepacivirus C'),(218,'Hepatitis B virus'),(219,'Hepatitis delta virus'),(220,'Hepatovirus A'),(221,'Herpes simplex virus unknown type'),(222,'Hirudo medicinalis'),(223,'Hirudo nipponia'),(224,'Hoeflea phototrophica'),(225,'Homo sapiens'),(226,'Hordeum vulgare'),(227,'Human alphaherpesvirus 1'),(228,'Human betaherpesvirus 5'),(229,'Human coronavirus HKU1'),(230,'Human gammaherpesvirus 4'),(231,'Human gammaherpesvirus 8'),(232,'Human immunodeficiency virus 1'),(233,'Human immunodeficiency virus 2'),(234,'Human immunodeficiency virus'),(235,'Human mastadenovirus C'),(236,'Human mastadenovirus D'),(237,'Human metapneumovirus'),(238,'Human orthopneumovirus'),(239,'Human papillomavirus'),(240,'Human rhinovirus sp.'),(241,'Humicola insolens'),(242,'Hungateiclostridium thermocellum'),(243,'Hydra vulgaris'),(244,'IncN plasmid R46'),(245,'Indiana vesiculovirus'),(246,'Infectious pancreatic necrosis virus'),(247,'Influenza A virus'),(248,'Influenza B virus'),(249,'Irpex lacteus'),(250,'Ixodes ricinus'),(251,'Japanese encephalitis virus'),(252,'Kitasatospora aureofaciens'),(253,'Kitasatospora'),(254,'Klebsiella pneumoniae'),(255,'Kluyveromyces lactis'),(256,'Kluyveromyces marxianus'),(257,'Komagataella pastoris'),(258,'Komagataella phaffii'),(259,'Lachnospiraceae bacterium C6A11'),(260,'Lactococcus lactis'),(261,'Lama glama'),(262,'Lathyrus ochrus'),(263,'Legionella longbeachae'),(264,'Legionella pneumophila'),(265,'Leishmania donovani'),(266,'Leishmania infantum'),(267,'Leishmania major'),(268,'Leiurus quinquestriatus'),(269,'Lens culinaris'),(270,'Listeria monocytogenes'),(271,'Locusta migratoria'),(272,'Lodderomyces elongisporus'),(273,'Loxodonta africana'),(274,'Lubomirskia baikalensis'),(275,'Lymphocytic choriomeningitis mammarenavirus'),(276,'Lyngbya aestuarii'),(277,'Lyngbya'),(278,'Lysobacter enzymogenes'),(279,'Macaca fuscata'),(280,'Macaca mulatta polyomavirus 1'),(281,'Macaca mulatta'),(282,'Maclura pomifera'),(283,'Magnetospirillum gryphiswaldense'),(284,'Mammalian rubulavirus 5'),(285,'Marasmius oreades'),(286,'Marburg marburgvirus'),(287,'Mason-Pfizer monkey virus'),(288,'Meleagris gallopavo'),(289,'Mesocricetus auratus polyomavirus 1'),(290,'Mesocricetus auratus'),(291,'Methanocaldococcus jannaschii'),(292,'Microcystis aeruginosa'),(293,'Microcystis sp.'),(294,'Middle East respiratory syndrome-related coronavirus'),(295,'Momordica balsamina'),(296,'Momordica charantia'),(297,'Momordica cochinchinensis'),(298,'Moniliophthora perniciosa'),(299,'Monosiga brevicollis'),(300,'Moorella thermoacetica'),(301,'Moringa oleifera'),(302,'Mule deerpox virus'),(303,'Mumps rubulavirus'),(304,'Murid gammaherpesvirus 4'),(305,'Murine coronavirus'),(306,'Murine leukemia virus'),(307,'Murine respirovirus'),(308,'Mus musculus polyomavirus 1'),(309,'Mus musculus'),(310,'Mus'),(311,'Mycobacteriaceae'),(312,'Mycobacterium marinum'),(313,'Mycobacterium tuberculosis'),(314,'Mycolicibacterium smegmatis'),(315,'Mycoplasma arthritidis'),(316,'Myxoma virus'),(317,'Naja kaouthia'),(318,'Naja sagittifera'),(319,'Nanoarchaeum equitans'),(320,'Neisseria gonorrhoeae'),(321,'Neisseria meningitidis'),(322,'Neurospora crassa'),(323,'Nicotiana plumbaginifolia'),(324,'Nicotiana tabacum'),(325,'Nipah henipavirus'),(326,'Nitrosomonas europaea'),(327,'Nodularia spumigena'),(328,'Nomascus leucogenys'),(329,'Norwalk virus'),(330,'Nostoc punctiforme'),(331,'Nostoc sp. PCC 7120 = FACHB-418'),(332,'Odorrana versabilis'),(333,'Omphalotus olearius'),(334,'Oncopeltus fasciatus'),(335,'Oncorhynchus gorbuscha'),(336,'Oncorhynchus sp.'),(337,'Ophiophagus hannah'),(338,'Oryctolagus cuniculus'),(339,'Oryza sativa'),(340,'Ovis aries'),(341,'Pachyrhizus erosus'),(342,'Pan troglodytes'),(343,'Parabacteroides merdae'),(344,'Paramecium bursaria Chlorella virus 1'),(345,'Paramecium tetraurelia'),(346,'Parengyodontium album'),(347,'Pectobacterium atrosepticum'),(348,'Penicillium janthinellum'),(349,'Peptide display vector fth1'),(350,'Petunia x hybrida'),(351,'Phaeospirillum molischianum'),(352,'Phage #D'),(353,'Phage display vector pTDisp'),(354,'Phage display vector pdvec0'),(355,'Phytophthora infestans'),(356,'Pisum sativum'),(357,'Planctopirus limnophila'),(358,'Planktothrix agardhii'),(359,'Planktothrix rubescens'),(360,'Planobispora rosea'),(361,'Plasmodium berghei'),(362,'Plasmodium falciparum'),(363,'Plasmodium knowlesi'),(364,'Plasmodium vivax'),(365,'Plasmodium yoelii'),(366,'Podisus maculiventris'),(367,'Poecilobdella manillensis'),(368,'Polyomavirus sp.'),(369,'Polypodiopsida'),(370,'Pongo abelii'),(371,'Porcine epidemic diarrhea virus'),(372,'Porcine reproductive and respiratory syndrome virus'),(373,'Porphyromonas gingivalis'),(374,'Potyviridae'),(375,'Primate T-lymphotropic virus 1'),(376,'Prochlorococcus marinus'),(377,'Proteus mirabilis'),(378,'Protobothrops mucrosquamatus'),(379,'Providencia stuartii'),(380,'Pseudoalteromonas sp. AS-11'),(381,'Pseudomonas aeruginosa'),(382,'Pseudomonas fluorescens'),(383,'Pseudomonas reinekei'),(384,'Pseudomonas savastanoi'),(385,'Pseudomonas sp. 101'),(386,'Pseudomonas sp. SY-77-1'),(387,'Pseudomonas sp.'),(388,'Pseudoxanthomonas mexicana'),(389,'Pteropus alecto'),(390,'Purpureocillium lilacinum'),(391,'Pyricularia oryzae'),(392,'Pyrobaculum calidifontis'),(393,'Pyrococcus furiosus'),(394,'Pyrococcus horikoshii'),(395,'Pyrrhocoris apterus'),(396,'Rabies lyssavirus'),(397,'Raphanus sativus'),(398,'Rattus norvegicus'),(399,'Rattus rattus'),(400,'Rattus'),(401,'Recombinant vesicular stomatitis Indiana virus rVSV-G/GFP'),(402,'Rhinovirus A'),(403,'Rhinovirus B'),(404,'Rhipicephalus microplus'),(405,'Rhizopus microsporus'),(406,'Rhodnius prolixus'),(407,'Rhodobacter sphaeroides'),(408,'Rhodoblastus acidophilus'),(409,'Ricinus communis'),(410,'Rickettsia conorii'),(411,'Rickettsia rickettsii'),(412,'Rickettsia typhi'),(413,'Rift Valley fever phlebovirus'),(414,'Rinderpest morbillivirus'),(415,'Rodent protoparvovirus 1'),(416,'Rotavirus A'),(417,'Rous sarcoma virus'),(418,'Sacbrood virus'),(419,'Saccharolobus solfataricus'),(420,'Saccharomyces cerevisiae'),(421,'Saimiriine gammaherpesvirus 2'),(422,'Salmo salar'),(423,'Salmonella enterica'),(424,'Schaalia radingae'),(425,'Scheffersomyces stipitis'),(426,'Schistocerca gregaria'),(427,'Schistosoma mansoni'),(428,'Schizosaccharomyces pombe'),(429,'Scytalidium lignicola'),(430,'Semliki Forest virus'),(431,'Senecavirus A'),(432,'Serratia marcescens'),(433,'Serratia sp. GF96'),(434,'Severe acute respiratory syndrome-related coronavirus'),(435,'Shewanella oneidensis'),(436,'Shigella flexneri'),(437,'Simian immunodeficiency virus'),(438,'Singapore grouper iridovirus'),(439,'Solanum tuberosum'),(440,'Southern rice black-streaked dwarf virus'),(441,'Spinacia oleracea'),(442,'Spodoptera frugiperda'),(443,'Squalus acanthias'),(444,'Staphylococcaceae'),(445,'Staphylococcus aureus'),(446,'Staphylococcus epidermidis'),(447,'Staphylococcus hominis'),(448,'Stenotrophomonas maltophilia'),(449,'Streptococcus agalactiae'),(450,'Streptococcus dysgalactiae'),(451,'Streptococcus pneumoniae'),(452,'Streptococcus pyogenes'),(453,'Streptococcus sp. \'group G\''),(454,'Streptococcus sp.'),(455,'Streptococcus suis'),(456,'Streptococcus thermophilus'),(457,'Streptomyces actuosus'),(458,'Streptomyces argenteolus'),(459,'Streptomyces atratus'),(460,'Streptomyces avidinii'),(461,'Streptomyces azureus'),(462,'Streptomyces cinnamoneus'),(463,'Streptomyces clavuligerus'),(464,'Streptomyces coelicolor'),(465,'Streptomyces echinatus'),(466,'Streptomyces griseus'),(467,'Streptomyces hawaiiensis'),(468,'Streptomyces hygroscopicus'),(469,'Streptomyces lasalocidi'),(470,'Streptomyces lividans'),(471,'Streptomyces mobaraensis'),(472,'Streptomyces muensis'),(473,'Streptomyces resistomycificus'),(474,'Streptomyces roseus'),(475,'Streptomyces sp.'),(476,'Streptomyces tsusimaensis'),(477,'Streptomyces'),(478,'Strongyloides stercoralis'),(479,'Sudan ebolavirus'),(480,'Sulfolobus acidocaldarius'),(481,'Sus scrofa'),(482,'Symploca'),(483,'Synechococcus elongatus'),(484,'Synechocystis sp. PCC 6803'),(485,'Taeniopygia guttata'),(486,'Tannerella forsythia'),(487,'Tenebrio molitor'),(488,'Tetrahymena thermophila'),(489,'Tetronarce californica'),(490,'Thauera aromatica'),(491,'Theileria parva'),(492,'Theonella sp.'),(493,'Thermincola potens'),(494,'Thermobaculum terrenum'),(495,'Thermobifida fusca'),(496,'Thermochromatium tepidum'),(497,'Thermococcus kodakarensis'),(498,'Thermomonospora curvata'),(499,'Thermoplasma acidophilum'),(500,'Thermosynechococcus elongatus'),(501,'Thermosynechococcus vulcanus'),(502,'Thermothielavioides terrestris'),(503,'Thermotoga maritima'),(504,'Thermus thermophilus'),(505,'Tobacco etch virus'),(506,'Tobacco vein mottling virus'),(507,'Tolypocladium inflatum'),(508,'Torpedo marmorata'),(509,'Toxoplasma gondii'),(510,'Treponema denticola'),(511,'Triatoma infestans'),(512,'Trichoderma polysporum'),(513,'Trichoderma reesei'),(514,'Trichomonas vaginalis'),(515,'Trichonephila clavipes'),(516,'Trichoplax adhaerens'),(517,'Trichosanthes anguina'),(518,'Trichosanthes kirilowii'),(519,'Triticum aestivum'),(520,'Trypanosoma brucei'),(521,'Trypanosoma cruzi'),(522,'Vaccinia virus'),(523,'Variola virus'),(524,'Veronica hederifolia'),(525,'Vesicular stomatitis virus'),(526,'Vibrio cholerae'),(527,'Vibrio proteolyticus'),(528,'Vibrio vulnificus'),(529,'Vicugna pacos'),(530,'Vigna angularis'),(531,'Vigna radiata'),(532,'Vigna unguiculata'),(533,'Weissella viridescens'),(534,'West Nile virus'),(535,'Xanthomonas campestris'),(536,'Xanthomonas citri'),(537,'Xanthomonas oryzae'),(538,'Xanthomonas virus Xp10'),(539,'Xenopus laevis'),(540,'Xenopus tropicalis'),(541,'Xenopus'),(542,'Yellow fever virus'),(543,'Yersinia enterocolitica'),(544,'Yersinia pestis'),(545,'Yersinia pseudotuberculosis'),(546,'Zaire ebolavirus'),(547,'Zea mays'),(548,'Zika virus'),(549,'[Candida] glabrata'),(550,'actinomycete 095-35'),(551,'artificial sequences'),(552,'synthetic construct'),(553,'uncultured Prochloron sp.'),(554,'uncultured beta proteobacterium UMTRA-608'),(555,'unidentified \'CNM-group\' bacterium HXN600'),(556,'unidentified adenovirus'),(557,'unidentified influenza virus'),(558,'unidentified');
/*!40000 ALTER TABLE `organism` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `pdb`
--

DROP TABLE IF EXISTS `pdb`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `pdb` (
  `id_pdb` int(11) NOT NULL AUTO_INCREMENT,
  `pdb` char(4) NOT NULL,
  `title` varchar(300) NOT NULL DEFAULT '',
  `method` varchar(50) DEFAULT NULL,
  `resolution` decimal(5,3) DEFAULT NULL,
  `classification` varchar(60) NOT NULL,
  `peptide_count` int(11) NOT NULL DEFAULT '0',
  `receptor_count` int(11) NOT NULL DEFAULT '0',
  `id_pdb_status` int(11) NOT NULL,
  PRIMARY KEY (`id_pdb`),
  UNIQUE KEY `PDB` (`pdb`)
) ENGINE=InnoDB AUTO_INCREMENT=8134 DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `pdb`
--

LOCK TABLES `pdb` WRITE;
/*!40000 ALTER TABLE `pdb` DISABLE KEYS */;
INSERT INTO `pdb` VALUES (1,'148l','A COVALENT ENZYME-SUBSTRATE INTERMEDIATE WITH SACCHARIDE DISTORTION IN A MUTANT T4 LYSOZYME','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(2,'1a07','C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(N,N-DIPENTYL AMINE)','X-RAY DIFFRACTION',2.200,'COMPLEX (TRANSFERASE/PEPTIDE)',2,2,1),(3,'1a08','C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR-GLU-(N,N- DIPENTYL AMINE)','X-RAY DIFFRACTION',2.200,'COMPLEX (TRANSFERASE/PEPTIDE)',2,2,1),(4,'1a09','C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N- DIPENTYL AMINE)','X-RAY DIFFRACTION',2.000,'COMPLEX (TRANSFERASE/PEPTIDE)',2,2,1),(5,'1a1a','C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)','X-RAY DIFFRACTION',2.000,'COMPLEX (TRANSFERASE/PEPTIDE)',2,2,1),(6,'1a1b','C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)','X-RAY DIFFRACTION',2.200,'COMPLEX (TRANSFERASE/PEPTIDE)',2,2,1),(7,'1a1c','C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(-(CH2)3- CYCLOPENTYL))','X-RAY DIFFRACTION',2.400,'COMPLEX (TRANSFERASE/PEPTIDE)',2,2,1),(8,'1a1e','C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3- BUTYLPIPERIDINE)','X-RAY DIFFRACTION',2.200,'COMPLEX (TRANSFERASE/PEPTIDE)',2,2,1),(9,'1a1m','MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2','X-RAY DIFFRACTION',2.300,'COMPLEX (ANTIGEN/PEPTIDE)',1,1,1),(10,'1a1n','MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1','X-RAY DIFFRACTION',2.000,'COMPLEX (ANTIGEN/PEPTIDE)',1,1,1),(11,'1a1o','MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM','X-RAY DIFFRACTION',2.300,'COMPLEX (ANTIGEN/PEPTIDE)',1,1,1),(12,'1a1r','HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.500,'VIRAL PROTEIN',2,2,1),(13,'1a2c','STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A BLUE-GREEN ALGA','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(14,'1a2x','COMPLEX OF TROPONIN C WITH A 47 RESIDUE (1-47) FRAGMENT OF TROPONIN I','X-RAY DIFFRACTION',2.300,'COMPLEX (SKELETAL MUSCLE/MUSCLE PROTE',1,1,1),(15,'1a30','HIV-1 PROTEASE COMPLEXED WITH A TRIPEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(16,'1a3b','COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG1','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(17,'1a3e','COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG2','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(18,'1a3r','FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)','X-RAY DIFFRACTION',2.100,'VIRAL PROTEIN/IMMUNE SYSTEM',1,2,1),(19,'1a46','THROMBIN COMPLEXED WITH HIRUGEN AND A BETA-STRAND MIMETIC INHIBITOR','X-RAY DIFFRACTION',2.120,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(20,'1a4w','CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE-CONTAINING INHIBITORS: PROBES OF THE S1\' BINDING SITE','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(21,'1a5g','HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN','X-RAY DIFFRACTION',2.060,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(22,'1a61','THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(23,'1a7c','HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE','X-RAY DIFFRACTION',1.950,'HYDROLASE INHIBITOR/PEPTIDE',2,1,1),(24,'1a9e','DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS','X-RAY DIFFRACTION',2.500,'COMPLEX (MHC CLASS I/PEPTIDE)',1,1,1),(25,'1ab9','CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN','X-RAY DIFFRACTION',1.600,'COMPLEX (SERINE PROTEASE/PEPTIDE)',2,2,1),(26,'1abi','STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF THE S\' SUBSITES OF SUBSTRATES AND INHIBITORS','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(27,'1abj','STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF THE S\' SUBSITES OF SUBSTRATES AND INHIBITORS','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(28,'1abt','NMR SOLUTION STRUCTURE OF AN ALPHA-BUNGAROTOXIN(SLASH) NICOTINIC RECEPTOR PEPTIDE COMPLEX','SOLUTION NMR',NULL,'TOXIN',1,1,1),(29,'1ad8','COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(30,'1ae8','HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D-PHE-PRO-AZALYS-ONP','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(31,'1afe','HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO-AZALYS-ONP','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(32,'1afq','CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(33,'1agb','ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)','X-RAY DIFFRACTION',2.200,'HISTOCOMPATIBILITY COMPLEX',1,1,1),(34,'1agc','ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)','X-RAY DIFFRACTION',2.100,'HISTOCOMPATIBILITY COMPLEX',1,1,1),(35,'1agd','ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)','X-RAY DIFFRACTION',2.050,'HISTOCOMPATIBILITY COMPLEX',1,1,1),(36,'1age','ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)','X-RAY DIFFRACTION',2.300,'HISTOCOMPATIBILITY COMPLEX',1,1,1),(37,'1agf','ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)','X-RAY DIFFRACTION',2.200,'HISTOCOMPATIBILITY COMPLEX',1,1,1),(38,'1aht','CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND P-AMIDINOPHENYLPYRUVATE AT 1.6 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(39,'1ai8','HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROMPG','X-RAY DIFFRACTION',1.850,'BLOOD COAGULATION/HYDROLASE INHIBITOR',2,1,1),(40,'1aix','HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL','X-RAY DIFFRACTION',2.100,'BLOOD COAGULATION/HYDROLASE INHIBITOR',2,1,1),(41,'1akh','MAT A1/ALPHA2/DNA TERNARY COMPLEX','X-RAY DIFFRACTION',2.500,'DNA BINDING PROTEIN/DNA',1,1,1),(42,'1an1','LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX','X-RAY DIFFRACTION',2.030,'COMPLEX (SERINE PROTEASE/INHIBITOR)',1,1,1),(43,'1aot','NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (PROTO-ONCOGENE/EARLY PROTEIN',1,1,1),(44,'1aou','NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, 22 STRUCTURES','SOLUTION NMR',NULL,'COMPLEX (PROTO-ONCOGENE/EARLY PROTEIN',1,1,1),(45,'1apm','2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT','X-RAY DIFFRACTION',2.000,'TRANSFERASE(PHOSPHOTRANSFERASE)',1,1,1),(46,'1apt','CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(47,'1apu','CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(48,'1apv','CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(49,'1apw','CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(50,'1aqc','X11 PTB DOMAIN-10MER PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.300,'COMPLEX (PEPTIDE BINDING MODULE/PEPTI',2,2,1),(51,'1aqd','HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE','X-RAY DIFFRACTION',2.450,'COMPLEX (MHC PROTEIN/ANTIGEN)',4,8,1),(52,'1as4','CLEAVED ANTICHYMOTRYPSIN A349R','X-RAY DIFFRACTION',2.100,'SERPIN',1,1,1),(53,'1atp','2.2 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH MNATP AND A PEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.200,'TRANSFERASE(PHOSPHOTRANSFERASE)',1,1,1),(54,'1avf','ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH','X-RAY DIFFRACTION',2.360,'ASPARTYL PROTEASE',2,2,1),(55,'1aw8','PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE','X-RAY DIFFRACTION',2.200,'DECARBOXYLASE',2,2,1),(56,'1awf','NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(57,'1awi','HUMAN PLATELET PROFILIN COMPLEXED WITH THE L-PRO10 PEPTIDE','X-RAY DIFFRACTION',2.200,'COMPLEX (ACTIN-BINDING PROTEIN/PEPTID',1,2,1),(58,'1awq','CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER)','X-RAY DIFFRACTION',1.580,'COMPLEX (ISOMERASE/PEPTIDE)',1,1,1),(59,'1awr','CYPA COMPLEXED WITH HAGPIA','X-RAY DIFFRACTION',1.580,'COMPLEX (ISOMERASE/PEPTIDE)',6,6,1),(60,'1awu','CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER)','X-RAY DIFFRACTION',2.340,'COMPLEX (ISOMERASE/PEPTIDE)',1,1,1),(61,'1awv','CYPA COMPLEXED WITH HVGPIA','X-RAY DIFFRACTION',2.340,'COMPLEX (ISOMERASE/PEPTIDE)',6,6,1),(62,'1axd','STRUCTURE OF GLUTATHIONE S-TRANSFERASE-I BOUND WITH THE LIGAND LACTOYLGLUTATHIONE','X-RAY DIFFRACTION',2.500,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(63,'1ay6','THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(64,'1aya','CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO- TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE','X-RAY DIFFRACTION',2.050,'HYDROLASE(SH2 DOMAIN)',2,2,1),(65,'1ayc','CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO- TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE','X-RAY DIFFRACTION',2.300,'HYDROLASE(SH2 DOMAIN)',1,1,1),(66,'1aym','HUMAN RHINOVIRUS 16 COAT PROTEIN AT HIGH RESOLUTION','X-RAY DIFFRACTION',2.150,'VIRUS',1,2,1),(67,'1b05','STRUCTURE OF OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYS-CYS-LYS','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(68,'1b0g','CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX','X-RAY DIFFRACTION',2.500,'HISTOCOMPATIBILITY ANTIGEN',2,2,1),(69,'1b0h','OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- NAPTHYLALANYL-LYSINE','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(70,'1b0n','SINR PROTEIN/SINI PROTEIN COMPLEX','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION REGULATOR',1,1,1),(71,'1b1h','OLIGO-PEPTIDE BINDING PROTEIN/TRIPEPTIDE (LYS HPE LYS) COMPLEX','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(72,'1b2h','OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL-ORNITHYL-LYSINE','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(73,'1b32','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KMK','X-RAY DIFFRACTION',1.750,'PEPTIDE BINDING PROTEIN',1,1,1),(74,'1b3f','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KHK','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(75,'1b3g','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KIK','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(76,'1b3h','OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- CYCLOHEXYLALANYL-LYSINE','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(77,'1b3l','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KGK','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',2,2,1),(78,'1b40','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KFK','X-RAY DIFFRACTION',2.200,'PEPTIDE BINDING PROTEIN',1,1,1),(79,'1b46','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KPK','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(80,'1b4h','OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- DIAMINOBUTYRIC ACID-LYSINE','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(81,'1b4z','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KDK','X-RAY DIFFRACTION',1.750,'PEPTIDE  BINDING PROTEIN',1,1,1),(82,'1b51','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KSK','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(83,'1b52','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KTK','X-RAY DIFFRACTION',2.300,'PEPTIDE  BINDING PROTEIN',1,1,1),(84,'1b58','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KYK','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(85,'1b5g','HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN','X-RAY DIFFRACTION',2.070,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(86,'1b5h','OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL-DIAMINOPROPANOIC ACID-LYSINE','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(87,'1b5i','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KNK','X-RAY DIFFRACTION',1.900,'PEPTIDE  BINDING PROTEIN',1,1,1),(88,'1b5j','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KQK','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(89,'1b6h','OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL-NORVALYL- LYSINE','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(90,'1b6j','HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(91,'1b7h','OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- NORLEUCYL-LYSINE','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(92,'1b7x','STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D- PHE-PRO-ARG-CHLOROMETHYLKETONE','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(93,'1b8d','CRYSTAL STRUCTURE OF A PHYCOUROBILIN-CONTAINING PHYCOERYTHRIN','X-RAY DIFFRACTION',1.900,'PHOTOSYNTHESIS',1,2,1),(94,'1b8q','SOLUTION STRUCTURE OF THE EXTENDED NEURONAL NITRIC OXIDE SYNTHASE PDZ DOMAIN COMPLEXED WITH AN ASSOCIATED PEPTIDE','SOLUTION NMR',NULL,'OXIDOREDUCTASE',1,1,1),(95,'1b9j','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KLK','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(96,'1ba8','THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(97,'1bb0','THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(98,'1bbr','THE STRUCTURE OF RESIDUES 7-16 OF THE A ALPHA CHAIN OF HUMAN FIBRINOGEN BOUND TO BOVINE THROMBIN AT 2.3 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.300,'SERINE PROTEASE',6,4,1),(99,'1bc5','CHEMOTAXIS RECEPTOR RECOGNITION BY PROTEIN METHYLTRANSFERASE CHER','X-RAY DIFFRACTION',2.200,'COMPLEX (METHYLTRANSFERASE/PEPTIDE)',1,1,1),(100,'1bck','HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORIN','X-RAY DIFFRACTION',1.800,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(101,'1bcr','COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, ANTIPAIN, AND ARGININE AT ROOM TEMPERATURE','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(102,'1bcs','COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, CHYMOSTATIN, AND ARGININE AT 100 DEGREES KELVIN','X-RAY DIFFRACTION',2.080,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(103,'1bcu','ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(104,'1bd2','COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201','X-RAY DIFFRACTION',2.500,'COMPLEX (MHC/VIRAL PEPTIDE/RECEPTOR)',1,3,1),(105,'1be9','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM CRIPT.','X-RAY DIFFRACTION',1.820,'PEPTIDE RECOGNITION',1,1,1),(106,'1bhf','P56LCK SH2 DOMAIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(107,'1bhx','X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357','X-RAY DIFFRACTION',2.300,'SERINE PROTEASE',2,2,1),(108,'1bii','THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110','X-RAY DIFFRACTION',2.400,'COMPLEX (MHC I/PEPTIDE)',1,1,1),(109,'1bjr','COMPLEX FORMED BETWEEN PROTEOLYTICALLY GENERATED LACTOFERRIN FRAGMENT AND PROTEINASE K','X-RAY DIFFRACTION',2.440,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(110,'1bll','X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE STRUCTURE OF BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH AMASTATIN: FORMULATION OF A CATALYTIC MECHANISM FEATURING A GEM-DIOLATE TRANSITION STATE','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(111,'1bm2','GRB2-SH2 DOMAIN IN COMPLEX WITH CYCLO-[N-ALPHA-ACETYL-L-THI ALYSYL-O-PHOSPHOTYROSYL-VALYL-ASPARAGYL-VALYL-PROLYL] (PKF273-791)','X-RAY DIFFRACTION',2.100,'HORMONE/GROWTH FACTOR',1,1,1),(112,'1bmb','GRB2-SH2 DOMAIN IN COMPLEX WITH KPFY*VNVEF (PKF270-974)','X-RAY DIFFRACTION',1.800,'HORMONE/GROWTH FACTOR',1,1,1),(113,'1bqp','THE STRUCTURE OF THE PEA LECTIN-D-MANNOPYRANOSE COMPLEX','X-RAY DIFFRACTION',2.100,'PLANT PROTEIN',2,2,1),(114,'1bs6','PEPTIDE DEFORMYLASE AS NI2+ CONTAINING FORM IN COMPLEX WITH TRIPEPTIDE MET-ALA-SER','X-RAY DIFFRACTION',2.100,'HYDROLASE',3,3,1),(115,'1bs8','PEPTIDE DEFORMYLASE AS ZN2+ CONTAINING FORM IN COMPLEX WITH TRIPEPTIDE MET-ALA-SER','X-RAY DIFFRACTION',2.200,'HYDROLASE',3,3,1),(116,'1bt6','P11 (S100A10), LIGAND OF ANNEXIN II IN COMPLEX WITH ANNEXIN II N-TERMINUS','X-RAY DIFFRACTION',2.400,'COMPLEX (LIGAND/ANNEXIN)',2,2,1),(117,'1bth','STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR','X-RAY DIFFRACTION',2.300,'COMPLEX (SERINE PROTEASE/INHIBITOR)',2,2,1),(118,'1bxl','STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (APOPTOSIS/PEPTIDE)',1,1,1),(119,'1bxp','SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, 20 STRUCTURES','SOLUTION NMR',NULL,'COMPLEX (TOXIN/PEPTIDE)',1,1,1),(120,'1bzh','CYCLIC PEPTIDE INHIBITOR OF HUMAN PTP1B','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(121,'1c1u','RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES','X-RAY DIFFRACTION',1.750,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(122,'1c1v','RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES','X-RAY DIFFRACTION',1.980,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(123,'1c1w','RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(124,'1c4u','SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(125,'1c4v','SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(126,'1c5f','CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A','X-RAY DIFFRACTION',2.470,'ISOMERASE/IMMUNOSUPPRESSANT',8,8,1),(127,'1c5l','STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR','X-RAY DIFFRACTION',1.470,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(128,'1c5n','STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(129,'1c5o','STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR','X-RAY DIFFRACTION',1.900,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(130,'1c5w','STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR','X-RAY DIFFRACTION',1.940,'BLOOD CLOTTING',1,1,1),(131,'1c5x','STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR','X-RAY DIFFRACTION',1.750,'BLOOD CLOTTING',1,1,1),(132,'1c5y','STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR','X-RAY DIFFRACTION',1.650,'BLOOD CLOTTING',1,1,1),(133,'1c5z','STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR','X-RAY DIFFRACTION',1.850,'BLOOD CLOTTING',1,1,1),(134,'1ca0','BOVINE CHYMOTRYPSIN COMPLEXED TO APPI','X-RAY DIFFRACTION',2.100,'COMPLEX (SERINE PROTEASE/INHIBITOR)',2,4,1),(135,'1ca8','THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(136,'1ca9','STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2','X-RAY DIFFRACTION',2.300,'TNF SIGNALING',2,3,1),(137,'1cdk','CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (E.C.2.7.1.37) (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(138,'1cdl','TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.000,'CALCIUM-BINDING PROTEIN',4,4,1),(139,'1cdm','MODULATION OF CALMODULIN PLASTICITY IN MOLECULAR RECOGNITION ON THE BASIS OF X-RAY STRUCTURES','X-RAY DIFFRACTION',2.000,'CALCIUM-BINDING PROTEIN',1,1,1),(140,'1ce1','1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,2,1),(141,'1cf0','HUMAN PLATELET PROFILIN COMPLEXED WITH AN L-PRO10- IODOTYROSINE PEPTIDE','X-RAY DIFFRACTION',2.200,'COMPLEX (ACTIN-BINDING PROTEIN/PEPTID',1,2,1),(142,'1cf4','CDC42/ACK GTPASE-BINDING DOMAIN COMPLEX','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(143,'1cfa','SOLUTION STRUCTURE OF A SEMI-SYNTHETIC C5A RECEPTOR ANTAGONIST AT PH 5.2, 303K, NMR, 20 STRUCTURES','SOLUTION NMR',NULL,'IMMUNE SYSTEM/INHIBITOR',1,1,1),(144,'1cff','NMR SOLUTION STRUCTURE OF A COMPLEX OF CALMODULIN WITH A BINDING PEPTIDE OF THE CA2+-PUMP','SOLUTION NMR',NULL,'CALMODULIN',1,1,1),(145,'1cho','CRYSTAL AND MOLECULAR STRUCTURES OF THE COMPLEX OF ALPHA-*CHYMOTRYPSIN WITH ITS INHIBITOR TURKEY OVOMUCOID THIRD DOMAIN AT 1.8 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(146,'1cjf','PROFILIN BINDS PROLINE-RICH LIGANDS IN TWO DISTINCT AMIDE BACKBONE ORIENTATIONS','X-RAY DIFFRACTION',2.300,'STRUCTURAL REGULATION PROTEIN',2,2,1),(147,'1cjr','X-RAY CRYSTALLOGRAPHIC STUDIES OF DENATURATION IN RIBONUCLEASE S','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(148,'1ckk','CALMODULIN/RAT CA2+/CALMODULIN DEPENDENT PROTEIN KINASE FRAGMENT','SOLUTION NMR',NULL,'CALMODULIN-PEPTIDE COMPLEX',1,1,1),(149,'1clv','YELLOW MEAL WORM ALPHA-AMYLASE IN COMPLEX WITH THE AMARANTH ALPHA- AMYLASE INHIBITOR','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(150,'1cm1','MOTIONS OF CALMODULIN-SINGLE-CONFORMER REFINEMENT','X-RAY DIFFRACTION',2.000,'COMPLEX (CALCIUM-BINDING/TRANSFERASE)',1,1,1),(151,'1cm4','MOTIONS OF CALMODULIN-FOUR-CONFORMER REFINEMENT','X-RAY DIFFRACTION',2.000,'CALCIUM-BINDING/TRANSFERASE',1,1,1),(152,'1cmi','STRUCTURE OF THE HUMAN PIN/LC8 DIMER WITH A BOUND PEPTIDE','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE/OXIDOREDUCTASE INHIBIT',2,2,1),(153,'1cmx','STRUCTURAL BASIS FOR THE SPECIFICITY OF UBIQUITIN C- TERMINAL HYDROLASES','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,2,1),(154,'1cn3','INTERACTION OF POLYOMAVIRUS INTERNAL PROTEIN VP2 WITH MAJOR CAPSID PROTEIN VP1 AND IMPLICATIONS FOR PARTICIPATION OF VP2 IN VIRAL ENTRY','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN',1,4,1),(155,'1co7','R117H MUTANT RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(156,'1cp3','CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(157,'1cpi','REGIOSELECTIVE STRUCTURAL AND FUNCTIONAL MIMICRY OF PEPTIDES. DESIGN OF HYDROLYTICALLY STABLE CYCLIC PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE','X-RAY DIFFRACTION',2.050,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(158,'1cqg','HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59-71 OF THE P50 SUBUNIT OF NFKB), NMR, 31 STRUCTURES','SOLUTION NMR',NULL,'COMPLEX (ELECTRON TRANSPORT/PEPTIDE)',1,1,1),(159,'1cqh','HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59-71 OF THE P50 SUBUNIT OF NFKB), NMR, MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (ELECTRON TRANSPORT/PEPTIDE)',1,1,1),(160,'1csb','CRYSTAL STRUCTURE OF CATHEPSIN B INHIBITED WITH CA030 AT 2.1 ANGSTROMS RESOLUTION: A BASIS FOR THE DESIGN OF SPECIFIC EPOXYSUCCINYL INHIBITORS','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(161,'1csy','SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF THE HIGH AFFINITY IMMUNOGLOBIN G RECEPTOR, NMR','SOLUTION NMR',NULL,'COMPLEX (PHOSPHOTRANSFERASE/PEPTIDE)',1,1,1),(162,'1csz','SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF THE HIGH AFFINITY IMMUNOGLOBIN G RECEPTOR, NMR','SOLUTION NMR',NULL,'COMPLEX (PHOSPHOTRANSFERASE/PEPTIDE)',1,1,1),(163,'1cvu','CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2','X-RAY DIFFRACTION',2.400,'OXIDOREDUCTASE/PEPTIDE',1,1,1),(164,'1cwa','X-RAY STRUCTURE OF A MONOMERIC CYCLOPHILIN A-CYCLOSPORIN A CRYSTAL COMPLEX AT 2.1 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.100,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(165,'1cwb','THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION FOR ITS ANOMALOUSLY HIGH IMMUNOSUPPRESSIVE ACTIVITY','X-RAY DIFFRACTION',2.200,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(166,'1cwc','IMPROVED BINDING AFFINITY FOR CYCLOPHILIN A BY A CYCLOSPORIN DERIVATIVE SINGLY MODIFIED AT ITS EFFECTOR DOMAIN','X-RAY DIFFRACTION',1.860,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(167,'1cwd','HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.250,'PHOSPHOTRANSFERASE/TRANSFERASE INHIBI',1,1,1),(168,'1cwe','HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSFERASE/PEPTIDE',2,2,1),(169,'1cwf','HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORIN','X-RAY DIFFRACTION',1.860,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(170,'1cwh','HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORIN','X-RAY DIFFRACTION',1.860,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(171,'1cwi','HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-(N-METHYL)-D-ALANINE CYCLOSPORIN','X-RAY DIFFRACTION',1.900,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(172,'1cwj','HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-S-METHYL-SARCOSINE CYCLOSPORIN','X-RAY DIFFRACTION',1.800,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(173,'1cwk','HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7-DIHYDRO)MEBMT 2-VAL 3-D-(2- S-METHYL)SARCOSINE CYCLOSPORIN','X-RAY DIFFRACTION',1.800,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(174,'1cwl','HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4-HYDROXY-MELEU CYCLOSPORIN','X-RAY DIFFRACTION',1.800,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(175,'1cwm','HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORIN','X-RAY DIFFRACTION',2.000,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(176,'1cwo','HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 CYCLOSPORIN','X-RAY DIFFRACTION',1.860,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(177,'1cyn','CYCLOPHILIN B COMPLEXED WITH [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN','X-RAY DIFFRACTION',1.850,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(178,'1czi','CHYMOSIN COMPLEX WITH THE INHIBITOR CP-113972','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(179,'1czy','CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE TRAF DOMAIN OF HUMAN TRAF2 AND AN LMP1 BINDING PEPTIDE','X-RAY DIFFRACTION',2.000,'APOPTOSIS',2,2,1),(180,'1d00','STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5- RESIDUE CD40 PEPTIDE','X-RAY DIFFRACTION',2.000,'APOPTOSIS',8,8,1),(181,'1d01','STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE','X-RAY DIFFRACTION',2.000,'APOPTOSIS',3,4,1),(182,'1d0a','STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE','X-RAY DIFFRACTION',2.000,'APOPTOSIS',6,6,1),(183,'1d0j','STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE','X-RAY DIFFRACTION',2.500,'APOPTOSIS',5,5,1),(184,'1d3d','CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZOTHIOPHENE INHIBITOR 4','X-RAY DIFFRACTION',2.040,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(185,'1d3p','CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 3','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(186,'1d4p','CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5- AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBITOR','X-RAY DIFFRACTION',2.070,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(187,'1d4t','CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH A SLAM PEPTIDE','X-RAY DIFFRACTION',1.100,'SIGNALING PROTEIN',1,1,1),(188,'1d4w','CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH SLAM PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',2,2,1),(189,'1d5d','THE ROLE OF PHENYLALANINE 8 IN THE STABILIZATION OF THE S PROTEIN-S PEPTIDE INTERACTION: PACKING AND CAVITIES','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(190,'1d5e','THE ROLE OF PHENYLALANINE 8 IN THE STABILIZATION OF THE S PROTEIN-S PEPTIDE INTERACTION: PACKING AND CAVITIES','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(191,'1d5g','SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E COMPLEXED WITH A PEPTIDE','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(192,'1d5h','RNASE S(F8A). MUTANT RIBONUCLEASE S.','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(193,'1d5m','X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/PEPTIDE INHIBITOR',1,2,1),(194,'1d5x','X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB','X-RAY DIFFRACTION',2.450,'IMMUNE SYSTEM/PEPTIDE INHIBITOR',1,2,1),(195,'1d5z','X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/PEPTIDE INHIBITOR',1,2,1),(196,'1d6e','CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB','X-RAY DIFFRACTION',2.450,'IMMUNE SYSTEM/PEPTIDE INHIBITOR',1,2,1),(197,'1d6w','STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTROPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(198,'1d7q','HUMAN TRANSLATION INITIATION FACTOR EIF1A','SOLUTION NMR',NULL,'GENE REGULATION',1,1,1),(199,'1d8d','CO-CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A K-RAS4B PEPTIDE SUBSTRATE AND FPP ANALOG AT 2.0A RESOLUTION','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,2,1),(200,'1d8t','CRYSTAL STRUCTURE OF ELONGATION FACTOR, TU (EF-TU-MGGDP) COMPLEXED WITH GE2270A, A THIAZOLYL PEPTIDE ANTIBIOTIC','X-RAY DIFFRACTION',2.350,'HYDROLASE/ANTIBIOTIC',2,2,1),(201,'1d9i','STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(202,'1dd3','CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L12 FROM THERMOTOGA MARITIMA','X-RAY DIFFRACTION',2.000,'RIBOSOME',2,2,1),(203,'1dd4','CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L12 FROM THERMOTOGA MARITIM','X-RAY DIFFRACTION',2.400,'RIBOSOME',2,2,1),(204,'1ddm','SOLUTION STRUCTURE OF THE NUMB PTB DOMAIN COMPLEXED TO A NAK PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN/TRANSFERASE',1,1,1),(205,'1ddv','CRYSTAL STRUCTURE OF THE HOMER EVH1 DOMAIN WITH BOUND MGLUR PEPTIDE','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN',1,1,1),(206,'1de7','INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA-THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE SUBSTRATE',4,2,1),(207,'1dev','CRYSTAL STRUCTURE OF SMAD2 MH2 DOMAIN BOUND TO THE SMAD-BINDING DOMAIN OF SARA','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN',2,2,1),(208,'1dit','COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(209,'1dkd','CRYSTAL STRUCTURE OF A GROEL (APICAL DOMAIN) AND A DODECAMERIC PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.100,'CHAPERONE',4,4,1),(210,'1dkx','THE SUBSTRATE BINDING DOMAIN OF DNAK IN COMPLEX WITH A SUBSTRATE PEPTIDE, DETERMINED FROM TYPE 1 SELENOMETHIONYL CRYSTALS','X-RAY DIFFRACTION',2.000,'COMPLEX (MOLECULAR CHAPERONE/PEPTIDE)',1,1,1),(211,'1dkz','THE SUBSTRATE BINDING DOMAIN OF DNAK IN COMPLEX WITH A SUBSTRATE PEPTIDE, DETERMINED FROM TYPE 1 NATIVE CRYSTALS','X-RAY DIFFRACTION',2.000,'COMPLEX (MOLECULAR CHAPERONE/PEPTIDE)',1,1,1),(212,'1dlk','CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR','X-RAY DIFFRACTION',2.140,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(213,'1dm4','SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7- 16)','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,1,1),(214,'1doj','CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN*RWJ-51438 COMPLEX AT 1.7 A','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(215,'1dow','CRYSTAL STRUCTURE OF A CHIMERA OF BETA-CATENIN AND ALPHA- CATENIN','X-RAY DIFFRACTION',1.800,'CELL ADHESION',1,1,1),(216,'1dp5','THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(217,'1dpj','THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(218,'1dpu','SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF HUMAN RPA32 COMPLEXED WITH UNG2(73-88)','SOLUTION NMR',NULL,'DNA BINDING PROTEIN',1,1,1),(219,'1dt7','SOLUTION STRUCTURE OF THE C-TERMINAL NEGATIVE REGULATORY DOMAIN OF P53 IN A COMPLEX WITH CA2+-BOUND S100B(BB)','SOLUTION NMR',NULL,'SIGNALING PROTEIN',2,2,1),(220,'1duy','CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',2,2,1),(221,'1duz','HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(222,'1dx5','CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',4,5,1),(223,'1dxp','INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (APO STRUCTURE)','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,2,1),(224,'1dy8','INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR II)','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(225,'1dy9','INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR I)','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(226,'1dzi','INTEGRIN ALPHA2 I DOMAIN / COLLAGEN COMPLEX','X-RAY DIFFRACTION',2.100,'INTEGRIN',3,1,1),(227,'1e0a','CDC42 COMPLEXED WITH THE GTPASE BINDING DOMAIN OF P21 ACTIVATED KINASE','SOLUTION NMR',NULL,'SIGNALLING PROTEIN/KINASE',1,1,1),(228,'1e27','NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI)','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(229,'1e4w','CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,2,1),(230,'1e4x','CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,4,1),(231,'1e54','ANION-SELECTIVE PORIN FROM COMAMONAS ACIDOVORANS','X-RAY DIFFRACTION',2.100,'OUTER MEMBRANE PROTEIN',1,1,1),(232,'1e6i','BROMODOMAIN FROM GCN5 COMPLEXED WITH ACETYLATED H4 PEPTIDE','X-RAY DIFFRACTION',1.870,'GENE REGULATION',1,1,1),(233,'1e79','BOVINE F1-ATPASE INHIBITED BY DCCD (DICYCLOHEXYLCARBODIIMIDE)','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,2,1),(234,'1e8n','PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH PEPTIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(235,'1e91','STRUCTURE OF THE COMPLEX OF THE MAD1-SIN3B INTERACTION DOMAINS','SOLUTION NMR',NULL,'EUKARYOTIC TRANSCRIPTIONAL REGULATION',1,1,1),(236,'1eb1','COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N-METHYL-ARGININE INHIBITOR','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(237,'1ee4','CRYSTAL STRUCTURE OF YEAST KARYOPHERIN (IMPORTIN) ALPHA IN A COMPLEX WITH A C-MYC NLS PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN',4,2,1),(238,'1ee5','YEAST KARYOPHERIN (IMPORTIN) ALPHA IN A COMPLEX WITH A NUCLEOPLASMIN NLS PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSPORT PROTEIN',1,1,1),(239,'1een','CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-D-A-D-BPA-PTYR-L-I-P-Q-Q-G','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(240,'1eeo','CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-E-L-E-F-PTYR-M-D-Y-E-NH2','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(241,'1ees','SOLUTION STRUCTURE OF CDC42HS COMPLEXED WITH A PEPTIDE DERIVED FROM P-21 ACTIVATED KINASE, NMR, 20 STRUCTURES','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(242,'1eey','CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',2,2,1),(243,'1eez','CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(244,'1eg4','STRUCTURE OF A DYSTROPHIN WW DOMAIN FRAGMENT IN COMPLEX WITH A BETA-DYSTROGLYCAN PEPTIDE','X-RAY DIFFRACTION',2.000,'STRUCTURAL PROTEIN',1,1,1),(245,'1ehk','CRYSTAL STRUCTURE OF THE ABERRANT BA3-CYTOCHROME-C OXIDASE FROM THERMUS THERMOPHILUS','X-RAY DIFFRACTION',2.400,'OXIDOREDUCTASE',1,2,1),(246,'1ej4','COCRYSTAL STRUCTURE OF EIF4E/4E-BP1 PEPTIDE','X-RAY DIFFRACTION',2.250,'TRANSLATION',1,1,1),(247,'1ejh','EIF4E/EIF4G PEPTIDE/7-METHYL-GDP','X-RAY DIFFRACTION',2.200,'TRANSLATION',4,4,1),(248,'1ejo','FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G- H LOOP FROM FMDV.','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(249,'1ekb','THE SERINE PROTEASE DOMAIN OF ENTEROPEPTIDASE BOUND TO INHIBITOR VAL- ASP-ASP-ASP-ASP-LYS-CHLOROMETHANE','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(250,'1elr','CRYSTAL STRUCTURE OF THE TPR2A DOMAIN OF HOP IN COMPLEX WITH THE HSP90 PEPTIDE MEEVD','X-RAY DIFFRACTION',1.900,'CHAPERONE',1,1,1),(251,'1elw','CRYSTAL STRUCTURE OF THE TPR1 DOMAIN OF HOP IN COMPLEX WITH A HSC70 PEPTIDE','X-RAY DIFFRACTION',1.600,'CHAPERONE',2,2,1),(252,'1emu','STRUCTURE OF THE AXIN RGS-HOMOLOGOUS DOMAIN IN COMPLEX WITH A SAMP REPEAT FROM APC','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN',1,1,1),(253,'1eoj','DESIGN OF P1\' AND P3\' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(254,'1eol','DESIGN OF P1\' AND P3\' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(255,'1epl','A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(256,'1epm','A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(257,'1ept','REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN','X-RAY DIFFRACTION',1.800,'HYDROLASE (SERINE PROTEASE)',1,2,1),(258,'1er8','THE ACTIVE SITE OF ASPARTIC PROTEINASES','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(259,'1etr','REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(260,'1ets','REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(261,'1ett','REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(262,'1evh','EVH1 DOMAIN FROM MURINE ENABLED IN COMPLEX WITH ACTA PEPTIDE','X-RAY DIFFRACTION',1.800,'CONTRACTILE PROTEIN',1,1,1),(263,'1eyx','CRYSTAL STRUCTURE OF R-PHYCOERYTHRIN AT 2.2 ANGSTROMS','X-RAY DIFFRACTION',2.250,'PHOTOSYNTHESIS',2,2,1),(264,'1f0c','STRUCTURE OF THE VIRAL SERPIN CRMA','X-RAY DIFFRACTION',2.260,'VIRAL PROTEIN',1,1,1),(265,'1f1j','CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP- CHO','X-RAY DIFFRACTION',2.350,'APOPTOSIS, HYDROLASE/HYDROLASE INHIBI',2,2,1),(266,'1f1w','SRC SH2 THREF1TRP MUTANT COMPLEXED WITH THE PHOSPHOPEPTIDE S(PTR)VNVQN','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(267,'1f2s','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(268,'1f3r','COMPLEX BETWEEN FV ANTIBODY FRAGMENT AND AN ANALOGUE OF THE MAIN IMMUNOGENIC REGION OF THE ACETYLCHOLINE RECEPTOR','SOLUTION NMR',NULL,'IMMUNE SYSTEM',1,1,1),(269,'1f47','THE BACTERIAL CELL-DIVISION PROTEIN ZIPA AND ITS INTERACTION WITH AN FTSZ FRAGMENT REVEALED BY X-RAY CRYSTALLOGRAPHY','X-RAY DIFFRACTION',1.950,'CELL CYCLE',1,1,1),(270,'1f4v','CRYSTAL STRUCTURE OF ACTIVATED CHEY BOUND TO THE N-TERMINUS OF FLIM','X-RAY DIFFRACTION',2.220,'SIGNALING PROTEIN',3,3,1),(271,'1f58','IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323','X-RAY DIFFRACTION',2.000,'VIRAL PROTEIN/IMMUNE SYSTEM',1,2,1),(272,'1f7a','HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE.','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,2,1),(273,'1f8a','STRUCTURAL BASIS FOR THE PHOSPHOSERINE-PROLINE RECOGNITION BY GROUP IV WW DOMAINS','X-RAY DIFFRACTION',1.840,'ISOMERASE',1,1,1),(274,'1f8h','STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15 IN COMPLEX WITH PTGSSSTNPFR','SOLUTION NMR',NULL,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(275,'1f95','SOLUTION STRUCTURE OF DYNEIN LIGHT CHAIN 8 (DLC8) AND BIM PEPTIDE COMPLEX','SOLUTION NMR',NULL,'CONTRACTILE PROTEIN/PEPTIDE',2,2,1),(276,'1f96','SOLUTION STRUCTURE OF DYNEIN LIGHT CHAIN 8 (DLC8) AND NNOS PEPTIDE COMPLEX','SOLUTION NMR',NULL,'INHIBITOR/OXIDOREDUCTASE',2,2,1),(277,'1fch','CRYSTAL STRUCTURE OF THE PTS1 COMPLEXED TO THE TPR REGION OF HUMAN PEX5','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN',2,2,1),(278,'1fev','CRYSTAL STRUCTURE OF THE ALA4AIB MUTATION IN RNASE S','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(279,'1ff1','STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15 IN COMPLEX WITH PTGSSSTNPFL','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(280,'1fgl','CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF HIV-1 GAG PROTEIN','X-RAY DIFFRACTION',1.800,'ISOMERASE/VIRAL PROTEIN',1,1,1),(281,'1fhr','SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(282,'1fi8','RAT GRANZYME B [N66Q] COMPLEXED TO ECOTIN [81-84 IEPD]','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(283,'1fiv','STRUCTURE OF AN INHIBITOR COMPLEX OF PROTEINASE FROM FELINE IMMUNODEFICIENCY VIRUS','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(284,'1fiw','THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(285,'1fjm','PROTEIN SERINE/THREONINE PHOSPHATASE-1 (ALPHA ISOFORM, TYPE 1) COMPLEXED WITH MICROCYSTIN-LR TOXIN','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(286,'1fkn','STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(287,'1fle','CRYSTAL STRUCTURE OF ELAFIN COMPLEXED WITH PORCINE PANCREATIC ELASTASE','X-RAY DIFFRACTION',1.900,'COMPLEX (SERINE PROTEASE/INHIBITOR)',1,1,1),(288,'1fm6','THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',4,4,1),(289,'1fm9','THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES.','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(290,'1fmo','CRYSTAL STRUCTURE OF A POLYHISTIDINE-TAGGED RECOMBINANT CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH THE PEPTIDE INHIBITOR PKI(5-24) AND ADENOSINE','X-RAY DIFFRACTION',2.200,'COMPLEX (PHOSPHOTRANSFERASE/INHIBITOR',1,1,1),(291,'1fn8','FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',0.810,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(292,'1fo0','MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,3,1),(293,'1fpc','ACTIVE SITE MIMETIC INHIBITION OF THROMBIN','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(294,'1fph','THE INTERACTION OF THROMBIN WITH FIBRINOGEN: A STRUCTURAL BASIS FOR ITS SPECIFICITY','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(295,'1fpr','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN THE CATALYTIC DOMAIN OF SHP-1 AND AN IN VITRO PEPTIDE SUBSTRATE PY469 DERIVED FROM SHPS-1.','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',1,1,1),(296,'1fqj','CRYSTAL STRUCTURE OF THE HETEROTRIMERIC COMPLEX OF THE RGS DOMAIN OF RGS9, THE GAMMA SUBUNIT OF PHOSPHODIESTERASE AND THE GT/I1 CHIMERA ALPHA SUBUNIT [(RGS9)-(PDEGAMMA)-(GT/I1ALPHA)-(GDP)-(ALF4-)-(MG2+)]','X-RAY DIFFRACTION',2.020,'SIGNALING PROTEIN',1,3,1),(297,'1fs1','INSIGHTS INTO SCF UBIQUITIN LIGASES FROM THE STRUCTURE OF THE SKP1-SKP2 COMPLEX','X-RAY DIFFRACTION',1.800,'LIGASE',2,2,1),(298,'1fse','CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS REGULATORY PROTEIN GERE','X-RAY DIFFRACTION',2.050,'TRANSCRIPTION',1,2,1),(299,'1fu5','NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3- KINASE COMPLEXED TO A DOUBLY PHOSPHORYLATED PEPTIDE DERIVED FROM POLYOMAVIRUS MIDDLE T ANTIGEN','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN',1,1,1),(300,'1fv1','STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,4,1),(301,'1fy4','FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',0.810,'HYDROLASE',1,1,1),(302,'1fy5','FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',0.810,'HYDROLASE',1,1,1),(303,'1fyn','PHOSPHOTRANSFERASE','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(304,'1fyr','DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX','X-RAY DIFFRACTION',2.400,'HORMONE/GROWTH FACTOR',4,4,1),(305,'1fzc','CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS','X-RAY DIFFRACTION',2.300,'BLOOD COAGULATION',4,4,1),(306,'1fzg','CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE','X-RAY DIFFRACTION',2.500,'BLOOD COAGULATION',4,4,1),(307,'1fzj','MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(308,'1fzk','MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(309,'1fzm','MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(310,'1fzo','MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(311,'1g0v','THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(312,'1g1e','NMR STRUCTURE OF THE HUMAN MAD1 TRANSREPRESSION DOMAIN SID IN COMPLEX WITH MAMMALIAN SIN3A PAH2 DOMAIN','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(313,'1g1f','CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A TRI-PHOSPHORYLATED PEPTIDE (RDI(PTR) ETD(PTR)(PTR)RK) FROM THE INSULIN RECEPTOR KINASE','X-RAY DIFFRACTION',2.000,'HYDROLASE, SIGNALING PROTEIN',1,1,1),(314,'1g1g','CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A MONO-PHOSPHORYLATED PEPTIDE (ETDY(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE','X-RAY DIFFRACTION',2.200,'HYDROLASE, SIGNALING PROTEIN',1,1,1),(315,'1g1h','CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A BIS-PHOSPHORYLATED PEPTIDE (ETD(PTR)(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE','X-RAY DIFFRACTION',2.400,'HYDROLASE, SIGNALING PROTEIN',1,1,1),(316,'1g1s','P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM, MEMBRANE PROTEIN',2,2,1),(317,'1g30','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(318,'1g32','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(319,'1g37','CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(320,'1g3f','NMR STRUCTURE OF A 9 RESIDUE PEPTIDE FROM SMAC/DIABLO COMPLEXED TO THE BIR3 DOMAIN OF XIAP','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(321,'1g3j','CRYSTAL STRUCTURE OF THE XTCF3-CBD/BETA-CATENIN ARMADILLO REPEAT COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(322,'1g5j','COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(323,'1g65','CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(324,'1g6g','X-RAY STRUCTURE OF THE N-TERMINAL FHA DOMAIN FROM S. CEREVISIAE RAD53P IN COMPLEX WITH A PHOSPHOTHREONINE PEPTIDE AT 1.6 A RESOLUTION','X-RAY DIFFRACTION',1.600,'CELL CYCLE',2,2,1),(325,'1g7p','CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(326,'1g7q','CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(327,'1g9i','CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(328,'1ga6','CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH A FRAGMENT OF TYROSTATIN (THIS ENZYME RENAMED \"SEDOLISIN\" IN 2003)','X-RAY DIFFRACTION',1.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(329,'1gbb','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(330,'1gbc','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(331,'1gbd','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(332,'1gbf','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(333,'1gbh','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(334,'1gbi','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(335,'1gbk','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID','X-RAY DIFFRACTION',2.130,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(336,'1gbl','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(337,'1gbm','ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID','X-RAY DIFFRACTION',2.280,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(338,'1gbr','ORIENTATION OF PEPTIDE FRAGMENTS FROM SOS PROTEINS BOUND TO THE N-TERMINAL SH3 DOMAIN OF GRB2 DETERMINED BY NMR SPECTROSCOPY','SOLUTION NMR',NULL,'SIGNAL TRANSDUCTION PROTEIN',1,1,1),(339,'1gct','IS GAMMA-CHYMOTRYPSIN A TETRAPEPTIDE ACYL-ENZYME ADDUCT OF GAMMA- CHYMOTRYPSIN?','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',2,2,1),(340,'1gd2','CRYSTAL STRUCTURE OF BZIP TRANSCRIPTION FACTOR PAP1 BOUND TO DNA','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/DNA',1,1,1),(341,'1gdn','FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',0.810,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(342,'1gdu','FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',1.070,'HYDROLASE',1,1,1),(343,'1gec','GLYCYL ENDOPEPTIDASE-COMPLEX WITH BENZYLOXYCARBONYL-LEUCINE-VALINE- GLYCINE-METHYLENE COVALENTLY BOUND TO CYSTEINE 25','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(344,'1gg6','CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-PHENYLALANINE TRIFLUOROMETHYL KETONE BOUND AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(345,'1ggd','CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-LEUCIL- PHENYLALANINE ALDEHYDE BOUND AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(346,'1gha','A SECOND ACTIVE SITE IN CHYMOTRYPSIN? THE X-RAY CRYSTAL STRUCTURE OF N-ACETYL-D-TRYPTOPHAN BOUND TO GAMMA-CHYMOTRYPSIN','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(347,'1ghb','A SECOND ACTIVE SITE IN CHYMOTRYPSIN? THE X-RAY CRYSTAL STRUCTURE OF N-ACETYL-D-TRYPTOPHAN BOUND TO GAMMA-CHYMOTRYPSIN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(348,'1ghv','A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(349,'1ghw','A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(350,'1ghx','A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(351,'1ghy','A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(352,'1gi7','A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.790,'BLOOD CLOTTING, HYDROLASE',1,1,1),(353,'1gi8','A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.750,'BLOOD CLOTTING, HYDROLASE',1,1,1),(354,'1gi9','A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE','X-RAY DIFFRACTION',1.800,'BLOOD CLOTTING, HYDROLASE',1,1,1),(355,'1gj4','SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN','X-RAY DIFFRACTION',1.810,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(356,'1gj5','SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN','X-RAY DIFFRACTION',1.730,'BLOOD CLOTTING,HYDROLASE/INHIBITOR',2,1,1),(357,'1gj7','ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS','X-RAY DIFFRACTION',1.500,'BLOOD CLOTTING, HYDROLASE',1,1,1),(358,'1gj8','ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS','X-RAY DIFFRACTION',1.640,'BLOOD CLOTTING, HYDROLASE',1,1,1),(359,'1gj9','ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS','X-RAY DIFFRACTION',1.800,'BLOOD CLOTTING, HYDROLASE',1,1,1),(360,'1gja','ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS','X-RAY DIFFRACTION',1.560,'BLOOD CLOTTING, HYDROLASE',1,1,1),(361,'1gjb','ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS','X-RAY DIFFRACTION',1.900,'BLOOD CLOTTING, HYDROLASE',1,1,1),(362,'1gjc','ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS','X-RAY DIFFRACTION',1.730,'BLOOD CLOTTING, HYDROLASE',1,1,1),(363,'1gjd','ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS','X-RAY DIFFRACTION',1.750,'BLOOD CLOTTING, HYDROLASE',1,1,1),(364,'1gl1','STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA','X-RAY DIFFRACTION',2.100,'HYDROLASE/INHIBITOR',3,3,1),(365,'1gmc','THE X-RAY CRYSTAL STRUCTURE OF THE TETRAHEDRAL INTERMEDIATE OF GAMMA- CHYMOTRYPSIN IN HEXANE','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(366,'1gmd','X-RAY CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN IN HEXANE','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(367,'1gmh','REFINED CRYSTAL STRUCTURE OF \"AGED\" AND \"NON-AGED\" ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN','X-RAY DIFFRACTION',2.100,'HYDROLASE(SERINE PROTEINASE)',1,2,1),(368,'1gtj','CRYSTAL STRUCTURE OF THE THERMOSTABLE SERINE-CARBOXYL TYPE PROTEINASE, KUMAMOLISIN (KSCP) - COMPLEX WITH AC-ILE-ALA-PHE-CHO','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(369,'1guw','STRUCTURE OF THE CHROMODOMAIN FROM MOUSE HP1BETA IN COMPLEX WITH THE LYSINE 9-METHYL HISTONE H3 N-TERMINAL PEPTIDE, NMR, 25 STRUCTURES','SOLUTION NMR',NULL,'CHROMATIN-BINDING',1,1,1),(370,'1gux','RB POCKET BOUND TO E7 LXCXE MOTIF','X-RAY DIFFRACTION',1.850,'COMPLEX (TRANSCRIPTION REG/PEPTIDE)',1,1,1),(371,'1gvk','PORCINE PANCREATIC ELASTASE ACYL ENZYME AT 0.95 A RESOLUTION','X-RAY DIFFRACTION',0.940,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(372,'1gvu','ENDOTHIAPEPSIN COMPLEX WITH H189','X-RAY DIFFRACTION',0.940,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(373,'1gvx','ENDOTHIAPEPSIN COMPLEXED WITH H256','X-RAY DIFFRACTION',1.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(374,'1gwq','HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE','X-RAY DIFFRACTION',2.450,'NUCLEAR RECEPTOR',2,2,1),(375,'1gwr','HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE','X-RAY DIFFRACTION',2.400,'NUCLEAR RECEPTOR',2,2,1),(376,'1gyb','N77Y POINT MUTANT OF YNTF2 BOUND TO FXFG NUCLEOPORIN REPEAT','X-RAY DIFFRACTION',1.900,'NUCLEAR TRANSPORT',4,4,1),(377,'1h0g','COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGADIN FROM CLONOSTACHYS','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(378,'1h24','CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F','X-RAY DIFFRACTION',2.500,'TRANSFERASE',1,1,1),(379,'1h25','CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN','X-RAY DIFFRACTION',2.500,'TRANSFERASE',1,1,1),(380,'1h26','CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53','X-RAY DIFFRACTION',2.240,'CELL CYCLE',1,1,1),(381,'1h27','CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(382,'1h2k','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION ACTIVATOR/INHIBITOR',1,1,1),(383,'1h2l','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION ACTIVATOR/INHIBITOR',1,1,1),(384,'1h2m','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION ACTIVATOR/INHIBITOR',1,1,1),(385,'1h3h','STRUCTURAL BASIS FOR SPECIFIC RECOGNITION OF AN RXXK-CONTAINING SLP-76 PEPTIDE BY THE GADS C-TERMINAL SH3 DOMAIN','SOLUTION NMR',NULL,'PROTEIN-BINDING',1,1,1),(386,'1h3o','CRYSTAL STRUCTURE OF THE HUMAN TAF4-TAF12 (TAFII135-TAFII20) COMPLEX','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION/TBP-ASSOCIATED FACTORS',2,2,1),(387,'1h6w','CRYSTAL STRUCTURE OF A HEAT- AND PROTEASE-STABLE FRAGMENT OF THE BACTERIOPHAGE T4 SHORT FIBRE','X-RAY DIFFRACTION',1.900,'STRUCTURAL PROTEIN',1,1,1),(388,'1h8b','EF-HANDS 3,4 FROM ALPHA-ACTININ / Z-REPEAT 7 FROM TITIN','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(389,'1h8d','X-RAY STRUCTURE OF THE HUMAN ALPHA-THROMBIN COMPLEX WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(390,'1h8e','(ADP.ALF4)2(ADP.SO4) BOVINE F1-ATPASE (ALL THREE CATALYTIC SITES OCCUPIED)','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,2,1),(391,'1h8i','X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(392,'1h9h','COMPLEX OF EETI-II WITH PORCINE TRYPSIN','X-RAY DIFFRACTION',1.500,'HYDROLASE INHIBITOR',1,1,1),(393,'1h9i','COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN','X-RAY DIFFRACTION',1.900,'HYDROLASE/INHIBITOR',1,1,1),(394,'1h9l','PORCINE PANCREATIC ELASTASE COMPLEXED WITH ACETYL-VAL-GLU-PRO-ILE-COOH','X-RAY DIFFRACTION',1.670,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(395,'1h9o','PHOSPHATIDYLINOSITOL 3-KINASE, P85-ALPHA SUBUNIT: C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE FROM THE PDGF RECEPTOR, CRYSTAL STRUCTURE AT 1.79 A','X-RAY DIFFRACTION',1.790,'TRANSFERASE/RECEPTOR',1,1,1),(396,'1haa','A BETA-HAIRPIN STRUCTURE IN A 13-MER PEPTIDE THAT BINDS A-BUNGAROTOXIN WITH HIGH AFFINITY AND NEUTRALIZES ITS TOXICITY','SOLUTION NMR',NULL,'TOXIN/PEPTIDE',1,1,1),(397,'1hag','THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK- THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(398,'1hah','THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK- THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN','X-RAY DIFFRACTION',2.300,'COMPLEX(SERINE PROTEINASE/INHIBITOR)',2,1,1),(399,'1hai','THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK- THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(400,'1haj','A BETA-HAIRPIN STRUCTURE IN A 13-MER PEPTIDE THAT BINDS A-BUNGAROTOXIN WITH HIGH AFFINITY AND NEUTRALIZES ITS TOXICITY','SOLUTION NMR',NULL,'TOXIN/PEPTIDE',1,1,1),(401,'1hax','SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (A) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 AT PH 5','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(402,'1haz','SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (C) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 9 FOR 1 MINUTE','X-RAY DIFFRACTION',1.400,'SERINE PROTEINASE/HYDROLASE SUBSTRATE',1,1,1),(403,'1hbt','HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(404,'1hc9','ALPHA-BUNGAROTOXIN COMPLEXED WITH HIGH AFFINITY PEPTIDE','X-RAY DIFFRACTION',1.800,'TOXIN/PEPTIDE',2,2,1),(405,'1hcs','NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX','SOLUTION NMR',NULL,'COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)',1,1,1),(406,'1hct','NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX','SOLUTION NMR',NULL,'COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)',1,1,1),(407,'1hef','THE CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF HYDROXYETHYLENE- BASED INHIBITORS BOUND TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE SHOW THAT THE INHIBITORS ARE PRESENT IN TWO DISTINCT ORIENTATIONS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(408,'1hgt','STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA- THROMBIN','X-RAY DIFFRACTION',2.200,'HYDROLASE(SERINE PROTEASE)',2,1,1),(409,'1hhi','THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2','X-RAY DIFFRACTION',2.500,'HISTOCOMPATIBILITY ANTIGEN',2,2,1),(410,'1hhj','THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2','X-RAY DIFFRACTION',2.500,'HISTOCOMPATIBILITY ANTIGEN',2,2,1),(411,'1hhk','THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2','X-RAY DIFFRACTION',2.500,'HISTOCOMPATIBILITY ANTIGEN',2,2,1),(412,'1hia','KALLIKREIN COMPLEXED WITH HIRUSTASIN','X-RAY DIFFRACTION',2.400,'COMPLEX (PROTEASE/INHIBITOR)',2,4,1),(413,'1hja','LYS 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH ALPHA-CHYMOTRYPSIN','X-RAY DIFFRACTION',2.300,'COMPLEX (HYDROLASE/INHIBITOR)',1,2,1),(414,'1hkd','STRUCTURE OF PEA LECTIN IN COMPLEX WITH ALPHA-METHYL-D-GLUCOPYRANOSIDE','X-RAY DIFFRACTION',2.090,'PLANT LECTIN',2,2,1),(415,'1hle','CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.950,'HYDROLASE INHIBITOR(SERINE PROTEINASE',1,1,1),(416,'1hne','STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A PEPTIDE CHLOROMETHYL KETONE INHIBITOR AT 1.84-ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.840,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(417,'1hoc','THE THREE-DIMENSIONAL STRUCTURE OF H-2DB AT 2.4 ANGSTROMS RESOLUTION: IMPLICATIONS FOR ANTIGEN-DETERMINANT SELECTION','X-RAY DIFFRACTION',2.400,'HISTOCOMPATIBILITY ANTIGEN',1,1,1),(418,'1hoy','NMR STRUCTURE OF THE COMPLEX BETWEEN A-BUNGAROTOXIN AND A MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR','SOLUTION NMR',NULL,'TOXIN',1,1,1),(419,'1hpg','A GLUTAMIC ACID SPECIFIC SERINE PROTEASE UTILIZES A NOVEL HISTIDINE TRIAD IN SUBSTRATE BINDING','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(420,'1hqq','MINIPROTEIN MP-2 (M9A) COMPLEX WITH STREPTAVIDIN','X-RAY DIFFRACTION',1.700,'UNKNOWN FUNCTION',4,4,1),(421,'1hqw','CRYSTAL STRUCTURE OF THE COMPLEX OF CONCANAVALIN A WITH A TRIPEPTIDE YPY','X-RAY DIFFRACTION',2.400,'LECTIN BINDING',1,1,1),(422,'1hsa','THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC','X-RAY DIFFRACTION',2.100,'HISTOCOMPATIBILITY ANTIGEN',2,2,1),(423,'1hsb','DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(424,'1htl','MUTATION OF A BURIED RESIDUE CAUSES LACK OF ACTIVITY BUT NO CONFORMATIONAL CHANGE: CRYSTAL STRUCTURE OF E. COLI HEAT- LABILE ENTEROTOXIN MUTANT VAL 97--> LYS','X-RAY DIFFRACTION',2.500,'ENTEROTOXIN',1,6,1),(425,'1htm','STRUCTURE OF INFLUENZA HAEMAGGLUTININ AT THE PH OF MEMBRANE FUSION','X-RAY DIFFRACTION',2.500,'VIRAL PROTEIN',3,3,1),(426,'1htr','CRYSTAL AND MOLECULAR STRUCTURES OF HUMAN PROGASTRICSIN AT 1.62 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.620,'ASPARTYL PROTEASE',1,1,1),(427,'1huc','THE REFINED 2.15 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF HUMAN LIVER CATHEPSIN B: THE STRUCTURAL BASIS FOR ITS SPECIFICITY','X-RAY DIFFRACTION',2.100,'THIOL PROTEASE',2,2,1),(428,'1hv2','SOLUTION STRUCTURE OF YEAST ELONGIN C IN COMPLEX WITH A VON HIPPEL-LINDAU PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(429,'1hxe','SERINE PROTEASE','X-RAY DIFFRACTION',2.100,'HYDROLASEE/HYDROLASE INHIBITOR',2,1,1),(430,'1hxf','HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(431,'1hxl','MINIPROTEIN MP-2 (V10A) COMPLEX WITH STREPTAVIDIN','X-RAY DIFFRACTION',1.800,'UNKNOWN FUNCTION',2,2,1),(432,'1hxz','MINIPROTEIN MP-2 COMPLEX WITH STREPTAVIDIN','X-RAY DIFFRACTION',1.800,'UNKNOWN FUNCTION',2,2,1),(433,'1hy2','MINIPROTEIN MP-1 COMPLEX WITH STREPTAVIDIN','X-RAY DIFFRACTION',2.000,'UNKNOWN FUNCTION',4,4,1),(434,'1i1y','CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,2,1),(435,'1i31','MU2 ADAPTIN SUBUNIT (AP50) OF AP2 CLATHRIN ADAPTOR, COMPLEXED WITH EGFR INTERNALIZATION PEPTIDE FYRALM AT 2.5 A RESOLUTION','X-RAY DIFFRACTION',2.500,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(436,'1i3z','MURINE EAT2 SH2 DOMAIN IN COMPLEX WITH SLAM PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.150,'SIGNALING PROTEIN',1,1,1),(437,'1i4f','CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM',1,1,1),(438,'1i4o','CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX','X-RAY DIFFRACTION',2.400,'APOPTOSIS/HYDROLASE',2,2,1),(439,'1i51','CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP','X-RAY DIFFRACTION',2.450,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(440,'1i73','COMPLEX OF PRO-LEU-L-TRP PHOSPHONATE WITH THE CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(441,'1i7a','EVH1 DOMAIN FROM MURINE HOMER 2B/VESL 2','X-RAY DIFFRACTION',2.240,'SIGNALING PROTEIN',1,2,1),(442,'1i7r','CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,2,1),(443,'1i7u','CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(444,'1i8i','CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT ROOM TEMPERATURE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(445,'1i8k','CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT LIQUID NITROGEN TEMPERATURE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,2,1),(446,'1iak','HISTOCOMPATIBILITY ANTIGEN I-AK','X-RAY DIFFRACTION',1.900,'HISTOCOMPATIBILITY ANTIGEN I-AK',1,2,1),(447,'1iau','HUMAN GRANZYME B IN COMPLEX WITH AC-IEPD-CHO','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(448,'1icf','CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,4,1),(449,'1id5','CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEX WITH PROTEASE INHIBITOR ECOTIN','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(450,'1idg','THE NMR SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND AN 18MER COGNATE PEPTIDE','SOLUTION NMR',NULL,'TOXIN',1,1,1),(451,'1idh','THE NMR SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND AN 18MER COGNATE PEPTIDE','SOLUTION NMR',NULL,'TOXIN',1,1,1),(452,'1ihj','CRYSTAL STRUCTURE OF THE N-TERMINAL PDZ DOMAIN OF INAD IN COMPLEX WITH A NORPA C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',2,2,1),(453,'1ihs','CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ALPHA-THROMBIN AND NON- HYDROLYZABLE BIFUNCTIONAL INHIBITORS, HIRUTONIN-2 AND HIRUTONIN-6','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(454,'1iht','CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ALPHA-THROMBIN AND NON- HYDROLYZABLE BIFUNCTIONAL INHIBITORS, HIRUTONIN-2 AND HIRUTONIN-6','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(455,'1iid','CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE N- MYRISTOYLTRANSFERASE WITH BOUND S-(2-OXO)PENTADECYLCOA AND THE OCTAPEPTIDE GLYASKLA','X-RAY DIFFRACTION',2.500,'TRANSFERASE',1,1,1),(456,'1ik9','CRYSTAL STRUCTURE OF A XRCC4-DNA LIGASE IV COMPLEX','X-RAY DIFFRACTION',2.300,'GENE REGULATION/LIGASE',1,2,1),(457,'1ikf','A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM/IMMUNOSUPPRESSANT',1,2,1),(458,'1ilp','CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8','SOLUTION NMR',NULL,'CYTOKINE',1,1,1),(459,'1ilq','CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 (MINIMIZED MEAN)','SOLUTION NMR',NULL,'CYTOKINE',1,1,1),(460,'1im3','CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN/IMMUNE SYSTEM',4,4,1),(461,'1inq','STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13A, COMPLEXED TO H2-DB','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(462,'1iq5','CALMODULIN/NEMATODE CA2+/CALMODULIN DEPENDENT KINASE KINASE FRAGMENT','X-RAY DIFFRACTION',1.800,'METAL BINDING PROTEIN/PROTEIN BINDING',1,1,1),(463,'1ir3','PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG','X-RAY DIFFRACTION',1.900,'COMPLEX (TRANSFERASE/SUBSTRATE)',1,1,1),(464,'1irs','IRS-1 PTB DOMAIN COMPLEXED WITH A IL-4 RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)',1,1,1),(465,'1is0','CRYSTAL STRUCTURE OF A COMPLEX OF THE SRC SH2 DOMAIN WITH CONFORMATIONALLY CONSTRAINED PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(466,'1isq','PYROCOCCUS FURIOSUS PCNA COMPLEXED WITH RFCL PIP-BOX PEPTIDE','X-RAY DIFFRACTION',2.300,'DNA BINDING PROTEIN',1,1,1),(467,'1iwq','CRYSTAL STRUCTURE OF MARCKS CALMODULIN BINDING DOMAIN PEPTIDE COMPLEXED WITH CA2+/CALMODULIN','X-RAY DIFFRACTION',2.000,'METAL BINDING PROTEIN/PROTEIN BINDING',1,1,1),(468,'1ize','CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(469,'1j19','CRYSTAL STRUCTURE OF THE RADXIN FERM DOMAIN COMPLEXED WITH THE ICAM-2 CYTOPLASMIC PEPTIDE','X-RAY DIFFRACTION',2.400,'CELL ADHESION',1,1,1),(470,'1j2j','CRYSTAL STRUCTURE OF GGA1 GAT N-TERMINAL REGION IN COMPLEX WITH ARF1 GTP FORM','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(471,'1j2x','CRYSTAL STRUCTURE OF RAP74 C-TERMINAL DOMAIN COMPLEXED WITH FCP1 C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(472,'1j4k','SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE DERIVED FROM RAD9','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(473,'1j4l','SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTHREONYL PEPTIDE DERIVED FROM RAD9','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(474,'1j4p','NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T155) PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE/CELL CYCLE',1,1,1),(475,'1j4q','NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T192) PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE/CELL CYCLE',1,1,1),(476,'1j71','STRUCTURE OF THE EXTRACELLULAR ASPARTIC PROTEINASE FROM CANDIDA TROPICALIS YEAST.','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(477,'1j7z','OSMOLYTE STABILIZATION OF RIBONUCLEASE','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(478,'1j80','OSMOLYTE STABILIZATION OF RNASE','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(479,'1j81','OSMOLYTE STABILIZATION OF RNASE','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(480,'1j82','OSMOLYTE STABILIZATION OF RNASE','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(481,'1j8h','CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,4,1),(482,'1jac','A NOVEL MODE OF CARBOHYDRATE RECOGNITION IN JACALIN, A MORACEAE PLANT LECTIN WITH A BETA-PRISM','X-RAY DIFFRACTION',2.430,'LECTIN',4,4,1),(483,'1jan','COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (PHE79 FORM)','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(484,'1jap','COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)','X-RAY DIFFRACTION',1.820,'COMPLEX (METALLOPROTEASE/INHIBITOR)',1,1,1),(485,'1jb0','CRYSTAL STRUCTURE OF PHOTOSYSTEM I: A PHOTOSYNTHETIC REACTION CENTER AND CORE ANTENNA SYSTEM FROM CYANOBACTERIA','X-RAY DIFFRACTION',2.500,'PHOTOSYNTHESIS',5,4,1),(486,'1jbd','NMR STRUCTURE OF THE COMPLEX BETWEEN ALPHA-BUNGAROTOXIN AND A MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR','SOLUTION NMR',NULL,'TOXIN',1,1,1),(487,'1jbp','CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A SUBSTRATE PEPTIDE, ADP AND DETERGENT','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(488,'1jbu','COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH INHIBITORY EXOSITE PEPTIDE A-183','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(489,'1jcr','CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE NON-SUBSTRATE TETRAPEPTIDE INHIBITOR CVFM AND FARNESYL DIPHOSPHATE SUBSTRATE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,2,1),(490,'1jcs','CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE PEPTIDE SUBSTRATE TKCVFM AND AN ANALOG OF FARNESYL DIPHOSPHATE','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,2,1),(491,'1jd5','CRYSTAL STRUCTURE OF DIAP1-BIR2/GRIM','X-RAY DIFFRACTION',1.900,'HYDROLASE/PEPTIDE',1,1,1),(492,'1jdh','CRYSTAL STRUCTURE OF BETA-CATENIN AND HTCF-4','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(493,'1jdp','CRYSTAL STRUCTURE OF HORMONE/RECEPTOR COMPLEX','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,2,1),(494,'1jeg','SOLUTION STRUCTURE OF THE SH3 DOMAIN FROM C-TERMINAL SRC KINASE COMPLEXED WITH A PEPTIDE FROM THE TYROSINE PHOSPHATASE PEP','SOLUTION NMR',NULL,'TRANSFERASE/HYDROLASE',1,1,1),(495,'1jet','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KAK','X-RAY DIFFRACTION',1.200,'COMPLEX (PEPTIDE TRANSPORT/PEPTIDE)',1,1,1),(496,'1jeu','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KEK','X-RAY DIFFRACTION',1.250,'COMPLEX (PEPTIDE TRANSPORT/PEPTIDE)',1,1,1),(497,'1jev','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KWK','X-RAY DIFFRACTION',1.300,'COMPLEX (PEPTIDE TRANSPORT/PEPTIDE)',1,1,1),(498,'1jf1','CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(499,'1jg3','CRYSTAL STRUCTURE OF L-ISOASPARTYL (D-ASPARTYL) O-METHYLTRANSFERASE WITH ADENOSINE & VYP(ISP)HA SUBSTRATE','X-RAY DIFFRACTION',2.100,'TRANSFERASE',2,2,1),(500,'1jgd','HLA-B*2709 BOUND TO DECA-PEPTIDE S10R','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(501,'1jge','HLA-B*2705 BOUND TO NONA-PEPTIDE M9','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(502,'1jgn','SOLUTION STRUCTURE OF THE C-TERMINAL PABC DOMAIN OF HUMAN POLY(A)-BINDING PROTEIN IN COMPLEX WITH THE PEPTIDE FROM PAIP2','SOLUTION NMR',NULL,'RNA BINDING PROTEIN',1,1,1),(503,'1jh4','SOLUTION STRUCTURE OF THE C-TERMINAL PABC DOMAIN OF HUMAN POLY(A)-BINDING PROTEIN IN COMPLEX WITH THE PEPTIDE FROM PAIP1','SOLUTION NMR',NULL,'RNA BINDING PROTEIN',1,1,1),(504,'1jht','CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART- 1/MELAN-A.','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',1,1,1),(505,'1jj2','FULLY REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.400,'RIBOSOME',1,1,1),(506,'1jk4','DES 1-6 BOVINE NEUROPHYSIN II COMPLEX WITH VASOPRESSIN','X-RAY DIFFRACTION',2.300,'NEUROPEPTIDE',1,1,1),(507,'1jk8','CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(508,'1jlu','CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATED SUBSTRATE PEPTIDE AND DETERGENT','X-RAY DIFFRACTION',2.250,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(509,'1jm4','NMR STRUCTURE OF P/CAF BROMODOMAIN IN COMPLEX WITH HIV-1 TAT PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(510,'1jmo','CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX','X-RAY DIFFRACTION',2.200,'BLOOD CLOTTING',1,1,1),(511,'1jmt','X-RAY STRUCTURE OF A CORE U2AF65/U2AF35 HETERODIMER','X-RAY DIFFRACTION',2.200,'RNA BINDING PROTEIN',1,1,1),(512,'1jot','STRUCTURE OF THE LECTIN MPA COMPLEXED WITH T-ANTIGEN DISACCHARIDE','X-RAY DIFFRACTION',2.200,'LECTIN',1,1,1),(513,'1jou','CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH AN UNOCCUPIED ACTIVE SITE','X-RAY DIFFRACTION',1.800,'BLOOD CLOTTING',3,3,1),(514,'1jpf','CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB','X-RAY DIFFRACTION',2.180,'IMMUNE SYSTEM',1,1,1),(515,'1jpg','CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(516,'1jpl','GGA3 VHS DOMAIN COMPLEXED WITH C-TERMINAL PEPTIDE FROM CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',4,4,1),(517,'1jpw','CRYSTAL STRUCTURE OF A HUMAN TCF-4 / BETA-CATENIN COMPLEX','X-RAY DIFFRACTION',2.500,'CELL ADHESION',3,3,1),(518,'1jq8','DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE LEU-ALA-ILE-TYR-SER AT 2.0 RESOLUTION','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(519,'1jq9','CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE PHE-LEU-SER- TYR-LYS AT 1.8 RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(520,'1jrr','HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP','X-RAY DIFFRACTION',1.600,'PEPTIDE BINDING PROTEIN',1,1,1),(521,'1jrs','HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(522,'1jrt','HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(523,'1jsp','NMR STRUCTURE OF CBP BROMODOMAIN IN COMPLEX WITH P53 PEPTIDE','SOLUTION NMR',NULL,'DNA BINDING PROTEIN',1,1,1),(524,'1ju5','TERNARY COMPLEX OF AN CRK SH2 DOMAIN, CRK-DERIVED PHOPHOPEPTIDE, AND ABL SH3 DOMAIN BY NMR SPECTROSCOPY','SOLUTION NMR',NULL,'PROTEIN BINDING/TRANSFERASE',1,1,1),(525,'1juf','STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13B, COMPLEXED TO H2-DB','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(526,'1juq','GGA3 VHS DOMAIN COMPLEXED WITH C-TERMINAL PEPTIDE FROM CATION- DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN',4,4,1),(527,'1jw6','CRYSTAL STRUCTURE OF THE COMPLEX OF CONCANAVALIN A AND HEXAPEPTIDE','X-RAY DIFFRACTION',1.930,'SUGAR BINDING PROTEIN',1,1,1),(528,'1jwg','VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH CATION-INDEPENDENT M6PR C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT/PROTEIN BINDING',2,2,1),(529,'1jwu','CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(530,'1jxp','BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN COMPLEX',2,2,1),(531,'1jyq','XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A HIGHLY AFFINE PHOSPHO PEPTIDE','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN/PEPTIDE INHIBITOR',2,2,1),(532,'1jyr','XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A PHOSPHORYLATED PEPTIDE','X-RAY DIFFRACTION',1.550,'SIGNALING PROTEIN/INHIBITOR',1,1,1),(533,'1k21','HUMAN THROMBIN-INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.860,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(534,'1k22','HUMAN THROMBIN-INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.930,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(535,'1k2d','CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,2,1),(536,'1k2m','SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE DERIVED FROM RAD9','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(537,'1k2n','SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTHREONYL PEPTIDE DERIVED FROM RAD9','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(538,'1k3a','STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(539,'1k3n','NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T155) PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE/CELL CYCLE',1,1,1),(540,'1k3q','NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T192) PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE/CELL CYCLE',1,1,1),(541,'1k4u','SOLUTION STRUCTURE OF THE C-TERMINAL SH3 DOMAIN OF P67PHOX COMPLEXED WITH THE C-TERMINAL TAIL REGION OF P47PHOX','SOLUTION NMR',NULL,'HORMONE/GROWTH FACTOR',1,1,1),(542,'1k4w','X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ROR BETA LIGAND-BINDING DOMAIN IN THE ACTIVE CONFORMATION','X-RAY DIFFRACTION',1.900,'HORMONE/GROWTH FACTOR',1,1,1),(543,'1k5n','HLA-B*2709 BOUND TO NONA-PEPTIDE M9','X-RAY DIFFRACTION',1.090,'IMMUNE SYSTEM',1,1,1),(544,'1k74','THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-ACTIVATOR PEPTIDES.','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(545,'1k7l','THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE.','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',4,4,1),(546,'1k8d','CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(547,'1ka6','SAP/SH2D1A BOUND TO PEPTIDE N-PY','SOLUTION NMR',NULL,'IMMUNE SYSTEM',1,1,1),(548,'1ka7','SAP/SH2D1A BOUND TO PEPTIDE N-Y-C','SOLUTION NMR',NULL,'IMMUNE SYSTEM',1,1,1),(549,'1kap','THREE-DIMENSIONAL STRUCTURE OF THE ALKALINE PROTEASE OF PSEUDOMONAS AERUGINOSA: A TWO-DOMAIN PROTEIN WITH A CALCIUM BINDING PARALLEL BETA ROLL MOTIF','X-RAY DIFFRACTION',1.640,'ZINC METALLOPROTEASE',1,1,1),(550,'1kat','SOLUTION STRUCTURE OF A PHAGE-DERIVED PEPTIDE ANTAGONIST IN COMPLEX WITH VASCULAR ENDOTHELIAL GROWTH FACTOR','SOLUTION NMR',NULL,'CELL CYCLE, HORMONE/GROWTH FACTOR',2,2,1),(551,'1kbg','MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(552,'1kc2','STRUCTURE OF THE TRIPLE (LYS(BETA)D3ALA, ASP(BETA)C8ALA, ASPCD2ALA) MUTANT OF THE SRC SH2 DOMAIN BOUND TO THE PQPYEEIPI PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(553,'1kc4','NMR STRUCTURAL ANALYSIS OF THE COMPLEX FORMED BETWEEN ALPHA- BUNGAROTOXIN AND THE PRINCIPAL ALPHA-NEUROTOXIN BINDING SEQUENCE ON THE ALPHA7 SUBUNIT OF A NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR','SOLUTION NMR',NULL,'TOXIN',1,1,1),(554,'1kc5','CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(555,'1kcs','CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(556,'1kdx','KIX DOMAIN OF MOUSE CBP (CREB BINDING PROTEIN) IN COMPLEX WITH PHOSPHORYLATED KINASE INDUCIBLE DOMAIN (PKID) OF RAT CREB (CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN), NMR 17 STRUCTURES','SOLUTION NMR',NULL,'TRANSCRIPTION REGULATION COMPLEX',1,1,1),(557,'1khp','MONOCLINIC FORM OF PAPAIN/ZLFG-DAM COVALENT COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(558,'1khq','ORTHORHOMBIC FORM OF PAPAIN/ZLFG-DAM COVALENT COMPLEX','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(559,'1kil','THREE-DIMENSIONAL STRUCTURE OF THE COMPLEXIN/SNARE COMPLEX','X-RAY DIFFRACTION',2.300,'MEMBRANE PROTEIN',1,2,1),(560,'1kj3','MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(561,'1kj7','SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,2,1),(562,'1kjf','SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,2,1),(563,'1kjg','SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,2,1),(564,'1kjh','SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,2,1),(565,'1kjm','TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',1,1,1),(566,'1kjv','TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE','X-RAY DIFFRACTION',1.480,'IMMUNE SYSTEM',1,1,1),(567,'1kl3','AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM1-STREPII','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN',4,4,1),(568,'1kl5','AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM2-STREPII','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',4,4,1),(569,'1kl8','NMR STRUCTURAL ANALYSIS OF THE COMPLEX FORMED BETWEEN ALPHA- BUNGAROTOXIN AND THE PRINCIPAL ALPHA-NEUROTOXIN BINDING SEQUENCE ON THE ALPHA7 SUBUNIT OF A NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR','SOLUTION NMR',NULL,'TOXIN',1,1,1),(570,'1klg','CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37, THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM/TOXIN',1,2,1),(571,'1klq','THE MAD2 SPINDLE CHECKPOINT PROTEIN UNDERGOES SIMILAR MAJOR CONFORMATIONAL CHANGES UPON BINDING TO EITHER MAD1 OR CDC20','SOLUTION NMR',NULL,'CELL CYCLE',1,1,1),(572,'1klu','CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)','X-RAY DIFFRACTION',1.930,'IMMUNE SYSTEM/TOXIN',1,2,1),(573,'1kpu','HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/VSV8','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(574,'1kpv','HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/SEV9','X-RAY DIFFRACTION',1.710,'IMMUNE SYSTEM',1,1,1),(575,'1kts','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(576,'1ktt','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(577,'1ku8','CRYSTAL STRUCTURE OF JACALIN','X-RAY DIFFRACTION',1.750,'SUGAR BINDING PROTEIN',4,4,1),(578,'1kug','CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH ITS ENDOGENOUS INHIBITOR PENW','X-RAY DIFFRACTION',1.370,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(579,'1kui','CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEQW.','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(580,'1kuj','CRYSTAL STRUCTURE OF JACALIN COMPLEXED WITH 1-O-METHYL- ALPHA-D-MANNOSE','X-RAY DIFFRACTION',2.000,'SUGAR BINDING PROTEIN',4,4,1),(581,'1kuk','CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEKW.','X-RAY DIFFRACTION',1.450,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(582,'1ky6','AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW PEPTIDE','X-RAY DIFFRACTION',2.000,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(583,'1ky7','THE AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH AMPHIPHYSIN FXDXF','X-RAY DIFFRACTION',2.150,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(584,'1kyd','AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW PEPTIDE','X-RAY DIFFRACTION',2.000,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(585,'1kyf','AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPS15 DPF PEPTIDE','X-RAY DIFFRACTION',1.220,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(586,'1kyu','AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPS15 DPF PEPTIDE','X-RAY DIFFRACTION',1.800,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(587,'1kzo','PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYLATED K-RAS4B PEPTIDE PRODUCT AND FARNESYL DIPHOSPHATE SUBSTRATE BOUND SIMULTANEOUSLY','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE SUBSTRATE',1,2,1),(588,'1kzp','PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYLATED K-RAS4B PEPTIDE PRODUCT','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE SUBSTRATE',1,2,1),(589,'1l2i','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION RECEPTOR/COACTIVATOR',2,2,1),(590,'1l2z','CD2BP2-GYF DOMAIN IN COMPLEX WITH PROLINE-RICH CD2 TAIL SEGMENT PEPTIDE','SOLUTION NMR',NULL,'PEPTIDE BINDING/SIGNALING PROTEIN',1,1,1),(591,'1l3e','NMR STRUCTURES OF THE HIF-1ALPHA CTAD/P300 CH1 COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(592,'1l3r','CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(593,'1l4w','NMR STRUCTURE OF AN ACHR-PEPTIDE (TORPEDO CALIFORNICA, ALPHA-SUBUNIT RESIDUES 182-202) IN COMPLEX WITH ALPHA- BUNGAROTOXIN','SOLUTION NMR',NULL,'RECEPTOR, TOXIN',1,1,1),(594,'1l6o','XENOPUS DISHEVELLED PDZ DOMAIN','X-RAY DIFFRACTION',2.200,'GENE REGULATION',3,3,1),(595,'1l6x','FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,1,1),(596,'1l7z','CRYSTAL STRUCTURE OF CA2+/CALMODULIN COMPLEXED WITH MYRISTOYLATED CAP-23/NAP-22 PEPTIDE','X-RAY DIFFRACTION',2.300,'METAL BINDING PROTEIN/PROTEIN BINDING',1,1,1),(597,'1lb5','TRAF6-RANK COMPLEX','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',1,1,1),(598,'1lb6','TRAF6-CD40 COMPLEX','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(599,'1lcj','SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOTYROSYL PEPTIDE EPQPYEEIPIYL','X-RAY DIFFRACTION',1.800,'COMPLEX (KINASE/PEPTIDE)',1,1,1),(600,'1lck','SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PHOSPHOTYROSYL PEPTIDE TEGQPYQPQPA','X-RAY DIFFRACTION',2.500,'COMPLEX (KINASE/PEPTIDE)',1,1,1),(601,'1ld9','THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE','X-RAY DIFFRACTION',2.400,'MAJOR HISTOCOMPATIBILITY COMPLEX',2,2,1),(602,'1ldt','COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN','X-RAY DIFFRACTION',1.900,'COMPLEX (HYDROLASE/INHIBITOR)',1,1,1),(603,'1leg','CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,1,1),(604,'1lek','CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',1,1,1),(605,'1len','REFINEMENT OF TWO CRYSTAL FORMS OF LENTIL LECTIN AT 1.8 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.800,'LECTIN',2,2,1),(606,'1les','LENTIL LECTIN COMPLEXED WITH SUCROSE','X-RAY DIFFRACTION',1.900,'LECTIN',2,2,1),(607,'1lew','CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(608,'1lez','CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(609,'1lf8','COMPLEX OF GGA3-VHS DOMAIN AND CI-MPR C-TERMINAL PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',4,4,1),(610,'1lgh','CRYSTAL STRUCTURE OF THE LIGHT-HARVESTING COMPLEX II (B800-850) FROM RHODOSPIRILLUM MOLISCHIANUM','X-RAY DIFFRACTION',2.400,'LIGHT HARVESTING COMPLEX',4,4,1),(611,'1lhc','HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROARG-OH','X-RAY DIFFRACTION',1.950,'COMPLEX (SERINE PROTEASE/INHIBITOR)',2,1,1),(612,'1lhd','HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROLYS-OH','X-RAY DIFFRACTION',2.350,'COMPLEX (SERINE PROTEASE/INHIBITOR)',2,1,1),(613,'1lhe','HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-N- BUTYL-AMIDINO-GLYCINE-OH','X-RAY DIFFRACTION',2.250,'COMPLEX (SERINE PROTEASE/INHIBITOR)',2,1,1),(614,'1lhf','HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO- HOMOLYS-OH','X-RAY DIFFRACTION',2.400,'COMPLEX (SERINE PROTEASE/INHIBITOR)',2,1,1),(615,'1lhg','HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO- BOROORNITHINE-OH','X-RAY DIFFRACTION',2.250,'COMPLEX (SERINE PROTEASE/INHIBITOR)',2,1,1),(616,'1lj2','RECOGNITION OF EIF4G BY ROTAVIRUS NSP3 REVEALS A BASIS FOR MRNA CIRCULARIZATION','X-RAY DIFFRACTION',2.380,'VIRAL PROTEIN/ TRANSLATION',2,2,1),(617,'1ljz','NMR STRUCTURE OF AN ACHR-PEPTIDE (TORPEDO CALIFORNICA, ALPHA-SUBUNIT RESIDUES 182-202) IN COMPLEX WITH ALPHA-BUNGAROTOXIN','SOLUTION NMR',NULL,'RECEPTOR, TOXIN',1,1,1),(618,'1lk2','1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE','X-RAY DIFFRACTION',1.350,'IMMUNE SYSTEM',1,1,1),(619,'1lkk','HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-ILE (PYEEI PEPTIDE)','X-RAY DIFFRACTION',1.000,'COMPLEX (TYROSINE KINASE/PEPTIDE)',1,1,1),(620,'1lkl','HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-GLY (PYEEG PEPTIDE)','X-RAY DIFFRACTION',1.800,'COMPLEX (TYROSINE KINASE/PEPTIDE)',1,1,1),(621,'1lm8','STRUCTURE OF A HIF-1A-PVHL-ELONGINB-ELONGINC COMPLEX','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',1,1,1),(622,'1lmw','LMW U-PA STRUCTURE COMPLEXED WITH EGRCMK (GLU-GLY-ARG CHLOROMETHYL KETONE)','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(623,'1loa','THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE','X-RAY DIFFRACTION',2.200,'LECTIN',4,4,1),(624,'1lob','THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE- BINDING SITE','X-RAY DIFFRACTION',2.000,'LECTIN',4,4,1),(625,'1loc','INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL','X-RAY DIFFRACTION',2.050,'SUGAR BINDING PROTEIN',4,4,1),(626,'1lod','INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL','X-RAY DIFFRACTION',2.050,'LECTIN',4,4,1),(627,'1loe','X-RAY CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT AT 1.9 ANGSTROMS RESOLUTION OF ISOLECTIN I FROM THE SEEDS OF LATHYRUS OCHRUS','X-RAY DIFFRACTION',1.900,'LECTIN',2,2,1),(628,'1lof','X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.300,'LECTIN',1,2,1),(629,'1log','X-RAY STRUCTURE OF A (ALPHA-MAN(1-3)BETA-MAN(1-4)GLCNAC)-LECTIN COMPLEX AT 2.1 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.100,'LECTIN',1,2,1),(630,'1lop','CYCLOPHILIN A COMPLEXED WITH SUCCINYL-ALA-PRO-ALA-P-NITROANILIDE','X-RAY DIFFRACTION',1.800,'ISOMERASE/ISOMERASE INHIBITOR',1,1,1),(631,'1lp9','XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,6,1),(632,'1lq8','CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR','X-RAY DIFFRACTION',2.400,'BLOOD CLOTTING',4,4,1),(633,'1lqb','CRYSTAL STRUCTURE OF A HYDROXYLATED HIF-1 ALPHA PEPTIDE BOUND TO THE PVHL/ELONGIN-C/ELONGIN-B COMPLEX','X-RAY DIFFRACTION',2.000,'GENE REGULATION',1,2,1),(634,'1lqv','CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR WITH PHOSPHOLIPID IN THE GROOVE IN COMPLEX WITH GLA DOMAIN OF PROTEIN C.','X-RAY DIFFRACTION',1.600,'BLOOD CLOTTING',2,2,1),(635,'1lta','2.2 ANGSTROMS CRYSTAL STRUCTURE OF E. COLI HEAT-LABILE ENTEROTOXIN (LT) WITH BOUND GALACTOSE','X-RAY DIFFRACTION',2.200,'ENTEROTOXIN',1,6,1),(636,'1ltg','THE ARG7LYS MUTANT OF HEAT-LABILE ENTEROTOXIN EXHIBITS GREAT FLEXIBILITY OF ACTIVE SITE LOOP 47-56 OF THE A SUBUNIT','X-RAY DIFFRACTION',2.400,'ENTEROTOXIN',1,6,1),(637,'1lti','HEAT-LABILE ENTEROTOXIN (LT-I) COMPLEX WITH T-ANTIGEN','X-RAY DIFFRACTION',2.130,'ENTEROTOXIN',1,6,1),(638,'1lts','REFINED STRUCTURE OF E. COLI HEAT LABILE ENTEROTOXIN, A CLOSE RELATIVE OF CHOLERA TOXIN','X-RAY DIFFRACTION',1.950,'TOXIN',1,6,1),(639,'1ltt','LACTOSE BINDING TO HEAT-LABILE ENTEROTOXIN REVEALED BY X-RAY CRYSTALLOGRAPHY','X-RAY DIFFRACTION',2.300,'TOXIN',1,6,1),(640,'1lvb','CATALYTICALLY INACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH SUBSTRATE','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN',2,2,1),(641,'1lvm','CATALYTICALLY ACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH PRODUCT','X-RAY DIFFRACTION',1.800,'VIRAL PROTEIN',3,2,1),(642,'1lxf','STRUCTURE OF THE REGULATORY N-DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH HUMAN CARDIAC TROPONIN-I(147- 163) AND BEPRIDIL','SOLUTION NMR',NULL,'METAL BINDING PROTEIN, PROTEIN BINDIN',1,1,1),(643,'1lxg','SOLUTION STRUCTURE OF ALPHA-COBRATOXIN COMPLEXED WITH A COGNATE PEPTIDE (STRUCTURE ENSEMBLE)','SOLUTION NMR',NULL,'TOXIN',1,1,1),(644,'1lxh','SOLUTION STRUCTURE OF ALPHA-COBRATOXIN COMPLEXED WITH A COGNATE PEPTIDE (MINIMIZED AVERAGE STRUCTURE)','SOLUTION NMR',NULL,'TOXIN',1,1,1),(645,'1lyb','CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(646,'1m05','HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(647,'1m0v','NMR STRUCTURE OF THE TYPE III SECRETORY DOMAIN OF YERSINIA YOPH COMPLEXED WITH THE SKAP-HOM PHOSPHO-PEPTIDE N-ACETYL- DEPYDDPF-NH2','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(648,'1m1d','TETRAHYMENA GCN5 WITH BOUND BISUBSTRATE ANALOG INHIBITOR','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(649,'1m21','CRYSTAL STRUCTURE ANALYSIS OF THE PEPTIDE AMIDASE PAM IN COMPLEX WITH THE COMPETITIVE INHIBITOR CHYMOSTATIN','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(650,'1m26','CRYSTAL STRUCTURE OF JACALIN-T-ANTIGEN COMPLEX','X-RAY DIFFRACTION',1.620,'SUGAR BINDING PROTEIN, PLANT PROTEIN',4,4,1),(651,'1m27','CRYSTAL STRUCTURE OF SAP/FYNSH3/SLAM TERNARY COMPLEX','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN, TRANSFERASE',1,1,1),(652,'1m2z','CRYSTAL STRUCTURE OF A DIMER COMPLEX OF THE HUMAN GLUCOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEXAMETHASONE AND A TIF2 COACTIVATOR MOTIF','X-RAY DIFFRACTION',2.500,'HORMONE/HORMONE ACTIVATOR',2,2,1),(653,'1m43','CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO 2.4 A','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(654,'1m45','CRYSTAL STRUCTURE OF MLC1P BOUND TO IQ2 OF MYO2P, A CLASS V MYOSIN','X-RAY DIFFRACTION',1.650,'CELL CYCLE PROTEIN',1,1,1),(655,'1m46','CRYSTAL STRUCTURE OF MLC1P BOUND TO IQ4 OF MYO2P, A CLASS V MYOSIN','X-RAY DIFFRACTION',2.100,'CELL CYCLE PROTEIN',1,1,1),(656,'1m4h','CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR OM00-3','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(657,'1m4p','STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP \"LATE DOMAIN\" PEPTIDE, DYANA ENSEMBLE','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN',1,1,1),(658,'1m4q','STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP \"LATE DOMAIN\" PEPTIDE, CNS ENSEMBLE','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN',1,1,1),(659,'1m56','STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',2,5,1),(660,'1m6o','CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(661,'1m72','CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',3,3,1),(662,'1m7e','CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN(PTB) OF MOUSE DISABLED 2(DAB2):IMPLICATIONS FOR REELING SIGNALING','X-RAY DIFFRACTION',2.450,'SIGNALING PROTEIN',3,3,1),(663,'1m93','1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA','X-RAY DIFFRACTION',1.650,'VIRAL PROTEIN',2,1,1),(664,'1ma3','STRUCTURE OF A SIR2 ENZYME BOUND TO AN ACETYLATED P53 PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING, TRANSCRIPTION',1,1,1),(665,'1mct','THE REFINED 1.6 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PORCINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY','X-RAY DIFFRACTION',1.600,'COMPLEX(PROTEINASE/INHIBITOR)',1,1,1),(666,'1mcv','CRYSTAL STRUCTURE ANALYSIS OF A HYBRID SQUASH INHIBITOR IN COMPLEX WITH PORCINE PANCREATIC ELASTASE','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(667,'1mdi','HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN MUTANT HUMAN THIOREDOXIN AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB','SOLUTION NMR',NULL,'COMPLEX (ELECTRON TRANSPORT/PEPTIDE)',1,1,1),(668,'1mdj','HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB (RESIDUES 56-68 OF THE P50 SUBUNIT OF NFKB)','SOLUTION NMR',NULL,'COMPLEX (ELECTRON TRANSPORT/PEPTIDE)',1,1,1),(669,'1mdk','HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB (RESIDUES 56-68 OF THE P50 SUBUNIT OF NFKB)','SOLUTION NMR',NULL,'COMPLEX (ELECTRON TRANSPORT/PEPTIDE)',1,1,1),(670,'1mey','CRYSTAL STRUCTURE OF A DESIGNED ZINC FINGER PROTEIN BOUND TO DNA','X-RAY DIFFRACTION',2.200,'TRANSFERASE/DNA',1,1,1),(671,'1mf4','STRUCTURE-BASED DESIGN OF POTENT AND SELECTIVE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AND A DESIGNED PEPTIDE INHIBITOR AT 1.9 A RESOLUTION','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(672,'1mfg','THE STRUCTURE OF ERBIN PDZ DOMAIN BOUND TO THE CARBOXY- TERMINAL TAIL OF THE ERBB2 RECEPTOR','X-RAY DIFFRACTION',1.250,'SIGNALING PROTEIN',1,1,1),(673,'1mfl','THE STRUCTURE OF ERBIN PDZ DOMAIN BOUND TO THE CARBOXY- TERMINAL TAIL OF THE ERBB2 RECEPTOR','X-RAY DIFFRACTION',1.880,'SIGNALING PROTEIN',1,1,1),(674,'1mhc','MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.100,'HISTOCOMPATIBILITY ANTIGEN/PEPTIDE',2,2,1),(675,'1mhw','DESIGN OF NON-COVALENT INHIBITORS OF HUMAN CATHEPSIN L. FROM THE 96- RESIDUE PROREGION TO OPTIMIZED TRIPEPTIDES','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',6,2,1),(676,'1mi5','THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,3,1),(677,'1mik','THE ROLE OF WATER MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5- HYDROXYNORVALINE)-2-CYCLOSPORIN: SYNTHESIS, BIOLOGICAL ACTIVITY, AND CRYSTALLOGRAPHIC ANALYSIS WITH CYCLOPHILIN A','X-RAY DIFFRACTION',1.760,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(678,'1miz','CRYSTAL STRUCTURE OF AN INTEGRIN BETA3-TALIN CHIMERA','X-RAY DIFFRACTION',1.900,'STRUCTURAL PROTEIN',1,1,1),(679,'1mk7','CRYSTAL STRUCTURE OF AN INTEGRIN BETA3-TALIN CHIMERA','X-RAY DIFFRACTION',2.200,'STRUCTURAL PROTEIN',2,2,1),(680,'1mkw','THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA- THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING','X-RAY DIFFRACTION',2.300,'COMPLEX (BLOOD COAGULATION/PROENZYME)',1,1,1),(681,'1mkx','THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA- THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING','X-RAY DIFFRACTION',2.200,'COMPLEX (BLOOD COAGULATION/PROENZYME)',1,1,1),(682,'1mox','CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA','X-RAY DIFFRACTION',2.500,'TRANSFERASE/GROWTH FACTOR',2,2,1),(683,'1mq1','CA2+-S100B-TRTK-12 COMPLEX','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',2,2,1),(684,'1mt1','THE CRYSTAL STRUCTURE OF PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE FROM METHANOCOCCUS JANNASCHII','X-RAY DIFFRACTION',2.200,'LYASE',6,6,1),(685,'1mt7','VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE SUBSTRATE',1,2,1),(686,'1mt8','VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE SUBSTRATE',1,2,1),(687,'1mt9','VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE SUBSTRATE',1,2,1),(688,'1mtp','THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE','X-RAY DIFFRACTION',1.500,'STRUCTURAL GENOMICS',1,1,1),(689,'1mu6','CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622','X-RAY DIFFRACTION',1.990,'BLOOD CLOTTING,HYDROLASE/INHIBITOR',2,1,1),(690,'1mu8','THROMBIN-HIRUGEN_L-378,650','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(691,'1mue','THROMBIN-HIRUGEN-L405,426','X-RAY DIFFRACTION',2.000,'HYDROLASE INHIBITOR',2,1,1),(692,'1muj','CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',1,2,1),(693,'1mv0','NMR STRUCTURE OF THE TUMOR SUPPRESSOR BIN1: ALTERNATIVE SPLICING IN MELANOMA AND INTERACTION WITH C-MYC','SOLUTION NMR',NULL,'ENDOCYTOSIS/EXOCYTOSIS, TRANSCRIPTION',1,1,1),(694,'1mv9','CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE EICOSANOID DHA (DOCOSA HEXAENOIC ACID) AND A COACTIVATOR PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(695,'1mvc','CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(696,'1mvf','MAZE ADDICTION ANTIDOTE','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',2,2,1),(697,'1mvu','SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE','X-RAY DIFFRACTION',1.780,'IMMUNE SYSTEM',1,2,1),(698,'1mw4','SOLUTION STRUCTURE OF THE HUMAN GRB7-SH2 DOMAIN IN COMPLEX WITH A 10 AMINO ACID PEPTIDE PY1139','SOLUTION NMR',NULL,'HORMONE/GROWTH FACTOR/TRANSFERASE',1,1,1),(699,'1mwa','2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,6,1),(700,'1mwn','SOLUTION NMR STRUCTURE OF S100B BOUND TO THE HIGH-AFFINITY TARGET PEPTIDE TRTK-12','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',2,2,1),(701,'1mxe','STRUCTURE OF THE COMPLEX OF CALMODULIN WITH THE TARGET SEQUENCE OF CAMKI','X-RAY DIFFRACTION',1.700,'METAL BINDING PROTEIN',2,2,1),(702,'1mxl','STRUCTURE OF CARDIAC TROPONIN C-TROPONIN I COMPLEX','SOLUTION NMR',NULL,'CALCIUM-BINDING PROTEIN',1,1,1),(703,'1mzn','CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',4,4,1),(704,'1mzw','CRYSTAL STRUCTURE OF A U4/U6 SNRNP COMPLEX BETWEEN HUMAN SPLICEOSOMAL CYCLOPHILIN H AND A U4/U6-60K PEPTIDE','X-RAY DIFFRACTION',2.000,'ISOMERASE',1,1,1),(705,'1n0w','CRYSTAL STRUCTURE OF A RAD51-BRCA2 BRC REPEAT COMPLEX','X-RAY DIFFRACTION',1.700,'GENE REGULATION/ANTITUMOR PROTEIN',1,1,1),(706,'1n0x','CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,4,1),(707,'1n12','CRYSTAL STRUCTURE OF THE PAPE (N-TERMINAL-DELETED) PILUS SUBUNIT BOUND TO A PEPTIDE CORRESPONDING TO THE N-TERMINAL EXTENSION OF THE PAPK PILUS SUBUNIT (RESIDUES 1-11) FROM UROPATHOGENIC E. COLI','X-RAY DIFFRACTION',1.870,'CHAPERONE',2,2,1),(708,'1n13','THE CRYSTAL STRUCTURE OF PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE FROM METHANOCOCCUS JANNASHII','X-RAY DIFFRACTION',1.400,'LYASE',6,6,1),(709,'1n2d','TERNARY COMPLEX OF MLC1P BOUND TO IQ2 AND IQ3 OF MYO2P, A CLASS V MYOSIN','X-RAY DIFFRACTION',2.000,'CELL CYCLE',1,2,1),(710,'1n2r','A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION.','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(711,'1n4h','CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA','X-RAY DIFFRACTION',2.100,'HORMONE/GROWTH FACTOR',1,1,1),(712,'1n4m','STRUCTURE OF RB TUMOR SUPPRESSOR BOUND TO THE TRANSACTIVATION DOMAIN OF E2F-2','X-RAY DIFFRACTION',2.200,'CELL CYCLE',3,2,1),(713,'1n4q','PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GGPP ANALOG AND A KKKSKTKCVIL PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSFERASE',6,12,1),(714,'1n51','AMINOPEPTIDASE P IN COMPLEX WITH THE INHIBITOR APSTATIN','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(715,'1n64','CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6','X-RAY DIFFRACTION',2.340,'IMMUNE SYSTEM',1,2,1),(716,'1n6j','STRUCTURAL BASIS OF SEQUENCE-SPECIFIC RECRUITMENT OF HISTONE DEACETYLASES BY MYOCYTE ENHANCER FACTOR-2','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION/DNA',1,2,1),(717,'1n7f','CRYSTAL STRUCTURE OF THE SIXTH PDZ DOMAIN OF GRIP1 IN COMPLEX WITH LIPRIN C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',2,2,1),(718,'1n7t','ERBIN PDZ DOMAIN BOUND TO A PHAGE-DERIVED PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(719,'1n8o','CRYSTAL STRUCTURE OF A COMPLEX BETWEEN BOVINE CHYMOTRYPSIN AND ECOTIN','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,2,1),(720,'1nan','MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(721,'1nb5','CRYSTAL STRUCTURE OF STEFIN A IN COMPLEX WITH CATHEPSIN H','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',4,8,1),(722,'1ncq','THE STRUCTURE OF HRV14 WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND','X-RAY DIFFRACTION',2.500,'VIRUS',1,3,1),(723,'1nd2','THE STRUCTURE OF RHINOVIRUS 16','X-RAY DIFFRACTION',2.500,'VIRUS',1,2,1),(724,'1nes','STRUCTURE OF THE PRODUCT COMPLEX OF ACETYL-ALA-PRO-ALA WITH PORCINE PANCREATIC ELASTASE AT 1.65 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(725,'1nh0','1.03 A STRUCTURE OF HIV-1 PROTEASE: INHIBITOR BINDING INSIDE AND OUTSIDE THE ACTIVE SITE','X-RAY DIFFRACTION',1.030,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(726,'1nh2','CRYSTAL STRUCTURE OF A YEAST TFIIA/TBP/DNA COMPLEX','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION/DNA',2,2,1),(727,'1niw','CRYSTAL STRUCTURE OF ENDOTHELIAL NITRIC OXIDE SYNTHASE PEPTIDE BOUND TO CALMODULIN','X-RAY DIFFRACTION',2.050,'SIGNALING PROTEIN/OXIDOREDUCTASE',4,4,1),(728,'1njt','COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(729,'1nkz','CRYSTAL STRUCTURE OF LH2 B800-850 FROM RPS. ACIDOPHILA AT 2.0 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.000,'MEMBRANE PROTEIN',3,2,1),(730,'1nln','CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEINASE WITH ITS 11 AMINO ACID COFACTOR AT 1.6 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(731,'1nm6','THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT 1.8A','X-RAY DIFFRACTION',1.800,'BLOOD CLOTTING/HYDROLASE INHIBITOR',1,1,1),(732,'1no9','DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATING NOVEL P1 BINDING FUNCTIONS: MOLECULAR AND X-RAY CRYSTALLOGRAPHIC STUDIES.','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(733,'1nop','CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE (TDP1) IN COMPLEX WITH VANADATE, DNA AND A HUMAN TOPOISOMERASE I-DERIVED PEPTIDE','X-RAY DIFFRACTION',2.300,'HYDROLASE/DNA',1,1,1),(734,'1npq','STRUCTURE OF A RHODAMINE-LABELED N-DOMAIN TROPONIN C MUTANT (CA2+ SATURATED) IN COMPLEX WITH SKELETAL TROPONIN I 115- 131','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(735,'1nq7','CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION',1,1,1),(736,'1nrl','CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND SR12813','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(737,'1nrr','CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(738,'1nrs','CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(739,'1nt1','THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR','X-RAY DIFFRACTION',2.000,'BLOOD CLOTTING/HYDROLASE INHIBITOR',1,1,1),(740,'1ntv','CRYSTAL STRUCTURE OF THE DISABLED-1 (DAB1) PTB DOMAIN-APOER2 PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.500,'SIGNALING PROTEIN',1,1,1),(741,'1nu2','CRYSTAL STRUCTURE OF THE MURINE DISABLED-1 (DAB1) PTB DOMAIN-APOER2 PEPTIDE-PI-4,5P2 TERNARY COMPLEX','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN',1,1,1),(742,'1nu7','STAPHYLOCOAGULASE-THROMBIN COMPLEX','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(743,'1nu8','CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV) IN COMPLEX WITH DIPROTIN A (IPI)','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(744,'1nvp','HUMAN TFIIA/TBP/DNA COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION/DNA',2,2,1),(745,'1nvq','THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(746,'1nvr','THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/STAUROSPORINE','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(747,'1nvs','THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(748,'1nwd','SOLUTION STRUCTURE OF CA2+/CALMODULIN BOUND TO THE C- TERMINAL DOMAIN OF PETUNIA GLUTAMATE DECARBOXYLASE','SOLUTION NMR',NULL,'BINDING PROTEIN/HYDROLASE',2,1,1),(749,'1nx0','STRUCTURE OF CALPAIN DOMAIN 6 IN COMPLEX WITH CALPASTATIN DIC','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',3,2,1),(750,'1nx1','CALPAIN DOMAIN VI COMPLEXED WITH CALPASTATIN INHIBITORY DOMAIN C (DIC)','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(751,'1ny2','HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(752,'1nzl','CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYEPYIPI','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(753,'1nzq','D-PHE-PRO-ARG-TYPE THROMBIN INHIBITOR','X-RAY DIFFRACTION',2.180,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(754,'1nzv','CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYIPYVPA','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(755,'1o0d','HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO-ARG-TYPE INHIBITOR AND A C- TERMINAL HIRUDIN DERIVED EXO-SITE INHIBITOR','X-RAY DIFFRACTION',2.440,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(756,'1o0p','SOLUTION STRUCTURE OF THE THIRD RNA RECOGNITION MOTIF (RRM) OF U2AF65 IN COMPLEX WITH AN N-TERMINAL SF1 PEPTIDE','SOLUTION NMR',NULL,'RNA BINDING PROTEIN',1,1,1),(757,'1o2g','ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS','X-RAY DIFFRACTION',1.580,'BLOOD CLOTTING,HYDROLASE/INHIBITOR',2,1,1),(758,'1o3p','ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS','X-RAY DIFFRACTION',1.810,'BLOOD CLOTTING, HYDROLASE',1,1,1),(759,'1o5a','DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)','X-RAY DIFFRACTION',1.680,'BLOOD CLOTTING, HYDROLASE',1,1,1),(760,'1o5b','DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)','X-RAY DIFFRACTION',1.850,'BLOOD CLOTTING, HYDROLASE',1,1,1),(761,'1o5c','DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)','X-RAY DIFFRACTION',1.630,'BLOOD CLOTTING, HYDROLASE',1,1,1),(762,'1o5g','DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)','X-RAY DIFFRACTION',1.750,'BLOOD CLOTTING,HYDROLASE/INHIBITOR',2,1,1),(763,'1o6k','STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP','X-RAY DIFFRACTION',1.700,'TRANSFERASE',1,1,1),(764,'1o6l','CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE','X-RAY DIFFRACTION',1.600,'TRANSFERASE',1,1,1),(765,'1o9a','SOLUTION STRUCTURE OF THE COMPLEX OF 1F12F1 FROM FIBRONECTIN WITH B3 FROM FNBB FROM S. DYSGALACTIAE','SOLUTION NMR',NULL,'CELL ADHESION',1,1,1),(766,'1o9d','STRUCTURAL VIEW OF A FUNGAL TOXIN ACTING ON A 14-3-3 REGULATORY COMPLEX','X-RAY DIFFRACTION',2.300,'PROTEIN-BINDING',1,1,1),(767,'1o9s','CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE HUMAN HISTONE METHYLTRANSFERASE SET7/9','X-RAY DIFFRACTION',1.750,'TRANSFERASE',2,2,1),(768,'1o9u','GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSFERASE/TRANSFERASE SUBSTRATE',1,1,1),(769,'1oau','FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(770,'1obx','CRYSTAL STRUCTURE OF THE COMPLEX OF PDZ2 OF SYNTENIN WITH AN INTERLEUKIN 5 RECEPTOR ALPHA PEPTIDE.','X-RAY DIFFRACTION',1.350,'CELL ADHESION',1,1,1),(771,'1oby','CRYSTAL STRUCTURE OF THE COMPLEX OF PDZ2 OF SYNTENIN WITH A SYNDECAN-4 PEPTIDE.','X-RAY DIFFRACTION',1.850,'CELL ADHESION',2,2,1),(772,'1obz','CRYSTAL STRUCTURE OF THE COMPLEX OF THE PDZ TANDEM OF SYNTENIN WITH AN INTERLEUKIN 5 RECEPTOR ALPHA PEPTIDE.','X-RAY DIFFRACTION',1.700,'CELL ADHESION',1,1,1),(773,'1oc0','PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN','X-RAY DIFFRACTION',2.280,'HYDROLASE/INHIBITOR',1,1,1),(774,'1ocr','BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE','X-RAY DIFFRACTION',2.350,'OXIDOREDUCTASE',6,10,1),(775,'1oeb','MONA/GADS SH3C DOMAIN','X-RAY DIFFRACTION',1.760,'PROTEIN BINDING',1,1,1),(776,'1oex','ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261','X-RAY DIFFRACTION',1.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(777,'1of2','CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(778,'1ofs','PEA LECTIN-SUCROSE COMPLEX','X-RAY DIFFRACTION',1.800,'LECTIN',2,2,1),(779,'1oga','A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM/RECEPTOR',1,3,1),(780,'1ogt','CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)','X-RAY DIFFRACTION',1.470,'IMMUNE SYSTEM',1,1,1),(781,'1ohe','STRUCTURE OF CDC14B PHOSPHATASE WITH A PEPTIDE LIGAND','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(782,'1oj5','CRYSTAL STRUCTURE OF THE NCO-A1 PAS-B DOMAIN BOUND TO THE STAT6 TRANSACTIVATION DOMAIN LXXLL MOTIF','X-RAY DIFFRACTION',2.200,'TRANSCRIPTIONAL COACTIVATOR',1,1,1),(783,'1ok7','A CONSERVED PROTEIN BINDING-SITE ON BACTERIAL SLIDING CLAMPS','X-RAY DIFFRACTION',1.650,'TRANSFERASE',1,1,1),(784,'1okv','CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2','X-RAY DIFFRACTION',2.400,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(785,'1okw','CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2','X-RAY DIFFRACTION',2.500,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(786,'1ol5','STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND BOUND TO TPX2 1-43','X-RAY DIFFRACTION',2.500,'TRANSFERASE/CELL CYCLE',1,1,1),(787,'1ola','THE STRUCTURAL BASIS OF MULTISPECIFICITY IN THE OLIGOPEPTIDE-BINDING PROTEIN OPPA','X-RAY DIFFRACTION',2.100,'BINDING PROTEIN',1,1,1),(788,'1olc','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH LYS-LYS- LYS-ALA','X-RAY DIFFRACTION',2.100,'COMPLEX (BINDING PROTEIN/PEPTIDE)',1,1,1),(789,'1om2','SOLUTION NMR STRUCTURE OF THE MITOCHONDRIAL PROTEIN IMPORT RECEPTOR TOM20 FROM RAT IN A COMPLEX WITH A PRESEQUENCE PEPTIDE DERIVED FROM RAT ALDEHYDE DEHYDROGENASE (ALDH)','SOLUTION NMR',NULL,'RECEPTOR/OXIDOREDUCTASE COMPLEX',1,1,1),(790,'1om9','STRUCTURE OF THE GGA1-APPENDAGE IN COMPLEX WITH THE P56 BINDING PEPTIDE','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT, SIGNALING PROTEIN',2,2,1),(791,'1onv','NMR STRUCTURE OF A COMPLEX CONTAINING THE TFIIF SUBUNIT RAP74 AND THE RNAP II CTD PHOSPHATASE FCP1','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(792,'1oo4','P395S MUTANT OF THE P85 REGULATORY SUBUNIT OF THE N- TERMINAL SRC HOMOLOGY 2 DOMAIN OF PI3-KINASE COMPLEXED TO A PEPTIDE DERIVED FROM PDGFR','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(793,'1ook','CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND HUMAN ALPHA-THROMBIN','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,1,1),(794,'1opi','SOLUTION STRUCTURE OF THE THIRD RNA RECOGNITION MOTIF (RRM) OF U2AF65 IN COMPLEX WITH AN N-TERMINAL SF1 PEPTIDE','SOLUTION NMR',NULL,'RNA BINDING PROTEIN',1,1,1),(795,'1oqe','CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',8,10,1),(796,'1oqn','CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN (PTB) OF MOUSE DISABLED 1 (DAB1)','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',2,2,1),(797,'1oqo','COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(798,'1oqp','STRUCTURE OF THE CA2+/C-TERMINAL DOMAIN OF CALTRACTIN IN COMPLEX WITH THE CDC31P-BINDING DOMAIN FROM KAR1P','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(799,'1or8','STRUCTURE OF THE PREDOMINANT PROTEIN ARGININE METHYLTRANSFERASE PRMT1','X-RAY DIFFRACTION',2.350,'TRANSFERASE',4,1,1),(800,'1ory','FLAGELLAR EXPORT CHAPERONE IN COMPLEX WITH ITS COGNATE BINDING PARTNER','X-RAY DIFFRACTION',2.450,'CHAPERONE',1,1,1),(801,'1osv','STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR','X-RAY DIFFRACTION',2.500,'DNA BINDING PROTEIN',3,2,1),(802,'1osz','MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',2.100,'COMPLEX (MHC I/PEPTIDE)',1,1,1),(803,'1ot5','THE 2.4 ANGSTROM CRYSTAL STRUCTURE OF KEX2 IN COMPLEX WITH A PEPTIDYL- BORONIC ACID INHIBITOR','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(804,'1otr','SOLUTION STRUCTURE OF A CUE-UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'CELL CYCLE',1,1,1),(805,'1ou8','STRUCTURE OF AN AAA+ PROTEASE DELIVERY PROTEIN IN COMPLEX WITH A PEPTIDE DEGRADATION TAG','X-RAY DIFFRACTION',1.600,'TRANSPORT PROTEIN',2,2,1),(806,'1ov3','STRUCTURE OF THE P22PHOX-P47PHOX COMPLEX','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE ACTIVATOR',2,2,1),(807,'1ow6','PAXILLIN LD4 MOTIF BOUND TO THE FOCAL ADHESION TARGETING (FAT) DOMAIN OF THE FOCAL ADHESION KINASE','X-RAY DIFFRACTION',2.350,'TRANSFERASE',2,2,1),(808,'1ox1','CRYSTAL STRUCTURE OF THE BOVINE TRYPSIN COMPLEX WITH A SYNTHETIC 11 PEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(809,'1oxg','CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN ORGANIC SOLVENT TREATED BOVINE ALPHA-CHYMOTRYPSIN AND ITS AUTOCATALYTICALLY PRODUCED HIGHLY POTENT 14-RESIDUE PEPTIDE AT 2.2 RESOLUTION','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(810,'1oxn','STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)','X-RAY DIFFRACTION',2.200,'APOPTOSIS/PEPTIDE',1,1,1),(811,'1oxq','STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP)','X-RAY DIFFRACTION',2.300,'APOPTOSIS/PEPTIDE',1,1,1),(812,'1oyt','COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR','X-RAY DIFFRACTION',1.670,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(813,'1ozs','C-DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH THE INHIBITORY REGION OF HUMAN CARDIAC TROPONIN I','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(814,'1p02','STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(815,'1p03','STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(816,'1p05','STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(817,'1p06','STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES','X-RAY DIFFRACTION',2.340,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(818,'1p10','STRUCTURAL PLASTICITY AS A DETERMINANT OF ENZYME SPECIFICITY. CREATING BROADLY SPECIFIC PROTEASES','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(819,'1p11','CRYSTAL STRUCTURES OF ALPHA-LYTIC PROTEASE COMPLEXES WITH IRREVERSIBLY BOUND PHOSPHONATE ESTERS','X-RAY DIFFRACTION',1.930,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(820,'1p12','CRYSTAL STRUCTURES OF ALPHA-LYTIC PROTEASE COMPLEXES WITH IRREVERSIBLY BOUND PHOSPHONATE ESTERS','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(821,'1p13','CRYSTAL STRUCTURE OF THE SRC SH2 DOMAIN COMPLEXED WITH PEPTIDE (SDPYANFK)','X-RAY DIFFRACTION',1.630,'TRANSFERASE',2,2,1),(822,'1p3q','MECHANISM OF UBIQUITIN RECOGNITION BY THE CUE DOMAIN OF VPS9','X-RAY DIFFRACTION',1.700,'TRANSLATION',2,2,1),(823,'1p4b','THREE-DIMENSIONAL STRUCTURE OF A SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE PEPTIDE GCN4(7P-14P).','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',1,2,1),(824,'1p4n','CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMX:UDP-MURNAC- PENTAPEPTIDE COMPLEX','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE SUBSTRATE',1,1,1),(825,'1p4u','CRYSTAL STRUCTURE OF GGA3 GAE DOMAIN IN COMPLEX WITH RABAPTIN-5 PEPTIDE','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT',1,1,1),(826,'1p7v','STRUCTURE OF A COMPLEX FORMED BETWEEN PROTEINASE K AND A DESIGNED HEPTAPEPTIDE INHIBITOR PRO-ALA-PRO-PHE-ALA-ALA- ALA AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',1.080,'HYDROLASE',1,1,1),(827,'1p7w','CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH A DESIGNED HEPTAPEPTIDE INHIBITOR PRO-ALA-PRO-PHE-ALA-SER-ALA AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',1.020,'HYDROLASE',1,1,1),(828,'1p9d','HIGH-RESOLUTION STRUCTURE OF THE COMPLEX OF HHR23A UBIQUITIN-LIKE DOMAIN AND THE C-TERMINAL UBIQUITIN- INTERACTING MOTIF OF PROTEASOME SUBUNIT S5A','SOLUTION NMR',NULL,'REPLICATION',1,1,1),(829,'1p9u','CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS','X-RAY DIFFRACTION',2.370,'HYDROLASE/HYDROLASE INHIBITOR',2,3,1),(830,'1pau','CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(831,'1pcx','CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT, SEC24, COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN BET1','X-RAY DIFFRACTION',2.500,'TRANSPORT PROTEIN',1,1,1),(832,'1pd7','EXTENDED SID OF MAD1 BOUND TO THE PAH2 DOMAIN OF MSIN3B','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(833,'1pek','STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH A SUBSTRATE-ANALOGUE HEXA-PEPTIDE INHIBITOR AT 2.2 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(834,'1pfg','STRATEGY TO DESIGN INHIBITORS: STRUCTURE OF A COMPLEX OF PROTEINASE K WITH A DESIGNED OCTAPEPTIDE INHIBITOR N-AC-PRO-ALA-PRO-PHE-DALA-ALA- ALA-ALA-NH2 AT 2.5A RESOLUTION','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(835,'1pic','PHOSPHATIDYLINOSITOL 3-KINASE, P85-ALPHA SUBUNIT: C- TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE FROM THE PDGF RECEPTOR, NMR, MINIMIZED MEAN STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (PHOSPHOTRANSFERASE/RECEPTOR)',1,1,1),(836,'1pip','CRYSTAL STRUCTURE OF PAPAIN-SUCCINYL-GLN-VAL-VAL-ALA-ALA-P- NITROANILIDE COMPLEX AT 1.7 ANGSTROMS RESOLUTION: NONCOVALENT BINDING MODE OF A COMMON SEQUENCE OF ENDOGENOUS THIOL PROTEASE INHIBITORS','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(837,'1pj8','STRUCTURE OF A TERNARY COMPLEX OF PROTEINASE K, MERCURY AND A SUBSTRATE-ANALOGUE HEXAPEPTIDE AT 2.2 A RESOLUTION','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(838,'1pjm','MOUSE IMPORTIN ALPHA-BIPARTITE NLS FROM HUMAN RETINOBLASTOMA PROTEIN COMPLEX','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT',1,1,1),(839,'1pjn','MOUSE IMPORTIN ALPHA-BIPARTITE NLS N1N2 FROM XENOPUS LAEVIS PHOSPHOPROTEIN COMPLEX','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT',1,1,1),(840,'1pjp','THE 2.2 A CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH SUCCINYL- ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(841,'1pmx','INSULIN-LIKE GROWTH FACTOR-I BOUND TO A PHAGE-DERIVED PEPTIDE','SOLUTION NMR',NULL,'HORMONE/GROWTH FACTOR',1,1,1),(842,'1pnb','STRUCTURE OF NAPIN BNIB, NMR, 10 STRUCTURES','SOLUTION NMR',NULL,'SEED STORAGE PROTEIN',1,1,1),(843,'1pop','X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A PAPAIN-LEUPEPTIN COMPLEX','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(844,'1pq1','CRYSTAL STRUCTURE OF BCL-XL/BIM','X-RAY DIFFRACTION',1.650,'APOPTOSIS',1,1,1),(845,'1pq8','TRYPSIN AT PH 4 AT ATOMIC RESOLUTION','X-RAY DIFFRACTION',1.000,'HYDROLASE',1,1,1),(846,'1psb','SOLUTION STRUCTURE OF CALCIUM LOADED S100B COMPLEXED TO A PEPTIDE FROM N-TERMINAL REGULATORY DOMAIN OF NDR KINASE.','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',2,2,1),(847,'1pso','THE CRYSTAL STRUCTURE OF HUMAN PEPSIN AND ITS COMPLEX WITH PEPSTATIN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(848,'1pts','CRYSTAL STRUCTURE AND LIGAND BINDING STUDIES OF A SCREENED PEPTIDE COMPLEXED WITH STREPTAVIDIN','X-RAY DIFFRACTION',2.000,'BIOTIN-BINDING PROTEIN/PEPTIDE',1,1,1),(849,'1pu9','CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A 19-RESIDUE HISTONE H3 PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSFERASE/STRUCTURAL PROTEIN',1,1,1),(850,'1pua','CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A PHOSPHORYLATED, 19-RESIDUE HISTONE H3 PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSFERASE/STRUCTURAL PROTEIN',1,1,1),(851,'1pvc','REFINEMENT OF THE SABIN STRAIN OF TYPE 3 POLIOVIRUS AT 2.4 ANGSTROMS AND THE CRYSTAL STRUCTURES OF ITS VARIANTS AT 2.9 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.400,'VIRUS',1,1,1),(852,'1pxd','CRYSTAL STRUCTURE OF THE COMPLEX OF JACALIN WITH MESO- TETRASULPHONATOPHENYLPORPHYRIN.','X-RAY DIFFRACTION',1.800,'SUGAR BINDING PROTEIN',1,1,1),(853,'1pyo','CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP- GLU-SER-ASP-CHO','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(854,'1pyu','PROCESSED ASPARTATE DECARBOXYLASE MUTANT WITH SER25 MUTATED TO CYS','X-RAY DIFFRACTION',1.900,'LYASE',2,2,1),(855,'1pyw','HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ, FVKQNA(MAA)AL, IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM/PROTEIN BINDING/TOXIN',1,2,1),(856,'1pz5','STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,2,1),(857,'1pzl','CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR SRC-1 PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(858,'1q0w','SOLUTION STRUCTURE OF VPS27 AMINO-TERMINAL UIM-UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'TRANSPORT PROTEIN',1,1,1),(859,'1q1a','STRUCTURE OF THE YEAST HST2 PROTEIN DEACETYLASE IN TERNARY COMPLEX WITH 2\'-O-ACETYL ADP RIBOSE AND HISTONE PEPTIDE','X-RAY DIFFRACTION',1.500,'GENE REGULATION',1,1,1),(860,'1q1j','CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(861,'1q1s','MOUSE IMPORTIN ALPHA- PHOSPHORYLATED SV40 CN PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',2,1,1),(862,'1q1t','MOUSE IMPORTIN ALPHA: NON-PHOSPHORYLATED SV40 CN PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT',2,1,1),(863,'1q2c','CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A 19- RESIDUE HISTONE H4 PEPTIDE','X-RAY DIFFRACTION',2.250,'TRANSFERASE/STRUCTURAL PROTEIN',1,1,1),(864,'1q2d','CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A 19-RESIDUE P53 PEPTIDE','X-RAY DIFFRACTION',2.250,'TRANSFERASE/STRUCTURAL PROTEIN',1,1,1),(865,'1q3p','CRYSTAL STRUCTURE OF THE SHANK PDZ-LIGAND COMPLEX REVEALS A CLASS I PDZ INTERACTION AND A NOVEL PDZ-PDZ DIMERIZATION','X-RAY DIFFRACTION',2.250,'PEPTIDE BINDING PROTEIN',2,2,1),(866,'1q4k','THE POLO-BOX DOMAIN OF PLK1 IN COMPLEX WITH A PHOSPHO- PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSFERASE',3,3,1),(867,'1q4q','CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX','X-RAY DIFFRACTION',2.100,'APOPTOSIS INHIBITOR',10,10,1),(868,'1q5l','NMR STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF DNAK BOUND TO THE PEPTIDE NRLLLTG','SOLUTION NMR',NULL,'CHAPERONE',1,1,1),(869,'1q5w','UBIQUITIN RECOGNITION BY NPL4 ZINC-FINGERS','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(870,'1q61','PKA TRIPLE MUTANT MODEL OF PKB','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(871,'1q62','PKA DOUBLE MUTANT MODEL OF PKB','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(872,'1q8t','THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(873,'1q8u','THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR H-1152P','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(874,'1q8w','THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077)','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(875,'1q94','STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,2,1),(876,'1qbq','STRUCTURE OF RAT FARNESYL PROTEIN TRANSFERASE COMPLEXED WITH A CVIM PEPTIDE AND ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID.','X-RAY DIFFRACTION',2.400,'TRANSFERASE',1,2,1),(877,'1qbv','CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE-MIMETIC INHIBITOR','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(878,'1qd6','OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI','X-RAY DIFFRACTION',2.100,'MEMBRANE PROTEIN',2,2,1),(879,'1qew','HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271- 279)','X-RAY DIFFRACTION',2.200,'COMPLEX (MHC PROTEINTIGEN)',1,1,1),(880,'1qfn','GLUTAREDOXIN-1-RIBONUCLEOTIDE REDUCTASE B1 MIXED DISULFIDE BOND','SOLUTION NMR',NULL,'ELECTRON TRANSPORT/OXIDOREDUCTASE',1,1,1),(881,'1qg1','GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH AN SHC-DERIVED PEPTIDE','SOLUTION NMR',NULL,'HORMONE/GROWTH FACTOR',1,1,1),(882,'1qgk','STRUCTURE OF IMPORTIN BETA BOUND TO THE IBB DOMAIN OF IMPORTIN ALPHA','X-RAY DIFFRACTION',2.500,'TRANSPORT RECEPTOR',1,1,1),(883,'1qgr','STRUCTURE OF IMPORTIN BETA BOUND TO THE IBB DOMAIN OF IMPORTIN ALPHA (II CRYSTAL FORM, GROWN AT LOW PH)','X-RAY DIFFRACTION',2.300,'TRANSPORT RECEPTOR',1,1,1),(884,'1qhr','NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.200,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(885,'1qix','PORCINE PANCREATIC ELASTASE COMPLEXED WITH HUMAN BETA-CASOMORPHIN-7','X-RAY DIFFRACTION',1.900,'SERINE PROTEINASE',1,1,1),(886,'1qj1','NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(887,'1qj6','NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(888,'1qj7','NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(889,'1qja','14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 2)','X-RAY DIFFRACTION',2.000,'KINASE INHIBITOR/PEPTIDE',2,2,1),(890,'1qjb','14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 1)','X-RAY DIFFRACTION',2.000,'KINASE INHIBITOR/PEPTIDE',2,2,1),(891,'1qjj','STRUCTURE OF ASTACIN WITH A HYDROXAMIC ACID INHIBITOR','X-RAY DIFFRACTION',1.860,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(892,'1qka','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KRK','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT',1,1,1),(893,'1qkb','OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KVK','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT',1,1,1),(894,'1qkz','FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,2,1),(895,'1qls','S100C (S100A11),OR CALGIZZARIN, IN COMPLEX WITH ANNEXIN I N-TERMINUS','X-RAY DIFFRACTION',2.300,'METAL-BINDING PROTEIN/INHIBITOR',1,1,1),(896,'1qmz','PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.200,'CELL CYCLE',2,4,1),(897,'1qng','PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A','X-RAY DIFFRACTION',2.100,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(898,'1qnh','PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A','X-RAY DIFFRACTION',2.100,'ISOMERASE/IMMUNOSUPPRESSANT',2,2,1),(899,'1qnz','NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE','SOLUTION NMR',NULL,'IMMUNE SYSTEM',1,2,1),(900,'1qo3','COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD','X-RAY DIFFRACTION',2.300,'RECEPTOR/IMMUNE SYSTEM',1,1,1),(901,'1qqp','FOOT-AND-MOUTH DISEASE VIRUS/ OLIGOSACCHARIDE RECEPTOR COMPLEX.','X-RAY DIFFRACTION',1.900,'VIRUS',1,3,1),(902,'1qr1','POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,2,1),(903,'1qr3','STRUCTURE OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH FR901277, A NOVEL MACROCYCLIC INHIBITOR OF ELASTASES AT 1.6 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(904,'1qs7','THE 1.8 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.800,'METAL BINDING PROTEIN/PEPTIDE',2,2,1),(905,'1qs8','CRYSTAL STRUCTURE OF THE P. VIVAX ASPARTIC PROTEINASE PLASMEPSIN COMPLEXED WITH THE INHIBITOR PEPSTATIN A','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(906,'1qsc','CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF2 IN A COMPLEX WITH A PEPTIDE FROM THE CD40 RECEPTOR','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',3,3,1),(907,'1qsn','CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND HISTONE H3 PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(908,'1qtn','CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE','X-RAY DIFFRACTION',1.200,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(909,'1qtx','THE 1.65 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.650,'SIGNALING PROTEIN',1,1,1),(910,'1qur','HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE-BASED SYNTHETIC INHIBITOR','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(911,'1qvo','STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE','X-RAY DIFFRACTION',2.220,'IMMUNE SYSTEM',2,2,1),(912,'1qxa','CRYSTAL STRUCTURE OF SORTASE B COMPLEXED WITH GLY3','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(913,'1qz0','CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(914,'1qz7','BETA-CATENIN BINDING DOMAIN OF AXIN IN COMPLEX WITH BETA- CATENIN','X-RAY DIFFRACTION',2.200,'CELL ADHESION',1,1,1),(915,'1r17','CRYSTAL STRUCTURE ANALYSIS OF S.EPIDERMIDIS ADHESIN SDRG BINDING TO FIBRINOGEN (ADHESIN-LIGAND COMPLEX)','X-RAY DIFFRACTION',1.860,'CELL ADHESION',2,2,1),(916,'1r1p','STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',4,4,1),(917,'1r1q','STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',2,2,1),(918,'1r1s','STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',4,4,1),(919,'1r2b','CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN COMPLEXED WITH A SMRT CO-REPRESSOR PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(920,'1r5v','EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',2,4,1),(921,'1r64','THE 2.2 A CRYSTAL STRUCTURE OF KEX2 PROTEASE IN COMPLEX WITH AC-ARG- GLU-LYS-BOROARG PEPTIDYL BORONIC ACID INHIBITOR','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(922,'1r8u','NMR STRUCTURE OF CBP TAZ1/CITED2 COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION/TRANSCRIPTION ACTIVATOR',1,1,1),(923,'1r9n','CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A DECAPEPTIDE (TNPY) AT 2.3 ANG. RESOLUTION','X-RAY DIFFRACTION',2.300,'HYDROLASE',4,4,1),(924,'1rbc','CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES','X-RAY DIFFRACTION',2.000,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(925,'1rbd','CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES','X-RAY DIFFRACTION',1.700,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(926,'1rbe','CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES','X-RAY DIFFRACTION',1.750,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(927,'1rbf','CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES','X-RAY DIFFRACTION',1.800,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(928,'1rbg','CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES','X-RAY DIFFRACTION',1.800,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(929,'1rbh','CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES','X-RAY DIFFRACTION',1.700,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(930,'1rbi','CRYSTALLOGRAPHIC STRUCTURES OF RIBONUCLEASE S VARIANTS WITH NONPOLAR SUBSTITUTION AT POSITION 13: PACKING AND CAVITIES','X-RAY DIFFRACTION',1.800,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(931,'1rd3','2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(932,'1rdq','HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE','X-RAY DIFFRACTION',1.260,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(933,'1rdt','CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER','X-RAY DIFFRACTION',2.400,'HORMONE/GROWTH FACTOR',2,2,1),(934,'1re3','CRYSTAL STRUCTURE OF FRAGMENT D OF BBETAD398A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE','X-RAY DIFFRACTION',2.450,'BLOOD CLOTTING',2,2,1),(935,'1rff','CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTAPEPTIDE KLNYYDPR, AND TETRANUCLEOTIDE AGTT.','X-RAY DIFFRACTION',1.700,'HYDROLASE/DNA',2,2,1),(936,'1rfi','CRYSTAL STRUCTURE OF HUMAN TYROSYL-DNA PHOSPHODIESTERASE COMPLEXED WITH VANADATE, PENTAPEPTIDE KLNYK, AND TETRANUCLEOTIDE AGTC','X-RAY DIFFRACTION',2.200,'HYDROLASE/DNA',2,2,1),(937,'1rgj','NMR STRUCTURE OF THE COMPLEX BETWEEN ALPHA-BUNGAROTOXIN AND MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR WITH ENHANCED ACTIVITY','SOLUTION NMR',NULL,'TOXIN',1,1,1),(938,'1rgr','CYCLIC PEPTIDES TARGETING PDZ DOMAINS OF PSD-95: STRUCTURAL BASIS FOR ENHANCED AFFINITY AND ENZYMATIC STABILITY','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN/DE NOVO PROTEIN',1,1,1),(939,'1rhk','CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL-PROPYL- KETONE INHIBITOR','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(940,'1riw','THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOR OSCILLARIN','X-RAY DIFFRACTION',2.040,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(941,'1rjk','CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2MD AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',1.990,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(942,'1rjy','MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(943,'1rk1','MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(944,'1rk3','CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 1,25-DIHYDROXYVITAMIN D3 AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',2.200,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(945,'1rk8','STRUCTURE OF THE CYTOSOLIC PROTEIN PYM BOUND TO THE MAGO- Y14 CORE OF THE EXON JUNCTION COMPLEX','X-RAY DIFFRACTION',1.900,'TRANSLATION',1,2,1),(946,'1rkg','CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2MBISP AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',1.900,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(947,'1rkh','CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2AM20R AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',2.280,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(948,'1rmh','RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL','X-RAY DIFFRACTION',2.400,'ISOMERASE/ ISOMERASE SUBSTRATE',2,2,1),(949,'1rrv','X-RAY CRYSTAL STRUCTURE OF TDP-VANCOSAMINYLTRANSFERASE GTFD AS A COMPLEX WITH TDP AND THE NATURAL SUBSTRATE, DESVANCOSAMINYL VANCOMYCIN.','X-RAY DIFFRACTION',2.000,'TRANSFERASE/ANTIBIOTIC',2,2,1),(950,'1rst','COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG PEPTIDE','X-RAY DIFFRACTION',1.700,'COMPLEX (SIGNAL PROTEIN/PEPTIDE)',1,1,1),(951,'1rsu','COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG II PEPTIDE','X-RAY DIFFRACTION',1.700,'COMPLEX (SIGNAL PROTEIN/PEPTIDE)',1,1,1),(952,'1rtf','COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA]','X-RAY DIFFRACTION',2.300,'SERINE PROTEASE',1,1,1),(953,'1rxz','C-TERMINAL REGION OF A. FULGIDUS FEN-1 COMPLEXED WITH A. FULGIDUS PCNA','X-RAY DIFFRACTION',2.000,'REPLICATION',1,1,1),(954,'1rzx','CRYSTAL STRUCTURE OF A PAR-6 PDZ-PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.100,'CELL CYCLE',1,1,1),(955,'1s2k','STRUCTURE OF SCP-B A MEMBER OF THE EQOLISIN FAMILY OF PEPTIDASES IN A COMPLEX WITH A TRIPEPTIDE ALA-ILE-HIS','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(956,'1s4v','THE 2.0 A CRYSTAL STRUCTURE OF THE KDEL-TAILED CYSTEINE ENDOPEPTIDASE FUNCTIONING IN PROGRAMMED CELL DEATH OF RICINUS COMMUNIS ENDOSPERM','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(957,'1s4z','HP1 CHROMO SHADOW DOMAIN IN COMPLEX WITH PXVXL MOTIF OF CAF- 1','SOLUTION NMR',NULL,'GENE REGULATION',1,2,1),(958,'1s5p','STRUCTURE AND SUBSTRATE BINDING PROPERTIES OF COBB, A SIR2 HOMOLOG PROTEIN DEACETYLASE FROM ESCHERICIA COLI.','X-RAY DIFFRACTION',1.960,'HYDROLASE',1,1,1),(959,'1s5q','SOLUTION STRUCTURE OF MAD1 SID-MSIN3A PAH2 COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(960,'1s5r','SOLUTION STRUCTURE OF HBP1 SID-MSIN3A PAH2 COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(961,'1s6c','CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN KCHIP1 AND KV4.2 N1-30','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(962,'1s72','REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.400,'RIBOSOME',1,1,1),(963,'1s7q','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS','X-RAY DIFFRACTION',1.990,'IMMUNE SYSTEM',1,1,1),(964,'1s7s','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS','X-RAY DIFFRACTION',1.990,'IMMUNE SYSTEM',1,1,1),(965,'1s7t','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(966,'1s7u','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',4,4,1),(967,'1s7v','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,2,1),(968,'1s7w','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',4,5,1),(969,'1s7x','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',4,5,1),(970,'1s8d','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(971,'1s9v','CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE','X-RAY DIFFRACTION',2.220,'IMMUNE SYSTEM',2,4,1),(972,'1s9w','CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(973,'1s9x','CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(974,'1s9y','CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(975,'1sb0','SOLUTION STRUCTURE OF THE KIX DOMAIN OF CBP BOUND TO THE TRANSACTIVATION DOMAIN OF C-MYB','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(976,'1sb1','NOVEL NON-COVALENT THROMBIN INHIBITORS INCORPORATING P1 4,5,6,7- TETRAHYDROBENZOTHIAZOLE ARGININE SIDE CHAIN MIMETICS','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(977,'1sbw','CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE FRAGMENT COMPLEX WITH BOVINE BETA-TRYPSIN AT 1.8A RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(978,'1sdx','CRYSTAL STRUCTURE OF THE ZINC SATURATED C-TERMINAL HALF OF BOVINE LACTOFERRIN AT 2.0 A RESOLUTION REVEALS TWO ADDITIONAL ZINC BINDING SITES','X-RAY DIFFRACTION',2.060,'TRANSPORT PROTEIN',1,1,1),(979,'1sdz','CRYSTAL STRUCTURE OF DIAP1 BIR1 BOUND TO A REAPER PEPTIDE','X-RAY DIFFRACTION',1.780,'APOPTOSIS',1,1,1),(980,'1se0','CRYSTAL STRUCTURE OF DIAP1 BIR1 BOUND TO A GRIM PEPTIDE','X-RAY DIFFRACTION',1.750,'APOPTOSIS',1,1,1),(981,'1sfi','HIGH RESOLUTION STRUCTURE OF A POTENT, CYCLIC PROTEASE INHIBITOR FROM SUNFLOWER SEEDS','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(982,'1sfq','FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK','X-RAY DIFFRACTION',1.910,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(983,'1sg8','CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(984,'1sgc','THE 1.8 ANGSTROMS STRUCTURE OF THE COMPLEX BETWEEN CHYMOSTATIN AND STREPTOMYCES GRISEUS PROTEASE A. A MODEL FOR SERINE PROTEASE CATALYTIC TETRAHEDRAL INTERMEDIATES','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(985,'1sgi','CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(986,'1sha','CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES','X-RAY DIFFRACTION',1.500,'PHOSPHOTRANSFERASE',1,1,1),(987,'1shb','CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES','X-RAY DIFFRACTION',2.000,'PHOSPHOTRANSFERASE',1,1,1),(988,'1shc','SHC PTB DOMAIN COMPLEXED WITH A TRKA RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)',1,1,1),(989,'1shd','PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS','X-RAY DIFFRACTION',2.000,'COMPLEX(TRANSFERASE/PEPTIDE)',1,1,1),(990,'1shh','SLOW FORM OF THROMBIN BOUND WITH PPACK','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(991,'1sio','STRUCTURE OF KUMAMOLISIN-AS COMPLEXED WITH A COVALENTLY-BOUND INHIBITOR, ACIPF','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',3,3,1),(992,'1sje','HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION','X-RAY DIFFRACTION',2.450,'IMMUNE SYSTEM',1,2,1),(993,'1sjh','HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',1,2,1),(994,'1skg','STRUCTURE-BASED RATIONAL DRUG DESIGN: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A PENTAPEPTIDE VAL-ALA-PHE-ARG- SER','X-RAY DIFFRACTION',1.210,'HYDROLASE',1,1,1),(995,'1sl3','CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT P1 HETEROCYCLE- ARYL BASED INHIBITOR','X-RAY DIFFRACTION',1.810,'BLOOD CLOTTING,HYDROLASE/INHIBITOR',1,1,1),(996,'1sld','STREPTAVIDIN, PH 7.5, BOUND TO CYCLIC DISULFIDE-BONDED PEPTIDE LIGAND AC-CHPQFC-NH2','X-RAY DIFFRACTION',2.500,'COMPLEX(BIOTIN-BINDING PROTEIN/PEPTID',1,1,1),(997,'1sle','STREPTAVIDIN, PH 5.0, BOUND TO CYCLIC PEPTIDE AC-CHPQGPPC- NH2','X-RAY DIFFRACTION',2.000,'COMPLEX(BIOTIN-BINDING PROTEIN/PEPTID',2,2,1),(998,'1slg','STREPTAVIDIN, PH 5.6, BOUND TO PEPTIDE FCHPQNT','X-RAY DIFFRACTION',1.760,'COMPLEX(BIOTIN-BINDING PROTEIN/PEPTID',2,2,1),(999,'1sm3','CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE','X-RAY DIFFRACTION',1.950,'COMPLEX (ANTIBODY/PEPTIDE EPITOPE)',1,2,1),(1000,'1smf','STUDIES ON AN ARTIFICIAL TRYPSIN INHIBITOR PEPTIDE DERIVED FROM THE MUNG BEAN INHIBITOR','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1001,'1smh','PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N- TERMINAL HELIX','X-RAY DIFFRACTION',2.040,'SIGNALING PROTEIN,TRANSFERASE/INHIBIT',1,1,1),(1002,'1smr','THE 3-D STRUCTURE OF MOUSE SUBMAXILLARY RENIN COMPLEXED WITH A DECAPEPTIDE INHIBITOR CH-66 BASED ON THE 4-16 FRAGMENT OF RAT ANGIOTENSINOGEN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(1003,'1soz','CRYSTAL STRUCTURE OF DEGS PROTEASE IN COMPLEX WITH AN ACTIVATING PEPTIDE','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,2,1),(1004,'1sp4','CRYSTAL STRUCTURE OF NS-134 IN COMPLEX WITH BOVINE CATHEPSIN B: A TWO HEADED EPOXYSUCCINYL INHIBITOR EXTENDS ALONG THE WHOLE ACTIVE SITE CLEFT','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1005,'1sp5','CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A PRODUCT OF AUTOPROTEOLYSIS','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,2,1),(1006,'1sqk','CRYSTAL STRUCTURE OF CIBOULOT IN COMPLEX WITH SKELETAL ACTIN','X-RAY DIFFRACTION',2.500,'STRUCTURAL PROTEIN/PROTEIN BINDING',1,1,1),(1007,'1sqz','DESIGN OF SPECIFIC INHIBITORS OF PHOPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOPHOLIPASE A2 AND A DESIGNED PEPTIDE DEHYDRO-ILE-ALA-ARG-SER AT 1.2A RESOLUTION','X-RAY DIFFRACTION',1.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1008,'1srn','THE REFINED CRYSTAL STRUCTURE OF A FULLY ACTIVE SEMISYNTHETIC RIBONUCLEASE AT 1.8 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE (NUCLEIC ACID,RNA)',1,1,1),(1009,'1ssa','A STRUCTURAL INVESTIGATION OF CATALYTICALLY MODIFIED F12OL AND F12OY SEMISYNTHETIC RIBONUCLEASES','X-RAY DIFFRACTION',2.000,'HYDROLASE(ENDORIBONUCLEASE)',1,1,1),(1010,'1ssb','A STRUCTURAL INVESTIGATION OF CATALYTICALLY MODIFIED F12OL AND F12OY SEMISYNTHETIC RIBONUCLEASES','X-RAY DIFFRACTION',2.000,'HYDROLASE(ENDORIBONUCLEASE)',1,1,1),(1011,'1ssc','THE 1.6 ANGSTROMS STRUCTURE OF A SEMISYNTHETIC RIBONUCLEASE CRYSTALLIZED FROM AQUEOUS ETHANOL. COMPARISON WITH CRYSTALS FROM SALT SOLUTIONS AND WITH RNASE A FROM AQUEOUS ALCOHOL SOLUTIONS','X-RAY DIFFRACTION',2.000,'ENDONUCLEASE',1,1,1),(1012,'1sse','SOLUTION STRUCTURE OF THE OXIDIZED FORM OF THE YAP1 REDOX DOMAIN','SOLUTION NMR',NULL,'TRANSCRIPTION ACTIVATOR',1,1,1),(1013,'1ssh','CRYSTAL STRUCTURE OF THE SH3 DOMAIN FROM A S. CEREVISIAE HYPOTHETICAL 40.4 KDA PROTEIN IN COMPLEX WITH A PEPTIDE','X-RAY DIFFRACTION',1.400,'CONTRACTILE PROTEIN',1,1,1),(1014,'1stc','CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE','X-RAY DIFFRACTION',2.300,'COMPLEX (TRANSFERASE/INHIBITOR)',1,1,1),(1015,'1str','STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE AC- CHPQNT-NH2 DIMER','X-RAY DIFFRACTION',1.800,'COMPLEX (GLYCOPROTEIN/PEPTIDE)',2,2,1),(1016,'1sts','STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE FCHPQNT- NH2 DIMER','X-RAY DIFFRACTION',1.950,'COMPLEX (GLYCOPROTEIN/PEPTIDE)',2,2,1),(1017,'1sua','SUBTILISIN BPN\'','X-RAY DIFFRACTION',2.100,'COMPLEX (HYDROLASE/PEPTIDE)',1,1,1),(1018,'1suy','NMR STRUCTURE OF THE THKAIA180C-CIIABD COMPLEX (AVERAGE MINIMIZED STRUCTURE)','SOLUTION NMR',NULL,'CIRCADIAN CLOCK PROTEIN',2,2,1),(1019,'1sv1','NMR STRUCTURE OF THE THKAIA180C-CIIABD COMPLEX (25-STRUCTURE ENSEMBLE)','SOLUTION NMR',NULL,'CIRCADIAN CLOCK PROTEIN',2,2,1),(1020,'1sve','CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 1','X-RAY DIFFRACTION',2.490,'TRANSFERASE',1,1,1),(1021,'1svf','PARAMYXOVIRUS SV5 FUSION PROTEIN CORE','X-RAY DIFFRACTION',1.400,'VIRAL PROTEIN',2,2,1),(1022,'1svg','CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 4','X-RAY DIFFRACTION',2.020,'TRANSFERASE',1,1,1),(1023,'1svh','CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 8','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(1024,'1svz','CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE','X-RAY DIFFRACTION',1.890,'IMMUNE SYSTEM',2,2,1),(1025,'1sy9','STRUCTURE OF CALMODULIN COMPLEXED WITH A FRAGMENT OF THE OLFACTORY CNG CHANNEL','SOLUTION NMR',NULL,'CALCIUM-BINDING PROTEIN',1,1,1),(1026,'1syq','HUMAN VINCULIN HEAD DOMAIN VH1, RESIDUES 1-258, IN COMPLEX WITH HUMAN TALIN\'S VINCULIN BINDING SITE 1, RESIDUES 607-636','X-RAY DIFFRACTION',2.420,'CELL ADHESION',1,1,1),(1027,'1sys','CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(1028,'1syv','HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(1029,'1sza','THE RNA POLYMERASE II CTD IN MRNA PROCESSING: BETA-TURN RECOGNITION AND BETA-SPIRAL MODEL','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(1030,'1szc','STRUCTURAL BASIS FOR NICOTINAMIDE CLEAVAGE AND ADP-RIBOSE TRANSFER BY NAD+-DEPENDENT SIR2 HISTONE/PROTEIN DEACETYLASES','X-RAY DIFFRACTION',1.750,'GENE REGULATION',1,1,1),(1031,'1szd','STRUCTURAL BASIS FOR NICOTINAMIDE CLEAVAGE AND ADP-RIBOSE TRANSFER BY NAD+-DEPENDENT SIR2 HISTONE/PROTEIN DEACETYLASES','X-RAY DIFFRACTION',1.500,'GENE REGULATION',1,1,1),(1032,'1t01','VINCULIN COMPLEXED WITH THE VBS1 HELIX FROM TALIN','X-RAY DIFFRACTION',2.060,'CELL ADHESION, STRUCTURAL PROTEIN',1,1,1),(1033,'1t08','CRYSTAL STRUCTURE OF BETA-CATENIN/ICAT HELICAL DOMAIN/UNPHOSPHORYLATED APC R3','X-RAY DIFFRACTION',2.100,'CELL ADHESION/CELL CYCLE',2,1,1),(1034,'1t0f','CRYSTAL STRUCTURE OF THE TNSA/TNSC(504-555) COMPLEX','X-RAY DIFFRACTION',1.850,'DNA BINDING PROTEIN',2,2,1),(1035,'1t0j','CRYSTAL STRUCTURE OF A COMPLEX BETWEEN VOLTAGE-GATED CALCIUM CHANNEL BETA2A SUBUNIT AND A PEPTIDE OF THE ALPHA1C SUBUNIT','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,1,1),(1036,'1t0m','CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(1037,'1t0n','CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(1038,'1t15','CRYSTAL STRUCTURE OF THE BRCA1 BRCT DOMAINS IN COMPLEX WITH THE PHOSPHORYLATED INTERACTING REGION FROM BACH1 HELICASE','X-RAY DIFFRACTION',1.850,'ANTITUMOR PROTEIN',1,1,1),(1039,'1t1w','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(1040,'1t1x','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(1041,'1t1y','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(1042,'1t1z','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(1043,'1t20','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(1044,'1t21','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL','X-RAY DIFFRACTION',2.190,'IMMUNE SYSTEM',1,1,1),(1045,'1t22','STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(1046,'1t29','CRYSTAL STRUCTURE OF THE BRCA1 BRCT REPEATS BOUND TO A PHOSPHORYLATED BACH1 PEPTIDE','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',1,1,1),(1047,'1t3l','STRUCTURAL ANALYSIS OF THE VOLTAGE-DEPENDENT CALCIUM CHANNEL BETA SUBUNIT FUNCTIONAL CORE IN COMPLEX WITH ALPHA1 INTERACTION DOMAIN','X-RAY DIFFRACTION',2.200,'TRANSPORT PROTEIN',1,1,1),(1048,'1t4f','STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH AN OPTIMIZED P53 PEPTIDE','X-RAY DIFFRACTION',1.900,'LIGASE',1,1,1),(1049,'1t4u','CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND TO THROMBIN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1050,'1t4v','CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND TO THROMBIN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1051,'1t5w','HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,4,1),(1052,'1t5x','HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(1053,'1t5z','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN (LBD) WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR ARA70','X-RAY DIFFRACTION',2.300,'HORMONE/GROWTH FACTOR',1,1,1),(1054,'1t63','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX3','X-RAY DIFFRACTION',2.070,'HORMONE/GROWTH FACTOR',1,1,1),(1055,'1t65','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FORM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX 2 BOUND IN A NON-HELICAL CONFORMATION','X-RAY DIFFRACTION',1.660,'HORMONE/GROWTH FACTOR',1,1,1),(1056,'1t73','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXFF MOTIF','X-RAY DIFFRACTION',2.200,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(1057,'1t74','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A WXXLF MOTIF','X-RAY DIFFRACTION',2.000,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(1058,'1t76','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A WXXVW MOTIF','X-RAY DIFFRACTION',2.100,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(1059,'1t79','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXLW MOTIF','X-RAY DIFFRACTION',1.800,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(1060,'1t7d','CRYSTAL STRUCTURE OF ESCHERICHIA COLI TYPE I SIGNAL PEPTIDASE IN COMPLEX WITH A LIPOPEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.470,'HYDROLASE/ANTIBIOTIC',2,2,1),(1061,'1t7f','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A LXXLL MOTIF','X-RAY DIFFRACTION',1.600,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(1062,'1t7m','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXYF MOTIF','X-RAY DIFFRACTION',1.600,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(1063,'1t7r','CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXLF MOTIF','X-RAY DIFFRACTION',1.400,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(1064,'1ta2','CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1065,'1ta6','CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1066,'1tab','STRUCTURE OF THE TRYPSIN-BINDING DOMAIN OF BOWMAN-BIRK TYPE PROTEASE INHIBITOR AND ITS INTERACTION WITH TRYPSIN','X-RAY DIFFRACTION',2.300,'HYDROLASE (SERINE PROTEINASE)',1,1,1),(1067,'1tb6','2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX','X-RAY DIFFRACTION',2.500,'HYDROLASE/BLOOD CLOTTING',1,1,1),(1068,'1tbz','HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N-[5- (AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L- PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1069,'1tce','SOLUTION NMR STRUCTURE OF THE SHC SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM THE T-CELL RECEPTOR, MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)',1,1,1),(1070,'1tdv','NON-SPECIFIC BINDING TO PHOSPHOLIPASE A2:CRYSTAL STRUCTURE OF THE COMPLEX OF PLA2 WITH A DESIGNED PEPTIDE TYR-TRP-ALA- ALA-ALA-ALA AT 1.7A RESOLUTION','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(1071,'1tet','CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS','X-RAY DIFFRACTION',2.300,'IMMUNOGLOBULIN',1,2,1),(1072,'1tfc','CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(1073,'1tg1','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PHOSPHOLIPASE A2 AND A DESIGNED PEPTIDE INHIBITOR PHQ-LEU-VAL-ARG-TYR AT 1.2A RESOLUTION','X-RAY DIFFRACTION',1.250,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1074,'1tg4','DESIGN OF SPECIFIC INHIBITORS OF GROUPII PHOSPHOLIPASE A2(PLA2): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PLA2 AND DESIGNED PEPTIDE PHE-LEU-ALA-TYR- LYS AT 1.7A RESOLUTION','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(1075,'1thp','STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG- CHLOROMETHYLKETONE','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1076,'1thr','STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR','X-RAY DIFFRACTION',2.300,'HYDROLASE(SERINE PROTEINASE)',2,1,1),(1077,'1ths','STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1078,'1tii','ESCHERICHIA COLI HEAT LABILE ENTEROTOXIN TYPE IIB','X-RAY DIFFRACTION',2.250,'ENTEROTOXIN',1,6,1),(1079,'1tj9','STRUCTURE OF THE COMPLEXED FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND A RATIONALLY DESIGNED TETRA PEPTIDE,VAL-ALA-ARG-SER AT 1.1A RESOLUTION','X-RAY DIFFRACTION',1.100,'HYDROLASE',1,1,1),(1080,'1tjg','CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE','X-RAY DIFFRACTION',2.000,'VIRAL PROTEIN/IMMUNE SYSTEM',1,2,1),(1081,'1tjh','CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE','X-RAY DIFFRACTION',2.100,'VIRAL PROTEIN/IMMUNE SYSTEM',1,2,1),(1082,'1tji','CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN/IMMUNE SYSTEM',1,2,1),(1083,'1tjk','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 WITH A DESIGNED PENTAPEPTIDE, PHE- LEU- SER- THR- LYS AT 1.2 A RESOLUTION','X-RAY DIFFRACTION',1.250,'HYDROLASE',1,1,1),(1084,'1tk2','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN ALKALINE PROTEINASE SAVINASE AND GRAMICIDIN S AT 1.5A RESOLUTION','X-RAY DIFFRACTION',1.540,'HYDROLASE/ANTIBIOTIC',1,1,1),(1085,'1tk4','CRYSTAL STRUCTURE OF RUSSELLS VIPER PHOSPHOLIPASE A2 IN COMPLEX WITH A SPECIFICALLY DESIGNED TETRAPEPTIDE ALA-ILE- ARG-SER AT 1.1 A RESOLUTION','X-RAY DIFFRACTION',1.100,'HYDROLASE',1,1,1),(1086,'1tl9','HIGH RESOLUTION CRYSTAL STRUCTURE OF CALPAIN I PROTEASE CORE IN COMPLEX WITH LEUPEPTIN','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1087,'1tmb','MOLECULAR BASIS FOR THE INHIBITION OF HUMAN ALPHA-THROMBIN BY THE MACROCYCLIC PEPTIDE CYCLOTHEONAMIDE A','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(1088,'1tmc','THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN','X-RAY DIFFRACTION',2.300,'HISTOCOMPATIBILITY ANTIGEN',1,1,1),(1089,'1tmt','CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(1090,'1tmu','CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1091,'1tn6','PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A RAP2A PEPTIDE SUBSTRATE AND A FPP ANALOG AT 1.8A RESOLUTION','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,2,1),(1092,'1tn7','PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A TC21 PEPTIDE SUBSTRATE AND A FPP ANALOG AT 2.3A RESOLUTION','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,2,1),(1093,'1tn8','PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A H-RAS PEPTIDE SUBSTRATE AND A FPP ANALOG AT 2.25A RESOLUTION','X-RAY DIFFRACTION',2.250,'TRANSFERASE',1,2,1),(1094,'1tom','ALPHA-THROMBIN COMPLEXED WITH HIRUGEN','X-RAY DIFFRACTION',1.800,'BLOOD COAGULATION/HYDROLASE INHIBITOR',2,1,1),(1095,'1toq','CRYSTAL STRUCTURE OF A GALACTOSE SPECIFIC LECTIN FROM ARTOCARPUS HIRSUTA IN COMPLEX WITH METHYL-A-D-GALACTOSE','X-RAY DIFFRACTION',2.500,'SUGAR BINDING PROTEIN',4,4,1),(1096,'1tp3','PDZ3 DOMAIN OF PSD-95 PROTEIN COMPLEXED WITH KKETPV PEPTIDE LIGAND','X-RAY DIFFRACTION',1.990,'PROTEIN BINDING',1,1,1),(1097,'1tp5','CRYSTAL STRUCTURE OF PDZ3 DOMAIN OF PSD-95 PROTEIN COMPLEXED WITH A PEPTIDE LIGAND KKETWV','X-RAY DIFFRACTION',1.540,'PEPTIDE BINDING PROTEIN',1,1,1),(1098,'1tps','ATOMIC STRUCTURE OF THE TRYPSIN-A90720A COMPLEX: A UNIFIED APPROACH TO STRUCTURE AND FUNCTION','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1099,'1tq7','CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN MUTANT W215A/E217A BOUND TO PPACK','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1100,'1tsq','CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT','X-RAY DIFFRACTION',2.000,'HYDROLASE/VIRAL PROTEIN',1,2,1),(1101,'1tsu','CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT','X-RAY DIFFRACTION',2.100,'VIRAL PROTEIN/HYDROLASE',1,2,1),(1102,'1ttw','CRYSTAL STRUCTURE OF THE YERSINIA PESTIS TYPE III SECRETION CHAPERONE SYCH IN COMPLEX WITH A STABLE FRAGMENT OF YSCM2','X-RAY DIFFRACTION',2.380,'CHAPERONE',1,1,1),(1103,'1tu3','CRYSTAL STRUCTURE OF RAB5 COMPLEX WITH RABAPTIN5 C-TERMINAL DOMAIN','X-RAY DIFFRACTION',2.310,'PROTEIN TRANSPORT',3,4,1),(1104,'1tvb','CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(1105,'1tvh','CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(1106,'1tw6','STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 9MER PEPTIDE DERIVED FROM SMAC','X-RAY DIFFRACTION',1.710,'INHIBITOR/APOPTOSIS',2,2,1),(1107,'1twb','SSPB DISULFIDE CROSSLINKED TO AN SSRA DEGRADATION TAG','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,2,1),(1108,'1twf','RNA POLYMERASE II COMPLEXED WITH UTP AT 2.3 A RESOLUTION','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,4,1),(1109,'1twq','CRYSTAL STRUCTURE OF THE C-TERMINAL PGN-BINDING DOMAIN OF HUMAN PGRP- IALPHA IN COMPLEX WITH PGN ANALOG MURAMYL TRIPEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM, MEMBRANE PROTEIN',1,1,1),(1110,'1twx','CRYSTAL STRUCTURE OF THE THROMBIN MUTANT D221A/D222K','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1111,'1ty4','CRYSTAL STRUCTURE OF A CED-9/EGL-1 COMPLEX','X-RAY DIFFRACTION',2.200,'APOPTOSIS',2,2,1),(1112,'1tze','SIGNAL TRANSDUCTION ADAPTOR GROWTH FACTOR, GRB2 SH2 DOMAIN COMPLEXED WITH PHOSPHOTYROSYL HEPTAPEPTIDE LYS-PRO-PHE-PTYR-VAL-ASN-VAL-NH2 (KFPPYVNC-NH2)','X-RAY DIFFRACTION',2.100,'COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)',1,1,1),(1113,'1tzg','CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,4,1),(1114,'1tzs','CRYSTAL STRUCTURE OF AN ACTIVATION INTERMEDIATE OF CATHEPSIN E','X-RAY DIFFRACTION',2.350,'HYDROLASE',2,1,1),(1115,'1u00','HSCA SUBSTRATE BINDING DOMAIN COMPLEXED WITH THE ISCU RECOGNITION PEPTIDE ELPPVKIHC','X-RAY DIFFRACTION',1.950,'CHAPERONE',1,1,1),(1116,'1u38','AUTO-INHIBITION MECHANISM OF X11S/MINTS FAMILY SCAFFOLD PROTEINS REVEALED BY THE CLOSED CONFORMATION OF THE TANDEM PDZ DOMAINS','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(1117,'1u3h','CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A','X-RAY DIFFRACTION',2.420,'IMMUNE SYSTEM',2,8,1),(1118,'1u3r','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-338','X-RAY DIFFRACTION',2.210,'TRANSCRIPTION',2,2,1),(1119,'1u3s','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-797','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(1120,'1u6h','VINCULIN HEAD (0-258) IN COMPLEX WITH THE TALIN VINCULIN BINDING SITE 2 (849-879)','X-RAY DIFFRACTION',2.380,'CELL ADHESION',1,1,1),(1121,'1u7b','CRYSTAL STRUCTURE OF HPCNA BOUND TO RESIDUES 331-350 OF THE FLAP ENDONUCLEASE-1 (FEN1)','X-RAY DIFFRACTION',1.880,'REPLICATION',1,1,1),(1122,'1u8g','CRYSTAL STRUCTURE OF A HIV-1 PROTEASE IN COMPLEX WITH PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1123,'1u8h','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(1124,'1u8i','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(1125,'1u8j','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(1126,'1u8k','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(1127,'1u8m','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(1128,'1u8q','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(1129,'1u8t','CRYSTAL STRUCTURE OF CHEY D13K Y106W ALONE AND IN COMPLEX WITH A FLIM PEPTIDE','X-RAY DIFFRACTION',1.500,'SIGNALING PROTEIN',2,3,1),(1130,'1u91','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC)','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(1131,'1u92','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC)','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(1132,'1u93','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC)','X-RAY DIFFRACTION',2.370,'IMMUNE SYSTEM',1,2,1),(1133,'1u95','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(1134,'1u9e','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(1135,'1u9l','STRUCTURAL BASIS FOR A NUSA- PROTEIN N INTERACTION','X-RAY DIFFRACTION',1.900,'RNA BINDING PROTEIN',1,2,1),(1136,'1ucy','THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A ALPHA (RESIDUES 7- 19). THREE COMPLEXES, ONE WITH EPSILON-THROMBIN AND TWO WITH ALPHA-THROMBIN','X-RAY DIFFRACTION',2.200,'COMPLEX (SERINE PROTEASE/COAGULATION)',6,4,1),(1137,'1uef','CRYSTAL STRUCTURE OF DOK1 PTB DOMAIN COMPLEX','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING/TRANSFERASE',2,2,1),(1138,'1uel','SOLUTION STRUCTURE OF UBIQUITIN-LIKE DOMAIN OF HHR23B COMPLEXED WITH UBIQUITIN-INTERACTING MOTIF OF PROTEASOME SUBUNIT S5A','SOLUTION NMR',NULL,'GENE REGULATION/PROTEIN BINDING',1,1,1),(1139,'1ugw','CRYSTAL STRUCTURE OF JACALIN- GAL COMPLEX','X-RAY DIFFRACTION',1.700,'SUGAR BINDING PROTEIN',4,4,1),(1140,'1ugx','CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-T-ANTIGEN (GAL-BETA(1-3)- GALNAC-ALPHA-O-ME) COMPLEX','X-RAY DIFFRACTION',1.600,'SUGAR BINDING PROTEIN',1,1,1),(1141,'1ugy','CRYSTAL STRUCTURE OF JACALIN- MELLIBIOSE (GAL-ALPHA(1-6)- GLC) COMPLEX','X-RAY DIFFRACTION',2.400,'SUGAR BINDING PROTEIN',4,4,1),(1142,'1uhb','CRYSTAL STRUCTURE OF PORCINE ALPHA TRYPSIN BOUND WITH AUTO CATALYTICALY PRODUCED NATIVE PEPTIDE AT 2.15 A RESOLUTION','X-RAY DIFFRACTION',2.150,'HYDROLASE',1,2,1),(1143,'1uhd','CRYSTAL STRUCTURE OF ASPARTATE DECARBOXYLASE, PYRUVOLY GROUP BOUND FORM','X-RAY DIFFRACTION',2.000,'LYASE',1,1,1),(1144,'1uhe','CRYSTAL STRUCTURE OF ASPARTATE DECARBOXYLASE, ISOASPARGINE COMPLEX','X-RAY DIFFRACTION',1.550,'LYASE',1,1,1),(1145,'1ujk','VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH C-TERMINAL PHOSPHOPEPTIDE FROM BACE','X-RAY DIFFRACTION',1.900,'PROTEIN TRANSPORT/HYDROLASE',2,2,1),(1146,'1uk4','CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) COMPLEXED WITH AN INHIBITOR','X-RAY DIFFRACTION',2.500,'HYDROLASE',3,2,1),(1147,'1ukh','STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125','X-RAY DIFFRACTION',2.350,'TRANSFERASE',1,1,1),(1148,'1uma','ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N-DIMETHYLCARBAMOYL)- ALPHA-AZALYSINE','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1149,'1umw','STRUCTURE OF A HUMAN PLK1 POLO-BOX DOMAIN/PHOSPHOPEPTIDE COMPLEX','X-RAY DIFFRACTION',1.900,'TRANSFERASE',2,2,1),(1150,'1uoo','PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLY-PHE-ARG-PRO','X-RAY DIFFRACTION',2.350,'HYDROLASE',1,1,1),(1151,'1uop','PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLY-PHE-GLU-PRO','X-RAY DIFFRACTION',1.850,'HYDROLASE',1,1,1),(1152,'1uoq','PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLU-PHE-SER-PRO','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(1153,'1upk','CRYSTAL STRUCTURE OF MO25 IN COMPLEX WITH A C-TERMINAL PEPTIDE OF STRAD','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(1154,'1upt','STRUCTURE OF A COMPLEX OF THE GOLGIN-245 GRIP DOMAIN WITH ARL1','X-RAY DIFFRACTION',1.700,'HYDROLASE/PROTEIN-BINDING',2,4,1),(1155,'1url','N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH GLYCOPEPTIDE','X-RAY DIFFRACTION',2.400,'SUGAR BINDING PROTEIN/IMMUNE SYSTEM',1,1,1),(1156,'1utc','CLATHRIN TERMINAL DOMAIN COMPLEXED WITH TLPWDLWTT','X-RAY DIFFRACTION',2.300,'ENDOCYTOSIS',2,2,1),(1157,'1uvq','CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,2,1),(1158,'1uvt','BOVINE THROMBIN--BM14.1248 COMPLEX','X-RAY DIFFRACTION',2.500,'SERINE PROTEASE',1,1,1),(1159,'1uwx','P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,4,1),(1160,'1uxs','CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS','X-RAY DIFFRACTION',1.550,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(1161,'1uxw','CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS','X-RAY DIFFRACTION',1.710,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(1162,'1v18','THE CRYSTAL STRUCTURE OF BETA-CATENIN ARMADILLO REPEAT COMPLEXED WITH A PHOSPHORYLATED APC 20MER REPEAT.','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',1,1,1),(1163,'1v1t','CRYSTAL STRUCTURE OF THE PDZ TANDEM OF HUMAN SYNTENIN IN COMPLEX WITH TNEYKV PEPTIDE','X-RAY DIFFRACTION',1.800,'CELL ADHESION',2,2,1),(1164,'1v54','BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',6,10,1),(1165,'1v55','BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE','X-RAY DIFFRACTION',1.900,'OXIDOREDUCTASE',6,10,1),(1166,'1v6d','THE CRYSTAL STRUCTURE OF THE TRYPSIN COMPLEX WITH SYNTHETIC HETEROCHIRAL PEPTIDE','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(1167,'1v9t','STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT BOUND TO SUCCINYL-ALA- PRO-ALA-P-NITROANILIDE','X-RAY DIFFRACTION',1.700,'ISOMERASE/ISOMERASE INHIBITOR',1,1,1),(1168,'1vac','MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN','X-RAY DIFFRACTION',2.500,'COMPLEX (MHC I/PEPTIDE)',1,1,1),(1169,'1vad','MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE','X-RAY DIFFRACTION',2.500,'COMPLEX (MHC I/PEPTIDE)',1,1,1),(1170,'1vai','STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT BOUND TO N- ACETYL-ALA-ALA-PRO-ALA-7-AMINO-4-METHYLCOUMARIN','X-RAY DIFFRACTION',1.800,'ISOMERASE',1,1,1),(1171,'1vbs','STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D)ALA CONTAINING TETRAPEPTIDE','X-RAY DIFFRACTION',2.000,'ISOMERASE/ ISOMERASE SUBSTRATE',1,1,1),(1172,'1vbt','STRUCTURE OF CYCLOPHILIN COMPLEXED WITH SULFUR-SUBSTITUTED TETRAPEPTIDE AAPF','X-RAY DIFFRACTION',2.300,'ISOMERASE/ISOMERASE SUBSTRATE',2,2,1),(1173,'1vc3','CRYSTAL STRUCTURE OF L-ASPARTATE-ALPHA-DECARBOXYLASE','X-RAY DIFFRACTION',1.500,'LYASE',1,1,1),(1174,'1vdn','CRYSTAL STRUCTURE OF YEAST CYCLOPHILIN A COMPLEXED WITH ACE-ALA-ALA- PRO-ALA-7-AMINO-4-METHYLCOUMARIN','X-RAY DIFFRACTION',1.600,'ISOMERASE/ISOMERASE INHIBITOR',1,1,1),(1175,'1vf6','2.1 ANGSTROM CRYSTAL STRUCTURE OF THE PALS-1-L27N AND PATJ L27 HETERODIMER COMPLEX','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING/PROTEIN TRANSPORT',1,1,1),(1176,'1vgc','GAMMA-CHYMOTRYPSIN L-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.900,'SERINE PROTEASE',1,2,1),(1177,'1vgk','THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION','X-RAY DIFFRACTION',2.060,'IMMUNE SYSTEM',1,1,1),(1178,'1vj6','PDZ2 FROM PTP-BL IN COMPLEX WITH THE C-TERMINAL LIGAND FROM THE APC PROTEIN','SOLUTION NMR',NULL,'HYDROLASE/SIGNALING PROTEIN',1,1,1),(1179,'1vpp','COMPLEX BETWEEN VEGF AND A RECEPTOR BLOCKING PEPTIDE','X-RAY DIFFRACTION',1.900,'GROWTH FACTOR/GROWTH FACTOR INHIBITOR',2,2,1),(1180,'1vq7','THE STRUCTURE OF THE TRANSITION STATE ANALOGUE \"DCA\" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.500,'RIBOSOME',1,1,1),(1181,'1vq8','THE STRUCTURE OF CCDA-PHE-CAP-BIO AND THE ANTIBIOTIC SPARSOMYCIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.200,'RIBOSOME',1,1,1),(1182,'1vq9','THE STRUCTURE OF CCA-PHE-CAP-BIO AND THE ANTIBIOTIC SPARSOMYCIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.400,'RIBOSOME',1,1,1),(1183,'1vqk','THE STRUCTURE OF CCDA-PHE-CAP-BIO BOUND TO THE A SITE OF THE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.300,'RIBOSOME',1,1,1),(1184,'1vql','THE STRUCTURE OF THE TRANSITION STATE ANALOGUE \"DCSN\" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.300,'RIBOSOME',1,1,1),(1185,'1vqm','THE STRUCTURE OF THE TRANSITION STATE ANALOGUE \"DAN\" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.300,'RIBOSOME',1,1,1),(1186,'1vqn','THE STRUCTURE OF CC-HPMN AND CCA-PHE-CAP-BIO BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.400,'RIBOSOME',1,1,1),(1187,'1vqo','THE STRUCTURE OF CCPMN BOUND TO THE LARGE RIBOSOMAL SUBUNIT HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.200,'RIBOSOME',1,1,1),(1188,'1vqp','THE STRUCTURE OF THE TRANSITION STATE ANALOGUE \"RAP\" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.250,'RIBOSOME',1,1,1),(1189,'1vr1','SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR-1','X-RAY DIFFRACTION',1.900,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(1190,'1vrk','THE 1.9 ANGSTROM STRUCTURE OF E84K-CALMODULIN RS20 PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.900,'COMPLEX(CALCIUM-BINDING PROTEIN/PEPTI',1,1,1),(1191,'1vwa','STREPTAVIDIN-FSHPQNT','X-RAY DIFFRACTION',1.850,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',2,2,1),(1192,'1vwb','STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 11.8','X-RAY DIFFRACTION',1.820,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1193,'1vwc','STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 2.0','X-RAY DIFFRACTION',1.860,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1194,'1vwd','STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.0','X-RAY DIFFRACTION',1.870,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1195,'1vwe','STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.6','X-RAY DIFFRACTION',1.500,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1196,'1vwf','STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 3.67','X-RAY DIFFRACTION',1.920,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1197,'1vwg','STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE-BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-NH2, PH 2.5','X-RAY DIFFRACTION',1.460,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1198,'1vwh','STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE- BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-NH2, PH 3.5','X-RAY DIFFRACTION',1.480,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1199,'1vwi','STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 1.5, I222 COMPLEX','X-RAY DIFFRACTION',1.500,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',2,2,1),(1200,'1vwj','STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I222 COMPLEX','X-RAY DIFFRACTION',1.450,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',2,2,1),(1201,'1vwk','STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2','X-RAY DIFFRACTION',1.450,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',2,2,1),(1202,'1vwl','STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I222 COMPLEX','X-RAY DIFFRACTION',1.450,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',2,2,1),(1203,'1vwm','STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.2','X-RAY DIFFRACTION',1.600,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1204,'1vwn','STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.8','X-RAY DIFFRACTION',1.850,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1205,'1vwo','STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.85','X-RAY DIFFRACTION',1.650,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1206,'1vwp','STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.5','X-RAY DIFFRACTION',1.750,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1207,'1vwq','STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I4122 COMPLEX','X-RAY DIFFRACTION',1.700,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1208,'1vwr','STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I4122 COMPLEX','X-RAY DIFFRACTION',1.500,'COMPLEX (BIOTIN-BINDING PROTEIN/PEPTI',1,1,1),(1209,'1vzq','COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165','X-RAY DIFFRACTION',1.540,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1210,'1w0v','CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1','X-RAY DIFFRACTION',2.270,'IMMUNE SYSTEM',1,1,1),(1211,'1w0w','CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(1212,'1w3c','CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(1213,'1w70','SH3 DOMAIN OF P40PHOX COMPLEXED WITH C-TERMINAL POLYPROLINE REGION OF P47PHOX','X-RAY DIFFRACTION',1.460,'SH3 DOMAIN',2,2,1),(1214,'1w72','CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',2,6,1),(1215,'1w7g','ALPHA-THROMBIN COMPLEX WITH SULFATED HIRUDIN (RESIDUES 54-65) AND L- ARGININE TEMPLATE INHIBITOR CS107','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1216,'1w7v','ZNMG SUBSTITUTED AMINOPEPTIDASE P FROM E. COLI','X-RAY DIFFRACTION',2.000,'HYDROLASE',4,4,1),(1217,'1w80','CRYSTAL STRUCTURE OF THE ALPHA-ADAPTIN APPENDAGE DOMAIN, FROM THE AP2 ADAPTOR COMPLEX, BOUND TO 2 PEPTIDES FROM SYNAPTOJANIN170','X-RAY DIFFRACTION',1.900,'ENDOCYTOSIS/EXOCYTOSIS',2,1,1),(1218,'1w85','THE CRYSTAL STRUCTURE OF PYRUVATE DEHYDROGENASE E1 BOUND TO THE PERIPHERAL SUBUNIT BINDING DOMAIN OF E2','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',2,4,1),(1219,'1w88','THE CRYSTAL STRUCTURE OF PYRUVATE DEHYDROGENASE E1(D180N, E183Q) BOUND TO THE PERIPHERAL SUBUNIT BINDING DOMAIN OF E2','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',2,4,1),(1220,'1w9e','CRYSTAL STRUCTURE OF THE PDZ TANDEM OF HUMAN SYNTENIN IN COMPLEX WITH TNEFYF PEPTIDE','X-RAY DIFFRACTION',1.560,'CELL ADHESION',3,2,1),(1221,'1w9o','CRYSTAL STRUCTURE OF THE PDZ TANDEM OF HUMAN SYNTENIN IN COMPLEX WITH TNEYYV PEPTIDE','X-RAY DIFFRACTION',2.250,'CELL ADHESION',2,2,1),(1222,'1w9q','CRYSTAL STRUCTURE OF THE PDZ TANDEM OF HUMAN SYNTENIN IN COMPLEX WITH TNEFAF PEPTIDE','X-RAY DIFFRACTION',1.700,'CELL ADHESION',1,1,1),(1223,'1w9u','SPECIFICITY AND AFFNITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGADIN AGAINST ASPERGILLUS FUMIGATUS CHITINASE','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(1224,'1wa7','SH3 DOMAIN OF HUMAN LYN TYROSINE KINASE IN COMPLEX WITH A HERPESVIRAL LIGAND','SOLUTION NMR',NULL,'SH3 DOMAIN',1,1,1),(1225,'1waw','SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGADIN AGAINST HUMAN CHITINASE','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1226,'1way','ACTIVE SITE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.020,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1227,'1wbg','ACTIVE SITE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1228,'1wbp','SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSFERASE',1,1,1),(1229,'1wbx','CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(1230,'1wby','CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(1231,'1wbz','CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(1232,'1wcy','CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH DIPROTIN A','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(1233,'1wkr','CRYSTAL STRUCTURE OF ASPARTIC PROTEINASE FROM IRPEX LACTEUS','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1234,'1wkw','CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF EIF4E-M7GPPPA-4EBP1 PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSLATION/PROTEIN BINDING',1,1,1),(1235,'1wlp','SOLUTION STRUCTURE OF THE P22PHOX-P47PHOX COMPLEX','SOLUTION NMR',NULL,'OXIDOREDUCTASE/SIGNALING PROTEIN',1,1,1),(1236,'1wrz','CALMODULIN COMPLEXED WITH A PEPTIDE FROM A HUMAN DEATH-ASSOCIATED PROTEIN KINASE','X-RAY DIFFRACTION',2.000,'METAL BINDING PROTEIN/TRANSFERASE',1,1,1),(1237,'1ws4','CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-MANNOSE COMPLEX: PROMISCUITY VS SPECIFICITY','X-RAY DIFFRACTION',1.900,'SUGAR BINDING PROTEIN',4,4,1),(1238,'1ws5','CRYSTAL STRUCTURE OF JACALIN-ME-ALPHA-MANNOSE COMPLEX: PROMISCUITY VS SPECIFICITY','X-RAY DIFFRACTION',1.900,'SUGAR BINDING PROTEIN',4,4,1),(1239,'1wvm','CRYSTAL STRUCTURE OF PSYCHROPHILIC SUBTILISIN-LIKE SERINE PROTEASE APA1 FROM ANTARCTIC PSYCHROTROPH PSEUDOALEROMONAS SP. AS-11, COMPLEXED WITH INHIBITOR CHYMOSTATIN','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(1240,'1x11','X11 PTB DOMAIN','X-RAY DIFFRACTION',2.500,'COMPLEX (PEPTIDE BINDING MODULE/PEPTI',2,2,1),(1241,'1x2r','STRUCTURAL BASIS FOR THE DEFECTS OF HUMAN LUNG CANCER SOMATIC MUTATIONS IN THE REPRESSION ACTIVITY OF KEAP1 ON NRF2','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',1,1,1),(1242,'1x76','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(1243,'1x78','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(1244,'1x7b','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(1245,'1x7j','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(1246,'1x7q','CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE','X-RAY DIFFRACTION',1.450,'IMMUNE SYSTEM',1,1,1),(1247,'1x7r','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(1248,'1x8s','STRUCTURE OF THE PAR-6 PDZ DOMAIN WITH A PALS1 INTERNAL LIGAND','X-RAY DIFFRACTION',2.500,'CELL CYCLE',1,1,1),(1249,'1xb0','STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2','X-RAY DIFFRACTION',2.200,'APOPTOSIS',6,6,1),(1250,'1xb7','X-RAY STRUCTURE OF ERRALPHA LBD IN COMPLEX WITH A PGC- 1ALPHA PEPTIDE AT 2.5A RESOLUTION','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',1,1,1),(1251,'1xdh','STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(1252,'1xh3','CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501','X-RAY DIFFRACTION',1.480,'IMMUNE SYSTEM',1,1,1),(1253,'1xh4','CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS','X-RAY DIFFRACTION',2.450,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1254,'1xh5','CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS','X-RAY DIFFRACTION',2.050,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1255,'1xh6','CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1256,'1xh7','CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS','X-RAY DIFFRACTION',2.470,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1257,'1xh8','CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS','X-RAY DIFFRACTION',1.600,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1258,'1xh9','CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS','X-RAY DIFFRACTION',1.640,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1259,'1xha','CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS','X-RAY DIFFRACTION',2.460,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1260,'1xiu','CRYSTAL STRUCTURE OF THE AGONIST-BOUND LIGAND-BINDING DOMAIN OF BIOMPHALARIA GLABRATA RXR','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/TRANSFERASE',2,2,1),(1261,'1xm1','NONBASIC THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1262,'1xme','STRUCTURE OF RECOMBINANT CYTOCHROME BA3 OXIDASE FROM THERMUS THERMOPHILUS','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',1,2,1),(1263,'1xmn','CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(1264,'1xn2','NEW SUBSTRATE BINDING POCKETS FOR BETA-SECRETASE.','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(1265,'1xn3','CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONG INHIBITOR WITH ADDITIONAL UPSTREAM RESIDUES.','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1266,'1xoc','THE STRUCTURE OF THE OLIGOPEPTIDE-BINDING PROTEIN, APPA, FROM BACILLUS SUBTILIS IN COMPLEX WITH A NONAPEPTIDE.','X-RAY DIFFRACTION',1.550,'TRANSPORT PROTEIN',1,1,1),(1267,'1xow','CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH AN ANDROGEN RECEPTOR NH2-TERMINAL PEPTIDE, AR20-30, AND R1881','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(1268,'1xq7','CYCLOPHILIN FROM TRYPANOSOMA CRUZI BOUND TO CYCLOSPORIN A','X-RAY DIFFRACTION',2.070,'ISOMERASE/IMMUNOSUPPRESSANT',3,3,1),(1269,'1xqh','CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE METHYLTRANSFERASE SET9 (ALSO KNOWN AS SET7/9) WITH A P53 PEPTIDE AND SAH','X-RAY DIFFRACTION',1.750,'TRANSFERASE',2,2,1),(1270,'1xr0','STRUCTURAL BASIS OF SNT PTB DOMAIN INTERACTIONS WITH DISTINCT NEUROTROPHIC RECEPTORS','SOLUTION NMR',NULL,'SIGNALING PROTEIN/GROWTH FACTOR RECEP',1,1,1),(1271,'1xr8','CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(1272,'1xr9','CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3','X-RAY DIFFRACTION',1.790,'IMMUNE SYSTEM/LIGASE',1,1,1),(1273,'1xrp','CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE PRO-LEU-GLY-GLY','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(1274,'1xtc','CHOLERA TOXIN','X-RAY DIFFRACTION',2.400,'TOXIN',1,6,1),(1275,'1xu1','THE CRYSTAL STRUCTURE OF APRIL BOUND TO TACI','X-RAY DIFFRACTION',1.900,'CYTOKINE, HORMONE/GROWTH FACTOR RECEP',3,3,1),(1276,'1xu2','THE CRYSTAL STRUCTURE OF APRIL BOUND TO BCMA','X-RAY DIFFRACTION',2.350,'CYTOKINE, HORMONE/GROWTH FACTOR RECEP',3,3,1),(1277,'1xvm','TRYPSIN FROM FUSARIUM OXYSPORUM- ROOM TEMPERATURE TO ATOMIC RESOLUTION','X-RAY DIFFRACTION',1.100,'HYDROLASE',1,1,1),(1278,'1xxv','YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE CONTAINING HEXAPEPTIDE AT TWO SITES','X-RAY DIFFRACTION',2.500,'HYDROLASE',4,2,1),(1279,'1y0y','CRYSTAL STRUCTURE OF TETRAHEDRAL AMINOPEPTIDASE FROM P. HORIKOSHII IN COMPLEX WITH AMASTATIN','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1280,'1y2a','STRUCTURE OF MAMMALIAN IMPORTIN BOUND TO THE NON-CLASSICAL PLSCR1-NLS','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT',1,1,1),(1281,'1y3a','STRUCTURE OF G-ALPHA-I1 BOUND TO A GDP-SELECTIVE PEPTIDE PROVIDES INSIGHT INTO GUANINE NUCLEOTIDE EXCHANGE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',4,4,1),(1282,'1y43','CRYSTAL STRUCTURE OF ASPERGILLOGLUTAMIC PEPTIDASE FROM ASPERGILLUS NIGER','X-RAY DIFFRACTION',1.400,'HYDROLASE',1,1,1),(1283,'1y7l','O-ACETYLSERINE SULFHYDRYLASE COMPLEX','X-RAY DIFFRACTION',1.550,'TRANSFERASE',1,1,1),(1284,'1y98','STRUCTURE OF THE BRCT REPEATS OF BRCA1 BOUND TO A CTIP PHOSPHOPEPTIDE.','X-RAY DIFFRACTION',2.500,'ANTITUMOR PROTEIN',1,1,1),(1285,'1ybo','CRYSTAL STRUCTURE OF THE PDZ TANDEM OF HUMAN SYNTENIN WITH SYNDECAN PEPTIDE','X-RAY DIFFRACTION',2.300,'STRUCTURAL PROTEIN',2,2,1),(1286,'1yc5','SIR2-P53 PEPTIDE-NICOTINAMIDE','X-RAY DIFFRACTION',1.400,'HYDROLASE',1,1,1),(1287,'1ycp','THE CRYSTAL STRUCTURE OF FIBRINOGEN-AA PEPTIDE 1-23 (F8Y) BOUND TO BOVINE THROMBIN EXPLAINS WHY THE MUTATION OF PHE-8 TO TYROSINE STRONGLY INHIBITS NORMAL CLEAVAGE AT ARGININE-16','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE SUBSTRATE',4,3,1),(1288,'1ycq','XENOPUS LAEVIS MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF HUMAN P53','X-RAY DIFFRACTION',2.300,'COMPLEX (ONCOGENE PROTEIN/PEPTIDE)',1,1,1),(1289,'1ydi','HUMAN VINCULIN HEAD DOMAIN (VH1, 1-258) IN COMPLEX WITH HUMAN ALPHA-ACTININ\'S VINCULIN-BINDING SITE (RESIDUES 731- 760)','X-RAY DIFFRACTION',1.800,'CELL ADHESION, STRUCTURAL PROTEIN',1,1,1),(1290,'1ydp','1.9A CRYSTAL STRUCTURE OF HLA-G','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(1291,'1ydr','STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR 1-(5- ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE','X-RAY DIFFRACTION',2.200,'COMPLEX (PHOSPHOTRANSFERASE/INHIBITOR',1,1,1),(1292,'1yds','STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR [N-(2-METHYLAMINO)ETHYL]-5- ISOQUINOLINESULFONAMIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1293,'1ydt','STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2- (4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE','X-RAY DIFFRACTION',2.300,'COMPLEX (PHOSPHOTRANSFERASE/INHIBITOR',1,1,1),(1294,'1yf4','CRYSTAL STRUCTURE OF TRYPSIN-VASOPRESSIN COMPLEX','X-RAY DIFFRACTION',1.980,'HYDROLASE/HORMONE/GROWTH FACTOR',1,1,1),(1295,'1yfn','VERSATILE MODES OF PEPTIDE RECOGNITION BY THE AAA+ ADAPTOR PROTEIN SSPB- THE CRYSTAL STRUCTURE OF A SSPB-RSEA COMPLEX','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',4,4,1),(1296,'1yhq','CRYSTAL STRUCTURE OF AZITHROMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI','X-RAY DIFFRACTION',2.400,'RIBOSOME',1,1,1),(1297,'1yjm','CRYSTAL STRUCTURE OF THE FHA DOMAIN OF MOUSE POLYNUCLEOTIDE KINASE IN COMPLEX WITH AN XRCC4-DERIVED PHOSPHOPEPTIDE.','X-RAY DIFFRACTION',2.200,'TRANSFERASE/DNA BINDING PROTEIN',3,3,1),(1298,'1yk0','STRUCTURE OF NATRIURETIC PEPTIDE RECEPTOR-C COMPLEXED WITH ATRIAL NATRIURETIC PEPTIDE','X-RAY DIFFRACTION',2.400,'HORMONE/GROWTH FACTOR RECEPTOR',1,2,1),(1299,'1ym0','CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT B: A NOVEL, GLYCOSYLATED TWO-CHAINED TRYPSIN','X-RAY DIFFRACTION',2.060,'HYDROLASE',1,1,1),(1300,'1ym2','CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AUR200','X-RAY DIFFRACTION',2.050,'HYDROLASE/HYDROLASE INHIBITOR',3,3,1),(1301,'1ym4','CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AMK640','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',3,3,1),(1302,'1ymt','MOUSE SF-1 LBD','X-RAY DIFFRACTION',1.200,'TRANSCRIPTION',1,1,1),(1303,'1yn6','CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(1304,'1yn7','CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(1305,'1yok','CRYSTAL STRUCTURE OF HUMAN LRH-1 BOUND WITH TIF-2 PEPTIDE AND PHOSPHATIDYLGLYCEROL','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,1,1),(1306,'1yp0','STRUCTURE OF THE STEROIDOGENIC FACTOR-1 LIGAND BINDING DOMAIN BOUND TO PHOSPHOLIPID AND A SHP PEPTIDE MOTIF','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION',1,1,1),(1307,'1yp1','CRYSTAL STRUCTURE OF A NON-HEMORRHAGIC FIBRIN(OGEN)OLYTIC METALLOPROTEINASE FROM VENOM OF AGKISTRODON ACUTUS','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(1308,'1ype','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.810,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(1309,'1ypg','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.800,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(1310,'1yph','HIGH RESOLUTION STRUCTURE OF BOVINE ALPHA-CHYMOTRYPSIN','X-RAY DIFFRACTION',1.340,'HYDROLASE',2,4,1),(1311,'1ypj','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.780,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(1312,'1ypk','THROMBIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.780,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1313,'1ypl','X-RAY CRYSTAL STRUCTURE OF THROMBIN INHIBITED BY SYNTHETIC CYANOPEPTIDE ANALOGUE RA-1008','X-RAY DIFFRACTION',1.850,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(1314,'1ypm','X-RAY CRYSTAL STRUCTURE OF THROMBIN INHIBITED BY SYNTHETIC CYANOPEPTIDE ANALOGUE RA-1014','X-RAY DIFFRACTION',1.850,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(1315,'1yr5','1.7-A STRUCTURE OF CALMODULIN BOUND TO A PEPTIDE FROM DAP KINASE','X-RAY DIFFRACTION',1.700,'METAL BINDING PROTEIN/TRANSFERASE',1,1,1),(1316,'1yrk','THE C2 DOMAIN OF PKC<DELTA> IS A NEW PHOSPHO-TYROSINE BINDING DOMAIN','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING',1,1,1),(1317,'1yrn','CRYSTAL STRUCTURE OF THE MATA1/MATALPHA2 HOMEODOMAIN HETERODIMER BOUND TO DNA','X-RAY DIFFRACTION',2.500,'DNA BINDING PROTEIN/DNA',1,1,1),(1318,'1ytf','YEAST TFIIA/TBP/DNA COMPLEX','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/DNA',2,2,1),(1319,'1ytg','SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT','X-RAY DIFFRACTION',2.300,'HYDROLASE/PEPTIDE',1,2,1),(1320,'1yth','SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT','X-RAY DIFFRACTION',2.200,'HYDROLASE/PEPTIDE',1,2,1),(1321,'1yti','SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT','X-RAY DIFFRACTION',2.200,'COMPLEX (HYDROLASE/PEPTIDE)',1,1,1),(1322,'1ytj','SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT','X-RAY DIFFRACTION',2.500,'HYDROLASE/PEPTIDE',1,1,1),(1323,'1ytv','MALTOSE-BINDING PROTEIN FUSION TO A C-TERMINAL FRAGMENT OF THE V1A VASOPRESSIN RECEPTOR','X-RAY DIFFRACTION',1.800,'SUGAR BINDING PROTEIN, HORMONE RECEPT',2,2,1),(1324,'1yu6','CRYSTAL STRUCTURE OF THE SUBTILISIN CARLSBERG:OMTKY3 COMPLEX','X-RAY DIFFRACTION',1.550,'HYDROLASE',1,1,1),(1325,'1yuc','HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO PHOSPHOLIPID AND A FRAGMENT OF HUMAN SHP','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION REGULATION',2,2,1),(1326,'1yvh','CRYSTAL STRUCTURE OF THE C-CBL TKB DOMAIN IN COMPLEX WITH THE APS PTYR-618 PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.050,'LIGASE,SIGNALING PROTEIN,IMMUNE SYSTE',1,1,1),(1327,'1ywt','CRYSTAL STRUCTURE OF THE HUMAN SIGMA ISOFORM OF 14-3-3 IN COMPLEX WITH A MODE-1 PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN/DE NOVO PROTEIN',2,2,1),(1328,'1yy6','THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH AN EBNA1 PEPTIDE','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(1329,'1yye','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-202196','X-RAY DIFFRACTION',2.030,'TRANSCRIPTION',2,2,1),(1330,'1yym','CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN/IMMUNE SYSTEM',2,2,1),(1331,'1yyp','CRYSTAL STRUCTURE OF CYTOMEGALOVIRUS UL44 BOUND TO C-TERMINAL PEPTIDE FROM CMV UL54','X-RAY DIFFRACTION',2.500,'REPLICATION/TRANSFERASE',1,1,1),(1332,'1z3l','X-RAY CRYSTAL STRUCTURE OF A MUTANT RIBONUCLEASE S (F8ANB)','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(1333,'1z3m','CRYSTAL STRUCTURE OF MUTANT RIBONUCLEASE S (F8NVA)','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(1334,'1z3p','X-RAY CRYSTAL STRUCTURE OF A MUTANT RIBONUCLEASE S (M13NVA)','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(1335,'1z71','THROMBIN AND P2 PYRIDINE N-OXIDE INHIBITOR COMPLEX STRUCTURE','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1336,'1z8g','CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE TRANSMEMBRANE SERINE PROTEASE HEPSIN WITH COVALENTLY BOUND PREFERRED SUBSTRATE.','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1337,'1z8i','CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193A BOUND TO PPACK','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1338,'1z8j','CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193P BOUND TO PPACK','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1339,'1z9o','1.9 ANGSTROM CRYSTAL STRUCTURE OF THE RAT VAP-A MSP HOMOLOGY DOMAIN IN COMPLEX WITH THE RAT ORP1 FFAT MOTIF','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING/LIPID BINDING PROTEIN',6,6,1),(1340,'1zaf','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 3-BROMO-6-HYDROXY-2-(4-HYDROXY-PHENYL)-INDEN-1-ONE','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION/TRANSFERASE',2,2,1),(1341,'1zav','RIBOSOMAL PROTEIN L10-L12(NTD) COMPLEX, SPACE GROUP P21','X-RAY DIFFRACTION',1.900,'STRUCTURAL PROTEIN',6,1,1),(1342,'1zaw','RIBOSOMAL PROTEIN L10-L12(NTD) COMPLEX, SPACE GROUP P212121, FORM A','X-RAY DIFFRACTION',2.300,'STRUCTURAL PROTEIN',6,1,1),(1343,'1zax','RIBOSOMAL PROTEIN L10-L12(NTD) COMPLEX, SPACE GROUP P212121, FORM B','X-RAY DIFFRACTION',2.100,'STRUCTURAL PROTEIN',6,1,1),(1344,'1zb5','RECOGNITION OF PEPTIDE LIGANDS BY SIGNALLING PROTEIN FROM PORCINE MAMMARY GLAND (SPP-40): CRYSTAL STRUCTURE OF THE COMPLEX OF SPP-40 WITH A PEPTIDE TRP-PRO-TRP AT 2.45A RESOLUTION','X-RAY DIFFRACTION',2.450,'SIGNALING PROTEIN',2,1,1),(1345,'1zba','FOOT-AND-MOUTH DISEASE VIRUS SEROTYPE A1061 COMPLEXED WITH OLIGOSACCHARIDE RECEPTOR.','X-RAY DIFFRACTION',2.000,'VIRUS',1,3,1),(1346,'1zbc','CRYSTAL STRUCTURE OF THE PORCINE SIGNALLING PROTEIN LIGANDED WITH THE PEPTIDE TRP-PRO-TRP (WPW) AT 2.3 A RESOLUTION','X-RAY DIFFRACTION',2.290,'SIGNALING PROTEIN',1,1,1),(1347,'1zdt','THE CRYSTAL STRUCTURE OF HUMAN STEROIDOGENIC FACTOR-1','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(1348,'1zdu','THE CRYSTAL STRUCTURE OF HUMAN LIVER RECEPTOR HOMOLOGUE-1','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,1,1),(1349,'1zea','STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE','X-RAY DIFFRACTION',1.780,'IMMUNE SYSTEM',1,2,1),(1350,'1zfp','GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PENTAPEPTIDE','X-RAY DIFFRACTION',1.800,'COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)',1,1,1),(1351,'1zgi','THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 21','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1352,'1zgv','THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 2','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1353,'1zgx','CRYSTAL STRUCTURE OF RIBONUCLEASE MUTANT','X-RAY DIFFRACTION',1.130,'HYDROLASE',1,1,1),(1354,'1zgy','STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(1355,'1zh7','STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(1356,'1zhk','CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(1357,'1zhl','CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(1358,'1zkk','CRYSTAL STRUCTURE OF HSET8 IN TERNARY COMPLEX WITH H4 PEPTIDE (16-24) AND ADOHCY','X-RAY DIFFRACTION',1.450,'TRANSFERASE',4,4,1),(1359,'1zky','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-3M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',2.250,'HORMONE/GROWTH FACTOR RECEPTOR',2,2,1),(1360,'1zoq','IRF3-CBP COMPLEX','X-RAY DIFFRACTION',2.370,'TRANSCRIPTION/TRANSFERASE',2,2,1),(1361,'1zrb','THROMBIN IN COMPLEX WITH AN AZAFLUORENYL INHIBITOR 23B','X-RAY DIFFRACTION',1.900,'BLOOD CLOTTING,HYDROLASE/INHIBITOR',1,1,1),(1362,'1zsd','CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(1363,'1zsg','BETA PIX-SH3 COMPLEXED WITH AN ATYPICAL PEPTIDE FROM ALPHA- PAK','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(1364,'1zt1','CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH AN OCTAPEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(1365,'1ztz','CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX','X-RAY DIFFRACTION',2.150,'HYDROLASE',1,2,1),(1366,'1zub','SOLUTION STRUCTURE OF THE RIM1ALPHA PDZ DOMAIN IN COMPLEX WITH AN ELKS1B C-TERMINAL PEPTIDE','SOLUTION NMR',NULL,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(1367,'1zuk','YEAST BBC1 SH3 DOMAIN COMPLEXED WITH A PEPTIDE FROM LAS17','X-RAY DIFFRACTION',1.900,'CONTRACTILE PROTEIN',1,2,1),(1368,'1zuz','CALMODULIN IN COMPLEX WITH A MUTANT PEPTIDE FROM HUMAN DRP-1 KINASE','X-RAY DIFFRACTION',1.910,'METAL BINDING PROTEIN/TRANSFERASE',1,1,1),(1369,'1zvz','VINCULIN HEAD (0-258) IN COMPLEX WITH THE TALIN ROD RESIDUE 820-844','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',1,1,1),(1370,'1zw2','VINCULIN HEAD (0-258) IN COMPLEX WITH THE TALIN ROD RESIDUES 2345-2369','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING',1,1,1),(1371,'1zy3','STRUCTURAL MODEL OF COMPLEX OF BCL-W PROTEIN WITH BID BH3- PEPTIDE','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(1372,'1zys','CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR','X-RAY DIFFRACTION',1.700,'SIGNALING PROTEIN, TRANSFERASE',1,1,1),(1373,'2a06','BOVINE CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN BOUND','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',3,6,1),(1374,'2a0q','STRUCTURE OF THROMBIN IN 400 MM POTASSIUM CHLORIDE','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,2,1),(1375,'2a0t','NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A BIOLOGICAL RELEVANT PHOSPHOPEPTIDE DERIVED FROM MADT1','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(1376,'2a25','CRYSTAL STRUCTURE OF SIAH1 SBD BOUND TO THE PEPTIDE EKPAAVVAPITTG FROM SIP','X-RAY DIFFRACTION',2.200,'LIGASE',1,1,1),(1377,'2a2x','ORALLY ACTIVE THROMBIN INHIBITORS IN COMPLEX WITH THROMBIN INH12','X-RAY DIFFRACTION',2.440,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1378,'2a3i','STRUCTURAL AND BIOCHEMICAL MECHANISMS FOR THE SPECIFICITY OF HORMONE BINDING AND COACTIVATOR ASSEMBLY BY MINERALOCORTICOID RECEPTOR','X-RAY DIFFRACTION',1.950,'TRANSFERASE',1,1,1),(1379,'2a3z','TERNARY COMPLEX OF THE WH2 DOMAIN OF WASP WITH ACTIN-DNASE I','X-RAY DIFFRACTION',2.080,'STRUCTURAL PROTEIN',1,1,1),(1380,'2a40','TERNARY COMPLEX OF THE WH2 DOMAIN OF WAVE WITH ACTIN-DNASE I','X-RAY DIFFRACTION',1.800,'STRUCTURAL PROTEIN',2,2,1),(1381,'2a4g','HEPATITIS C PROTEASE NS3-4A SERINE PROTEASE WITH KETOAMIDE INHIBITOR SCH225724 BOUND','X-RAY DIFFRACTION',2.500,'VIRAL PROTEIN',2,2,1),(1382,'2a4j','SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN (T94-Y172) OF THE HUMAN CENTRIN 2 IN COMPLEX WITH A 17 RESIDUES PEPTIDE (P1-XPC) FROM XERODERMA PIGMENTOSUM GROUP C PROTEIN','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1383,'2a4q','HCV NS3 PROTEASE WITH NS4A PEPTIDE AND A COVALENTLY BOUND MACROCYCLIC KETOAMIDE COMPOUND.','X-RAY DIFFRACTION',2.450,'VIRAL PROTEIN',2,2,1),(1384,'2a4r','HCV NS3 PROTEASE DOMAIN WITH A KETOAMIDE INHIBITOR COVALENTLY BOUND.','X-RAY DIFFRACTION',2.400,'VIRAL PROTEIN',2,2,1),(1385,'2a6i','CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(1386,'2a7u','NMR SOLUTION STRUCTURE OF THE E.COLI F-ATPASE DELTA SUBUNIT N-TERMINAL DOMAIN IN COMPLEX WITH ALPHA SUBUNIT N-TERMINAL 22 RESIDUES','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(1387,'2a83','CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM',1,1,1),(1388,'2a9h','NMR STRUCTURAL STUDIES OF A POTASSIUM CHANNEL / CHARYBDOTOXIN COMPLEX','SOLUTION NMR',NULL,'METAL TRANSPORT, MEMBRANE PROTEIN',1,4,1),(1389,'2abz','CRYSTAL STRUCTURE OF C19A/C43A MUTANT OF LEECH CARBOXYPEPTIDASE INHIBITOR IN COMPLEX WITH BOVINE CARBOXYPEPTIDASE A','X-RAY DIFFRACTION',2.160,'HYDROLASE/HYDROLASE INHIBITOR',1,3,1),(1390,'2adv','CRYSTAL STRUCTURES OF GLUTARYL 7-AMINOCEPHALOSPORANIC ACID ACYLASE: MUTATIONAL STUDY OF ACTIVATION MECHANISM','X-RAY DIFFRACTION',2.240,'HYDROLASE',1,2,1),(1391,'2aff','THE SOLUTION STRUCTURE OF THE KI67FHA/HNIFK(226-269)3P COMPLEX','SOLUTION NMR',NULL,'CELL CYCLE',1,1,1),(1392,'2afq','1.9 ANGSTROM CRYSTAL STRUCTURE OF WILD-TYPE HUMAN THROMBIN IN THE SODIUM FREE STATE','X-RAY DIFFRACTION',1.930,'BLOOD CLOTTING,HYDROLASE',2,2,1),(1393,'2age','SUCCINYL-AAPR-TRYPSIN ACYL-ENZYME AT 1.15 A RESOLUTION','X-RAY DIFFRACTION',1.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1394,'2agg','SUCCINYL-AAPK-TRYPSIN ACYL-ENZYME AT 1.28 A RESOLUTION','X-RAY DIFFRACTION',1.280,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1395,'2agh','STRUCTURAL BASIS FOR COOPERATIVE TRANSCRIPTION FACTOR BINDING TO THE CBP COACTIVATOR','SOLUTION NMR',NULL,'TRANSCRIPTION',2,1,1),(1396,'2agi','THE LEUPEPTIN-TRYPSIN COVALENT COMPLEX AT 1.14 A RESOLUTION','X-RAY DIFFRACTION',1.140,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1397,'2aij','FORMYLGLYCINE GENERATING ENZYME C336S MUTANT COVALENTLY BOUND TO SUBSTRATE PEPTIDE CTPSR','X-RAY DIFFRACTION',1.550,'HYDROLASE ACTIVATOR,PROTEIN BINDING',1,1,1),(1398,'2aik','FORMYLGLYCINE GENERATING ENZYME C336S MUTANT COVALENTLY BOUND TO SUBSTRATE PEPTIDE LCTPSRA','X-RAY DIFFRACTION',1.730,'HYDROLASE ACTIVATOR,PROTEIN BINDING',1,1,1),(1399,'2ain','SOLUTION STRUCTURE OF THE AF-6 PDZ DOMAIN COMPLEXED WITH THE C-TERMINAL PEPTIDE FROM THE BCR PROTEIN','SOLUTION NMR',NULL,'CELL ADHESION/TRANSFERASE',1,1,1),(1400,'2aiz','SOLUTION STRUCTURE OF PEPTIDOGLYCAN ASSOCIATED LIPOPROTEIN FROM HAEMOPHILUS INFLUENZA BOUND TO UDP-N-ACETYLMURAMOYL-L- ALANYL-D-GLUTAMYL-MESO-2,6-DIAMINOPIMELOYL-D-ALANYL-D- ALANINE','SOLUTION NMR',NULL,'MEMBRANE PROTEIN',1,1,1),(1401,'2ak4','CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',4,12,1),(1402,'2ak5','BETA PIX-SH3 COMPLEXED WITH A CBL-B PEPTIDE','X-RAY DIFFRACTION',1.850,'ENDOCYTOSIS/EXOCYTOSIS',1,1,1),(1403,'2aka','STRUCTURE OF THE NUCLEOTIDE-FREE MYOSIN II MOTOR DOMAIN FROM DICTYOSTELIUM DISCOIDEUM FUSED TO THE GTPASE DOMAIN OF DYNAMIN 1 FROM RATTUS NORVEGICUS','X-RAY DIFFRACTION',1.900,'CONTRACTILE PROTEIN',1,2,1),(1404,'2amq','CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(1405,'2ank','ORALLY ACTIVE THROMBIN INHIBITORS IN COMPLEX WITH THROMBIN AND AN EXOSITE DECAPEPTIDE','X-RAY DIFFRACTION',2.460,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1406,'2anm','TERNARY COMPLEX OF AN ORALLY ACTIVE THROMBIN INHIBITOR WITH HUMAN THROMBIN AND A C-TERMINAL HIRUDIN DERIVED EXO-SIT INHIBITOR','X-RAY DIFFRACTION',2.400,'BLOOD CLOTTING',1,1,1),(1407,'2ao6','CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TIF2(III) 740-753 PEPTIDE AND R1881','X-RAY DIFFRACTION',1.890,'TRANSCRIPTION',1,1,1),(1408,'2aof','CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P1-P6','X-RAY DIFFRACTION',1.320,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1409,'2aoh','CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P6-PR','X-RAY DIFFRACTION',1.420,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1410,'2aoi','CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P1-P6','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1411,'2aoj','CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG P6-PR','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1412,'2ap2','SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,2,1),(1413,'2aph','CRYSTAL STRUCTURE OF HUMAN PGRP-IALPHAC IN COMPLEX WITH MURAMYL PENTAPEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,2,1),(1414,'2aq9','STRUCTURE OF E. COLI LPXA WITH A BOUND PEPTIDE THAT IS COMPETITIVE WITH ACYL-ACP','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1415,'2arq','HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH','X-RAY DIFFRACTION',1.850,'HYDROLASE INHIBITOR/PEPTIDE',1,1,1),(1416,'2arr','HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH','X-RAY DIFFRACTION',1.550,'HYDROLASE INHIBITOR/PEPTIDE',1,1,1),(1417,'2asq','SOLUTION STRUCTURE OF SUMO-1 IN COMPLEX WITH A SUMO-BINDING MOTIF (SBM)','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1418,'2ast','CRYSTAL STRUCTURE OF SKP1-SKP2-CKS1 IN COMPLEX WITH A P27 PEPTIDE','X-RAY DIFFRACTION',2.300,'LIGASE/LIGASE INHIBITOR',1,2,1),(1419,'2asu','CRYSTAL STRUCTURE OF THE BETA-CHAIN OF HGFL/MSP','X-RAY DIFFRACTION',1.850,'HYDROLASE',1,1,1),(1420,'2atp','CRYSTAL STRUCTURE OF A CD8AB HETERODIMER','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,4,1),(1421,'2av1','CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',2,2,1),(1422,'2av7','CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.','X-RAY DIFFRACTION',2.050,'IMMUNE SYSTEM',2,2,1),(1423,'2awu','SYNAPSE ASSOCIATED PROTEIN 97 PDZ2 DOMAIN VARIANT C378G','X-RAY DIFFRACTION',2.440,'MEMBRANE PROTEIN',1,1,1),(1424,'2aww','SYNAPSE ASSOCIATED PROTEIN 97 PDZ2 DOMAIN VARIANT C378G WITH C- TERMINAL GLUR-A PEPTIDE','X-RAY DIFFRACTION',2.210,'MEMBRANE PROTEIN',1,1,1),(1425,'2ax3','CRYSTAL STRUCTURE OF A PUTATIVE CARBOHYDRATE KINASE (TM0922) FROM THERMOTOGA MARITIMA MSB8 AT 2.25 A RESOLUTION','X-RAY DIFFRACTION',2.270,'TRANSFERASE',1,1,1),(1426,'2axf','THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM/GENE REGULATION',1,1,1),(1427,'2axg','THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/GENE REGULATION',1,1,1),(1428,'2axi','HDM2 IN COMPLEX WITH A BETA-HAIRPIN','X-RAY DIFFRACTION',1.400,'LIGASE/LIGASE INHIBITOR',1,1,1),(1429,'2azm','CRYSTAL STRUCTURE OF THE MDC1 BRCT REPEAT IN COMPLEX WITH THE HISTONE TAIL OF GAMMA-H2AX','X-RAY DIFFRACTION',2.410,'CELL CYCLE',2,2,1),(1430,'2b0f','NMR STRUCTURE OF THE HUMAN RHINOVIRUS 3C PROTEASE (SEROTYPE 14) WITH COVALENTLY BOUND ACE-LEALFQ-ETHYLPROPIONATE INHIBITOR','SOLUTION NMR',NULL,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1431,'2b0s','CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(1432,'2b1a','CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',1,2,1),(1433,'2b1h','CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(1434,'2b1j','CRYSTAL STRUCTURE OF UNPHOSPHORYLATED CHEY BOUND TO THE N- TERMINUS OF FLIM','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',2,2,1),(1435,'2b1n','CRYSTAL STRUCTURE OF A PAPAIN-FOLD PROTEIN WITHOUT THE CATALYTIC CYSTEINE FROM SEEDS OF PACHYRHIZUS EROSUS','X-RAY DIFFRACTION',2.400,'SUGAR BINDING PROTEIN',1,1,1),(1436,'2b1v','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',1.800,'HORMONE/GROWTH FACTOR RECEPTOR',2,2,1),(1437,'2b1z','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17METHYL-17ALPHA-DIHYDROEQUILENIN AND A GLUCOC INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',1.780,'HORMONE/GROWTH FACTOR RECEPTOR',2,2,1),(1438,'2b23','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN AND A GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',2.100,'HORMONE/GROWTH FACTOR RECEPTOR',2,2,1),(1439,'2b2t','TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4 AND PHOSPHOTHREONINE 3','X-RAY DIFFRACTION',2.450,'PEPTIDE BINDING PROTEIN',1,1,1),(1440,'2b2w','TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4','X-RAY DIFFRACTION',2.400,'PEPTIDE BINDING PROTEIN',1,1,1),(1441,'2b3g','P53N (FRAGMENT 33-60) BOUND TO RPA70N','X-RAY DIFFRACTION',1.600,'REPLICATION',1,1,1),(1442,'2b5t','2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES','X-RAY DIFFRACTION',2.100,'BLOOD CLOTTING',2,3,1),(1443,'2b6n','THE 1.8 A CRYSTAL STRUCTURE OF A PROTEINASE K LIKE ENZYME FROM A PSYCHROTROPH SERRATIA SPECIES','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(1444,'2b9h','CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM STE7','X-RAY DIFFRACTION',1.550,'TRANSFERASE',1,1,1),(1445,'2b9i','CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM MSG5','X-RAY DIFFRACTION',2.500,'TRANSFERASE',1,1,1),(1446,'2b9j','CRYSTAL STRUCTURE OF FUS3 WITH A DOCKING MOTIF FROM FAR1','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(1447,'2bb4','PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ASP- PHE AT PH 5.0','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(1448,'2bba','CRYSTAL STRUCTURE AND THERMODYNAMIC CHARACTERIZATION OF THE EPHB4 RECEPTOR IN COMPLEX WITH AN EPHRIN-B2 ANTAGONIST PEPTIDE REVEALS THE DETERMINANTS FOR RECEPTOR SPECIFICITY.','X-RAY DIFFRACTION',1.650,'SIGNALING PROTEIN',1,1,1),(1449,'2bbm','SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR','SOLUTION NMR',NULL,'CALCIUM-BINDING PROTEIN',1,1,1),(1450,'2bbn','SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR','SOLUTION NMR',NULL,'CALCIUM-BINDING PROTEIN',1,1,1),(1451,'2bbu','SOLUTION STRUCTURE OF MOUSE SOCS3 IN COMPLEX WITH A PHOSPHOPEPTIDE FROM THE GP130 RECEPTOR','SOLUTION NMR',NULL,'CYTOKINE REGULATOR',1,1,1),(1452,'2bcd','X-RAY CRYSTAL STRUCTURE OF PROTEIN PHOSPHATASE-1 WITH THE MARINE TOXIN MOTUPORIN BOUND','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1453,'2bcx','CRYSTAL STRUCTURE OF CALMODULIN IN COMPLEX WITH A RYANODINE RECEPTOR PEPTIDE','X-RAY DIFFRACTION',2.000,'CALCIUM BINDING PROTEIN',1,1,1),(1454,'2bd2','PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG- PHE AT PH 5.0','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(1455,'2bd3','PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS- ALA-NH2 AT PH 5.0','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(1456,'2bd4','PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS- SER AT PH 5.0','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(1457,'2bd5','PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS- SER AT PH 5 AND IMMERSED IN PH 9 BUFFER FOR 30 SECONDS','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(1458,'2bd7','PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG- PHE AT PH 5.0 (50 MIN SOAK)','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(1459,'2bd8','PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG- PHE AT PH 5.0 (50 MIN SOAK) AND IMMERSED IN PH 9 BUFFER FOR 30 SECONDS','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(1460,'2bda','PORCINE PANCREATIC ELASTASE COMPLEXED WITH N-ACETYL-NPI AND ALA-ALA AT PH 5.0','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(1461,'2bdx','X-RAY CRYSTAL STRUCTURE OF DIHYDROMICROCYSTIN-LA BOUND TO PROTEIN PHOSPHATASE-1','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1462,'2bdy','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.610,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1463,'2be6','2.0 A CRYSTAL STRUCTURE OF THE CAV1.2 IQ DOMAIN-CA/CAM COMPLEX','X-RAY DIFFRACTION',2.000,'MEMBRANE PROTEIN',3,3,1),(1464,'2beu','REACTIVITY MODULATION OF HUMAN BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE BY AN INTERNAL MOLECULAR SWITCH','X-RAY DIFFRACTION',1.890,'OXIDOREDUCTASE',1,1,1),(1465,'2bev','REACTIVITY MODULATION OF HUMAN BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE BY AN INTERNAL MOLECULAR SWITCH','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',1,1,1),(1466,'2bew','REACTIVITY MODULATION OF HUMAN BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE BY AN INTERNAL MOLECULAR SWITCH','X-RAY DIFFRACTION',1.790,'OXIDOREDUCTASE',1,1,1),(1467,'2bez','STRUCTURE OF A PROTEOLITICALLY RESISTANT CORE FROM THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS S2 FUSION PROTEIN','X-RAY DIFFRACTION',1.600,'VIRAL PROTEIN',1,1,1),(1468,'2bfx','MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERADIN.','X-RAY DIFFRACTION',1.800,'TRANSFERASE',2,2,1),(1469,'2bfy','COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN.','X-RAY DIFFRACTION',1.800,'TRANSFERASE',2,2,1),(1470,'2bgr','CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,2,1),(1471,'2bha','E. COLI AMINOPEPTIDASE P IN COMPLEX WITH SUBSTRATE','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(1472,'2bhd','MG SUBSTITUTED E. COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(1473,'2bj4','ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST','X-RAY DIFFRACTION',2.000,'NUCLEAR RECEPTOR',2,2,1),(1474,'2bnq','STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM/RECEPTOR',1,3,1),(1475,'2bnr','STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM/RECEPTOR',1,3,1),(1476,'2bok','FACTOR XA - CATION','X-RAY DIFFRACTION',1.640,'HYDROLASE',1,1,1),(1477,'2bp3','CRYSTAL STRUCTURE OF FILAMIN A DOMAIN 17 AND GPIB ALPHA CYTOPLASMIC DOMAIN COMPLEX','X-RAY DIFFRACTION',2.320,'STRUCTURAL PROTEIN',2,2,1),(1478,'2bqz','CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE HUMAN HISTONE METHYLTRANSFERASE PR-SET7 (ALSO KNOWN AS SET8)','X-RAY DIFFRACTION',1.500,'TRANSFERASE',2,2,1),(1479,'2br8','CRYSTAL STRUCTURE OF ACETYLCHOLINE-BINDING PROTEIN (ACHBP) FROM APLYSIA CALIFORNICA IN COMPLEX WITH AN ALPHA- CONOTOXIN PNIA VARIANT','X-RAY DIFFRACTION',2.400,'RECEPTOR/INHIBITOR',5,5,1),(1480,'2br9','14-3-3 PROTEIN EPSILON (HUMAN) COMPLEXED TO PEPTIDE','X-RAY DIFFRACTION',1.750,'CELL REGULATOR PROTEIN',1,1,1),(1481,'2brq','CRYSTAL STRUCTURE OF THE FILAMIN A REPEAT 21 COMPLEXED WITH THE INTEGRIN BETA7 CYTOPLASMIC TAIL PEPTIDE','X-RAY DIFFRACTION',2.100,'STRUCTURAL PROTEIN',2,2,1),(1482,'2brr','COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,4,1),(1483,'2bsr','CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(1484,'2bss','CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(1485,'2bst','CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(1486,'2btc','BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II)','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1487,'2btx','SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'COMPLEX (TOXIN/PEPTIDE)',1,1,1),(1488,'2bug','SOLUTION STRUCTURE OF THE TPR DOMAIN FROM PROTEIN PHOSPHATASE 5 IN COMPLEX WITH HSP90 DERIVED PEPTIDE','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(1489,'2buo','HIV-1 CAPSID C-TERMINAL DOMAIN IN COMPLEX WITH AN INHIBITOR OF PARTICLE ASSEMBLY','X-RAY DIFFRACTION',1.700,'VIRAL PROTEIN/PEPTIDE',1,1,1),(1490,'2bvo','STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION','X-RAY DIFFRACTION',1.650,'GLYCOPROTEIN/PEPTIDE',1,1,1),(1491,'2bvp','STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION','X-RAY DIFFRACTION',1.350,'GLYCOPROTEIN/PEPTIDE',1,1,1),(1492,'2bvq','STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION','X-RAY DIFFRACTION',2.000,'GLYCOPROTEIN/PEPTIDE',1,1,1),(1493,'2bvr','HUMAN THROMBIN COMPLEXED WITH FRAGMENT-BASED SMALL MOLECULES OCCUPYING THE S1 POCKET','X-RAY DIFFRACTION',1.250,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1494,'2bvs','HUMAN THROMBIN COMPLEXED WITH FRAGMENT-BASED SMALL MOLECULES OCCUPYING THE S1 POCKET','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1495,'2bxt','DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A SOLUBILIZING CATIONIC P1-P2-LINKER','X-RAY DIFFRACTION',1.830,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1496,'2byp','CRYSTAL STRUCTURE OF APLYSIA CALIFORNICA ACHBP IN COMPLEX WITH ALPHA- CONOTOXIN IMI','X-RAY DIFFRACTION',2.070,'RECEPTOR',5,5,1),(1497,'2bzk','CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND PIMTIDE','X-RAY DIFFRACTION',2.450,'TRANSFERASE/PEPTIDE',1,1,1),(1498,'2bzw','THE CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH FULL-LENGTH BAD','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(1499,'2c1a','STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO) ETHYL)AMIDE','X-RAY DIFFRACTION',1.950,'TRANSFERASE/INHIBITOR',1,1,1),(1500,'2c1b','STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH (4R,2S)-5\'- (4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/INHIBITOR',1,1,1),(1501,'2c1e','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.','X-RAY DIFFRACTION',1.770,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1502,'2c1m','NUP50:IMPORTIN-ALPHA COMPLEX','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT/MEMBRANE PROTEIN',1,1,1),(1503,'2c1n','MOLECULAR BASIS FOR THE RECOGNITION OF PHOSPHORYLATED AND PHOSPHOACETYLATED HISTONE H3 BY 14-3-3','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',2,2,1),(1504,'2c2k','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.','X-RAY DIFFRACTION',1.870,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1505,'2c2m','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.','X-RAY DIFFRACTION',1.940,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1506,'2c2o','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.','X-RAY DIFFRACTION',2.450,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1507,'2c2z','CRYSTAL STRUCTURE OF CASPASE-8 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITOR','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1508,'2c3i','CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I','X-RAY DIFFRACTION',1.900,'TRANSFERASE/PEPTIDE',1,1,1),(1509,'2c5i','N-TERMINAL DOMAIN OF TLG1 COMPLEXED WITH N-TERMINUS OF VPS51 IN DISTORTED CONFORMATION','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',1,1,1),(1510,'2c5k','N-TERMINAL DOMAIN OF TLG1 COMPLEXED WITH N-TERMINUS OF VPS51','X-RAY DIFFRACTION',2.050,'PROTEIN TRANSPORT',1,1,1),(1511,'2c63','14-3-3 PROTEIN ETA (HUMAN) COMPLEXED TO PEPTIDE','X-RAY DIFFRACTION',2.150,'SIGNALING PROTEIN/PEPTIDE',4,4,1),(1512,'2c77','EF-TU COMPLEXED WITH A GTP ANALOG AND THE ANTIBIOTIC GE2270 A','X-RAY DIFFRACTION',1.600,'HYDROLASE/ANTIBIOTIC',1,1,1),(1513,'2c7n','HUMAN RABEX-5 RESIDUES 1-74 IN COMPLEX WITH UBIQUITIN','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING',2,4,1),(1514,'2c7u','CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.','X-RAY DIFFRACTION',2.380,'GLYCOPROTEIN/PEPTIDE',2,2,1),(1515,'2c8w','THROMBIN INHIBITORS','X-RAY DIFFRACTION',1.960,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1516,'2c8x','THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.170,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1517,'2c8y','THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1518,'2c8z','THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.140,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1519,'2c90','THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1520,'2c93','THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1521,'2c9t','CRYSTAL STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) FROM APLYSIA CALIFORNICA IN COMPLEX WITH ALPHA-CONOTOXIN IMI','X-RAY DIFFRACTION',2.250,'RECEPTOR/TOXIN',8,10,1),(1522,'2cbl','N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE ON ZAP-70','X-RAY DIFFRACTION',2.100,'COMPLEX (PROTO-ONCOGENE/PEPTIDE)',1,1,1),(1523,'2cch','THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE','X-RAY DIFFRACTION',1.700,'CELL CYCLE',2,2,1),(1524,'2cdr','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1525,'2ce8','AN EH1 PEPTIDE BOUND TO THE GROUCHO-TLE WD40 DOMAIN.','X-RAY DIFFRACTION',2.030,'TRANSCRIPTION REGULATION',2,2,1),(1526,'2ce9','A WRPW PEPTIDE BOUND TO THE GROUCHO-TLE WD40 DOMAIN.','X-RAY DIFFRACTION',2.120,'TRANSCRIPTION REGULATION',2,2,1),(1527,'2cf8','COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH AN INHIBITOR','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1528,'2cf9','COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH AN INHIBITOR','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1529,'2cha','THE STRUCTURE OF CRYSTALLINE ALPHA-CHYMOTRYPSIN, $V.THE ATOMIC STRUCTURE OF TOSYL-ALPHA-CHYMOTRYPSIN AT 2 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.000,'HYDROLASE (SERINE PROTEINASE)',2,4,1),(1530,'2ci9','NCK1 SH2-DOMAIN IN COMPLEX WITH A DODECAPHOSPHOPEPTIDE FROM EPEC PROTEIN TIR','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',2,2,1),(1531,'2cia','HUMAN NCK2 SH2-DOMAIN IN COMPLEX WITH A DECAPHOSPHOPEPTIDE FROM TRANSLOCATED INTIMIN RECEPTOR (TIR) OF EPEC','X-RAY DIFFRACTION',1.450,'SH2-DOMAIN',1,1,1),(1532,'2cik','INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450.','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(1533,'2cio','THE HIGH RESOLUTION X-RAY STRUCTURE OF PAPAIN COMPLEXED WITH FRAGMENTS OF THE TRYPANOSOMA BRUCEI CYSTEINE PROTEASE INHIBITOR ICP.','X-RAY DIFFRACTION',1.500,'HYDROLASE/INHIBITOR',1,1,1),(1534,'2cjx','EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1535,'2cjy','EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS','X-RAY DIFFRACTION',1.670,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1536,'2ck0','ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNOGLOBULIN',1,2,1),(1537,'2ck3','AZIDE INHIBITED BOVINE F1-ATPASE','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,2,1),(1538,'2clr','THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE','X-RAY DIFFRACTION',2.000,'HISTOCOMPATIBILITY ANTIGEN',2,2,1),(1539,'2clv','MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(1540,'2clz','MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(1541,'2cmy','CRYSTAL COMPLEX BETWEEN BOVINE TRYPSIN AND VERONICA HEDERIFOLIA TRYPSIN INHIBITOR','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(1542,'2cn0','COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED INHIBITOR','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1543,'2cnk','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1544,'2cnl','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.','X-RAY DIFFRACTION',1.670,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1545,'2cnn','CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1546,'2cnx','WDR5 AND HISTONE H3 LYSINE 4 DIMETHYL COMPLEX AT 2.1 ANGSTROM','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(1547,'2cny','SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH A 19-RESIDUE SAFA NTE PEPTIDE (I15A MUTANT)','X-RAY DIFFRACTION',1.900,'FIBRIL PROTEIN',1,1,1),(1548,'2cnz','SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH A 19-RESIDUE SAFA NTE PEPTIDE (V13A MUTANT)','X-RAY DIFFRACTION',1.800,'FIBRIL PROTEIN',1,1,1),(1549,'2co0','WDR5 AND UNMODIFIED HISTONE H3 COMPLEX AT 2.25 ANGSTROM','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION',2,2,1),(1550,'2co1','SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH A 19-RESIDUE SAFA NTE PEPTIDE (F17A MUTANT)','X-RAY DIFFRACTION',2.400,'FIBRIL PROTEIN',1,1,1),(1551,'2co2','SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH A 19-RESIDUE SAFA NTE PEPTIDE (F3A MUTANT)','X-RAY DIFFRACTION',2.300,'FIBRIL PROTEIN',1,1,1),(1552,'2co4','SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH A 19-RESIDUE SAFA NTE PEPTIDE','X-RAY DIFFRACTION',1.850,'FIBRIL PROTEIN',1,1,1),(1553,'2cv3','CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH A MACROCLYCLIC PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1554,'2cvy','STRUCTURES OF YEAST RIBONUCLEOTIDE REDUCTASE I','X-RAY DIFFRACTION',2.400,'OXIDOREDUCTASE',1,1,1),(1555,'2cwg','CRYSTALLOGRAPHIC REFINEMENT AND STRUCTURE ANALYSIS OF THE COMPLEX OF WHEAT GERM AGGLUTININ WITH A BIVALENT SIALOGLYCOPEPTIDE FROM GLYCOPHORIN A','X-RAY DIFFRACTION',2.000,'LECTIN(AGGLUTININ)',2,2,1),(1556,'2czy','SOLUTION STRUCTURE OF THE NRSF/REST-MSIN3B PAH1 COMPLEX','SOLUTION NMR',NULL,'GENE REGULATION',1,1,1),(1557,'2d10','CRYSTAL STRUCTURE OF THE RADIXIN FERM DOMAIN COMPLEXED WITH THE NHERF-1 C-TERMINAL TAIL PEPTIDE','X-RAY DIFFRACTION',2.500,'CELL ADHESION',4,4,1),(1558,'2d1k','TERNARY COMPLEX OF THE WH2 DOMAIN OF MIM WITH ACTIN-DNASE I','X-RAY DIFFRACTION',2.500,'STRUCTURAL PROTEIN',1,2,1),(1559,'2d1x','THE CRYSTAL STRUCTURE OF THE CORTACTIN-SH3 DOMAIN AND AMAP1- PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.900,'CELL INVASION',2,2,1),(1560,'2d3g','DOUBLE SIDED UBIQUITIN BINDING OF HRS-UIM','X-RAY DIFFRACTION',1.700,'PROTEIN TRANSPORT',1,2,1),(1561,'2d5w','THE CRYSTAL STRUCTURE OF OLIGOPEPTIDE BINDING PROTEIN FROM THERMUS THERMOPHILUS HB8 COMPLEXED WITH PENTAPEPTIDE','X-RAY DIFFRACTION',1.300,'PEPTIDE BINDING PROTEIN',2,2,1),(1562,'2d7c','CRYSTAL STRUCTURE OF HUMAN RAB11 IN COMPLEX WITH FIP3 RAB- BINDING DOMAIN','X-RAY DIFFRACTION',1.750,'PROTEIN TRANSPORT',2,2,1),(1563,'2d7d','STRUCTURAL INSIGHTS INTO THE CRYPTIC DNA DEPENDENT ATP-ASE ACTIVITY OF UVRB','X-RAY DIFFRACTION',2.100,'HYDROLASE/DNA',1,1,1),(1564,'2den','SOLUTION STRUCTURE OF THE UBIQUITIN-ASSOCIATED DOMAIN OF HUMAN BMSC- UBP AND ITS COMPLEX WITH UBIQUITIN','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1565,'2dew','CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE 4 IN COMPLEX WITH HISTONE H3 N-TERMINAL TAIL INCLUDING ARG8','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(1566,'2dex','CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE 4 IN COMPLEX WITH HISTONE H3 N-TERMINAL PEPTIDE INCLUDING ARG17','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(1567,'2dey','CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE 4 IN COMPLEX WITH HISTONE H4 N-TERMINAL TAIL INCLUDING ARG3','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(1568,'2dko','EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS','X-RAY DIFFRACTION',1.060,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1569,'2doh','THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF THE ANGIOGENESIS INHIBITOR, ANGIOSTATIN, BOUND A TO A PEPTIDE FROM THE GROUP A STREPTOCOCCAL SURFACE PROTEIN PAM','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(1570,'2dqk','CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH A SPECIFIC LACTOFERRIN PEPTIDE VAL-LEU-LEU-HIS AT 1.93 A RESOLUTION','X-RAY DIFFRACTION',1.930,'HYDROLASE',1,1,1),(1571,'2ds2','CRYSTAL STRUCTURE OF MABINLIN II','X-RAY DIFFRACTION',1.700,'PLANT PROTEIN',2,2,1),(1572,'2dt7','SOLUTION STRUCTURE OF THE SECOND SURP DOMAIN OF HUMAN SPLICING FACTOR SF3A120 IN COMPLEX WITH A FRAGMENT OF HUMAN SPLICING FACTOR SF3A60','SOLUTION NMR',NULL,'RNA BINDING PROTEIN',1,1,1),(1573,'2duj','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PROTEINASE K AND A SYNTHETIC PEPTIDE LEU-LEU-PHE-ASN-ASP AT 1.67 A RESOLUTION','X-RAY DIFFRACTION',1.670,'HYDROLASE',1,1,1),(1574,'2dvq','CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 COMPLEXED WITH ACETYLATED HISTONE H4 PEPTIDE','X-RAY DIFFRACTION',2.040,'TRANSCRIPTION',2,2,1),(1575,'2dvr','CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 COMPLEXED WITH ACETYLATED HISTONE H4 PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(1576,'2dxp','CRYSTAL STRUCTURE OF THE COMPLEX OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH PHOSPHOPEPTIDES A-(P)Y-R','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(1577,'2dyh','CRYSTAL STRUCTURE OF THE KEAP1 PROTEIN IN COMPLEXED WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(1578,'2dym','THE CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE ATG5- ATG16(1-46) COMPLEX','X-RAY DIFFRACTION',2.200,'PROTEIN TURNOVER/PROTEIN TURNOVER',4,4,1),(1579,'2dyo','THE CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE ATG5- ATG16(1-57) COMPLEX','X-RAY DIFFRACTION',1.970,'PROTEIN TURNOVER/PROTEIN TURNOVER',1,1,1),(1580,'2dyp','CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(1581,'2dyr','BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',6,10,1),(1582,'2dys','BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE',6,10,1),(1583,'2dze','CRYSTAL STRUCTURE OF HISTONE CHAPERONE ASF1 IN COMPLEX WITH A C-TERMINUS OF HISTONE H3','X-RAY DIFFRACTION',1.800,'CHAPERONE',1,2,1),(1584,'2e30','SOLUTION STRUCTURE OF THE CYTOPLASMIC REGION OF NA+/H+ EXCHANGER 1 COMPLEXED WITH ESSENTIAL COFACTOR CALCINEURIN B HOMOLOGOUS PROTEIN 1','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/TRANSPORT PROTE',1,1,1),(1585,'2e3k','CRYSTAL STRUCTURE OF THE HUMAN BRD2 SECOND BROMODOMAIN IN COMPLEXED WITH THE ACETYLATED HISTONE H4 PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,3,1),(1586,'2e4h','SOLUTION STRUCTURE OF CYTOSKELETAL PROTEIN IN COMPLEX WITH TUBULIN TAIL','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1587,'2e7l','STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,6,1),(1588,'2eax','CRYSTAL STRUCTURE OF HUMAN PGRP-IBETAC IN COMPLEX WITH GLYCOSAMYL MURAMYL PENTAPEPTIDE','X-RAY DIFFRACTION',2.100,'PEPTIDOGLYCAN-BINDING PROTEIN',1,1,1),(1589,'2eeo','CRYSTAL STRUCTURE OF T.TH. HB8 L-ASPARTATE-ALPHA-DECARBOXYLASE COMPLEXED WITH FUMARATE','X-RAY DIFFRACTION',1.600,'LYASE',1,1,1),(1590,'2egn','CRYSTAL STRUCTURE OF TAMALIN PDZ DOMAIN IN COMPLEX WITH MGLUR5 C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',1,1,1),(1591,'2eij','BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE','X-RAY DIFFRACTION',1.900,'OXIDOREDUCTASE',6,10,1),(1592,'2eik','CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',6,10,1),(1593,'2eil','CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',6,10,1),(1594,'2ejy','SOLUTION STRUCTURE OF THE P55 PDZ T85C DOMAIN COMPLEXED WITH THE GLYCOPHORIN C F127C PEPTIDE','SOLUTION NMR',NULL,'MEMBRANE PROTEIN',1,1,1),(1595,'2eq7','CRYSTAL STRUCTURE OF LIPOAMIDE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 WITH PSBDO','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',1,2,1),(1596,'2eq8','CRYSTAL STRUCTURE OF LIPOAMIDE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 WITH PSBDP','X-RAY DIFFRACTION',1.940,'OXIDOREDUCTASE',2,4,1),(1597,'2eq9','CRYSTAL STRUCTURE OF LIPOAMIDE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 WITH PSBDB','X-RAY DIFFRACTION',2.090,'OXIDOREDUCTASE',4,8,1),(1598,'2er6','THE STRUCTURE OF A SYNTHETIC PEPSIN INHIBITOR COMPLEXED WITH ENDOTHIAPEPSIN.','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1599,'2er7','X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1600,'2er9','X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES.','X-RAY DIFFRACTION',2.200,'HYDROLASE-HYDROLASE INHIBITOR',1,1,1),(1601,'2erz','CRYSTAL STRUCTURE OF C-AMP DEPENDENT KINASE (PKA) BOUND TO HYDROXYFASUDIL','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(1602,'2esl','HUMAN CYCLOPHILIN C IN COMPLEX WITH CYCLOSPORIN A','X-RAY DIFFRACTION',1.900,'ISOMERASE/IMMUNOSUPPRESSANT',6,6,1),(1603,'2etz','THE NMR MINIMIZED AVERAGE STRUCTURE OF THE ITK SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(1604,'2eu0','THE NMR ENSEMBLE STRUCTURE OF THE ITK SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(1605,'2f31','CRYSTAL STRUCTURE OF THE AUTOINHIBITORY SWITCH IN FORMIN MDIA1; THE DID/DAD COMPLEX','X-RAY DIFFRACTION',2.100,'STRUCTURAL PROTEIN',1,1,1),(1606,'2f3c','CRYSTAL STRUCTURE OF INFESTIN 1, A KAZAL-TYPE SERINEPROTEASE INHIBITOR, IN COMPLEX WITH TRYPSIN','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1607,'2f3y','CALMODULIN/IQ DOMAIN COMPLEX','X-RAY DIFFRACTION',1.450,'METAL BINDING PROTEIN',1,1,1),(1608,'2f3z','CALMODULIN/IQ-AA DOMAIN COMPLEX','X-RAY DIFFRACTION',1.600,'METAL BINDING PROTEIN',1,1,1),(1609,'2f49','CRYSTAL STRUCTURE OF FUS3 IN COMPLEX WITH A STE5 PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(1610,'2f4o','THE MOUSE PNGASE-HR23 COMPLEX REVEALS A COMPLETE REMODULATION OF THE PROTEIN-PROTEIN INTERFACE COMPARED TO ITS YEAST ORTHOLOGS','X-RAY DIFFRACTION',2.260,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1611,'2f53','DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,3,1),(1612,'2f5b','CRYSTAL STRUCTURE OF FAB\' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE','X-RAY DIFFRACTION',2.000,'IMMUNOGLOBULIN',1,2,1),(1613,'2f5z','CRYSTAL STRUCTURE OF HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE (E3) COMPLEXED TO THE E3-BINDING DOMAIN OF HUMAN E3- BINDING PROTEIN','X-RAY DIFFRACTION',2.180,'OXIDOREDUCTASE/PROTEIN BINDING',5,10,1),(1614,'2f69','TERNARY COMPLEX OF SET7/9 BOUND TO ADOHCY AND A TAF10 PEPTIDE','X-RAY DIFFRACTION',1.300,'TRANSFERASE',1,1,1),(1615,'2f6j','CRYSTAL STRUCTURE OF PHD FINGER-LINKER-BROMODOMAIN FRAGMENT OF HUMAN BPTF IN THE H3(1-15)K4ME3 BOUND STATE','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(1616,'2f7e','PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL)-1-(5-ISOQUINOLIN-6- YL-PYRIDIN-3-YLOXYMETHYL-ETYLAMINE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(1617,'2f7x','PROTEIN KINASE A BOUND TO (S)-2-(1H-INDOL-3-YL)-1-[5-((E)-2- PYRIDIN-4-YL-VINYL)-PYRIDIN-3-YLOXYMETHYL]-ETHYLAMINE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(1618,'2f91','1.2A RESOLUTION STRUCTURE OF A CRAYFISH TRYPSIN COMPLEXED WITH A PEPTIDE INHIBITOR, SGTI','X-RAY DIFFRACTION',1.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1619,'2f9d','2.5 ANGSTROM RESOLUTION STRUCTURE OF THE SPLICEOSOMAL PROTEIN P14 BOUND TO REGION OF SF3B155','X-RAY DIFFRACTION',2.500,'RNA BINDING PROTEIN',2,2,1),(1620,'2f9n','CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT K192Q/D216G IN COMPLEX WITH LEUPEPTIN','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(1621,'2f9p','CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G IN COMPLEX WITH LEUPEPTIN','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(1622,'2fai','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-2M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',2.100,'HORMONE/GROWTH FACTOR RECEPTOR',2,2,1),(1623,'2fci','STRUCTURAL BASIS FOR THE REQUIREMENT OF TWO PHOSPHOTYROSINES IN SIGNALING MEDIATED BY SYK TYROSINE KINASE','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(1624,'2feq','ORALLY ACTIVE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.440,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1625,'2fes','ORALLY ACTIVE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.420,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1626,'2ff3','CRYSTAL STRUCTURE OF GELSOLIN DOMAIN 1:N-WASP V2 MOTIF HYBRID IN COMPLEX WITH ACTIN','X-RAY DIFFRACTION',2.000,'STRUCTURAL PROTEIN/CONTRACTILE PROTEI',1,2,1),(1627,'2ff4','MYCOBACTERIUM TUBERCULOSIS EMBR IN COMPLEX WITH LOW AFFINITY PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(1628,'2ff6','CRYSTAL STRUCTURE OF GELSOLIN DOMAIN 1:CIBOULOT DOMAIN 2 HYBRID IN COMPLEX WITH ACTIN','X-RAY DIFFRACTION',2.050,'STRUCTURAL PROTEIN/CONTRACTILE PROTEI',1,2,1),(1629,'2fff','OPEN FORM OF A CLASS A TRANSPEPTIDASE DOMAIN','X-RAY DIFFRACTION',2.230,'MEMBRANE PROTEIN, TRANSFERASE',1,1,1),(1630,'2ffu','CRYSTAL STRUCTURE OF HUMAN PPGALNACT-2 COMPLEXED WITH UDP AND EA2','X-RAY DIFFRACTION',1.640,'TRANSFERASE',1,1,1),(1631,'2fge','CRYSTAL STRUCTURE OF PRESEQUENCE PROTEASE PREP FROM ARABIDOPSIS THALIANA','X-RAY DIFFRACTION',2.100,'HYDROLASE, PLANT PROTEIN',2,2,1),(1632,'2fgr','HIGH RESOLUTION XRAY STRUCTURE OF OMP32','X-RAY DIFFRACTION',1.500,'MEMBRANE PROTEIN',1,1,1),(1633,'2fho','NMR SOLUTION STRUCTURE OF THE HUMAN SPLICEOSOMAL PROTEIN COMPLEX P14-SF3B155','SOLUTION NMR',NULL,'RNA BINDING PROTEIN',1,1,1),(1634,'2fib','RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) COMPLEXED TO THE PEPTIDE GLY- PRO-ARG-PRO AT PH 6.0','X-RAY DIFFRACTION',2.010,'COMPLEX (BLOOD COAGULATION/PEPTIDE)',1,1,1),(1635,'2fiv','CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(1636,'2fka','CRYSTAL STRUCTURE OF MG(2+) AND BEF(3)(-)-BOUND CHEY IN COMPLEX WITH CHEZ(200-214) SOLVED FROM A F432 CRYSTAL GROWN IN CAPS (PH 10.5)','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,1,1),(1637,'2flk','CRYSTAL STRUCTURE OF CHEY IN COMPLEX WITH CHEZ(200-214) SOLVED FROM A F432 CRYSTAL GROWN IN CAPS (PH 10.5)','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',1,1,1),(1638,'2flu','CRYSTAL STRUCTURE OF THE KELCH-NEH2 COMPLEX','X-RAY DIFFRACTION',1.500,'LIGASE',1,1,1),(1639,'2flw','CRYSTAL STRUCTURE OF MG2+ AND BEF3- OUND CHEY IN COMPLEX WITH CHEZ 200-214 SOLVED FROM A F432 CRYSTAL GROWN IN HEPES (PH 7.5)','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,1,1),(1640,'2fmf','CRYSTAL STRUCTURE OF CHEY IN COMPLEX WITH CHEZ 200-214 SOLVED FROM A F432 CRYSTAL GROWN IN HEPES (PH 7.5)','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,1,1),(1641,'2fmh','CRYSTAL STRUCTURE OF MG2+ AND BEF3- BOUND CHEY IN COMPLEX WITH CHEZ 200-214 SOLVED FROM A F432 CRYSTAL GROWN IN TRIS (PH 8.4)','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,1,1),(1642,'2fmi','CRYSTAL STRUCTURE OF CHEY IN COMPLEX WITH CHEZ 200-214 SOLVED FROM A F432 CRYSTAL GROWN IN TRIS (PH 8.4)','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',1,1,1),(1643,'2fmk','CRYSTAL STRUCTURE OF MG2+ AND BEF3- BOUND CHEY IN COMPLEX WITH CHEZ 200-214 SOLVED FROM A P2(1)2(1)2 CRYSTAL GROWN IN MES (PH 6.0)','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,1,1),(1644,'2fns','CRYSTAL STRUCTURE OF WILD-TYPE INACTIVE (D25N) HIV-1 PROTEASE COMPLEXED WITH WILD-TYPE HIV-1 NC-P1 SUBSTRATE.','X-RAY DIFFRACTION',1.850,'HYDROLASE',1,2,1),(1645,'2fnt','CRYSTAL STRUCTURE OF A DRUG-RESISTANT (V82A) INACTIVE (D25N) HIV-1 PROTEASE COMPLEXED WITH AP2V VARIANT OF HIV-1 NC-P1 SUBSTRATE.','X-RAY DIFFRACTION',1.440,'HYDROLASE',1,2,1),(1646,'2fo5','CRYSTAL STRUCTURE OF RECOMBINANT BARLEY CYSTEINE ENDOPROTEASE B ISOFORM 2 (EP-B2) IN COMPLEX WITH LEUPEPTIN','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(1647,'2foj','THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH P53 PEPTIDE 364-367','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(1648,'2fom','DENGUE VIRUS NS2B/NS3 PROTEASE','X-RAY DIFFRACTION',1.500,'VIRAL PROTEIN/PROTEASE',1,1,1),(1649,'2foo','THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH P53 PEPTIDE 359-362','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(1650,'2fop','THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH MDM2 PEPTIDE 147-150','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(1651,'2fot','CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CALMODULIN AND ALPHAII-SPECTRIN','X-RAY DIFFRACTION',2.450,'METAL BINDING, STRUCTURAL PROTEIN',1,1,1),(1652,'2fp7','WEST NILE VIRUS NS2B/NS3PROTEASE IN COMPLEX WITH BZ-NLE-LYS-ARG-ARG-H','X-RAY DIFFRACTION',1.680,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1653,'2fsa','CRYSTAL STRUCTURE OF PHD FINGER-LINKER-BROMODOMAIN FRAGMENT OF HUMAN BPTF IN THE H3(1-15)K4ME2 BOUND STATE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(1654,'2fts','CRYSTAL STRUCTURE OF THE GLYCINE RECEPTOR-GEPHYRIN COMPLEX','X-RAY DIFFRACTION',2.410,'STRUCTURAL PROTEIN',1,1,1),(1655,'2fuu','NMR SOLUTION STRUCTURE OF THE PHD DOMAIN FROM THE HUMAN BPTF IN COMPLEX WITH H3(1-15)K4ME3 PEPTIDE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1656,'2fvj','A NOVEL ANTI-ADIPOGENIC PARTIAL AGONIST OF PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR-GAMMA (PPARG) RECRUITS PPARG-COACTIVATOR-1 ALPHA (PGC1A) BUT POTENTIATES INSULIN SIGNALING IN VITRO','X-RAY DIFFRACTION',1.990,'SIGNALING PROTEIN',1,1,1),(1657,'2fx7','CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41','X-RAY DIFFRACTION',1.760,'IMMUNE SYSTEM',1,2,1),(1658,'2fx8','CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',4,8,1),(1659,'2fx9','CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,4,1),(1660,'2fym','CRYSTAL STRUCTURE OF E. COLI ENOLASE COMPLEXED WITH THE MINIMAL BINDING SEGMENT OF RNASE E.','X-RAY DIFFRACTION',1.600,'LYASE',2,4,1),(1661,'2fys','CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3','X-RAY DIFFRACTION',2.500,'TRANSFERASE',2,2,1),(1662,'2fyy','THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(1663,'2fyz','STRUCTURAL OF MUMPS VIRUS FUSION PROTEIN CORE','X-RAY DIFFRACTION',2.200,'PROTEIN BINDING',2,1,1),(1664,'2fz3','THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(1665,'2g1t','A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN','X-RAY DIFFRACTION',1.800,'TRANSFERASE',4,4,1),(1666,'2g2l','CRYSTAL STRUCTURE OF THE SECOND PDZ DOMAIN OF SAP97 IN COMPLEX WITH A GLUR-A C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',2.350,'MEMBRANE PROTEIN',1,1,1),(1667,'2g30','BETA APPENDAGE OF AP2 COMPLEXED WITH ARH PEPTIDE','X-RAY DIFFRACTION',1.600,'ENDOCYTOSIS/EXOCYTOSIS',2,1,1),(1668,'2g35','NMR STRUCTURE OF TALIN-PTB IN COMPLEX WITH PIPKI','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1669,'2g3q','SOLUTION STRUCTURE OF EDE1 UBA-UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'ENDOCYTOSIS/SIGNALING PROTEIN',1,1,1),(1670,'2g46','STRUCTURE OF VSET IN COMPLEX WITH MEK27 H3 PEPT. AND COFACTOR PRODUCT SAH','SOLUTION NMR',NULL,'TRANSFERASE',2,2,1),(1671,'2g47','CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH AMYLOID-BETA (1-40)','X-RAY DIFFRACTION',2.100,'HYDROLASE',2,2,1),(1672,'2g49','CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH GLUCAGON','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(1673,'2g54','CRYSTAL STRUCTURE OF ZN-BOUND HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN B CHAIN','X-RAY DIFFRACTION',2.250,'HYDROLASE',2,2,1),(1674,'2g56','CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN B CHAIN','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(1675,'2g58','CRYSTAL STRUCTURE OF A COMPLEX OF PHOSPHOLIPASE A2 WITH A DESIGNED PEPTIDE INHIBITOR DEHYDRO-ILE-ALA-ARG-SER AT 0.98 A RESOLUTION','X-RAY DIFFRACTION',0.980,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1676,'2g5b','CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.','X-RAY DIFFRACTION',2.300,'APOPTOSIS',4,8,1),(1677,'2g5l','STREPTAVIDIN IN COMPLEX WITH NANOTAG','X-RAY DIFFRACTION',1.150,'PEPTIDE BINDING PROTEIN',2,2,1),(1678,'2g5o','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 2- (BUT-1-ENYL)-17BETA-ESTRADIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',2.300,'HORMONE/GROWTH FACTOR RECEPTOR',2,2,1),(1679,'2g8z','CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF SIGNALLING PROTEIN FROM SHEEP (SPS-40) WITH TRIMER AND DESIGNED PEPTIDE AT 2.5A RESOLUTION','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',1,1,1),(1680,'2g99','STRUCTURAL BASIS FOR THE SPECIFIC RECOGNITION OF METHYLATED HISTONE H3 LYSINE 4 BY THE WD-40 PROTEIN WDR5','X-RAY DIFFRACTION',1.900,'STRUCTURAL PROTEIN/DNA BINDING PROTEI',2,2,1),(1681,'2g9h','CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) IN COMPLEX WITH A HUMAN MHC CLASS II MOLECULE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,3,1),(1682,'2gch','REFINED CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN AT 1.9 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.900,'HYDROLASE (SERINE PROTEINASE)',1,2,1),(1683,'2gct','STRUCTURE OF GAMMA-CHYMOTRYPSIN IN THE RANGE PH 2.0 TO PH 10.5 SUGGESTS THAT GAMMA-CHYMOTRYPSIN IS A COVALENT ACYL-ENZYME ADDUCT AT LOW PH','X-RAY DIFFRACTION',1.800,'HYDROLASE/PEPTIDE',2,2,1),(1684,'2gde','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',2.000,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(1685,'2gfa','DOUBLE TUDOR DOMAIN COMPLEX STRUCTURE','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN',2,2,1),(1686,'2gfc','CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24','X-RAY DIFFRACTION',1.870,'TRANSFERASE',1,1,1),(1687,'2ggm','HUMAN CENTRIN 2 XERODERMA PIGMENTOSUM GROUP C PROTEIN COMPLEX','X-RAY DIFFRACTION',2.350,'CELL CYCLE',2,2,1),(1688,'2ggv','CRYSTAL STRUCTURE OF THE WEST NILE VIRUS NS2B-NS3 PROTEASE, HIS51ALA MUTANT','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(1689,'2ghq','CTD-SPECIFIC PHOSPHATASE SCP1 IN COMPLEX WITH PEPTIDE C- TERMINAL DOMAIN OF RNA POLYMERASE II','X-RAY DIFFRACTION',2.050,'HYDROLASE',2,2,1),(1690,'2ght','CTD-SPECIFIC PHOSPHATASE SCP1 IN COMPLEX WITH PEPTIDE FROM C-TERMINAL DOMAIN OF RNA POLYMERASE II','X-RAY DIFFRACTION',1.800,'HYDROLASE',2,2,1),(1691,'2git','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',2,2,1),(1692,'2gmt','THREE-DIMENSIONAL STRUCTURE OF CHYMOTRYPSIN INACTIVATED WITH (2S) N- ACETYL-L-ALANYL-L-PHENYLALANYL-CHLOROETHYL KETONE: IMPLICATIONS FOR THE MECHANISM OF INACTIVATION OF SERINE PROTEASES BY CHLOROKETONES','X-RAY DIFFRACTION',1.800,'HYDROLASE(SERINE PROTEINASE)',1,2,1),(1693,'2gnf','PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y- 27632','X-RAY DIFFRACTION',2.280,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1694,'2gng','PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE','X-RAY DIFFRACTION',1.870,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1695,'2gnh','PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P','X-RAY DIFFRACTION',2.050,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1696,'2gni','PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR FASUDIL (HA1077)','X-RAY DIFFRACTION',2.270,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1697,'2gnj','PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632','X-RAY DIFFRACTION',2.280,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(1698,'2gns','DESIGN OF SPECIFIC PEPTIDE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II PHOSPHOLIPASE A2 AND A DESIGNED PENTAPEPTIDE ALA- LEU- VAL- TYR- LYS AT 2.3 A RESOLUTION','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(1699,'2gp9','CRYSTAL STRUCTURE OF THE SLOW FORM OF THROMBIN IN A SELF- INHIBITED CONFORMATION','X-RAY DIFFRACTION',1.870,'HYDROLASE',1,1,1),(1700,'2gph','DOCKING MOTIF INTERACTIONS IN THE MAP KINASE ERK2','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(1701,'2gpo','ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A SYNTHETIC PEPTIDE FROM RIP140','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',1,1,1),(1702,'2gs0','NMR STRUCTURE OF THE COMPLEX BETWEEN THE PH DOMAIN OF THE TFB1 SUBUNIT FROM TFIIH AND THE ACTIVATION DOMAIN OF P53','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1703,'2gt9','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',2,2,1),(1704,'2gtk','STRUCTURE-BASED DESIGN OF INDOLE PROPIONIC ACIDS AS NOVEL PPARAG CO- AGONISTS','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION REGULATOR',1,1,1),(1705,'2gtw','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION','X-RAY DIFFRACTION',1.550,'IMMUNE SYSTEM',2,2,1),(1706,'2gtz','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',2,2,1),(1707,'2gu8','DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN,TRANSFERASE/INHIBIT',1,1,1),(1708,'2guo','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(1709,'2gv2','MDM2 IN COMPLEX WITH AN 8-MER P53 PEPTIDE ANALOGUE','X-RAY DIFFRACTION',1.800,'LIGASE',1,1,1),(1710,'2gvf','HCV NS3-4A PROTEASE DOMAIN COMPLEXED WITH A MACROCYCLIC KETOAMIDE INHIBITOR, SCH419021','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(1711,'2gzd','CRYSTAL STRUCTURE OF RAB11 IN COMPLEX WITH RAB11-FIP2','X-RAY DIFFRACTION',2.440,'PROTEIN TRANSPORT',2,2,1),(1712,'2h13','CRYSTAL STRUCTURE OF WDR5/HISTONE H3 COMPLEX','X-RAY DIFFRACTION',1.580,'TRANSCRIPTION',1,1,1),(1713,'2h1c','CRYSTAL STRUCTURE OF FITACB FROM NEISSERIA GONORRHOEAE','X-RAY DIFFRACTION',1.800,'GENE REGULATION',1,1,1),(1714,'2h1p','THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES','X-RAY DIFFRACTION',2.400,'COMPLEX (ANTIBODY/PEPTIDE)',1,2,1),(1715,'2h1u','PORCINE PANCREATIC ELASTASE COMPLEXED WITH METPHELEUGLU AT PH 5.0','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(1716,'2h2d','THE STRUCTURAL BASIS FOR SIRTUIN SUBSTRATE AFFINITY','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(1717,'2h2f','THE STRUCTURAL BASIS FOR SIRTUIN SUBSTRATE AFFINITY','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(1718,'2h2g','THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE AFFINITY','X-RAY DIFFRACTION',1.630,'HYDROLASE',1,1,1),(1719,'2h2h','THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE SPECIFICITY','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(1720,'2h48','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS362->ALA, CYS364->ALA, CYS397->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL- BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1721,'2h4f','SIR2-P53 PEPTIDE-NAD+','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(1722,'2h4h','SIR2 H116Y MUTANT-P53 PEPTIDE-NAD','X-RAY DIFFRACTION',1.990,'HYDROLASE',1,1,1),(1723,'2h4j','SIR2-DEACETYLATED PEPTIDE (FROM ENZYMATIC TURNOVER IN CRYSTAL)','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(1724,'2h4p','CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE CLEAVED CONFORMATION','X-RAY DIFFRACTION',1.700,'HYDROLASE INHIBITOR',1,1,1),(1725,'2h4q','CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE CLEAVED CONFORMATION','X-RAY DIFFRACTION',2.100,'HYDROLASE INHIBITOR',1,1,1),(1726,'2h4w','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1727,'2h4y','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->LYS) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1728,'2h51','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP AND ARG286->LYS) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)- PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1729,'2h54','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (THR388->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1730,'2h59','SIR2 H116A-DEACETYLATED P53 PEPTIDE-3\'-O-ACETYL ADP RIBOSE','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,2,1),(1731,'2h5d','0.9A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE COMPLEXED WITH A TRANSITION STATE ANALOGUE, MEOSUC-ALA-ALA-PRO-VAL BORONIC ACID','X-RAY DIFFRACTION',0.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1732,'2h5i','CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-DEVD-CHO','X-RAY DIFFRACTION',1.690,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1733,'2h5j','CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(1734,'2h65','CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(1735,'2h6f','PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYLATED DDPTASACVLS PEPTIDE PRODUCT AT 1.5A RESOLUTION','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,2,1),(1736,'2h6g','W102T PROTEIN FARNESYLTRANSFERASE MUTANT COMPLEXED WITH A GERANYLGERANYLATED DDPTASACVLS PEPTIDE PRODUCT AT 1.85A RESOLUTION','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,2,1),(1737,'2h6h','Y365F PROTEIN FARNESYLTRANSFERASE MUTANT COMPLEXED WITH A FARNESYLATED DDPTASACVLS PEPTIDE PRODUCT AT 1.8A','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,2,1),(1738,'2h6k','HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX','X-RAY DIFFRACTION',1.890,'GENE REGULATION',2,2,1),(1739,'2h6m','AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1740,'2h6n','HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX','X-RAY DIFFRACTION',1.500,'GENE REGULATION',2,2,1),(1741,'2h6p','CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE, KPIVVLHGY','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(1742,'2h6q','HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX','X-RAY DIFFRACTION',1.870,'GENE REGULATION',2,2,1),(1743,'2h6t','SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS COMPLEXED WITH PEPSTATIN A','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1744,'2h7d','SOLUTION STRUCTURE OF THE TALIN F3 DOMAIN IN COMPLEX WITH A CHIMERIC BETA3 INTEGRIN-PIP KINASE PEPTIDE','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1745,'2h7e','SOLUTION STRUCTURE OF THE TALIN F3 DOMAIN IN COMPLEX WITH A CHIMERIC BETA3 INTEGRIN-PIP KINASE PEPTIDE- MINIMIZED AVERAGE STRUCTURE','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1746,'2h8p','STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER','X-RAY DIFFRACTION',2.250,'MEMBRANE PROTEIN',1,1,1),(1747,'2h9e','CRYSTAL STRUCTURE OF FXA/SELECTIDE/NAPC2 TERNARY COMPLEX','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1748,'2h9h','AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS','X-RAY DIFFRACTION',1.390,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1749,'2h9m','WDR5 IN COMPLEX WITH UNMODIFIED H3K4 PEPTIDE','X-RAY DIFFRACTION',1.900,'STRUCTURAL GENOMICS, GENE REGULATION',2,2,1),(1750,'2h9n','WDR5 IN COMPLEX WITH MONOMETHYLATED H3K4 PEPTIDE','X-RAY DIFFRACTION',2.000,'STRUCTURAL GENOMICS, GENE REGULATION',2,2,1),(1751,'2h9p','WDR5 IN COMPLEX WITH TRIMETHYLATED H3K4 PEPTIDE','X-RAY DIFFRACTION',1.910,'STRUCTURAL GENOMICS, GENE REGULATION',1,1,1),(1752,'2h9t','CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN IN COMPLEX WITH SURAMIN','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,1,1),(1753,'2hal','AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS','X-RAY DIFFRACTION',1.350,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1754,'2hbq','CRYSTAL STRUCTURE OF WILDTYPE HUMAN CASPASE-1 IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1755,'2hbr','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1756,'2hby','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1757,'2hbz','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA, GLU390->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)- PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1758,'2hc4','CRYSTAL STRUCTURE OF THE LBD OF VDR OF DANIO RERIO IN COMPLEX WITH CALCITRIOL','X-RAY DIFFRACTION',2.200,'GENE REGULATION',1,1,1),(1759,'2hcj','TRYPSIN-MODIFIED ELONGATION FACTOR TU IN COMPLEX WITH TETRACYCLINE','X-RAY DIFFRACTION',2.120,'TRANSLATION',1,1,1),(1760,'2hd4','CRYSTAL STRUCTURE OF PROTEINASE K INHIBITED BY A LACTOFERRIN OCTAPEPTIDE GLY-ASP-GLU-GLN-GLY-GLU-ASN-LYS AT 2.15 A RESOLUTION','X-RAY DIFFRACTION',2.150,'HYDROLASE',1,1,1),(1761,'2hdx','CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.350,'SIGNALING PROTEIN',6,6,1),(1762,'2hfe','RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER','X-RAY DIFFRACTION',2.250,'MEMBRANE PROTEIN',1,1,1),(1763,'2hfp','CRYSTAL STRUCTURE OF PPAR GAMMA WITH N-SULFONYL-2-INDOLE CARBOXAMIDE LIGANDS','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(1764,'2hgt','STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(1765,'2hi8','HUMAN FORMYLGLYCINE GENERATING ENZYME, C336S MUTANT, BROMIDE CO- CRYSTALLIZATION','X-RAY DIFFRACTION',1.640,'HYDROLASE ACTIVATOR, PROTEIN BINDING',1,1,1),(1766,'2hjk','CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(1767,'2hjl','CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(1768,'2hkf','CRYSTAL STRUCTURE OF THE COMPLEX FAB M75- PEPTIDE','X-RAY DIFFRACTION',2.010,'IMMUNE SYSTEM',1,2,1),(1769,'2hl3','CRYSTAL STRUCTURE OF THE A49M MUTANT CAP-GLY DOMAIN OF HUMAN DYNACTIN- 1 (P150-GLUED) IN COMPLEX WITH HUMAN EB1 C-TERMINAL HEXAPEPTIDE','X-RAY DIFFRACTION',2.030,'STRUCTURAL PROTEIN',1,2,1),(1770,'2hmh','CRYSTAL STRUCTURE OF SOCS3 IN COMPLEX WITH GP130(PTYR757) PHOSPHOPEPTIDE.','X-RAY DIFFRACTION',2.000,'CYTOKINE REGULATOR',1,1,1),(1771,'2hn7','HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(1772,'2hnt','CRYSTALLOGRAPHIC STRUCTURE OF HUMAN GAMMA-THROMBIN','X-RAY DIFFRACTION',2.500,'SERINE PROTEASE',1,3,1),(1773,'2hob','CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C- TERMINI IN COMPLEX WITH A MICHAEL ACCEPTOR N3','X-RAY DIFFRACTION',1.950,'VIRAL PROTEIN',1,1,1),(1774,'2hpl','CRYSTAL STRUCTURE OF THE MOUSE P97/PNGASE COMPLEX','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(1775,'2hpz','CRYSTAL STRUCTURE OF PROTEINASE K COMPLEX WITH A SYNTHETIC PEPTIDE KLKLLVVIRLK AT 1.69 A RESOLUTION','X-RAY DIFFRACTION',1.690,'HYDROLASE',1,1,1),(1776,'2hqh','CRYSTAL STRUCTURE OF P150GLUED AND CLIP-170','X-RAY DIFFRACTION',1.800,'STRUCTURAL PROTEIN, PROTEIN BINDING',4,4,1),(1777,'2hqw','CRYSTAL STRUCTURE OF CA2+/CALMODULIN BOUND TO NMDA RECEPTOR NR1C1 PEPTIDE','X-RAY DIFFRACTION',1.900,'METAL BINDING PROTEIN',1,1,1),(1778,'2hrp','ANTIGEN-ANTIBODY COMPLEX','X-RAY DIFFRACTION',2.200,'COMPLEX (IMMUNOGLOBULIN/PEPTIDE)',2,4,1),(1779,'2ht9','THE STRUCTURE OF DIMERIC HUMAN GLUTAREDOXIN 2','X-RAY DIFFRACTION',1.900,'OXIDOREDUCTASE',1,1,1),(1780,'2hv8','CRYSTAL STRUCTURE OF GTP-BOUND RAB11 IN COMPLEX WITH FIP3','X-RAY DIFFRACTION',1.860,'PROTEIN TRANSPORT',1,3,1),(1781,'2hwl','CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH FIBRINOGEN GAMMA\' PEPTIDE','X-RAY DIFFRACTION',2.400,'HYDROLASE',3,2,1),(1782,'2i04','X-RAY CRYSTAL STRUCTURE OF MAGI-1 PDZ1 BOUND TO THE C- TERMINAL PEPTIDE OF HPV18 E6','X-RAY DIFFRACTION',2.150,'PEPTIDE BINDING PROTEIN',2,2,1),(1783,'2i0l','X-RAY CRYSTAL STRUCTURE OF SAP97 PDZ2 BOUND TO THE C- TERMINAL PEPTIDE OF HPV18 E6.','X-RAY DIFFRACTION',2.310,'PEPTIDE BINDING PROTEIN',2,2,1),(1784,'2i3h','STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 4-MER PEPTIDE (AVPW)','X-RAY DIFFRACTION',1.620,'INHIBITOR/APOPTOSIS',2,2,1),(1785,'2i3s','BUB3 COMPLEX WITH BUB1 GLEBS MOTIF','X-RAY DIFFRACTION',1.900,'CELL CYCLE',3,3,1),(1786,'2i5y','CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN/IMMUNE SYSTEM',2,2,1),(1787,'2i60','CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B','X-RAY DIFFRACTION',2.400,'VIRAL PROTEIN/IMMUNE SYSTEM',2,2,1),(1788,'2i6o','CRYSTAL STRUCTURE OF THE COMPLEX OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH PHOSPHOPEPTIDES N-G-(P)Y-K-N','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(1789,'2i94','NMR STRUCTURE OF RECOVERIN BOUND TO RHODOPSIN KINASE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1790,'2icw','CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',2,6,1),(1791,'2id4','THE 1.9 A STRUCTURE OF KEX2 IN COMPLEX WITH AN AC-R-E-R-K-CHLOROMETHYL KETONE INHIBITOR.','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(1792,'2ifr','CRYSTAL STRUCTURE OF SCYTALIDO-GLUTAMIC PEPTIDASE WITH A PEPTIDE BASED TRANSITION STATE ANALOG','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1793,'2ifw','CRYSTAL STRUCTURE OF SCYTALIDO-GLUTAMIC PEPTIDASE WITH A TRANSITION STATE ANALOG INHIBITOR','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(1794,'2ig0','STRUCTURE OF 53BP1/METHYLATED HISTONE PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.700,'CELL CYCLE',1,1,1),(1795,'2ihs','CRYSTAL STRUCTURE OF THE B30.2/SPRY DOMAIN OF GUSTAVUS IN COMPLEX WITH A 20-RESIDUE VASA PEPTIDE','X-RAY DIFFRACTION',2.200,'PEPTIDE BINDING PROTEIN',2,2,1),(1796,'2iij','STRUCTURE OF HUMAN ASF1A IN COMPLEX WITH HISTONE H3','SOLUTION NMR',NULL,'CHAPERONE',1,1,1),(1797,'2ijo','CRYSTAL STRUCTURE OF THE WEST NILE VIRUS NS2B-NS3 PROTEASE COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1798,'2ilm','FACTOR INHIBITING HIF-1 ALPHA D201A MUTANT IN COMPLEX WITH FE(II), ALPHA-KETOGLUTARATE AND HIF-1 ALPHA 35MER','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION REGULATOR, OXIDOREDUCTA',1,1,1),(1799,'2ipk','CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DR1 IN COMPLEX WITH THE FLUOROGENIC PEPTIDE, ACPKXVKQNTLKLAT (X=3-[5-(DIMETHYLAMINO)-1,3- DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL]-L-ALANINE) AND THE SUPERANTIGEN, SEC3 VARIANT 3B2','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,3,1),(1800,'2ipp','CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HUMAN LIVER CATHEPSIN B','X-RAY DIFFRACTION',2.150,'HYDROLASE',1,1,1),(1801,'2ipu','PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',2,4,1),(1802,'2iq6','CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE FROM VIBRIO PROTEOLYTICUS IN COMPLEXATION WITH LEUCYL-LEUCYL-LEUCINE.','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(1803,'2itk','HUMAN PIN1 BOUND TO D-PEPTIDE','X-RAY DIFFRACTION',1.450,'ISOMERASE/ISOMERASE INHIBITOR',1,1,1),(1804,'2iuh','CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH C-KIT PHOSPHOTYROSYL PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(1805,'2iui','CRYSTAL STRUCTURE OF THE PI3-KINASE P85 N-TERMINAL SH2 DOMAIN IN COMPLEX WITH PDGFR PHOSPHOTYROSYL PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSFERASE',2,2,1),(1806,'2iv9','B2-APPENDAGE FROM AP2 IN COMPLEX WITH EPS15 PEPTIDE','X-RAY DIFFRACTION',1.900,'ENDOCYTOSIS/REGULATOR',1,2,1),(1807,'2ivz','STRUCTURE OF TOLB IN COMPLEX WITH A PEPTIDE OF THE COLICIN E9 T-DOMAIN','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT/HYDROLASE',4,4,1),(1808,'2iwb','MECR1 UNBOUND EXTRACELLULAR ANTIBIOTIC-SENSOR DOMAIN.','X-RAY DIFFRACTION',1.800,'ANTIBIOTIC RESISTANCE',1,1,1),(1809,'2j0s','THE CRYSTAL STRUCTURE OF THE EXON JUNCTION COMPLEX AT 2.2 A RESOLUTION','X-RAY DIFFRACTION',2.210,'HYDROLASE',1,2,1),(1810,'2j30','THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1811,'2j31','THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1812,'2j32','THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1813,'2j33','THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1814,'2j4w','STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(1815,'2j7x','STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(1816,'2j7y','STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(1817,'2j9a','BLLAP IN COMPLEX WITH MICROGININ FR1','X-RAY DIFFRACTION',1.730,'HYDROLASE/INHIBITOR',1,1,1),(1818,'2j9j','ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR JG-365','X-RAY DIFFRACTION',1.040,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1819,'2j9n','ROBOTICALLY HARVESTED TRYPSIN COMPLEXED WITH BENZAMIDINE CONTAINING POLYPEPTIDE MEDIATED CRYSTAL CONTACTS','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,1,1),(1820,'2j9u','2 ANGSTROM X-RAY STRUCTURE OF THE YEAST ESCRT-I VPS28 C-TERMINUS IN COMPLEX WITH THE NZF-N DOMAIN FROM ESCRT-II','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT',2,2,1),(1821,'2jam','CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G','X-RAY DIFFRACTION',1.700,'TRANSFERASE',2,2,1),(1822,'2jby','A VIRAL PROTEIN UNEXPECTEDLY MIMICS THE STRUCTURE AND FUNCTION OF PRO- SURVIVAL BCL-2','X-RAY DIFFRACTION',2.410,'APOPTOSIS',1,1,1),(1823,'2jcc','AH3 RECOGNITION OF MUTANT HLA-A2 W167A','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,6,1),(1824,'2jd5','SKY1P BOUND TO NPL3P-DERIVED SUBSTRATE PEPTIDE','X-RAY DIFFRACTION',2.500,'TRANSFERASE',1,2,1),(1825,'2jdi','GROUND STATE STRUCTURE OF F1-ATPASE FROM BOVINE HEART MITOCHONDRIA (BOVINE F1-ATPASE CRYSTALLISED IN THE ABSENCE OF AZIDE)','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,2,1),(1826,'2jdl','STRUCTURE OF C-TERMINAL REGION OF ACIDIC P2 RIBOSOMAL PROTEIN COMPLEXED WITH TRICHOSANTHIN','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(1827,'2jdo','STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5- SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(1828,'2jdr','STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A- 443654','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(1829,'2jds','STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A- 443654','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(1830,'2jdt','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5- SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE','X-RAY DIFFRACTION',2.150,'TRANSFERASE',1,1,1),(1831,'2jdv','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654','X-RAY DIFFRACTION',2.080,'TRANSFERASE',1,1,1),(1832,'2je4','ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE IN COMPLEX WITH JG-365','X-RAY DIFFRACTION',1.070,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(1833,'2jet','CRYSTAL STRUCTURE OF A TRYPSIN-LIKE MUTANT (S189D , A226G) CHYMOTRYPSIN.','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,2,1),(1834,'2jf1','CRYSTAL STRUCTURE OF THE FILAMIN A REPEAT 21 COMPLEXED WITH THE INTEGRIN BETA2 CYTOPLASMIC TAIL PEPTIDE','X-RAY DIFFRACTION',2.200,'CELL ADHESION',1,1,1),(1835,'2jf9','ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',3,3,1),(1836,'2jgb','STRUCTURE OF HUMAN EIF4E HOMOLOGOUS PROTEIN 4EHP WITH M7GTP','X-RAY DIFFRACTION',1.700,'TRANSLATION',1,1,1),(1837,'2jgc','STRUCTURE OF THE HUMAN EIF4E HOMOLOGOUS PROTEIN, 4EHP WITHOUT LIGAND BOUND','X-RAY DIFFRACTION',2.400,'TRANSLATION',1,1,1),(1838,'2jh0','HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1839,'2jh5','HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1840,'2jh6','HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.210,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(1841,'2jk9','THE STRUCTURE OF  SPLA-RYANODINE RECEPTOR DOMAIN AND SOCS BOX CONTAINING 1 IN COMPLEX WITH A PAR-4 PEPTIDE','X-RAY DIFFRACTION',1.790,'APOPTOSIS',1,1,1),(1842,'2jkg','PLASMODIUM FALCIPARUM PROFILIN','X-RAY DIFFRACTION',1.890,'PROTEIN BINDING',1,1,1),(1843,'2jld','EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3','X-RAY DIFFRACTION',2.350,'TRANSFERASE',1,1,1),(1844,'2jm6','SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAB','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(1845,'2jma','R21A SPC-SH3:P41 COMPLEX','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1846,'2jmj','NMR SOLUTION STRUCTURE OF THE PHD DOMAIN FROM THE YEAST YNG1 PROTEIN IN COMPLEX WITH H3(1-9)K4ME3 PEPTIDE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1847,'2jmx','OSCP-NT (1-120) IN COMPLEX WITH N-TERMINAL (1-25) ALPHA SUBUNIT FROM F1-ATPASE','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(1848,'2jnd','3D NMR STRUCTURE OF ECD1 OF MCRF-R2B IN COMPLEX WITH ASTRESSIN','SOLUTION NMR',NULL,'LIGAND BINDING PROTEIN',1,1,1),(1849,'2jnw','SOLUTION STRUCTURE OF A ERCC1-XPA HETERODIMER','SOLUTION NMR',NULL,'DNA BINDING PROTEIN',1,1,1),(1850,'2joa','HTRA1 BOUND TO AN OPTIMIZED PEPTIDE: NMR ASSIGNMENT OF PDZ DOMAIN AND LIGAND RESONANCES','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1851,'2jod','PAC1-RSHORT N-TERMINAL EC DOMAIN PACAP(6-38) COMPLEX','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(1852,'2jog','STRUCTURE OF THE CALCINEURIN-NFAT COMPLEX','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(1853,'2jq7','MODEL FOR THIOSTREPTON BINDING TO THE RIBOSOMAL L11-RNA','SOLUTION NMR',NULL,'RIBOSOME/ANTIBIOTIC',1,1,1),(1854,'2jq9','VPS4A MIT-CHMP1A COMPLEX','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(1855,'2jqi','NMR STRUCTURE OF THE RAD53 FHA1 DOMAIN IN COMPLEX WITH A PHOSPHOTHREONIEN PEPTIDE DERIVED FROM RAD53 SCD1','SOLUTION NMR',NULL,'CELL CYCLE',1,1,1),(1856,'2jqk','VPS4B MIT-CHMP2B COMPLEX','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(1857,'2jql','NMR STRUCTURE OF THE YEAST DUN1 FHA DOMAIN IN COMPLEX WITH A DOUBLY PHOSPHORYLATED (PT) PEPTIDE DERIVED FROM RAD53 SCD1','SOLUTION NMR',NULL,'CELL CYCLE',1,1,1),(1858,'2jtt','SOLUTION STRUCTURE OF CALCIUM LOADED S100A6 BOUND TO C- TERMINAL SIAH-1 INTERACTING PROTEIN','SOLUTION NMR',NULL,'CALCIUM BINDING PROTEIN/ANTITUMOR PRO',2,2,1),(1859,'2jw1','STRUCTURAL CHARACTERIZATION OF THE TYPE III PILOTIN-SECRETIN INTERACTION IN SHIGELLA FLEXNERI BY NMR SPECTROSCOPY','SOLUTION NMR',NULL,'MEMBRANE PROTEIN',1,1,1),(1860,'2jxc','STRUCTURE OF THE EPS15-EH2 STONIN2 COMPLEX','SOLUTION NMR',NULL,'ENDOCYTOSIS/PROTEIN BINDING',1,1,1),(1861,'2jz3','SOCS BOX ELONGINBC TERNARY COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION INHIBITOR/TRANSCRIPTION',1,1,1),(1862,'2jzi','STRUCTURE OF CALMODULIN COMPLEXED WITH THE CALMODULIN BINDING DOMAIN OF CALCINEURIN','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1863,'2k00','SOLUTION STRUCTURE OF THE TALIN F3 IN COMPLEX WITH LAYILIN CYTODOMAIN','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1864,'2k03','STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING A SULFOTYROSINE AT POSTITION 21','SOLUTION NMR',NULL,'CYTOKINE',2,2,1),(1865,'2k04','STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING NO SULFOTYROSINES','SOLUTION NMR',NULL,'CYTOKINE',2,2,1),(1866,'2k05','STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING SULFOTYROSINES AT POSTITIONS 7, 12 AND 21','SOLUTION NMR',NULL,'CYTOKINE',2,2,1),(1867,'2k0f','CALMODULIN COMPLEXED WITH CALMODULIN-BINDING PEPTIDE FROM SMOOTH MUSCLE MYOSIN LIGHT CHAIN KINASE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1868,'2k17','SOLUTION STRUCTURE OF THE TAF3 PHD DOMAIN IN COMPLEX WITH A H3K4ME3 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1869,'2k1q','NMR STRUCTURE OF HEPATITIS C VIRUS NS3 SERINE PROTEASE COMPLEXED WITH THE NON-COVALENTLY BOUND PHENETHYLAMIDE INHIBITOR','SOLUTION NMR',NULL,'VIRAL PROTEIN',1,1,1),(1870,'2k20','SOLUTION STRUCTURE OF PAR-3 PDZ3 IN COMPLEX WITH PTEN PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(1871,'2k2f','SOLUTION STRUCTURE OF CA2+-S100A1-RYRP12','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',2,2,1),(1872,'2k2i','NMR SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN (T94-Y172) OF THE HUMAN CENTRIN 2 IN COMPLEX WITH A REPEAT SEQUENCE OF HUMAN SFI1 (R641-T660)','SOLUTION NMR',NULL,'CELL CYCLE',1,1,1),(1873,'2k2r','THE NMR STRUCTURE OF ALPHA-PARVIN CH2/PAXILLIN LD1 COMPLEX','SOLUTION NMR',NULL,'CELL ADHESION',1,1,1),(1874,'2k2u','NMR STRUCTURE OF THE COMPLEX BETWEEN TFB1 SUBUNIT OF TFIIH AND THE ACTIVATION DOMAIN OF VP16','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1875,'2k3u','STRUCTURE OF THE TYROSINE-SULFATED C5A RECEPTOR N-TERMINUS IN COMPLEX WITH THE IMMUNE EVASION PROTEIN CHIPS.','SOLUTION NMR',NULL,'IMMUNE SYSTEM',1,1,1),(1876,'2k3w','NMR STRUCTURE OF VPS4A-MIT-CHMP6','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(1877,'2k42','SOLUTION STRUCTURE OF THE GTPASE BINDING DOMAIN OF WASP IN COMPLEX WITH ESPFU, AN EHEC EFFECTOR','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(1878,'2k6q','LC3 P62 COMPLEX STRUCTURE','SOLUTION NMR',NULL,'APOPTOSIS INHIBITOR/APOPTOSIS',1,1,1),(1879,'2k7l','NMR STRUCTURE OF A COMPLEX FORMED BY THE C-TERMINAL DOMAIN OF HUMAN RAP74 AND A PHOSPHORYLATED PEPTIDE FROM THE CENTRAL DOMAIN OF THE FCP1','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1880,'2k7w','BAX ACTIVATION IS INITIATED AT A NOVEL INTERACTION SITE','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(1881,'2k8f','STRUCTURAL BASIS FOR THE REGULATION OF P53 FUNCTION BY P300','SOLUTION NMR',NULL,'TRANSFERASE/TRANSCRIPTION',1,1,1),(1882,'2k9u','SOLUTION NMR STRUCTURE OF THE FILAMIN-MIGFILIN COMPLEX','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1883,'2ka6','NMR STRUCTURE OF THE CBP-TAZ2/STAT1-TAD COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION REGULATOR',1,1,1),(1884,'2ka9','SOLUTION STRUCTURE OF PSD-95 PDZ12 COMPLEXED WITH CYPIN PEPTIDE','SOLUTION NMR',NULL,'CELL ADHESION',2,1,1),(1885,'2kbm','CA-S100A1 INTERACTING WITH TRTK12','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',2,2,1),(1886,'2kbr','SOLUTION STRUCTURE OF HARMONIN N TERMINAL DOMAIN IN COMPLEX WITH A INTERNAL PEPTIDE OF CADHERIN23','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN/CELL ADHESION',1,1,1),(1887,'2kbs','SOLUTION STRUCTURE OF HARMONIN PDZ2 IN COMPLEX WITH THE CARBOXYL TAIL PEPTIDE OF CADHERIN23','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN/CELL ADHESION',1,1,1),(1888,'2kbw','SOLUTION STRUCTURE OF HUMAN MCL-1 COMPLEXED WITH HUMAN BID_BH3 PEPTIDE','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(1889,'2kc8','STRUCTURE OF E. COLI TOXIN RELE (R81A/R83A) MUTANT IN COMPLEX WITH ANTITOXIN RELBC (K47-L79) PEPTIDE','SOLUTION NMR',NULL,'TOXIN/TOXIN REPRESSOR',1,1,1),(1890,'2kdu','STRUCTURAL BASIS OF THE MUNC13-1/CA2+-CALMODULIN INTERACTION: A NOVEL 1-26 CALMODULIN BINDING MOTIF WITH A BIPARTITE BINDING MODE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/EXOCYTOSIS',1,1,1),(1891,'2ke1','MOLECULAR BASIS OF NON-MODIFIED HISTONE H3 TAIL RECOGNITION BY THE FIRST PHD FINGER OF AUTOIMMUNE REGULATOR','SOLUTION NMR',NULL,'GENE REGULATION',1,1,1),(1892,'2kff','STRUCTURE OF THE C-TERMINAL DOMAIN OF EHD1 WITH FNYESTNPFTAK','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1893,'2kfg','STRUCTURE OF THE C-TERMINAL DOMAIN OF EHD1 IN COMPLEX WITH FNYESTDPFTAK','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1894,'2kfh','STRUCTURE OF THE C-TERMINAL DOMAIN OF EHD1 WITH FNYESTGPFTAK','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1895,'2kgb','NMR SOLUTION OF THE REGULATORY DOMAIN CARDIAC F77W-TROPONIN C IN COMPLEX WITH THE CARDIAC TROPONIN I 144-163 SWITCH PEPTIDE','SOLUTION NMR',NULL,'CONTRACTILE PROTEIN/CA BINDING PROTEI',1,1,1),(1896,'2khs','SOLUTION STRUCTURE OF SNASE121:SNASE(111-143) COMPLEX','SOLUTION NMR',NULL,'HYDROLASE',1,1,1),(1897,'2khw','SOLUTION STRUCTURE OF THE HUMAN POLYMERASE IOTA UBM2- UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'TRANSFERASE/PROTEIN BINDING',1,1,1),(1898,'2kid','SOLUTION STRUCTURE OF THE S. AUREUS SORTASE A-SUBSTRATE COMPLEX','SOLUTION NMR',NULL,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1899,'2kj4','SOLUTION STRUCTURE OF THE COMPLEX OF VEK-30 AND PLASMINOGEN KRINGLE 2','SOLUTION NMR',NULL,'BLOOD CLOTTING',1,1,1),(1900,'2kje','NMR STRUCTURE OF CBP TAZ2 AND ADENOVIRAL E1A COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1901,'2kne','CALMODULIN WRAPS AROUND ITS BINDING DOMAIN IN THE PLASMA MEMBRANE CA2+ PUMP ANCHORED BY A NOVEL 18-1 MOTIF','SOLUTION NMR',NULL,'METAL TRANSPORT',1,1,1),(1902,'2knh','THE SOLUTION STRUCTURE OF THE ETAFH DOMAIN OF AML1-ETO COMPLEXED WITH HEB PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION REGULATOR',1,1,1),(1903,'2koh','NMR STRUCTURE OF MOUSE PAR3-PDZ3 IN COMPLEX WITH VE-CADHERIN C-TERMINUS','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1904,'2kpl','MAGI-1 PDZ1 / E6CT','SOLUTION NMR',NULL,'PROTEIN BINDING/ONCOPROTEIN',1,1,1),(1905,'2kqf','SOLUTION STRUCTURE OF MAST205-PDZ COMPLEXED WITH THE C-TERMINUS OF A RABIES VIRUS G PROTEIN','SOLUTION NMR',NULL,'SIGNALING PROTEIN/PEPTIDE BINDING PRO',1,1,1),(1906,'2kqs','PHOSPHORYLATION OF SUMO-INTERACTING MOTIF BY CK2 ENHANCES DAXX SUMO BINDING ACTIVITY','SOLUTION NMR',NULL,'TRANSCRIPTION, APOPTOSIS',1,1,1),(1907,'2krb','SOLUTION STRUCTURE OF EIF3B-RRM BOUND TO EIF3J PEPTIDE','SOLUTION NMR',NULL,'TRANSLATION',1,1,1),(1908,'2krd','SOLUTION STRUCTURE OF THE REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH THE SWITCH REGION OF CARDIAC TROPONIN I AND W7','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN',1,1,1),(1909,'2kri','STRUCTURE OF A COMPLEX BETWEEN DOMAIN V OF BETA2-GLYCOPROTEIN I AND THE FOURTH LIGAND-BINDING MODULE FROM LDLR DETERMINED WITH HADDOCK','SOLUTION NMR',NULL,'PROTEIN BINDING/ENDOCYTOSIS',1,1,1),(1910,'2ks9','SOLUTION CONFORMATION OF SUBSTANCE P IN WATER COMPLEXED WITH NK1R','SOLUTION NMR',NULL,'NEUROPEPTIDE RECEPTOR/NEUROPEPTIDE',1,1,1),(1911,'2ksa','SUBSTANCE P IN DMPC/CHAPS ISOTROPIC Q=0.25 BICELLES AS A LIGAND FOR NK1R','SOLUTION NMR',NULL,'NEUROPEPTIDE RECEPTOR/NEUROPEPTIDE',1,1,1),(1912,'2ksb','SUBSTANCE P IN ISOTROPIC Q=0.25 DMPC/CHAPS/GM1 BICELLES AS A LIGAND FOR NK1R','SOLUTION NMR',NULL,'NEUROPEPTIDE RECEPTOR/NEUROPEPTIDE',1,1,1),(1913,'2ksp','MECHANISM FOR THE SELECTIVE INTERACTION OF C-TERMINAL EH-DOMAIN PROTEINS WITH SPECIFIC NPF-CONTAINING PARTNERS','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1914,'2kt5','RRM DOMAIN OF MRNA EXPORT ADAPTOR REF2-I BOUND TO HSV-1 ICP27 PEPTIDE','SOLUTION NMR',NULL,'RNA BINDING PROTEIN / VIRAL PROTEIN',1,1,1),(1915,'2ktb','SOLUTION STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN POLYBROMO IN COMPLEX WITH AN ACETYLATED PEPTIDE FROM HISTONE 3','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1916,'2ktf','SOLUTION NMR STRUCTURE OF HUMAN POLYMERASE IOTA UBM2 IN COMPLEX WITH UBIQUITIN','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1917,'2kup','SOLUTION STRUCTURE OF THE COMPLEX OF THE PTB DOMAIN OF SNT-2 AND 19- RESIDUE PEPTIDE (AA 1571-1589) OF HALK','SOLUTION NMR',NULL,'SIGNALING PROTEIN/ONCOPROTEIN',1,1,1),(1918,'2kvm','SOLUTION STRUCTURE OF THE CBX7 CHROMODOMAIN IN COMPLEX WITH A H3K27ME2 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1919,'2kwf','THE STRUCTURE OF E-PROTEIN ACTIVATION DOMAIN 1 BOUND TO THE KIX DOMAIN OF CBP/P300 ELUCIDATES LEUKEMIA INDUCTION BY E2A-PBX1','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1920,'2kwj','SOLUTION STRUCTURES OF THE DOUBLE PHD FINGERS OF HUMAN TRANSCRIPTIONAL PROTEIN DPF3 BOUND TO A HISTONE PEPTIDE CONTAINING ACETYLATION AT LYSINE 14','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1921,'2kwk','SOLUTION STRUCTURES OF THE DOUBLE PHD FINGERS OF HUMAN TRANSCRIPTIONAL PROTEIN DPF3B BOUND TO A H3 PEPTIDE WILD TYPE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1922,'2kwn','SOLUTION STRUCTURE OF THE DOUBLE PHD (PLANT HOMEODOMAIN) FINGERS OF HUMAN TRANSCRIPTIONAL PROTEIN DPF3B BOUND TO A HISTONE H4 PEPTIDE CONTAINING ACETYLATION AT LYSINE 16','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1923,'2kwo','SOLUTION STRUCTURE OF THE DOUBLE PHD (PLANT HOMEODOMAIN) FINGERS OF HUMAN TRANSCRIPTIONAL PROTEIN DPF3B BOUND TO A HISTONE H4 PEPTIDE CONTAINING N-TERMINAL ACETYLATION AT SERINE 1','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1924,'2kwu','SOLUTION STRUCTURE OF UBM2 OF MURINE POLYMERASE IOTA IN COMPLEX WITH UBIQUITIN','SOLUTION NMR',NULL,'PROTEIN BINDING/SIGNALING PROTEIN',1,1,1),(1925,'2kwv','SOLUTION STRUCTURE OF UBM1 OF MURINE POLYMERASE IOTA IN COMPLEX WITH UBIQUITIN','SOLUTION NMR',NULL,'PROTEIN BINDING/SIGNALING PROTEIN',1,1,1),(1926,'2kxc','1H, 13C, AND 15N CHEMICAL SHIFT ASSIGNMENTS FOR IRTKS-SH3 AND ESPFU- R47 COMPLEX','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1927,'2kxh','SOLUTION STRUCTURE OF THE FIRST TWO RRM DOMAINS OF FIR IN THE COMPLEX WITH FBP NBOX PEPTIDE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1928,'2kxq','SOLUTION STRUCTURE OF SMURF2 WW2 AND WW3 BOUND TO SMAD7 PY MOTIF CONTAINING PEPTIDE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1929,'2kxw','STRUCTURE OF THE C-DOMAIN FRAGMENT OF APO CALMODULIN BOUND TO THE IQ MOTIF OF NAV1.2','SOLUTION NMR',NULL,'CALCIUM-BINDING PROTEIN/METAL TRANSPO',1,1,1),(1930,'2kyl','SOLUTION STRUCTURE OF MAST2-PDZ COMPLEXED WITH THE C-TERMINUS OF PTEN','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(1931,'2kym','SOLUTION STRUCTURE OF THE BEM1P SH3-CI DOMAIN FROM L.ELONGISPORUS IN COMPLEX WITH STE20P PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(1932,'2kzu','DAXX HELICAL BUNDLE (DHB) DOMAIN / RASSF1C COMPLEX','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(1933,'2l00','SOLUTION STRUCTURE OF THE NON-COVALENT COMPLEX OF THE ZNF216 A20 DOMAIN WITH UBIQUITIN','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/PEPTIDE BINDING',1,1,1),(1934,'2l0f','SOLUTION NMR STRUCTURE OF HUMAN POLYMERASE IOTA UBM2 (P692A MUTANT) IN COMPLEX WITH UBIQUITIN','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1935,'2l0i','SOLUTION STRUCTURE OF RTT103 CTD-INTERACTING DOMAIN BOUND TO A SER2 PHOSPHORYLATED CTD PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1936,'2l0y','COMPLEX HMIA40-HCOX17','SOLUTION NMR',NULL,'PROTEIN TRANSPORT/METAL TRANSPORT',1,1,1),(1937,'2l1c','SHC-PTB:BIPHOSPHORYLATED INTEGRIN BETA3 CYTOPLASMIC TAIL COMPLEX (1:1)','SOLUTION NMR',NULL,'CELL ADHESION',1,1,1),(1938,'2l1l','NMR SOLUTION STRUCTURE OF THE PHI0 PKI NES PEPTIDE IN COMPLEX WITH CRM1-RANGTP','SOLUTION NMR',NULL,'NUCLEAR PROTEIN',1,1,1),(1939,'2l1r','THE STRUCTURE OF THE CALCIUM-SENSITIZER, DFBP-O, IN COMPLEX WITH THE N-DOMAIN OF TROPONIN C AND THE SWITCH REGION OF TROPONIN I','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1940,'2l1w','THE SOLUTION STRUCTURE OF SOYBEAN CALMODULIN ISOFORM 4 COMPLEXED WITH THE VACUOLAR CALCIUM ATPASE BCA1 PEPTIDE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1941,'2l27','NMR STRUCTURE OF THE ECD1 OF CRF-R1 IN COMPLEX WITH A PEPTIDE AGONIST','SOLUTION NMR',NULL,'MEMBRANE PROTEIN, PEPTIDE BINDING PRO',1,1,1),(1942,'2l2i','NMR STRUCTURE OF THE COMPLEX BETWEEN THE TFB1 SUBUNIT OF TFIIH AND THE ACTIVATION DOMAIN OF EKLF','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1943,'2l35','STRUCTURE OF THE DAP12-NKG2C TRANSMEMBRANE HETEROTRIMER','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1944,'2l3r','NMR STRUCTURE OF UHRF1 TANDEM TUDOR DOMAINS IN A COMPLEX WITH HISTONE H3 PEPTIDE','SOLUTION NMR',NULL,'DNA BINDING PROTEIN/GENE REGULATION',1,1,1),(1945,'2l4k','WATER REFINED SOLUTION STRUCTURE OF THE HUMAN GRB7-SH2 DOMAIN IN COMPLEX WITH THE 10 AMINO ACID PEPTIDE PY1139','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(1946,'2l4t','GIP/GLUTAMINASE L PEPTIDE COMPLEX','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1947,'2l53','SOLUTION NMR STRUCTURE OF APO-CALMODULIN IN COMPLEX WITH THE IQ MOTIF OF HUMAN CARDIAC SODIUM CHANNEL NAV1.5','SOLUTION NMR',NULL,'CA-BINDING PROTEIN/PROTON TRANSPORT',1,1,1),(1948,'2l5e','COMPLEX BETWEEN BD1 OF BRD3 AND GATA-1 C-TAIL','SOLUTION NMR',NULL,'NUCLEAR PROTEIN/TRANSCRIPTION',1,1,1),(1949,'2l6e','NMR STRUCTURE OF THE MONOMERIC MUTANT C-TERMINAL DOMAIN OF HIV-1 CAPSID IN COMPLEX WITH STAPLED PEPTIDE INHIBITOR','SOLUTION NMR',NULL,'VIRAL PROTEIN/INHIBITOR',1,1,1),(1950,'2l6j','TAH1 COMPLEXED BY MEEVD','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1951,'2l6y','HADDOCK MODEL OF GATA1NF:LMO2LIM2-LDB1LID','SOLUTION NMR',NULL,'TRANSCRIPTION REGULATION/ONCOPROTEIN',1,1,1),(1952,'2l6z','HADDOCK MODEL OF GATA1NF:LMO2LIM2-LDB1LID WITH FOG','SOLUTION NMR',NULL,'TRANSCRIPTION REGULATION/ONCOPROTEIN',2,1,1),(1953,'2l7l','SOLUTION STRUCTURE OF CA2+/CALMODULIN COMPLEXED WITH A PEPTIDE REPRESENTING THE CALMODULIN-BINDING DOMAIN OF CALMODULIN KINASE I','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/TRANSFERASE',1,1,1),(1954,'2l7u','STRUCTURE OF CEL-PEP-RAGE V DOMAIN COMPLEX','SOLUTION NMR',NULL,'ALLERGEN',1,1,1),(1955,'2l8j','GABARAPL-1 NBR1-LIR COMPLEX STRUCTURE','SOLUTION NMR',NULL,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(1956,'2l9b','HETERODIMER BETWEEN RNA14P MONKEYTAIL DOMAIN AND RNA15P HINGE DOMAIN OF THE YEAST CF IA COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1957,'2l9s','SOLUTION STRUCTURE OF PF1 SID1-MSIN3A PAH2 COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1958,'2lal','CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT AT 2.3 ANGSTROMS RESOLUTION OF THE LENTIL LECTIN','X-RAY DIFFRACTION',1.800,'LECTIN',2,2,1),(1959,'2las','MOLECULAR DETERMINANTS OF PARALOGUE-SPECIFIC SUMO-SIM RECOGNITION','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1960,'2lbm','SOLUTION STRUCTURE OF THE ADD DOMAIN OF ATRX COMPLEXED WITH HISTONE TAIL H3 1-15 K9ME3','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/STRUCTURAL PROT',1,1,1),(1961,'2lcs','YEAST NBP2P SH3 DOMAIN IN COMPLEX WITH A PEPTIDE FROM STE20P','SOLUTION NMR',NULL,'TRANSFERASE, SIGNALING PROTEIN',1,1,1),(1962,'2lct','SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAIN COMPLEXED WITH A SYK-DERIVED DOUBLY PHOSPHORYLATED PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(1963,'2le8','THE PROTEIN COMPLEX FOR DNA REPLICATION','SOLUTION NMR',NULL,'REPLICATION',1,1,1),(1964,'2leh','SOLUTION STRUCTURE OF THE CORE SMN-GEMIN2 COMPLEX','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1965,'2lgf','SOLUTION STRUCTURE OF CA2+/CALMODULIN COMPLEXED WITH A PEPTIDE REPRESENTING THE CALMODULIN-BINDING DOMAIN OF L-SELECTIN','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(1966,'2lgg','STRUCTURE OF PHD DOMAIN OF UHRF1 IN COMPLEX WITH H3 PEPTIDE','SOLUTION NMR',NULL,'LIGASE/DNA BINDING PROTEIN',1,1,1),(1967,'2lgk','NMR STRUCTURE OF UHRF1 PHD DOMAINS IN A COMPLEX WITH HISTONE H3 PEPTIDE','SOLUTION NMR',NULL,'LIGASE/DNA BINDING PROTEIN',1,1,1),(1968,'2li5','NMR STRUCTURE OF ATG8-ATG7C30 COMPLEX','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(1969,'2lkm','STRUCTURAL BASIS FOR MOLECULAR INTERACTIONS INVOLVING MRG DOMAINS: IMPLICATIONS IN CHROMATIN BIOLOGY','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1970,'2ll6','SOLUTION NMR STRUCTURE OF CAM BOUND TO INOS CAM BINDING DOMAIN PEPTIDE','SOLUTION NMR',NULL,'OXIDOREDUCTASE',1,1,1),(1971,'2ll7','SOLUTION NMR STRUCTURE OF CAM BOUND TO THE ENOS CAM BINDING DOMAIN PEPTIDE','SOLUTION NMR',NULL,'OXIDOREDUCTASE',1,1,1),(1972,'2llo','SOLUTION NMR-DERIVED STRUCTURE OF CALMODULIN N-LOBE BOUND WITH ER ALPHA PEPTIDE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/HORMONE RECEPTO',1,1,1),(1973,'2llq','SOLUTION NMR-DERIVED STRUCTURE OF CALMODULIN C-LOBE BOUND WITH ER ALPHA PEPTIDE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/HORMONE RECEPTO',1,1,1),(1974,'2lnh','ENTEROHAEMORRHAGIC E. COLI (EHEC) EXPLOITS A TRYPTOPHAN SWITCH TO HIJACK HOST F-ACTIN ASSEMBLY','SOLUTION NMR',NULL,'SIGNALING PROTEIN/PROTEIN BINDING',1,2,1),(1975,'2lnk','SOLUTION STRUCTURE OF CA-BOUND S100A4 IN COMPLEX WITH NON-MUSCLE MYOSIN IIA','SOLUTION NMR',NULL,'CALCIUM BINDING PROTEIN',1,2,1),(1976,'2lnw','IDENTIFICATION AND STRUCTURAL BASIS FOR A NOVEL INTERACTION BETWEEN VAV2 AND ARAP3','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(1977,'2lo6','STRUCTURE OF NRD1 CID BOUND TO PHOSPHORYLATED RNAP II CTD','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1978,'2lob','PDZ DOMAIN OF CAL (CYSTIC FIBROSIS TRANSMEMBRANE REGULATOR-ASSOCIATED LIGAND)','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN',1,1,1),(1979,'2lox','NMR STRUCTURE OF THE COMPLEX BETWEEN THE PH DOMAIN OF THE TFB1 SUBUNIT FROM TFIIH AND RAD2','SOLUTION NMR',NULL,'TRANSCRIPTION/HYDROLASE',1,1,1),(1980,'2loz','THE NOVEL BINDING MODE OF DLC1 AND TENSIN2 PTB DOMAIN','SOLUTION NMR',NULL,'HYDROLASE/HYDROLASE ACTIVATOR',1,1,1),(1981,'2lp0','THE SOLUTION STRUCTURE OF HOMEODOMAIN-PROTEIN COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION/CELL CYCLE',1,1,1),(1982,'2lp8','SOLUTION STRUCTURE OF AN APOPTOSIS ACTIVATING PHOTOSWITCHABLE BAK PEPTIDE BOUND TO BCL-XL','SOLUTION NMR',NULL,'APOPTOSIS/APOPTOSIS ACTIVATOR',1,1,1),(1983,'2lpb','STRUCTURE OF THE COMPLEX OF THE CENTRAL ACTIVATION DOMAIN OF GCN4 BOUND TO THE MEDIATOR CO-ACTIVATOR DOMAIN 1 OF GAL11/MED15','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(1984,'2lpr','STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(1985,'2lqc','NMR SOLUTION STRUCTURE OF A CA2+-CALMODULIN WITH A BINDING MOTIF (NSCATE) PEPTIDE FROM THE N-TERMINAL CYTOPLASMIC DOMAIN OF THE L-TYPE VOLTAGE-CATED CALCIUM CHANNEL ALPHA1C SUBUNIT','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/TRANSPORT PROTE',1,1,1),(1986,'2lr1','STRUCTURAL MECHANISM FOR BAX INHIBITION BY CYTOMEGALOVIRUS PROTEIN VMIA','SOLUTION NMR',NULL,'APOPTOSIS/SIGNALING PROTEIN',1,1,1),(1987,'2lsi','SOLUTION STRUCTURE OF POLYMERASE-INTERACTING DOMAIN OF HUMAN REV1 IN COMPLEX WITH TRANSLESIONAL SYNTHESIS POLYMERASE KAPPA','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(1988,'2lsj','SOLUTION STRUCTURE OF THE MOUSE REV1 CTD IN COMPLEX WITH THE REV1- INTERACTING REGION (RIR)OF POL KAPPA','SOLUTION NMR',NULL,'PROTEIN BINDING/PROTEIN BINDING',1,1,1),(1989,'2lsk','C-TERMINAL DOMAIN OF HUMAN REV1 IN COMPLEX WITH DNA-POLYMERASE H (ETA)','SOLUTION NMR',NULL,'PROTEIN BINDING/PROTEIN BINDING',1,1,1),(1990,'2lsp','SOLUTION STRUCTURES OF BRD4 SECOND BROMODOMAIN WITH NF-KB-K310AC PEPTIDE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1991,'2lsr','SOLUTION STRUCTURE OF HARMONIN N TERMINAL DOMAIN IN COMPLEX WITH A EXON68 ENCODED PEPTIDE OF CADHERIN23','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN/CELL ADHESION',1,1,1),(1992,'2lsv','THE NMR HIGH RESOLUTION STRUCTURE OF YEAST TAH1 IN COMPLEX WITH THE HSP90 C-TERMINAL TAIL','SOLUTION NMR',NULL,'CHAPERONE-BINDING PROTEIN/CHAPERONE',1,1,1),(1993,'2ltn','DESIGN, EXPRESSION, AND CRYSTALLIZATION OF RECOMBINANT LECTIN FROM THE GARDEN PEA (PISUM SATIVUM)','X-RAY DIFFRACTION',1.700,'LECTIN',2,2,1),(1994,'2lue','LC3B OPTN-LIR PTOT COMPLEX STRUCTURE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(1995,'2lvm','SOLUTION STRUCTURE OF HUMAN 53BP1 TANDEM TUDOR DOMAINS IN COMPLEX WITH A HISTONE H4K20ME2 PEPTIDE','SOLUTION NMR',NULL,'CELL CYCLE',1,1,1),(1996,'2lxm','LIP5-CHMP5','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(1997,'2lxp','NMR STRUCTURE OF TWO DOMAINS IN UBIQUITIN LIGASE GP78, RING AND G2BR, BOUND TO ITS CONJUGATING ENZYME UBE2G','SOLUTION NMR',NULL,'LIGASE',1,1,1),(1998,'2lxs','ALLOSTERIC COMMUNICATION IN THE KIX DOMAIN PROCEEDS THROUGH DYNAMIC RE-PACKING OF THE HYDROPHOBIC CORE','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(1999,'2lxt','ALLOSTERIC COMMUNICATION IN THE KIX DOMAIN PROCEEDS THROUGH DYNAMIC RE-PACKING OF THE HYDROPHOBIC CORE','SOLUTION NMR',NULL,'TRANSFERASE/PROTEIN BINDING',2,1,1),(2000,'2ly4','HMGB1-FACILITATED P53 DNA BINDING OCCURS VIA HMG-BOX/P53 TRANSACTIVATION DOMAIN INTERACTION AND IS REGULATED BY THE ACIDIC TAIL','SOLUTION NMR',NULL,'NUCLEAR PROTEIN/ANTITUMOUR PROTEIN',1,1,1),(2001,'2lyd','THE SOLUTION STRUCTURE OF THE DM DCP1 EVH1 DOMAIN IN COMPLEX WITH THE XRN1 DBM PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION/PROTEIN BINDING',1,1,1),(2002,'2m04','SOLUTION STRUCTURE OF BCL-XL IN COMPLEX WITH PUMA BH3 PEPTIDE','SOLUTION NMR',NULL,'APOPTOSIS/PROTEIN BINDING',1,1,1),(2003,'2m0j','3D STRUCTURE OF CALMODULIN AND CALMODULIN BINDING DOMAIN OF OLFACTORY CYCLIC NUCLEOTIDE-GATED ION CHANNEL COMPLEX','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/METAL TRANSPORT',1,1,1),(2004,'2m0k','3D STRUCTURE OF CALMODULIN AND CALMODULIN BINDING DOMAIN OF RAT OLFACTORY CYCLIC NUCLEOTIDE-GATED ION CHANNEL','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/METAL TRANSPORT',1,1,1),(2005,'2m0o','THE SOLUTION STRUCTURE OF HUMAN PHF1 IN COMPLEX WITH H3K36ME3','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN',1,1,1),(2006,'2m0u','COMPLEX STRUCTURE OF C-TERMINAL CFTR PEPTIDE AND EXTENDED PDZ1 DOMAIN FROM NHERF1','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN/PROTEIN BINDI',1,1,1),(2007,'2m0v','COMPLEX STRUCTURE OF C-TERMINAL CFTR PEPTIDE AND EXTENDED PDZ2 DOMAIN FROM NHERF1','SOLUTION NMR',NULL,'PROTEIN BINDING/PROTEIN BINDING',1,1,1),(2008,'2m14','NMR STRUCTURE OF THE COMPLEX BETWEEN THE PH DOMAIN OF THE TFB1 SUBUNIT FROM TFIIH AND RAD4','SOLUTION NMR',NULL,'TRANSCRIPTION/DNA BINDING PROTEIN',1,1,1),(2009,'2m32','ALPHA-1 INTEGRIN I-DOMAIN IN COMPLEX WITH GLOGEN TRIPLE HELICAL PEPTIDE','SOLUTION NMR',NULL,'CELL ADHESION',3,1,1),(2010,'2m3m','SOLUTION STRUCTURE OF A COMPLEX CONSISTING OF HDLG/SAP-97 RESIDUES 318-406 AND HPV51 ONCOPROTEIN E6 RESIDUES 141-151','SOLUTION NMR',NULL,'ONCOPROTEIN/CELL ADHESION',1,1,1),(2011,'2m41','SOLUTION STRUCTURE OF THE AXH DOMAIN OF ATAXIN-1 IN COMPLEX WITH LIGAND PEPTIDE FROM CAPICUA','SOLUTION NMR',NULL,'TRANSCRIPTION REGULATOR',1,1,1),(2012,'2m55','NMR STRUCTURE OF THE COMPLEX OF AN N-TERMINALLY ACETYLATED ALPHA- SYNUCLEIN PEPTIDE WITH CALMODULIN','SOLUTION NMR',NULL,'CALCIUM BINDING PROTEIN/PROTEIN FIBRI',1,1,1),(2013,'2m5b','THE NMR STRUCTURE OF THE BID-BAK COMPLEX','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(2014,'2m5e','STRUCTURE OF THE C-DOMAIN OF CALCIUM-SATURATED CALMODULIN BOUND TO THE IQ MOTIF OF NAV1.2','SOLUTION NMR',NULL,'CALCIUM-BINDING PROTEIN/METAL TRANSPO',1,1,1),(2015,'2m8s','NMR STRUCTURE OF THE CYTOPLASMIC TAIL OF THE MEMBRANE FORM OF HEPARIN- BINDING EGF-LIKE GROWTH FACTOR (PROHB-EGF-CT) COMPLEXED WITH THE UBIQUITIN HOMOLOGY DOMAIN OF BCL-2-ASSOCIATED ATHANOGENE 1 FROM MUS MUSCULUS (MBAG-1-UBH)','SOLUTION NMR',NULL,'CHAPERONE/MEMBRANE PROTEIN',1,1,1),(2016,'2m9p','NMR STRUCTURE OF AN INHIBITOR BOUND DENGUE NS3 PROTEASE','SOLUTION NMR',NULL,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2017,'2m9q','NMR STRUCTURE OF AN INHIBITOR BOUND DENGUE NS3 PROTEASE','SOLUTION NMR',NULL,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2018,'2ma9','HIV-1 VIF SOCS-BOX AND ELONGIN BC SOLUTION STRUCTURE','SOLUTION NMR',NULL,'VIRAL PROTEIN/PROTEIN BINDING',1,2,1),(2019,'2mak','SOLUTION STRUCTURE OF THE STIM1 CC1-CC2 HOMODIMER IN COMPLEX WITH TWO ORAI1 C-TERMINAL DOMAINS.','SOLUTION NMR',NULL,'SIGNALING PROTEIN/TRANSPORT PROTEIN',2,2,1),(2020,'2mbb','SOLUTION STRUCTURE OF THE HUMAN POLYMERASE IOTA UBM1-UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'TRANSFERASE, SIGNALING PROTEIN',1,1,1),(2021,'2mbh','NMR STRUCTURE OF EKLF(22-40)/UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2022,'2mbz','STRUCTURAL BASIS OF A THIOPEPTIDE ANTIBIOTIC MULTIDRUG RESISTANCE SYSTEM FROM STREPTOMYCES LIVIDANS:PROMOTHIOCIN A IN COMPLEX WITH TIPAS','SOLUTION NMR',NULL,'TRANSCRIPTION ACTIVATOR/ANTIBIOTIC',1,1,1),(2023,'2mc0','STRUCTURAL BASIS OF A THIOPEPTIDE ANTIBIOTIC MULTIDRUG RESISTANCE SYSTEM FROM STREPTOMYCES LIVIDANS:NOSIHEPTIDE IN COMPLEX WITH TIPAS','SOLUTION NMR',NULL,'TRANSCRIPTION ACTIVATOR/ANTIBIOTIC',1,1,1),(2024,'2mc1','SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAIN COMPLEXED WITH A SYK-DERIVED SINGLY PHOSPHORYLATED PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(2025,'2mc6','A BACTERIOPHAGE TRANSCRIPTION REGULATOR INHIBITS BACTERIAL TRANSCRIPTION INITIATION BY SIGMA-FACTOR DISPLACEMENT','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2026,'2mes','BACKBONE 1H, 13C, 15N RESONANCE ASSIGNMENTS OF CALCIUM-BOUND CALMODULIN IN COMPLEX WITH PSD95 N-TERMINAL PEPTIDE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(2027,'2mfq','NMR SOLUTION STRUCTURES OF FRS2A PTB DOMAIN WITH NEUROTROPHIN RECEPTOR TRKB','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(2028,'2mg5','SOLUTION STRUCTURE OF CALMODULIN BOUND TO THE TARGET PEPTIDE OF ENDOTHELIAL NITROGEN OXIDE SYNTHASE PHOSPHORYLATED AT THR495','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/TARGET PEPTIDE',1,1,1),(2029,'2mgu','STRUCTURE OF THE COMPLEX BETWEEN CALMODULIN AND THE BINDING DOMAIN OF HIV-1 MATRIX PROTEIN','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2030,'2mh0','SOLUTION NMR STRUCTURE OF THE P300 TAZ2:ETAD1 COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION/TRANSFERASE',1,1,1),(2031,'2mha','CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H- 2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION','X-RAY DIFFRACTION',2.500,'HISTOCOMPATIBILITY ANTIGEN',2,2,1),(2032,'2mho','SOLUTION STATE STRUCTURE PSD-95 PDZ1 WITH 5HT2C RECEPTOR PEPTIDE','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2033,'2mip','CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(2034,'2mjf','SOLUTION STRUCTURE OF THE COMPLEX BETWEEN THE YEAST RSA1 AND HIT1 PROTEINS','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2035,'2mjv','SOLUTION STRUCTURES OF SECOND BROMODOMAIN OF BRD4 WITH DI-ACETYLATED TWIST PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2036,'2mkc','COOPERATIVE STRUCTURE OF THE HETEROTRIMERIC PRE-MRNA RETENTION AND SPLICING COMPLEX','SOLUTION NMR',NULL,'SPLICING',2,1,1),(2037,'2mkp','N DOMAIN OF CARDIAC TROPONIN C BOUND TO THE SWITCH FRAGMENT OF FAST SKELETAL TROPONIN I AT PH 6','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(2038,'2mkr','STRUCTURAL CHARACTERIZATION OF A COMPLEX BETWEEN THE ACIDIC TRANSACTIVATION DOMAIN OF EBNA2 AND THE TFB1/P62 SUBUNIT OF TFIIH.','SOLUTION NMR',NULL,'VIRAL PROTEIN/TRANSCRIPTION',1,1,1),(2039,'2mnj','NMR SOLUTION STRUCTURE OF THE YEAST PIH1 AND TAH1 C-TERMINAL DOMAINS COMPLEX','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2040,'2mnu','BACKBONE AND SIDE CHAIN 1H, 13C, AND 15N CHEMICAL SHIFT ASSIGNMENTS FOR EDB AND SPECIFIC BINDING APTIDE','SOLUTION NMR',NULL,'CELL ADHESION',1,1,1),(2041,'2mow','STRUCTURE OF NRD1P CID - TRF4P NIM COMPLEX','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2042,'2mp2','SOLUTION STRUCTURE OF SUMO DIMER IN COMPLEX WITH SIM2-3 FROM RNF4','SOLUTION NMR',NULL,'PROTEIN BINDING',1,2,1),(2043,'2mpm','STRUCTURAL BASIS OF RECEPTOR SULFOTYROSINE RECOGNITION BY A CC CHEMOKINE: THE N-TERMINAL REGION OF CCR3 BOUND TO CCL11/EOTAXIN-1','SOLUTION NMR',NULL,'CYTOKINE',1,1,1),(2044,'2mps','STRUCTURE OF COMPLEX OF MDM2(3-109) AND P73 TAD(10-25)','SOLUTION NMR',NULL,'LIGASE/PEPTIDE',1,1,1),(2045,'2mqs','TRANSIENT COLLAGEN TRIPLE HELIX BINDING TO A KEY METALLOPROTEINASE IN INVASION AND DEVELOPMENT: SPIN LABELS TO STRUCTURE','SOLUTION NMR',NULL,'HYDROLASE',3,1,1),(2046,'2mre','NMR STRUCTURE OF THE RAD18-UBZ/UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'REPLICATION/SIGNALING PROTEIN',1,1,1),(2047,'2mrk','FYN SH2 DOMAIN IN COMPLEX WITH THE NATURAL INHIBITORY PHOSPHOTYROSINE PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(2048,'2mro','STRUCTURE OF THE COMPLEX OF UBIQUITIN AND THE UBA DOMAIN FROM DNA- DAMAGE-INDUCIBLE 1 PROTEIN (DDI1)','SOLUTION NMR',NULL,'TRANSPORT PROTEIN/SIGNALING PROTEIN',1,1,1),(2049,'2ms4','CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF CRK-II','SOLUTION NMR',NULL,'ISOMERASE',1,1,1),(2050,'2msr','SOLUTION STRUCTURE OF LEDGF/P75 IBD IN COMPLEX WITH MLL1 PEPTIDE (140- 160)','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2051,'2mtp','THE STRUCTURE OF FILAMIN REPEAT 21 BOUND TO INTEGRIN','SOLUTION NMR',NULL,'PROTEIN BINDING/CELL ADHESION',2,1,1),(2052,'2mur','SOLUTION STRUCTURE OF THE HUMAN FAAP20 UBZ-UBIQUITIN COMPLEX','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2053,'2mv7','SOLUTION NMR STRUCTURE OF DOT1L IN COMPLEX WITH AF9 (DOT1L-AF9)','SOLUTION NMR',NULL,'PROTEIN BINDING/TRANSFERASE',1,1,1),(2054,'2mw2','HHA-H-NS46 CHARGE ZIPPER COMPLEX','SOLUTION NMR',NULL,'DNA BINDING PROTEIN',2,1,1),(2055,'2mwn','TALIN-F3 / RIAM N-TERMINAL PEPTIDE COMPLEX','SOLUTION NMR',NULL,'STRUCTURAL PROTEIN/SIGNALING PROTEIN',1,1,1),(2056,'2mwo','SOLUTION STRUCTURE OF 53BP1 TANDEM TUDOR DOMAINS IN COMPLEX WITH A P53K370ME2 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION/ANTITUMOR PROTEIN',1,1,1),(2057,'2mwp','SOLUTION STRUCTURE OF 53BP1 TANDEM TUDOR DOMAINS IN COMPLEX WITH A P53K382ME2 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION/ANTITUMOR PROTEIN',1,1,1),(2058,'2mwy','MDMX-P53','SOLUTION NMR',NULL,'CELL CYCLE/ANTITUMOR PROTEIN',1,1,1),(2059,'2mx6','COMPLEX STRUCTURE OF DVL PDZ DOMAIN WITH LIGAND','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN',1,1,1),(2060,'2my2','SNU17P-BUD13P STRUCTURE INTERMEDIATE DURING RES COMPLEX ASSEMBLY','SOLUTION NMR',NULL,'SPLICING',1,1,1),(2061,'2my3','SNU17P-PML1P STRUCTURE INTERMEDIATE DURING RES COMPLEX ASSEMBLY','SOLUTION NMR',NULL,'SPLICING',1,1,1),(2062,'2mzd','CHARACTERIZATION OF THE P300 TAZ2-P53 TAD2 COMPLEX AND COMPARISON WITH THE P300 TAZ2-P53 TAD1 COMPLEX','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2063,'2mzp','STRUCTURE AND DYNAMICS OF THE ACIDOSIS-RESISTANT A162H MUTANT OF THE SWITCH REGION OF TROPONIN I BOUND TO THE REGULATORY DOMAIN OF TROPONIN C','SOLUTION NMR',NULL,'CONTRACTILE PROTEIN',1,1,1),(2064,'2n01','NMR STRUCTURE OF VIRB9 C-TERMINAL DOMAIN IN COMPLEX WITH VIRB7 N- TERMINAL DOMAIN FROM XANTHOMONAS CITRI\'S T4SS','SOLUTION NMR',NULL,'PROTEIN TRANSPORT/PROTEIN TRANSPORT',1,1,1),(2065,'2n0y','NMR STRUCTURE OF THE COMPLEX BETWEEN THE C-TERMINAL DOMAIN OF THE RIFT VALLEY FEVER VIRUS PROTEIN NSS AND THE PH DOMAIN OF THE TFB1 SUBUNIT OF TFIIH','SOLUTION NMR',NULL,'TRANSCRIPTION/VIRAL PROTEIN',1,1,1),(2066,'2n13','COMPLEX STRUCTURE OF MYUB (1080-1122) OF HUMAN MYOSIN VI WITH K63-DIUB','SOLUTION NMR',NULL,'MOTOR PROTEIN/PROTEIN BINDING',2,2,1),(2067,'2n1g','STRUCTURE OF C-TERMINAL DOMAIN OF HUMAN POLYMERASE REV1 IN COMPLEX WITH POLD3 RIR-MOTIF','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(2068,'2n23','NMR STRUCTURE OF THE COMPLEX BETWEEN THE PH DOMAIN OF THE TFB1 SUBUNIT FROM TFIIH AND THE N-TERMINAL ACTIVATION DOMAIN OF EKLF (TAD1)','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2069,'2n2h','SOLUTION STRUCTURE OF SDS3 IN COMPLEX WITH SIN3A','SOLUTION NMR',NULL,'TRANSCRIPTION, PROTEIN BINDING',1,1,1),(2070,'2n3a','SOLUTION STRUCTURE OF LEDGF/P75 IBD IN COMPLEX WITH POGZ PEPTIDE (1389-1404)','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2071,'2n3k','HUMAN BRD4 ET DOMAIN IN COMPLEX WITH MLV INTEGRASE C-TERM','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2072,'2n4q','SOLUTION NMR STRUCTURE OF CBX8 IN COMPLEX WITH AF9 (CBX8-AF9)','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2073,'2n55','STRUCTURE OF CONSTITUTIVELY MONOMERIC CXCL12 IN COMPLEX WITH THE CXCR4 N-TERMINUS','SOLUTION NMR',NULL,'CYTOKINE/SIGNALING PROTEIN',1,1,1),(2074,'2n77','NMR SOLUTION STRUCTURE OF A COMPLEX OF PEP-19 BOUND TO THE C-DOMAIN OF APO CALMODULIN','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(2075,'2n8j','STRUCTURE AND 15N RELAXATION DATA OF CALMODULIN BOUND TO THE ENDOTHELIAL NITRIC OXIDE SYNTHASE CALMODULIN BINDING DOMAIN PEPTIDE AT PHYSIOLOGICAL CALCIUM CONCENTRATION','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2076,'2n8r','PRODUCTIVE COMPLEX BETWEEN MMP-12 AND SYNTHETIC TRIPLE-HELICAL COLLAGEN, REVEALED THROUGH PARAMAGNETIC NMR','SOLUTION NMR',NULL,'HYDROLASE/STRUCTURAL PROTEIN',3,1,1),(2077,'2n9e','STRUCTURE OF SUMO-2 BOUND TO PHOSPHORYLATED RAP80 SIM','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2078,'2n9p','SOLUTION STRUCTURE OF RNF126 N-TERMINAL ZINC FINGER DOMAIN IN COMPLEX WITH BAG6 UBIQUITIN-LIKE DOMAIN','SOLUTION NMR',NULL,'LIGASE',1,1,1),(2079,'2n9x','LC3 FUNDC1 COMPLEX STRUCTURE','SOLUTION NMR',NULL,'PROTEIN BINDING/PEPTIDE',1,1,1),(2080,'2nb1','P63/P73 HETERO-TETRAMERISATION DOMAIN','SOLUTION NMR',NULL,'TRANSCRIPTION',2,2,1),(2081,'2ncz','SOLUTION NMR STRUCTURES OF BRD4 ET DOMAIN IN COMPLEX WITH NSD3_1 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION/TRANSFERASE',1,1,1),(2082,'2nd0','SOLUTION NMR STRUCTURES OF BRD4 ET DOMAIN WITH LANA PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION/VIRAL PROTEIN',1,1,1),(2083,'2nd1','SOLUTION NMR STRUCTURES OF BRD4 ET DOMAIN IN COMPLEX WITH NSD3_3 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION/TRANSFERASE',1,1,1),(2084,'2ndf','SOLUTION NMR STRUCTURES OF AF9 YEATS DOMAIN IN COMPLEX WITH HISTON H3 ACETYLATION AT K18','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2085,'2ndg','SOLUTION NMR STRUCTURES OF AF9 YEATS DOMAIN IN COMPLEX WITH HISTONE H3 CROTONYLATION AT K18','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2086,'2nl9','CRYSTAL STRUCTURE OF THE MCL-1:BIM BH3 COMPLEX','X-RAY DIFFRACTION',1.550,'APOPTOSIS',1,1,1),(2087,'2nm1','STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR','X-RAY DIFFRACTION',2.150,'TOXIN,HYDROLASE',1,1,1),(2088,'2nmb','DNUMB PTB DOMAIN COMPLEXED WITH A PHOSPHOTYROSINE PEPTIDE, NMR, ENSEMBLE OF STRUCTURES.','SOLUTION NMR',NULL,'CELL CYCLE/GENE REGULATION',1,1,1),(2089,'2nna','STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DQ8 BOUND WITH A DEAMIDATED GLUTEN PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(2090,'2nnu','CRYSTAL STRUCTURE OF THE PAPILLOMAVIRUS DNA TETHERING COMPLEX E2:BRD4','X-RAY DIFFRACTION',1.590,'TRANSCRIPTION',1,1,1),(2091,'2npa','THE CRYSTAL STRUCTURE OF THE HUMAN PPARAPLPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A A-HYDROXYIMINO PHENYLPROPANOIC ACID','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(2092,'2nph','CRYSTAL STRUCTURE OF HIV1 PROTEASE IN SITU PRODUCT COMPLEX','X-RAY DIFFRACTION',1.650,'HYDROLASE',2,2,1),(2093,'2nqa','CATALYTIC DOMAIN OF HUMAN CALPAIN 8','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2094,'2nud','THE STRUCTURE OF THE TYPE III EFFECTOR AVRB COMPLEXED WITH A HIGH-AFFINITY RIN4 PEPTIDE','X-RAY DIFFRACTION',2.300,'TOXIN/PROTEIN BINDING',2,2,1),(2095,'2nv7','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-555','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(2096,'2nw3','CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(2097,'2nwn','NEW PHARMACOPHORE FOR SERINE PROTEASE INHIBITION REVEALED BY CRYSTAL STRUCTURE OF HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR COMPLEXED WITH A CYCLIC PEPTIDYL INHIBITOR, UPAIN-1','X-RAY DIFFRACTION',2.150,'HYDROLASE',1,1,1),(2098,'2nxd','STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH RT-RH ANALOGUE PEPTIDE GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE SUBSTRATE',1,2,1),(2099,'2nxl','STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE SUBSTRATE',1,2,1),(2100,'2nxm','STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE SUBSTRATE',1,2,1),(2101,'2o02','PHOSPHORYLATION INDEPENDENT INTERACTIONS BETWEEN 14-3-3 AND EXOENZYME S: FROM STRUCTURE TO PATHOGENESIS','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING/TOXIN',2,2,1),(2102,'2o4j','CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH VITIII 17-20Z AND THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',1.740,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(2103,'2o4r','CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH VITIII 17-20E AND THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',1.980,'HORMONE/GROWTH FACTOR RECEPTOR',1,1,1),(2104,'2o5g','CALMODULIN-SMOOTH MUSCLE LIGHT CHAIN KINASE PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.080,'METAL BINDING PROTEIN',1,1,1),(2105,'2o60','CALMODULIN BOUND TO PEPTIDE FROM NEURONAL NITRIC OXIDE SYNTHASE','X-RAY DIFFRACTION',1.550,'METAL BINDING PROTEIN',1,1,1),(2106,'2o8m','CRYSTAL STRUCTURE OF THE S139A MUTANT OF HEPATITIS C VIRUS NS3/4A PROTEASE','X-RAY DIFFRACTION',2.000,'VIRAL PROTEIN',2,2,1),(2107,'2o9k','WDR5 IN COMPLEX WITH DIMETHYLATED H3K4 PEPTIDE','X-RAY DIFFRACTION',1.900,'GENE REGULATION',2,2,1),(2108,'2o9q','THE CRYSTAL STRUCTURE OF BOVINE TRYPSIN COMPLEXED WITH A SMALL INHIBITION PEPTIDE ORB2K','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(2109,'2o9v','THE SECOND SH3 DOMAIN FROM PONSIN IN COMPLEX WITH THE PAXILLIN PROLINE RICH REGION','X-RAY DIFFRACTION',1.630,'SIGNALING PROTEIN/CELL ADHESION',1,1,1),(2110,'2obh','CENTRIN-XPC PEPTIDE','X-RAY DIFFRACTION',1.800,'CELL CYCLE',2,2,1),(2111,'2obq','DISCOVERY OF THE HCV NS3/4A PROTEASE INHIBITOR SCH503034. KEY STEPS IN STRUCTURE-BASED OPTIMIZATION','X-RAY DIFFRACTION',2.500,'VIRAL PROTEIN',2,2,1),(2112,'2oc0','STRUCTURE OF NS3 COMPLEXED WITH A KETOAMIDE INHIBITOR SCH491762','X-RAY DIFFRACTION',2.300,'VIRAL PROTEIN',2,2,1),(2113,'2occ','BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',6,10,1),(2114,'2ocv','STRUCTURAL BASIS OF NA+ ACTIVATION MIMICRY IN MURINE THROMBIN','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(2115,'2od2','CRYSTAL STRUCTURE OF YHST2 I117F MUTANT BOUND TO CARBA-NAD+ AND AN ACETYLATED H4 PEPTIDE','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(2116,'2od3','HUMAN THROMBIN CHIMERA WITH HUMAN RESIDUES 184A, 186, 186A, 186B, 186C AND 222 REPLACED BY MURINE THROMBIN EQUIVALENTS.','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2117,'2od7','CRYSTAL STRUCTURE OF YHST2 BOUND TO THE INTERMEDIATE ANALOGUE ADP-HPD, AND AND ACEYLATED H4 PEPTIDE','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(2118,'2od9','STRUCTURAL BASIS FOR NICOTINAMIDE INHIBITION AND BASE EXCHANGE IN SIR2 ENZYMES','X-RAY DIFFRACTION',2.050,'HYDROLASE',1,1,1),(2119,'2odb','THE CRYSTAL STRUCTURE OF HUMAN CDC42 IN COMPLEX WITH THE CRIB DOMAIN OF HUMAN P21-ACTIVATED KINASE 6 (PAK6)','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',1,1,1),(2120,'2odg','COMPLEX OF BARRIER-TO-AUTOINTEGRATION FACTOR AND LEM-DOMAIN OF EMERIN','SOLUTION NMR',NULL,'MEMBRANE PROTEIN, PROTEIN BINDING',1,2,1),(2121,'2ody','THROMBIN-BOUND BOOPHILIN DISPLAYS A FUNCTIONAL AND ACCESSIBLE REACTIVE-SITE LOOP','X-RAY DIFFRACTION',2.350,'BLOOD CLOTTING/BLOOD CLOTTING INHIBIT',2,3,1),(2122,'2ofq','NMR SOLUTION STRUCTURE OF A COMPLEX BETWEEN THE VIRB9/VIRB7 INTERACTION DOMAINS OF THE PKM101 TYPE IV SECRETION SYSTEM','SOLUTION NMR',NULL,'PROTEIN TRANSPORT/PROTEIN TRANSPORT',1,1,1),(2123,'2oh0','CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(2124,'2oi3','NMR STRUCTURE ANALYSIS OF THE HEMATOPOETIC CELL KINASE SH3 DOMAIN COMPLEXED WITH AN ARTIFICIAL HIGH AFFINITY LIGAND (PD1)','SOLUTION NMR',NULL,'TRANSFERASE',1,1,1),(2125,'2oi9','STRUCTURE OF THE 2C/LD/QL9 ALLOGENEIC COMPLEX','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',1,3,1),(2126,'2oin','CRYSTAL STRUCTURE OF HCV NS3-4A R155K MUNTANT','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(2127,'2oj2','NMR STRUCTURE ANALYSIS OF THE HEMATOPOETIC CELL KINASE SH3 DOMAIN COMPLEXED WITH AN ARTIFICIAL HIGH AFFINITY LIGAND (PD1)','SOLUTION NMR',NULL,'SIGNALING PROTEIN,TRANSFERASE/INHIBIT',1,1,1),(2128,'2ojf','CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(2129,'2oju','X-RAY STRUCTURE OF COMPLEX OF HUMAN CYCLOPHILIN J WITH CYCLOSPORIN A','X-RAY DIFFRACTION',2.400,'ISOMERASE/IMMUNOSUPPRESSANT',2,2,1),(2130,'2okr','CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER','X-RAY DIFFRACTION',2.000,'TRANSFERASE',2,2,1),(2131,'2olb','OLIGOPEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH TRI- LYSINE','X-RAY DIFFRACTION',1.400,'COMPLEX (BINDING PROTEIN/PEPTIDE)',1,1,1),(2132,'2om2','CRYSTAL STRUCTURE OF HUMAN G[ALPHA]I1 BOUND TO THE GOLOCO MOTIF OF RGS14','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN',2,2,1),(2133,'2oob','CRYSTAL STRUCTURE OF THE UBA DOMAIN FROM CBL-B UBIQUITIN LIGASE IN COMPLEX WITH UBIQUITIN','X-RAY DIFFRACTION',1.900,'LIGASE',1,1,1),(2134,'2oq1','TANDEM SH2 DOMAINS OF ZAP-70 WITH 19-MER ZETA1 PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(2135,'2oq6','CRYSTAL STRUCTURE OF JMJD2A COMPLEXED WITH HISTONE H3 PEPTIDE TRIMETHYLATED AT LYS9','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',2,2,1),(2136,'2oqs','STRUCTURE OF THE HDLG/SAP97 PDZ2 IN COMPLEX WITH HPV-18 PAPILLOMAVIRUS E6 PEPTIDE','SOLUTION NMR',NULL,'PEPTIDE-BINDING PROTEIN',1,1,1),(2137,'2orz','STRUCTURAL BASIS FOR LIGAND BINDING AND HEPARIN MEDIATED ACTIVATION OF NEUROPILIN','X-RAY DIFFRACTION',2.150,'SIGNALING PROTEIN, MEMBRANE PROTEIN',1,1,1),(2138,'2os2','CRYSTAL STRUCTURE OF JMJD2A COMPLEXED WITH HISTONE H3 PEPTIDE TRIMETHYLATED AT LYS36','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',2,2,1),(2139,'2os6','SOLUTION STRUCTURE OF LARG PDZ DOMAIN IN COMPLEX WITH C- TERMINAL OCTA-PEPTIDE OF PLEXIN B1','SOLUTION NMR',NULL,'CELL ADHESION',1,1,1),(2140,'2ot0','FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE IN COMPLEX WITH A C-TERMINAL PEPTIDE OF WISKOTT-ALDRICH SYNDROME PROTEIN','X-RAY DIFFRACTION',2.050,'LYASE',4,4,1),(2141,'2ot7','CRYSTAL STRUCTURE OF JMJD2A COMPLEXED WITH HISTONE H3 PEPTIDE MONOMETHYLATED AT LYS9','X-RAY DIFFRACTION',2.130,'OXIDOREDUCTASE',2,2,1),(2142,'2otu','CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX','X-RAY DIFFRACTION',1.680,'IMMUNE SYSTEM',4,8,1),(2143,'2otw','CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',2,4,1),(2144,'2ov2','THE CRYSTAL STRUCTURE OF THE HUMAN RAC3 IN COMPLEX WITH THE CRIB DOMAIN OF HUMAN P21-ACTIVATED KINASE 4 (PAK4)','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING/TRANSFERASE',8,8,1),(2145,'2ovh','PROGESTERONE RECEPTOR WITH BOUND ASOPRISNIL AND A PEPTIDE FROM THE CO- REPRESSOR SMRT','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(2146,'2ovr','STRUCTURE OF THE SKP1-FBW7-CYCLINEDEGN COMPLEX','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/CELL CYCLE',1,1,1),(2147,'2ox0','CRYSTAL STRUCTURE OF JMJD2A COMPLEXED WITH HISTONE H3 PEPTIDE DIMETHYLATED AT LYS9','X-RAY DIFFRACTION',1.950,'OXIDOREDUCTASE',2,2,1),(2148,'2oxw','HUMAN MMP-12 COMPLEXED WITH THE PEPTIDE IAG','X-RAY DIFFRACTION',1.150,'HYDROLASE',1,1,1),(2149,'2oxz','HUMAN MMP-12 IN COMPLEX WITH TWO PEPTIDES PQG AND IAG','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,1,1),(2150,'2oy2','HUMAN MMP-8 IN COMPLEX WITH PEPTIDE IAG','X-RAY DIFFRACTION',1.500,'HYDROLASE',2,2,1),(2151,'2oyh','CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAD298,301A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE','X-RAY DIFFRACTION',2.400,'BLOOD CLOTTING',4,4,1),(2152,'2p0r','STRUCTURE OF HUMAN CALPAIN 9 IN COMPLEX WITH LEUPEPTIN','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2153,'2p0w','HUMAN HISTONE ACETYLTRANSFERASE 1 (HAT1)','X-RAY DIFFRACTION',1.900,'TRANSFERASE',2,2,1),(2154,'2p15','CRYSTAL STRUCTURE OF THE ER ALPHA LIGAND BINDING DOMAIN WITH THE AGONIST ORTHO-TRIFLUOROMETHYLPHENYLVINYL ESTRADIOL','X-RAY DIFFRACTION',1.940,'HORMONE RECEPTOR',2,2,1),(2155,'2p1l','STRUCTURE OF THE BCL-XL:BECLIN 1 COMPLEX','X-RAY DIFFRACTION',2.500,'APOPTOSIS',4,4,1),(2156,'2p1n','MECHANISM OF AUXIN PERCEPTION BY THE TIR1 UBIQUTIN LIGASE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',2,2,1),(2157,'2p1o','MECHANISM OF AUXIN PERCEPTION BY THE TIR1 UBIQUITIN LIGASE','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN',1,1,1),(2158,'2p1q','MECHANISM OF AUXIN PERCEPTION BY THE TIR1 UBIQUITIN LIGASE','X-RAY DIFFRACTION',1.910,'SIGNALING PROTEIN',1,1,1),(2159,'2p1t','CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2\'-METHOXY)- TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2','X-RAY DIFFRACTION',1.800,'HORMONE RECEPTOR',1,1,1),(2160,'2p1u','CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2\'-ETHOXY)- TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2','X-RAY DIFFRACTION',2.200,'HORMONE RECEPTOR',1,1,1),(2161,'2p1v','CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2\'-PROPOXY)- TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2','X-RAY DIFFRACTION',2.200,'HORMONE RECEPTOR',1,1,1),(2162,'2p54','A CRYSTAL STRUCTURE OF PPAR ALPHA BOUND WITH SRC1 PEPTIDE AND GW735','X-RAY DIFFRACTION',1.790,'TRANSCRIPTION',1,1,1),(2163,'2p58','STRUCTURE OF THE YERSINIA PESTIS TYPE III SECRETION SYSTEM NEEDLE PROTEIN YSCF IN COMPLEX WITH ITS CHAPERONES YSCE/YSCG','X-RAY DIFFRACTION',1.800,'TRANSPORT PROTEIN/CHAPERONE',2,1,1),(2164,'2p5b','THE COMPLEX STRUCTURE OF JMJD2A AND TRIMETHYLATED H3K36 PEPTIDE','X-RAY DIFFRACTION',1.990,'METAL BINDING PROTEIN',2,2,1),(2165,'2p5e','CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY','X-RAY DIFFRACTION',1.890,'IMMUNE SYSTEM',1,3,1),(2166,'2p5w','CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,3,1),(2167,'2p6b','CRYSTAL STRUCTURE OF HUMAN CALCINEURIN IN COMPLEX WITH PVIVIT PEPTIDE','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE REGULATOR',1,2,1),(2168,'2p8l','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN','X-RAY DIFFRACTION',2.440,'VIRAL PROTEIN',1,2,1),(2169,'2p8o','CRYSTAL STRUCTURE OF A BENZOHYDROXAMIC ACID/VANADATE COMPLEX BOUND TO CHYMOTRYPSIN A','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,2,1),(2170,'2p8q','CRYSTAL STRUCTURE OF HUMAN IMPORTIN BETA BOUND TO THE SNURPORTIN1 IBB- DOMAIN','X-RAY DIFFRACTION',2.350,'PROTEIN TRANSPORT',1,1,1),(2171,'2pav','TERNARY COMPLEX OF PROFILIN-ACTIN WITH THE LAST POLY-PRO OF HUMAN VASP','X-RAY DIFFRACTION',1.800,'STRUCTURAL PROTEIN',1,2,1),(2172,'2pb8','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND PEPTIDE ALA-VAL-TYR-SER AT 2.0 A RESOLUTION','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(2173,'2pbd','TERNARY COMPLEX OF PROFILIN-ACTIN WITH THE POLY-PRO-GAB DOMAIN OF VASP*','X-RAY DIFFRACTION',1.500,'STRUCTURAL PROTEIN',1,2,1),(2174,'2pbk','CRYSTAL STRUCTURE OF KSHV PROTEASE IN COMPLEX WITH HEXAPEPTIDE PHOSPHONATE INHIBITOR','X-RAY DIFFRACTION',1.730,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2175,'2pc4','CRYSTAL STRUCTURE OF FRUCTOSE-BISPHOSPHATE ALDOLASE FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH TRAP-TAIL DETERMINED AT 2.4 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.400,'LYASE',1,1,1),(2176,'2pcu','HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH A CLEAVED HEXAPEPTIDE.','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(2177,'2pdz','SOLUTION STRUCTURE OF THE SYNTROPHIN PDZ DOMAIN IN COMPLEX WITH THE PEPTIDE GVKESLV, NMR, 15 STRUCTURES','SOLUTION NMR',NULL,'COMPLEX (SYNTROPHIN/PEPTIDE)',1,1,1),(2178,'2peh','CRYSTAL STRUCTURE OF THE UHM DOMAIN OF HUMAN SPF45 IN COMPLEX WITH SF3B155-ULM5','X-RAY DIFFRACTION',2.110,'PROTEIN BINDING',2,2,1),(2179,'2pgb','INHIBITOR-FREE HUMAN THROMBIN MUTANT C191A-C220A','X-RAY DIFFRACTION',1.540,'HYDROLASE',1,1,1),(2180,'2pgq','HUMAN THROMBIN MUTANT C191A-C220A IN COMPLEX WITH THE INHIBITOR PPACK','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2181,'2phe','MODEL FOR VP16 BINDING TO PC4','SOLUTION NMR',NULL,'TRANSCRIPTION',1,2,1),(2182,'2phg','MODEL FOR VP16 BINDING TO TFIIB','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2183,'2pie','CRYSTAL STRUCTURE OF THE FHA DOMAIN OF RNF8 IN COMPLEX WITH ITS OPTIMAL PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.350,'LIGASE',1,1,1),(2184,'2pkl','ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE','X-RAY DIFFRACTION',2.490,'HORMONE RECEPTOR',1,1,1),(2185,'2pks','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2186,'2pku','SOLUTION STRUCTURE OF PICK1 PDZ IN COMPLEX WITH THE CARBOXYL TAIL PEPTIDE OF GLUR2','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2187,'2pld','NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE','SOLUTION NMR',NULL,'PHOSPHORIC DIESTER HYDROLASE',1,1,1),(2188,'2ple','NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE','SOLUTION NMR',NULL,'PHOSPHORIC DIESTER HYDROLASE',1,1,1),(2189,'2plx','TRYPSIN COMPLEXED TO A SYNTHETIC PEPTIDE FROM VERONICA HEDERIFOLIA','X-RAY DIFFRACTION',1.560,'HYDROLASE',1,1,1),(2190,'2pon','SOLUTION STRUCTURE OF THE BCL-XL/BECLIN-1 COMPLEX','SOLUTION NMR',NULL,'APOPTOSIS INHIBITOR',1,1,1),(2191,'2poy','CRYPTOSPORIDIUM PARVUM CYCLOPHILIN TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE CGD2_4120 IN COMPLEX WITH CYCLOSPORIN A','X-RAY DIFFRACTION',1.800,'ISOMERASE/IMMUNOSUPPRESSANT',3,3,1),(2192,'2pq2','STRUCTURE OF SERINE PROTEINASE K COMPLEX WITH A HIGHLY FLEXIBLE HYDROPHOBIC PEPTIDE AT 1.8A RESOLUTION','X-RAY DIFFRACTION',1.820,'HYDROLASE',1,1,1),(2193,'2pq4','NMR SOLUTION STRUCTURE OF NAPD IN COMPLEX WITH NAPA1-35 SIGNAL PEPTIDE','SOLUTION NMR',NULL,'CHAPERONE/OXIDOREDUCTASE',1,1,1),(2194,'2pqk','X-RAY CRYSTAL STRUCTURE OF HUMAN MCL-1 IN COMPLEX WITH BIM BH3','X-RAY DIFFRACTION',2.000,'APOPTOSIS',1,1,1),(2195,'2pqn','CRYSTAL STRUCTURE OF YEAST FIS1 COMPLEXED WITH A FRAGMENT OF YEAST MDV1','X-RAY DIFFRACTION',2.150,'APOPTOSIS',1,1,1),(2196,'2pqr','CRYSTAL STRUCTURE OF YEAST FIS1 COMPLEXED WITH A FRAGMENT OF YEAST CAF4','X-RAY DIFFRACTION',1.880,'APOPTOSIS',2,2,1),(2197,'2pqw','CRYSTAL STRUCTURE OF L3MBTL1 IN COMPLEX WITH H4K20ME2 (RESIDUES 17- 25), TRIGONAL FORM','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(2198,'2pr3','FACTOR XA INHIBITOR','X-RAY DIFFRACTION',1.500,'BLOOD CLOTTING',1,1,1),(2199,'2prg','LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA','X-RAY DIFFRACTION',2.300,'COMPLEX (THIAZOLIDINEDIONE/RECEPTOR)',1,2,1),(2200,'2psx','CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2201,'2psy','CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN AND ZINC','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2202,'2puq','CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR','X-RAY DIFFRACTION',2.050,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2203,'2pux','CRYSTAL STRUCTURE OF MURINE THROMBIN IN COMPLEX WITH THE EXTRACELLULAR FRAGMENT OF MURINE PAR3','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,1,1),(2204,'2puy','CRYSTAL STRUCTURE OF THE BHC80 PHD FINGER','X-RAY DIFFRACTION',1.430,'TRANSCRIPTION',1,1,1),(2205,'2pv1','CRYSTALLOGRAPHIC STRUCTURE OF SURA FIRST PEPTIDYL-PROLYL ISOMERASE DOMAIN COMPLEXED WITH PEPTIDE WEYIPNV','X-RAY DIFFRACTION',1.300,'ISOMERASE',1,1,1),(2206,'2pv2','CRYSTALLOGRAPHIC STRUCTURE OF SURA FIRST PEPTIDYL-PROLYL ISOMERASE DOMAIN COMPLEXED WITH PEPTIDE NFTLKFWDIFRK','X-RAY DIFFRACTION',1.300,'ISOMERASE',2,4,1),(2207,'2pvf','CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(2208,'2pw8','CRYSTAL STRUCTURE OF SULFO-HIRUDIN COMPLEXED TO THROMBIN','X-RAY DIFFRACTION',1.840,'HYDROLASE',1,1,1),(2209,'2pxj','THE COMPLEX STRUCTURE OF JMJD2A AND MONOMETHYLATED H3K36 PEPTIDE','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',2,2,1),(2210,'2pxy','CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES','X-RAY DIFFRACTION',2.230,'IMMUNE SYSTEM',1,4,1),(2211,'2pye','CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,3,1),(2212,'2q0n','STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE','X-RAY DIFFRACTION',1.750,'TRANSFERASE',1,1,1),(2213,'2q3c','2.1 A RESOLUTION CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE (OASS) HOLOENZYME FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH THE INHIBITORY PEPTIDE DFSI','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(2214,'2q3y','ANCESTRAL CORTICIOD RECEPTOR IN COMPLEX WITH DOC','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(2215,'2q3z','TRANSGLUTAMINASE 2 UNDERGOES LARGE CONFORMATIONAL CHANGE UPON ACTIVATION','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(2216,'2q5a','HUMAN PIN1 BOUND TO L-PEPTIDE','X-RAY DIFFRACTION',1.500,'ISOMERASE/ISOMERASE INHIBITOR',1,1,1),(2217,'2q5y','CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF HNUP98','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',2,2,1),(2218,'2q6f','CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE IN COMPLEX WITH A MICHAEL ACCEPTOR INHIBITOR N3','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,2,1),(2219,'2q6g','CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE H41A MUTANT IN COMPLEX WITH AN N-TERMINAL SUBSTRATE','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(2220,'2q6w','THE STRUCTURE OF HLA-DRA, DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',2,4,1),(2221,'2q7i','THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE','X-RAY DIFFRACTION',1.870,'HORMONE',1,1,1),(2222,'2q7j','THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX 3 COACTIVATOR PEPTIDE 740-753','X-RAY DIFFRACTION',1.900,'HORMONE',1,1,1),(2223,'2q7k','THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE','X-RAY DIFFRACTION',1.800,'HORMONE',1,1,1),(2224,'2q7l','THE ANDROGEN RECEPTOR PROSTATE CANCER MUTANT H874Y LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX3 COACTIVATOR PEPTIDE 740-753','X-RAY DIFFRACTION',1.920,'HORMONE',1,1,1),(2225,'2q8c','CRYSTAL STRUCTURE OF JMJD2A IN TERNARY COMPLEX WITH AN HISTONE H3K9ME3 PEPTIDE AND 2-OXOGLUTARATE','X-RAY DIFFRACTION',2.050,'OXIDOREDUCTASE',2,2,1),(2226,'2q8d','CRYSTAL STRUCTURE OF JMJ2D2A IN TERNARY COMPLEX WITH HISTONE H3-K36ME2 AND SUCCINATE','X-RAY DIFFRACTION',2.290,'OXIDOREDUCTASE',2,2,1),(2227,'2q8e','SPECIFICITY AND MECHANISM OF JMJD2A, A TRIMETHYLLYSINE-SPECIFIC HISTONE DEMETHYLASE','X-RAY DIFFRACTION',2.050,'OXIDOREDUCTASE',2,2,1),(2228,'2q8y','STRUCTURAL INSIGHT INTO THE ENZYMATIC MECHANISM OF THE PHOPHOTHREONINE LYASE','X-RAY DIFFRACTION',2.000,'LYASE/TRANSFERASE',1,1,1),(2229,'2qa8','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH GENISTEIN','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',2,2,1),(2230,'2qa9','CRYSTAL STRUCTURE OF THE SECOND TETRAHEDRAL INTERMEDIATES OF SGPB AT PH 4.2','X-RAY DIFFRACTION',1.180,'HYDROLASE',1,1,1),(2231,'2qab','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH AN ETHYL INDAZOLE COMPOUND','X-RAY DIFFRACTION',1.890,'TRANSCRIPTION',2,2,1),(2232,'2qac','THE CLOSED MTIP-MYOSINA-TAIL COMPLEX FROM THE MALARIA PARASITE INVASION MACHINERY','X-RAY DIFFRACTION',1.700,'MEMBRANE PROTEIN',1,1,1),(2233,'2qbw','THE CRYSTAL STRUCTURE OF PDZ-FIBRONECTIN FUSION PROTEIN','X-RAY DIFFRACTION',1.800,'UNKNOWN FUNCTION',1,1,1),(2234,'2qbx','EPHB2/SNEW ANTAGONISTIC PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',2,2,1),(2235,'2qfa','CRYSTAL STRUCTURE OF A SURVIVIN-BOREALIN-INCENP CORE COMPLEX','X-RAY DIFFRACTION',1.400,'CELL CYCLE/CELL CYCLE/CELL CYCLE',1,2,1),(2236,'2qgt','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO AN ETHER ESTRADIOL COMPOUND','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',2,2,1),(2237,'2qgw','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH A CHLORO-INDAZOLE COMPOUND','X-RAY DIFFRACTION',2.390,'TRANSCRIPTION',2,2,1),(2238,'2qho','CRYSTAL STRUCTURE OF THE UBA DOMAIN FROM EDD UBIQUITIN LIGASE IN COMPLEX WITH UBIQUITIN','X-RAY DIFFRACTION',1.850,'PROTEIN BINDING/LIGASE',4,4,1),(2239,'2qhr','CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/VIRAL PROTEIN',1,2,1),(2240,'2qiy','YEAST DEUBIQUITINASE UBP3 AND BRE5 COFACTOR COMPLEX','X-RAY DIFFRACTION',1.690,'SIGNALING PROTEIN/HYDROLASE',2,2,1),(2241,'2qkh','CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GIP RECEPTOR IN COMPLEX WITH THE HORMONE GIP','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN/HORMONE',1,1,1),(2242,'2qki','HUMAN C3C IN COMPLEX WITH THE INHIBITOR COMPSTATIN','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM/HYDROLASE INHIBITOR',2,2,1),(2243,'2ql5','CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DMQD-CHO','X-RAY DIFFRACTION',2.340,'HYDROLASE/HYDROLASE INHIBITOR',3,4,1),(2244,'2ql7','CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',3,4,1),(2245,'2ql9','CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO','X-RAY DIFFRACTION',2.140,'HYDROLASE/HYDROLASE INHIBITOR',3,4,1),(2246,'2qlb','CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',3,4,1),(2247,'2qme','CRYSTAL STRUCTURE OF HUMAN RAC3 IN COMPLEX WITH CRIB DOMAIN OF HUMAN P21-ACTIVATED KINASE 1 (PAK1)','X-RAY DIFFRACTION',1.750,'SIGNALING PROTEIN/TRANSFERASE',1,1,1),(2248,'2qn6','STRUCTURE OF AN ARCHAEAL HETEROTRIMERIC INITIATION FACTOR 2 REVEALS A NUCLEOTIDE STATE BETWEEN THE GTP AND THE GDP STATES','X-RAY DIFFRACTION',2.150,'TRANSLATION',1,1,1),(2249,'2qos','CRYSTAL STRUCTURE OF COMPLEMENT PROTEIN C8 IN COMPLEX WITH A PEPTIDE CONTAINING THE C8 BINDING SITE ON C8','X-RAY DIFFRACTION',1.810,'IMMUNE SYSTEM',1,1,1),(2250,'2qpy','AR LBD WITH SMALL MOLECULE','X-RAY DIFFRACTION',2.500,'DNA BINDING PROTEIN',1,1,1),(2251,'2qqc','E109Q MUTANT OF PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE FROM METHANOCOCCUS JANNASHII','X-RAY DIFFRACTION',2.000,'LYASE',5,6,1),(2252,'2qqd','N47A MUTANT OF PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE FROM METHANOCOCCUS JANNASHII','X-RAY DIFFRACTION',2.000,'LYASE',1,3,1),(2253,'2qqf','HST2 BOUND TO ADP-HPD AND ACETYLATED HISTONE H4','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(2254,'2qqg','HST2 BOUND TO ADP-HPD, ACETYLLATED HISTONE H4 AND NICOTINAMIDE','X-RAY DIFFRACTION',2.050,'HYDROLASE',1,1,1),(2255,'2qr9','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DERIVATIVE COMPOUND','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(2256,'2qse','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH BURNED MEAT COMPOUND 4-OH-PHIP','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',2,2,1),(2257,'2qt5','CRYSTAL STRUCTURE OF GRIP1 PDZ12 IN COMPLEX WITH THE FRAS1 PEPTIDE','X-RAY DIFFRACTION',2.300,'PEPTIDE BINDING PROTEIN',2,2,1),(2258,'2qtv','STRUCTURE OF SEC23-SAR1 COMPLEXED WITH THE ACTIVE FRAGMENT OF SEC31','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT',1,2,1),(2259,'2qur','CRYSTAL STRUCTURE OF F327A/K285P MUTANT OF CAMP-DEPENDENT PROTEIN KINASE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN, TRANSFERASE',1,1,1),(2260,'2qv1','CRYSTAL STRUCTURE OF HCV NS3-4A V36M MUTANT','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,2,1),(2261,'2qxm','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO BURNED MEAT COMPOUND PHIP','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(2262,'2qxv','STRUCTURAL BASIS OF EZH2 RECOGNITION BY EED','X-RAY DIFFRACTION',1.820,'GENE REGULATION',1,1,1),(2263,'2qyf','CRYSTAL STRUCTURE OF THE MAD2/P31(COMET)/MAD2-BINDING PEPTIDE TERNARY COMPLEX','X-RAY DIFFRACTION',2.300,'CELL CYCLE',2,2,1),(2264,'2qzo','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH WAY-169916','X-RAY DIFFRACTION',1.720,'TRANSCRIPTION',2,2,1),(2265,'2qzx','SECRETED ASPARTIC PROTEINASE (SAP) 5 FROM CANDIDA ALBICANS','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2266,'2r0l','SHORT FORM HGFA WITH INHIBITORY FAB75','X-RAY DIFFRACTION',2.200,'HYDROLASE, IMMUNE SYSTEM',1,1,1),(2267,'2r0w','PFA2 FAB COMPLEXED WITH ABETA1-8','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(2268,'2r0z','PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(2269,'2r28','THE COMPLEX STRUCTURE OF CALMODULIN BOUND TO A CALCINEURIN PEPTIDE','X-RAY DIFFRACTION',1.860,'METAL BINDING PROTEIN/HYDROLASE',2,2,1),(2270,'2r2m','2-(2-CHLORO-6-FLUOROPHENYL)ACETAMIDES AS POTENT THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2271,'2r3y','CRYSTAL STRUCTURE OF THE DEGS PROTEASE IN COMPLEX WITH THE YWF ACTIVATING PEPTIDE','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE ACTIVATOR',3,3,1),(2272,'2r7g','STRUCTURE OF THE RETINOBLASTOMA PROTEIN POCKET DOMAIN IN COMPLEX WITH ADENOVIRUS E1A CR1 DOMAIN','X-RAY DIFFRACTION',1.670,'TRANSCRIPTION REPRESSOR, CELL CYCLE',3,2,1),(2273,'2r9q','CRYSTAL STRUCTURE OF 2\'-DEOXYCYTIDINE 5\'-TRIPHOSPHATE DEAMINASE FROM AGROBACTERIUM TUMEFACIENS','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(2274,'2rdl','HAMSTER CHYMASE 2','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2275,'2rfi','CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN EUCHROMATIC HISTONE METHYLTRANSFERASE 1 IN COMPLEX WITH SAH AND DIMETHYLATED H3K9 PEPTIDE','X-RAY DIFFRACTION',1.590,'TRANSFERASE',2,2,1),(2276,'2rfx','CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(2277,'2rhi','CRYSTAL STRUCTURE OF THE 3-MBT DOMAIN FROM HUMAN L3MBTL1 IN COMPLEX WITH H1.5K27ME2 AT 1.66 ANGSTROM','X-RAY DIFFRACTION',1.660,'TRANSCRIPTION/NUCLEAR PROTEIN',1,1,1),(2278,'2ri7','CRYSTAL STRUCTURE OF PHD FINGER-LINKER-BROMODOMAIN Y17E MUTANT FROM HUMAN BPTF IN THE H3(1-9)K4ME2 BOUND STATE','X-RAY DIFFRACTION',1.450,'TRANSCRIPTION/NUCLEAR PROTEIN',1,1,1),(2279,'2riv','CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN','X-RAY DIFFRACTION',1.500,'SIGNALING PROTEIN',1,1,1),(2280,'2riw','THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE','X-RAY DIFFRACTION',2.040,'SIGNALING PROTEIN',1,1,1),(2281,'2rje','CRYSTAL STRUCTURE OF L3MBTL1 IN COMPLEX WITH H4K20ME2 (RESIDUES 17- 25), ORTHORHOMBIC FORM II','X-RAY DIFFRACTION',1.860,'TRANSCRIPTION',2,2,1),(2282,'2rjf','CRYSTAL STRUCTURE OF L3MBTL1 IN COMPLEX WITH H4K20ME2 (RESIDUES 12- 30), ORTHORHOMBIC FORM I','X-RAY DIFFRACTION',2.050,'TRANSCRIPTION',2,2,1),(2283,'2rky','CRYSTAL STRUCTURE OF THE FOURTH AND FIFTH FIBRONECTIN F1 MODULES IN COMPLEX WITH A FRAGMENT OF STAPHYLOCOCCUS AUREUS FNBPA-1','X-RAY DIFFRACTION',1.800,'CELL ADHESION',2,2,1),(2284,'2rkz','CRYSTAL STRUCTURE OF THE SECOND AND THIRD FIBRONECTIN F1 MODULES IN COMPLEX WITH A FRAGMENT OF STAPHYLOCOCCUS AUREUS FNBPA-1','X-RAY DIFFRACTION',2.000,'CELL ADHESION',6,6,1),(2285,'2rl0','CRYSTAL STRUCTURE OF THE FOURTH AND FIFTH FIBRONECTIN F1 MODULES IN COMPLEX WITH A FRAGMENT OF STAPHYLOCOCCUS AUREUS FNBPA-5','X-RAY DIFFRACTION',2.000,'CELL ADHESION',6,6,1),(2286,'2rln','THERMODYNAMIC AND STRUCTURAL CONSEQUENCES OF CHANGING A SULPHUR ATOM TO A METHYLENE GROUP IN THE M13NLE MUTATION IN RIBONUCLEASE S','X-RAY DIFFRACTION',1.850,'HYDROLASE(PHOSPHORIC DIESTER,RNA)',1,1,1),(2287,'2rma','CRYSTAL STRUCTURES OF CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A AND N-METHYL-4-[(E)-2-BUTENYL]-4,4-DIMETHYLTHREONINE CYCLOSPORIN A','X-RAY DIFFRACTION',2.100,'ISOMERASE/IMMUNOSUPPRESSANT',10,10,1),(2288,'2rmb','CRYSTAL STRUCTURES OF CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A AND N-METHYL-4-[(E)-2-BUTENYL]-4,4-DIMETHYLTHREONINE CYCLOSPORIN A','X-RAY DIFFRACTION',2.100,'ISOMERASE/IMMUNOSUPPRESSANT',10,10,1),(2289,'2rmc','CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH IMMUNOSUPPRESSIVE DRUG CYCLOSPORIN A','X-RAY DIFFRACTION',1.640,'ISOMERASE/IMMUNOSUPPRESSANT',4,4,1),(2290,'2rmx','SOLUTION STRUCTURE OF THE SHP-1 C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM NKG2A','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(2291,'2rnw','THE STRUCTURAL BASIS FOR SITE-SPECIFIC LYSINE-ACETYLATED HISTONE RECOGNITION BY THE BROMODOMAINS OF THE HUMAN TRANSCRIPTIONAL CO-ACTIVATORS PCAF AND CBP','SOLUTION NMR',NULL,'TRANSFERASE/NUCLEAR PROTEIN',1,1,1),(2292,'2rnx','THE STRUCTURAL BASIS FOR SITE-SPECIFIC LYSINE-ACETYLATED HISTONE RECOGNITION BY THE BROMODOMAINS OF THE HUMAN TRANSCRIPTIONAL CO-ACTIVATORS PCAF AND CBP','SOLUTION NMR',NULL,'TRANSFERASE/NUCLEAR PROTEIN',1,1,1),(2293,'2rny','COMPLEX STRUCTURES OF CBP BROMODOMAIN WITH H4 ACK20 PEPTIDE','SOLUTION NMR',NULL,'TRANSFERASE/NUCLEAR PROTEIN',1,1,1),(2294,'2roc','SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH PUMA','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(2295,'2rod','SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAA','SOLUTION NMR',NULL,'APOPTOSIS',1,1,1),(2296,'2rol','STRUCTURAL BASIS OF PXXDY MOTIF RECOGNITION IN SH3 BINDING','SOLUTION NMR',NULL,'SPLICING/SIGNALING PROTEIN',1,1,1),(2297,'2ror','SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM SLP76','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(2298,'2roz','STRUCTURE OF THE C-TERMINAL PID DOMAIN OF FE65L1 COMPLEXED WITH THE CYTOPLASMIC TAIL OF APP REVEALS A NOVEL PEPTIDE BINDING MODE','SOLUTION NMR',NULL,'PEPTIDE BINDING PROTEIN',1,1,1),(2299,'2rpq','SOLUTION STRUCTURE OF A SUMO-INTERACTING MOTIF OF MBD1-CONTAINING CHROMATIN-ASSOCIATED FACTOR 1 BOUND TO SUMO-3','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2300,'2rqg','STRUCTURE OF GSPT1/ERF3A-PABC','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2301,'2rqh','STRUCTURE OF GSPT1/ERF3A-PABC','SOLUTION NMR',NULL,'PROTEIN BINDING',1,1,1),(2302,'2rqu','SOLUTION STRUCTURE OF THE COMPLEX BETWEEN THE DDEF1 SH3 DOMAIN AND THE APC SAMP1 MOTIF','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(2303,'2rqw','SOLUTION STRUCTURE OF BEM1P SH3CI DOMAIN COMPLEXED WITH STE20P-PRR PEPTIDE','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(2304,'2rr3','SOLUTION STRUCTURE OF THE COMPLEX BETWEEN HUMAN VAP-A MSP DOMAIN AND HUMAN OSBP FFAT MOTIF','SOLUTION NMR',NULL,'MEMBRANE PROTEIN/TRANSPORT PROTEIN',1,1,1),(2305,'2rr4','COMPLEX STRUCTURE OF THE ZF-CW DOMAIN AND THE H3K4ME3 PEPTIDE','SOLUTION NMR',NULL,'METAL-BINDING PROTEIN/NUCLEAR PROTEIN',1,1,1),(2306,'2rr9','THE SOLUTION STRUCTURE OF THE K63-UB2:TUIMS COMPLEX','SOLUTION NMR',NULL,'NUCLEAR PROTEIN',1,2,1),(2307,'2rs9','SOLUTION STRUCTURE OF THE BROMODOMAIN OF HUMAN BRPF1 IN COMPLEX WITH HISTONE H4K5AC PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2308,'2rsn','SOLUTION STRUCTURE OF THE CHROMODOMAIN OF CHP1 IN COMPLEX WITH H3K9ME3 PEPTIDE','SOLUTION NMR',NULL,'NUCLEAR PROTEIN',1,1,1),(2309,'2rsy','SOLUTION STRUCTURE OF THE SH2 DOMAIN OF CSK IN COMPLEX WITH A PHOSPHOPEPTIDE FROM CBP','SOLUTION NMR',NULL,'TRANSFERASE/SIGNALING PROTEIN',1,1,1),(2310,'2rt5','STRUCTURAL INSIGHTS INTO THE RECRUITMENT OF SMRT BY THE CO-REPRESSOR SHARP UNDER PHOSPHORYLATIVE REGULATION','SOLUTION NMR',NULL,'TRANSCRIPTION REGULATOR',1,1,1),(2311,'2rui','SOLUTION STRUCTURE OF THE BACILLUS ANTHRACIS SORTASE A-SUBSTRATE COMPLEX','SOLUTION NMR',NULL,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(2312,'2ruk','SOLUTION STRUCTURE OF THE COMPLEX BETWEEN P53 TRANSACTIVATION DOMAIN 2 AND TFIIH P62 PH DOMAIN','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(2313,'2rvb','SOLUTION STRUCTURE OF THE COMPLEX BETWEEN XPC ACIDIC DOMAIN AND TFIIH P62 PH DOMAIN','SOLUTION NMR',NULL,'DNA BINDING PROTEIN/TRANSCRIPTION',1,1,1),(2314,'2rvn','SOLUTION STRUCTURE OF THE CHROMODOMAIN OF HP1A WITH THE PHOSPHORYLATED N-TERMINAL TAIL COMPLEXED WITH H3K9ME3 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION/PEPTIDE',1,1,1),(2315,'2seb','X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II','X-RAY DIFFRACTION',2.500,'COMPLEX (MHC CLASS II/SUPERANTIGEN)',1,2,1),(2316,'2sta','ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA MAXIMA TRYPSIN INHIBITOR I)','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2317,'2stb','ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II)','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2318,'2thf','STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D-PHE-PRO-ARG- CHLOROMETHYLKETONE','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2319,'2uue','REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS','X-RAY DIFFRACTION',2.060,'TRANSFERASE/INHIBITOR',2,2,1),(2320,'2uuf','THROMBIN-HIRUGEN BINARY COMPLEX AT 1.26A RESOLUTION','X-RAY DIFFRACTION',1.260,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2321,'2uuj','THROMBIN-HIRUGEN-GW473178 TERNARY COMPLEX AT 1.32A RESOLUTION','X-RAY DIFFRACTION',1.320,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2322,'2uuk','THROMBIN-HIRUGEN-GW420128 TERNARY COMPLEX AT 1.39A RESOLUTION','X-RAY DIFFRACTION',1.390,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2323,'2uvx','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/INHIBITOR',1,1,1),(2324,'2uvy','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H- PURIN-6-YL)-BENZYL)-AMINE','X-RAY DIFFRACTION',1.950,'TRANSFERASE/INHIBITOR',1,1,1),(2325,'2uvz','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-( 9H-PURIN-6-YL)-PHENYL)-METHYLAMINE','X-RAY DIFFRACTION',1.940,'TRANSFERASE/INHIBITOR',1,1,1),(2326,'2uw0','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  6-(4-(4-(4- CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/INHIBITOR',1,1,1),(2327,'2uw3','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4- PHENYL-1H-PYRAZOLE','X-RAY DIFFRACTION',2.190,'TRANSFERASE/INHIBITOR',1,1,1),(2328,'2uw4','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL- 1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(2329,'2uw5','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  (R)-2-(4- CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE','X-RAY DIFFRACTION',2.140,'TRANSFERASE/INHIBITOR',1,1,1),(2330,'2uw6','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  (S)-2-(4- CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE','X-RAY DIFFRACTION',2.230,'TRANSFERASE/INHIBITOR',1,1,1),(2331,'2uw7','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  4-(4-CHLORO- PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/INHIBITOR',1,1,1),(2332,'2uw8','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO- PHENYL)-2-PHENYL-ETHYLAMINE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/INHIBITOR',1,1,1),(2333,'2uw9','STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO- PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/INHIBITOR',1,1,1),(2334,'2uwe','LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,6,1),(2335,'2uwj','STRUCTURE OF THE HETEROTRIMERIC COMPLEX WHICH REGULATES TYPE III SECRETION NEEDLE FORMATION','X-RAY DIFFRACTION',2.000,'CHAPERONE',1,2,1),(2336,'2uz6','ACHBP-TARGETED A-CONOTOXIN CORRELATES DISTINCT BINDING ORIENTATIONS WITH NACHR SUBTYPE SELECTIVITY.','X-RAY DIFFRACTION',2.400,'RECEPTOR/TOXIN',10,10,1),(2337,'2uzt','PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(2338,'2uzu','PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS','X-RAY DIFFRACTION',2.400,'TRANSFERASE',1,1,1),(2339,'2uzv','PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS','X-RAY DIFFRACTION',2.500,'TRANSFERASE',1,1,1),(2340,'2uzw','PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(2341,'2v17','STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,2,1),(2342,'2v1r','YEAST PEX13 SH3 DOMAIN COMPLEXED WITH A PEPTIDE FROM PEX14 AT 2.1 A RESOLUTION','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT',3,2,1),(2343,'2v1s','CRYSTAL STRUCTURE OF RAT TOM20-ALDH PRESEQUENCE COMPLEX','X-RAY DIFFRACTION',2.050,'OXIDOREDUCTASE',7,6,1),(2344,'2v1t','CRYSTAL STRUCTURE OF RAT TOM20-ALDH PRESEQUENCE COMPLEX','X-RAY DIFFRACTION',1.920,'OXIDOREDUCTASE',2,2,1),(2345,'2v2f','CRYSTAL STRUCTURE OF PBP1A FROM DRUG-RESISTANT STRAIN 5204 FROM STREPTOCOCCUS PNEUMONIAE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(2346,'2v2w','T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',2,2,1),(2347,'2v2x','T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',2,2,1),(2348,'2v3h','THROMBIN WITH 3-CYCLE NO F','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2349,'2v3o','THROMBIN WITH 3-CYCLE WITH F','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2350,'2v3s','STRUCTURAL INSIGHTS INTO THE RECOGNITION OF SUBSTRATES AND ACTIVATORS BY THE OSR1 KINASE','X-RAY DIFFRACTION',1.700,'TRANSFERASE',2,2,1),(2351,'2v3x','HIS243ALA ESCHERICHIA COLI AMINOPEPTIDASE P IN COMPLEX WITH SUBSTRATE','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(2352,'2v3y','HIS361ALA ESCHERICHIA COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(2353,'2v3z','GLU383ALA ESCHERICHIA COLI AMINOPEPTIDASE P IN COMPLEX WITH SUBSTRATE','X-RAY DIFFRACTION',1.560,'HYDROLASE',1,1,1),(2354,'2v51','STRUCTURE OF MAL-RPEL1 COMPLEXED TO ACTIN','X-RAY DIFFRACTION',2.350,'STRUCTURAL PROTEIN/CONTRACTILE PROTEI',2,2,1),(2355,'2v52','STRUCTURE OF MAL-RPEL2 COMPLEXED TO G-ACTIN','X-RAY DIFFRACTION',1.450,'STRUCTURAL PROTEIN/CONTRACTILE PROTEI',1,1,1),(2356,'2v5f','CRYSTAL STRUCTURE OF WILD TYPE PEPTIDE-BINDING DOMAIN OF HUMAN TYPE I COLLAGEN PROLYL 4-HYDROXYLASE.','X-RAY DIFFRACTION',2.030,'OXIDOREDUCTASE',1,1,1),(2357,'2v5w','CRYSTAL STRUCTURE OF HDAC8-SUBSTRATE COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE SUBSTRATE',3,2,1),(2358,'2v6q','CRYSTAL STRUCTURE OF A BHRF-1 : BIM BH3 COMPLEX','X-RAY DIFFRACTION',2.000,'APOPTOSIS',1,1,1),(2359,'2v6x','STRACTURAL INSIGHT INTO THE INTERACTION BETWEEN ESCRT-III AND VPS4','X-RAY DIFFRACTION',1.980,'PROTEIN TRANSPORT',1,1,1),(2360,'2v7d','14-3-3 PROTEIN ZETA IN COMPLEX WITH THR758 PHOSPHORYLATED INTEGRIN BETA2 PEPTIDE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',4,4,1),(2361,'2v7q','THE STRUCTURE OF F1-ATPASE INHIBITED BY I1-60HIS, A MONOMERIC FORM OF THE INHIBITOR PROTEIN, IF1.','X-RAY DIFFRACTION',2.100,'HYDROLASE',2,6,1),(2362,'2v83','CRYSTAL STRUCTURE OF RAG2-PHD FINGER IN COMPLEX WITH H3K4ME3 PEPTIDE','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',2,3,1),(2363,'2v85','CRYSTAL STRUCTURE OF RAG2-PHD FINGER IN COMPLEX WITH H3R2ME1K4ME3 PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',2,2,1),(2364,'2v86','CRYSTAL STRUCTURE OF RAG2-PHD FINGER IN COMPLEX WITH H3R2ME2AK4ME3 PEPTIDE','X-RAY DIFFRACTION',2.050,'PROTEIN BINDING',2,2,1),(2365,'2v87','CRYSTAL STRUCTURE OF RAG2-PHD FINGER IN COMPLEX WITH H3R2ME2SK4ME3 PEPTIDE','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',2,2,1),(2366,'2v88','CRYSTAL STRUCTURE OF RAG2-PHD FINGER IN COMPLEX WITH H3R2ME2SK4ME2 PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',2,2,1),(2367,'2v89','CRYSTAL STRUCTURE OF RAG2-PHD FINGER IN COMPLEX WITH H3K4ME3 PEPTIDE AT 1.1A RESOLUTION','X-RAY DIFFRACTION',1.100,'PROTEIN BINDING',2,2,1),(2368,'2v8c','MOUSE PROFILIN IIA IN COMPLEX WITH THE PROLINE-RICH DOMAIN OF VASP','X-RAY DIFFRACTION',1.980,'PROTEIN-BINDING',1,1,1),(2369,'2v8f','MOUSE PROFILIN IIA IN COMPLEX WITH A DOUBLE REPEAT FROM THE FH1 DOMAIN OF MDIA1','X-RAY DIFFRACTION',1.100,'PROTEIN-BINDING',1,2,1),(2370,'2v8w','CRYSTALLOGRAPHIC AND MASS SPECTROMETRIC CHARACTERISATION OF EIF4E WITH N7-CAP DERIVATIVES','X-RAY DIFFRACTION',2.300,'TRANSLATION',2,2,1),(2371,'2v8x','CRYSTALLOGRAPHIC AND MASS SPECTROMETRIC CHARACTERISATION OF EIF4E WITH N7-CAP DERIVATIVES','X-RAY DIFFRACTION',2.300,'TRANSLATION',2,2,1),(2372,'2v8y','CRYSTALLOGRAPHIC AND MASS SPECTROMETRIC CHARACTERISATION OF EIF4E WITH N7-CAP DERIVATIVES','X-RAY DIFFRACTION',2.100,'TRANSLATION',2,2,1),(2373,'2vaa','MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',2.300,'COMPLEX (MHC I/PEPTIDE)',1,1,1),(2374,'2vab','MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',2.500,'COMPLEX (MHC I/PEPTIDE)',1,1,1),(2375,'2vay','CALMODULIN COMPLEXED WITH CAV1.1 IQ PEPTIDE','X-RAY DIFFRACTION',1.940,'METAL TRANSPORT',1,1,1),(2376,'2vda','SOLUTION STRUCTURE OF THE SECA-SIGNAL PEPTIDE COMPLEX','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(2377,'2vdr','INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV','X-RAY DIFFRACTION',2.400,'CELL ADHESION/IMMUNE SYSTEM',1,2,1),(2378,'2vgc','GAMMA-CHYMOTRYPSIN D-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.800,'SERINE PROTEASE',1,2,1),(2379,'2vgo','CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE INHIBITOR','X-RAY DIFFRACTION',1.700,'TRANSFERASE',2,2,1),(2380,'2vgp','CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A AMINOTHIAZOLE INHIBITOR','X-RAY DIFFRACTION',1.700,'TRANSFERASE',2,2,1),(2381,'2vif','CRYSTAL STRUCTURE OF SOCS6 SH2 DOMAIN IN COMPLEX WITH A C-KIT PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.450,'SIGNALING PROTEIN',1,1,1),(2382,'2vj0','CRYSTAL STRUCTURE OF THE ALPHA-ADAPTIN APPENDAGE DOMAIN, FROM THE AP2 ADAPTOR COMPLEX, IN COMPLEX WITH AN FXDNF PEPTIDE FROM AMPHIPHYSIN1 AND A WVXF PEPTIDE FROM SYNAPTOJANIN P170','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',2,1,1),(2383,'2vkn','YEAST SHO1 SH3 DOMAIN COMPLEXED WITH A PEPTIDE FROM PBS2','X-RAY DIFFRACTION',2.050,'MEMBRANE PROTEIN',1,1,1),(2384,'2vlj','THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,3,1),(2385,'2vlk','THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,3,1),(2386,'2vll','THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',2,2,1),(2387,'2vlr','THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,6,1),(2388,'2vm6','HUMAN BCL2-A1 IN COMPLEX WITH BIM-BH3 PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(2389,'2vnw','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6- YL)PIPERIDIN-4-YL)METHANAMINE','X-RAY DIFFRACTION',2.090,'TRANSFERASE',1,1,1),(2390,'2vny','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6- YL)PIPERIDIN-4-YL)AMINE','X-RAY DIFFRACTION',1.960,'TRANSFERASE',1,1,1),(2391,'2vo0','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  C-(4-(4- CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YL)METHYLAMINE','X-RAY DIFFRACTION',1.940,'TRANSFERASE',1,1,1),(2392,'2vo3','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  C-(4-(4- CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YL)METHYLAMINE','X-RAY DIFFRACTION',1.980,'TRANSFERASE',1,1,1),(2393,'2vo6','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH  4-(4- CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN- 4-YLAMINE','X-RAY DIFFRACTION',1.970,'TRANSFERASE',1,1,1),(2394,'2vo7','STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H- PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE','X-RAY DIFFRACTION',1.980,'TRANSFERASE',1,1,1),(2395,'2vof','STRUCTURE OF MOUSE A1 BOUND TO THE PUMA BH3-DOMAIN','X-RAY DIFFRACTION',1.800,'APOPTOSIS',2,2,1),(2396,'2vog','STRUCTURE OF MOUSE A1 BOUND TO THE BMF BH3-DOMAIN','X-RAY DIFFRACTION',1.900,'APOPTOSIS',1,1,1),(2397,'2voh','STRUCTURE OF MOUSE A1 BOUND TO THE BAK BH3-DOMAIN','X-RAY DIFFRACTION',1.900,'APOPTOSIS',1,1,1),(2398,'2voi','STRUCTURE OF MOUSE A1 BOUND TO THE BID BH3-DOMAIN','X-RAY DIFFRACTION',2.100,'APOPTOSIS',1,1,1),(2399,'2vp7','DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX','X-RAY DIFFRACTION',1.650,'GENE REGULATION',1,1,1),(2400,'2vpb','DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX','X-RAY DIFFRACTION',1.590,'GENE REGULATION',1,1,1),(2401,'2vpe','DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX','X-RAY DIFFRACTION',1.700,'GENE REGULATION',4,2,1),(2402,'2vpg','DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX','X-RAY DIFFRACTION',1.600,'GENE REGULATION',4,2,1),(2403,'2vqe','MODIFIED URIDINES WITH C5-METHYLENE SUBSTITUENTS AT THE FIRST POSITION OF THE TRNA ANTICODON STABILIZE U-G WOBBLE PAIRING DURING DECODING','X-RAY DIFFRACTION',2.500,'RIBOSOME',1,1,1),(2404,'2vr3','STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF FIBRINOGEN BINDING TO CLFA FROM STAPHYLOCCCUS AUREUS','X-RAY DIFFRACTION',1.950,'CELL ADHESION',2,2,1),(2405,'2vrx','STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439','X-RAY DIFFRACTION',1.860,'CELL CYCLE/TRANSFERASE',2,2,1),(2406,'2vsl','CRYSTAL STRUCTURE OF XIAP BIR3 WITH A BIVALENT SMAC MIMETIC','X-RAY DIFFRACTION',2.100,'LIGASE',1,1,1),(2407,'2vt1','CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF SPA40, THE SPECIFICITY SWITCH FOR THE SHIGELLA FLEXNERI TYPE III SECRETION SYSTEM','X-RAY DIFFRACTION',2.000,'MEMBRANE PROTEIN',1,1,1),(2408,'2vu8','CRYSTAL STRUCTURE OF AN INSECT INHIBITOR WITH A FUNGAL TRYPSIN','X-RAY DIFFRACTION',1.800,'HYDROLASE/INHIBITOR',1,1,1),(2409,'2vut','CRYSTAL STRUCTURE OF NAD-BOUND NMRA-AREA ZINC FINGER COMPLEX','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',8,8,1),(2410,'2vwl','AMINOPYRROLIDINE FACTOR XA INHIBITOR','X-RAY DIFFRACTION',1.800,'BLOOD CLOTTING',1,1,1),(2411,'2vwn','AMINOPYRROLIDINE FACTOR XA INHIBITOR','X-RAY DIFFRACTION',1.610,'BLOOD CLOTTING',1,1,1),(2412,'2vwo','AMINOPYRROLIDINE FACTOR XA INHIBITOR','X-RAY DIFFRACTION',1.600,'BLOOD CLOTTING',1,1,1),(2413,'2vzd','CRYSTAL STRUCTURE OF THE C-TERMINAL CALPONIN HOMOLOGY DOMAIN OF ALPHA PARVIN IN COMPLEX WITH PAXILLIN LD1 MOTIF','X-RAY DIFFRACTION',2.100,'CELL ADHESION',2,2,1),(2414,'2vzg','CRYSTAL STRUCTURE OF THE C-TERMINAL CALPONIN HOMOLOGY DOMAIN OF ALPHA- PARVIN IN COMPLEX WITH PAXILLIN LD2 MOTIF','X-RAY DIFFRACTION',1.800,'CELL ADHESION',1,1,1),(2415,'2vzi','CRYSTAL STRUCTURE OF THE C-TERMINAL CALPONIN HOMOLOGY DOMAIN OF ALPHA- PARVIN IN COMPLEX WITH PAXILLIN LD4 MOTIF','X-RAY DIFFRACTION',2.200,'CELL ADHESION',1,1,1),(2416,'2w0p','CRYSTAL STRUCTURE OF THE FILAMIN A REPEAT 21 COMPLEXED WITH THE MIGFILIN PEPTIDE','X-RAY DIFFRACTION',1.900,'CELL ADHESION',1,2,1),(2417,'2w10','MONA SH3C IN COMPLEX','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,2,1),(2418,'2w2q','PCSK9-DELTAC D374H MUTANT BOUND TO WT EGF-A OF LDLR','X-RAY DIFFRACTION',2.330,'HYDROLASE/RECEPTOR',1,1,1),(2419,'2w2u','STRUCTURAL INSIGHT INTO THE INTERACTION BETWEEN ARCHAEAL ESCRT-III AND AAA-ATPASE','X-RAY DIFFRACTION',2.200,'HYDROLASE/TRANSPORT',2,2,1),(2420,'2w3i','CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(2421,'2w3k','CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1','X-RAY DIFFRACTION',2.050,'HYDROLASE',1,1,1),(2422,'2w3o','CRYSTAL STRUCTURE OF THE HUMAN PNKP FHA DOMAIN IN COMPLEX WITH AN XRCC1-DERIVED PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.850,'HYDROLASE,TRANSFERASE/PEPTIDE',2,2,1),(2423,'2w5z','TERNARY COMPLEX OF THE MIXED LINEAGE LEUKAEMIA (MLL1) SET DOMAIN WITH THE COFACTOR PRODUCT S-ADENOSYLHOMOCYSTEINE AND HISTONE PEPTIDE.','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(2424,'2w65','ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE','X-RAY DIFFRACTION',2.210,'IMMUNE SYSTEM',2,4,1),(2425,'2w73','HIGH-RESOLUTION STRUCTURE OF THE COMPLEX BETWEEN CALMODULIN AND A PEPTIDE FROM CALCINEURIN A','X-RAY DIFFRACTION',1.450,'METAL BINDING PROTEIN',4,4,1),(2426,'2w97','CRYSTAL STRUCTURE OF EIF4E BOUND TO GLYCEROL AND EIF4G1 PEPTIDE','X-RAY DIFFRACTION',2.290,'TRANSLATION',2,2,1),(2427,'2w9r','STRUCTURAL BASIS OF N-END RULE SUBSTRATE RECOGNITION IN ESCHERICHIA COLI BY THE CLPAP ADAPTOR PROTEIN CLPS','X-RAY DIFFRACTION',1.700,'CHAPERONE',1,1,1),(2428,'2wa8','STRUCTURAL BASIS OF N-END RULE SUBSTRATE RECOGNITION IN ESCHERICHIA COLI BY THE CLPAP ADAPTOR PROTEIN CLPS - THE PHE PEPTIDE STRUCTURE','X-RAY DIFFRACTION',2.150,'PEPTIDE-BINDING PROTEIN',2,2,1),(2429,'2wax','STRUCTURE OF THE HUMAN DDX6 C-TERMINAL DOMAIN IN COMPLEX WITH AN EDC3-FDF PEPTIDE','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(2430,'2way','STRUCTURE OF THE HUMAN DDX6 C-TERMINAL DOMAIN IN COMPLEX WITH AN EDC3-FDF PEPTIDE','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(2431,'2wev','TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN','X-RAY DIFFRACTION',2.300,'TRANSFERASE',2,2,1),(2432,'2wfj','ATOMIC RESOLUTION CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G IN COMPLEX WITH CYCLOSPORIN A.','X-RAY DIFFRACTION',0.750,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(2433,'2wh0','RECOGNITION OF AN INTRACHAIN TANDEM 14-3-3 BINDING SITE WITHIN PROTEIN KINASE C EPSILON','X-RAY DIFFRACTION',2.250,'SIGNALING PROTEIN',2,4,1),(2434,'2wh6','CRYSTAL STRUCTURE OF ANTI-APOPTOTIC BHRF1 IN COMPLEX WITH THE BIM BH3 DOMAIN','X-RAY DIFFRACTION',1.500,'APOPTOSIS',1,1,1),(2435,'2whx','A SECOND CONFORMATION OF THE NS3 PROTEASE-HELICASE FROM DENGUE VIRUS','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(2436,'2why','CRYSTAL STRUCTURE OF THE TRISCATECHOLATE SIDEROPHORE BINDING PROTEIN FEUA FROM BACILLUS SUBTILIS COMPLEXED WITH FERRI-BACILLIBACTIN','X-RAY DIFFRACTION',1.700,'TRANSPORT PROTEIN',1,1,1),(2437,'2wjg','STRUCTURE AND FUNCTION OF THE FEOB G-DOMAIN FROM METHANOCOCCUS JANNASCHII','X-RAY DIFFRACTION',2.200,'METAL TRANSPORT',1,1,1),(2438,'2wo6','HUMAN DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A IN COMPLEX WITH A CONSENSUS SUBSTRATE PEPTIDE','X-RAY DIFFRACTION',2.500,'TRANSFERASE/PEPTIDE',1,1,1),(2439,'2wok','CLAVULANIC ACID BIOSYNTHESIS OLIGOPEPTIDE BINDING PROTEIN 2 COMPLEXED WITH BRADYKININ','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN/PEPTIDE',1,1,1),(2440,'2wp1','STRUCTURE OF BRDT BROMODOMAIN 2 BOUND TO AN ACETYLATED HISTONE H3 PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION/PEPTIDE',2,2,1),(2441,'2wp2','STRUCTURE OF BRDT BROMODOMAIN BD1 BOUND TO A DIACETYLATED HISTONE H4 PEPTIDE.','X-RAY DIFFRACTION',2.370,'TRANSCRIPTION/PEPTIDE',2,2,1),(2442,'2wph','FACTOR IXA SUPERACTIVE TRIPLE MUTANT','X-RAY DIFFRACTION',1.500,'BLOOD CLOTTING',1,1,1),(2443,'2wpi','FACTOR IXA SUPERACTIVE DOUBLE MUTANT','X-RAY DIFFRACTION',1.990,'BLOOD CLOTTING',1,1,1),(2444,'2wpj','FACTOR IXA SUPERACTIVE TRIPLE MUTANT, NACL-SOAKED','X-RAY DIFFRACTION',1.600,'BLOOD CLOTTING',1,1,1),(2445,'2wpk','FACTOR IXA SUPERACTIVE TRIPLE MUTANT, ETHYLENE GLYCOL-SOAKED','X-RAY DIFFRACTION',2.210,'BLOOD CLOTTING',1,1,1),(2446,'2wpl','FACTOR IXA SUPERACTIVE TRIPLE MUTANT, EDTA-SOAKED','X-RAY DIFFRACTION',1.820,'BLOOD CLOTTING',1,1,1),(2447,'2wpm','FACTOR IXA SUPERACTIVE MUTANT, EGR-CMK INHIBITED','X-RAY DIFFRACTION',2.000,'BLOOD CLOTTING',1,1,1),(2448,'2wpv','CRYSTAL STRUCTURE OF S. CEREVISIAE GET4-GET5 COMPLEX','X-RAY DIFFRACTION',1.990,'PROTEIN BINDING',4,4,1),(2449,'2wuh','CRYSTAL STRUCTURE OF THE DDR2 DISCOIDIN DOMAIN BOUND TO A TRIPLE-HELICAL COLLAGEN PEPTIDE','X-RAY DIFFRACTION',1.600,'RECEPTOR/PEPTIDE',3,1,1),(2450,'2wv4','CRYSTAL STRUCTURE OF FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE IN COMPLEX WITH A DECAMERIC PEPTIDE CORRESPONDING TO THE VP1-2A CLEAVAGE JUNCTION','X-RAY DIFFRACTION',2.500,'HYDROLASE/PEPTIDE',2,2,1),(2451,'2wwz','TAB2 NZF DOMAIN IN COMPLEX WITH LYS63-LINKED DI-UBIQUITIN, P212121','X-RAY DIFFRACTION',1.400,'PROTEIN BINDING',1,2,1),(2452,'2wx0','TAB2 NZF DOMAIN IN COMPLEX WITH LYS63-LINKED DI-UBIQUITIN, P21','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',2,4,1),(2453,'2x04','CRYSTAL STRUCTURE OF THE PABC-TNRC6C COMPLEX','X-RAY DIFFRACTION',1.490,'PEPTIDE/RNA BINDING PROTEIN',2,2,1),(2454,'2x0x','RIBONUCLEOTIDE REDUCTASE R1 SUBUNIT OF E. COLI TO 2.3 A RESOLUTION','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',4,3,1),(2455,'2x2c','ACETYL-CYPA:CYCLOSPORINE COMPLEX','X-RAY DIFFRACTION',2.410,'ISOMERASE/IMMUNOSUPPRESSANT',5,5,1),(2456,'2x39','STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB','X-RAY DIFFRACTION',1.930,'TRANSFERASE',1,1,1),(2457,'2x4n','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT','X-RAY DIFFRACTION',2.340,'IMMUNE SYSTEM',2,3,1),(2458,'2x4o','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(2459,'2x4p','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(2460,'2x4q','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(2461,'2x4r','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(2462,'2x4t','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(2463,'2x4u','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,2,1),(2464,'2x4w','MOLECULAR BASIS OF HISTONE H3K36ME3 RECOGNITION BY THE PWWP DOMAIN OF BRPF1.','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION',1,1,1),(2465,'2x4x','MOLECULAR BASIS OF HISTONE H3K36ME3 RECOGNITION BY THE PWWP DOMAIN OF BRPF1.','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',4,4,1),(2466,'2x4y','MOLECULAR BASIS OF HISTONE H3K36ME3 RECOGNITION BY THE PWWP DOMAIN OF BRPF1.','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',8,8,1),(2467,'2x6m','STRUCTURE OF A SINGLE DOMAIN CAMELID ANTIBODY FRAGMENT IN COMPLEX WITH A C-TERMINAL PEPTIDE OF ALPHA-SYNUCLEIN','X-RAY DIFFRACTION',1.620,'IMMUNE SYSTEM',1,1,1),(2468,'2x70','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,3,1),(2469,'2x7k','THE CRYSTAL STRUCTURE OF PPIL1 IN COMPLEX WITH CYCLOSPORINE A SUGGESTS A BINDING MODE FOR SKIP','X-RAY DIFFRACTION',1.150,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(2470,'2xap','RIBONUCLEOTIDE REDUCTASE Y731NO2Y MODIFIED R1 SUBUNIT OF E. COLI TO 2. 1 A RESOLUTION','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',4,3,1),(2471,'2xbv','FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR','X-RAY DIFFRACTION',1.660,'BLOOD CLOTTING',1,1,1),(2472,'2xbx','FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR','X-RAY DIFFRACTION',1.850,'BLOOD CLOTTING',1,1,1),(2473,'2xby','FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR','X-RAY DIFFRACTION',2.020,'BLOOD CLOTTING',1,1,1),(2474,'2xc0','FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR','X-RAY DIFFRACTION',2.050,'BLOOD CLOTTING',1,1,1),(2475,'2xc5','FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR','X-RAY DIFFRACTION',1.700,'BLOOD CLOTTING',1,1,1),(2476,'2xc8','CRYSTAL STRUCTURE OF THE GENE 22 PRODUCT OF THE BACILLUS SUBTILIS SPP1 PHAGE','X-RAY DIFFRACTION',2.350,'VIRAL PROTEIN',1,1,1),(2477,'2xcb','CRYSTAL STRUCTURE OF PCRH IN COMPLEX WITH THE CHAPERONE BINDING REGION OF POPD','X-RAY DIFFRACTION',1.850,'PROTEIN BINDING',1,1,1),(2478,'2xcf','CRYSTAL STRUCTURE OF HCV NS3 PROTEASE WITH A BORONATE INHIBITOR','X-RAY DIFFRACTION',2.480,'HYDROLASE',2,2,1),(2479,'2xdw','INHIBITION OF PROLYL OLIGOPEPTIDASE WITH A SYNTHETIC UNNATURAL DIPEPTIDE','X-RAY DIFFRACTION',1.350,'HYDROLASE',1,1,1),(2480,'2xe4','STRUCTURE OF OLIGOPEPTIDASE B FROM LEISHMANIA MAJOR','X-RAY DIFFRACTION',1.650,'HYDROLASE/INHIBITOR',1,1,1),(2481,'2xfx','CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(2482,'2xjy','CRYSTAL STRUCTURE OF THE LMO2:LDB1-LID COMPLEX, P21 CRYSTAL FORM','X-RAY DIFFRACTION',2.400,'ONCOPROTEIN',1,1,1),(2483,'2xl2','WDR5 IN COMPLEX WITH AN RBBP5 PEPTIDE RECRUITED TO NOVEL SITE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(2484,'2xn3','CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID','X-RAY DIFFRACTION',2.090,'TRANSPORT',1,1,1),(2485,'2xn5','CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE','X-RAY DIFFRACTION',1.700,'TRANSPORT',1,1,1),(2486,'2xn6','CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN','X-RAY DIFFRACTION',1.290,'TRANSPORT',1,1,1),(2487,'2xn7','CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)','X-RAY DIFFRACTION',1.430,'TRANSPORT',1,1,1),(2488,'2xn9','CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR, STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,3,1),(2489,'2xo4','RIBONUCLEOTIDE REDUCTASE Y730NH2Y MODIFIED R1 SUBUNIT OF E. COLI','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE',4,3,1),(2490,'2xpn','CRYSTAL STRUCTURE OF A SPT6-IWS1(SPN1) COMPLEX FROM ENCEPHALITOZOON CUNICULI, FORM I','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',1,1,1),(2491,'2xpo','CRYSTAL STRUCTURE OF A SPT6-IWS1(SPN1) COMPLEX FROM ENCEPHALITOZOON CUNICULI, FORM II','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(2492,'2xpp','CRYSTAL STRUCTURE OF A SPT6-IWS1(SPN1) COMPLEX FROM ENCEPHALITOZOON CUNICULI, FORM III','X-RAY DIFFRACTION',1.740,'TRANSCRIPTION',1,1,1),(2493,'2xpx','CRYSTAL STRUCTURE OF BHRF1:BAK BH3 COMPLEX','X-RAY DIFFRACTION',2.050,'APOPTOSIS',1,1,1),(2494,'2xqq','HUMAN DYNEIN LIGHT CHAIN (DYNLL2) IN COMPLEX WITH AN IN VITRO EVOLVED PEPTIDE (AC-SRGTQTE).','X-RAY DIFFRACTION',1.310,'PROTEIN TRANSPORT',4,4,1),(2495,'2xrw','LINEAR BINDING MOTIFS FOR JNK AND FOR CALCINEURIN ANTAGONISTICALLY CONTROL THE NUCLEAR SHUTTLING OF NFAT4','X-RAY DIFFRACTION',1.330,'TRANSCRIPTION',1,1,1),(2496,'2xs1','CRYSTAL STRUCTURE OF ALIX IN COMPLEX WITH THE SIVMAC239 PYKEVTEDL LATE DOMAIN','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT/VIRAL PROTEIN',1,1,1),(2497,'2xs3','STRUCTURE OF KARILYSIN CATALYTIC MMP DOMAIN','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,2,1),(2498,'2xs4','STRUCTURE OF KARILYSIN CATALYTIC MMP DOMAIN IN COMPLEX WITH MAGNESIUM','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(2499,'2xs8','CRYSTAL STRUCTURE OF ALIX IN COMPLEX WITH THE SIVAGMTAN-1 AYDPARKLL LATE DOMAIN','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT/VIRAL PROTEIN',1,1,1),(2500,'2xtt','BOVINE TRYPSIN IN COMPLEX WITH EVOLUTIONARY ENHANCED SCHISTOCERCA GREGARIA PROTEASE INHIBITOR 1 (SGPI-1-P02)','X-RAY DIFFRACTION',0.930,'HYDROLASE',1,1,1),(2501,'2xu7','STRUCTURAL BASIS FOR RBAP48 BINDING TO FOG-1','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(2502,'2xum','FACTOR INHIBITING HIF (FIH) Q239H MUTANT IN COMPLEX WITH ZN(II), NOG AND ASP-SUBSTRATE PEPTIDE (20-MER)','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE/PEPTIDE',1,1,1),(2503,'2xxm','CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN IN COMPLEX WITH A CAMELID VHH AND THE CAI PEPTIDE.','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(2504,'2xxn','STRUCTURE OF THE VIRF4-HAUSP TRAF DOMAIN COMPLEX','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(2505,'2xyi','CRYSTAL STRUCTURE OF NURF55 IN COMPLEX WITH A H4 PEPTIDE','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION',1,1,1),(2506,'2xze','STRUCTURAL BASIS FOR AMSH-ESCRT-III CHMP3 INTERACTION','X-RAY DIFFRACTION',1.750,'HYDROLASE/PROTEIN TRANSPORT',2,2,1),(2507,'2xzq','CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(2508,'2y06','CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3-NITROPHENYL) - ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(2509,'2y07','CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(2510,'2y0i','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH TANKYRASE-2 (TNKS2) FRAGMENT PEPTIDE (21-MER)','X-RAY DIFFRACTION',2.280,'OXIDOREDUCTASE/PEPTIDE',1,1,1),(2511,'2y1l','CASPASE-8 IN COMPLEX WITH DARPIN-8.4','X-RAY DIFFRACTION',1.800,'HYDROLASE/INHIBITOR',2,4,1),(2512,'2y1n','STRUCTURE OF C-CBL-ZAP-70 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.000,'LIGASE/TRANSFERASE',2,2,1),(2513,'2y4v','CRYSTAL STRUCTURE OF HUMAN CALMODULIN IN COMPLEX WITH A DAP KINASE-1 MUTANT (W305Y) PEPTIDE','X-RAY DIFFRACTION',1.800,'METAL BINDING PROTEIN/TRANSFERASE',1,1,1),(2514,'2y5t','CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',3,2,1),(2515,'2y65','CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER KINESIN-1 MOTOR DOMAIN DIMER-TAIL COMPLEX','X-RAY DIFFRACTION',2.200,'MOTOR PROTEIN',3,4,1),(2516,'2y69','BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN','X-RAY DIFFRACTION',1.950,'ELECTRON TRANSPORT',6,10,1),(2517,'2y7l','STRUCTURE OF N-TERMINAL DOMAIN OF CANDIDA ALBICANS ALS9-2 IN COMPLEX WITH HUMAN FIBRINOGEN GAMMA PEPTIDE','X-RAY DIFFRACTION',1.490,'CELL ADHESION',1,1,1),(2518,'2y8o','CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A MAPK DOCKING PEPTIDE','X-RAY DIFFRACTION',1.950,'TRANSFERASE',1,1,1),(2519,'2y8t','CO-STRUCTURE OF AMA1 WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII','X-RAY DIFFRACTION',1.950,'MEMBRANE PROTEIN',2,2,1),(2520,'2y9q','CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE','X-RAY DIFFRACTION',1.550,'TRANSFERASE',1,1,1),(2521,'2yb8','CRYSTAL STRUCTURE OF NURF55 IN COMPLEX WITH SU(Z)12','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(2522,'2ybf','COMPLEX OF RAD18 (RAD6 BINDING DOMAIN) WITH RAD6B','X-RAY DIFFRACTION',2.000,'LIGASE',1,1,1),(2523,'2ybp','JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE AND HISTONE H3K36ME3 PEPTIDE (30-41)','X-RAY DIFFRACTION',2.020,'OXIDOREDUCTASE/PEPTIDE',2,2,1),(2524,'2ybs','JMJD2A COMPLEXED WITH S-2-HYDROXYGLUTARATE AND HISTONE H3K36ME3 PEPTIDE (30-41)','X-RAY DIFFRACTION',2.320,'OXIDOREDUCTASE/PEPTIDE',2,2,1),(2525,'2ych','PILM-PILN TYPE IV PILUS BIOGENESIS COMPLEX','X-RAY DIFFRACTION',2.200,'CELL CYCLE',1,1,1),(2526,'2yj1','PUMA BH3 FOLDAMER IN COMPLEX WITH BCL-XL','X-RAY DIFFRACTION',2.240,'APOPTOSIS',2,2,1),(2527,'2yja','STAPLED PEPTIDES BINDING TO ESTROGEN RECEPTOR ALPHA.','X-RAY DIFFRACTION',1.820,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(2528,'2yjd','STAPLED PEPTIDE BOUND TO ESTROGEN RECEPTOR BETA','X-RAY DIFFRACTION',1.930,'HORMONE RECEPTOR/PEPTIDE',2,2,1),(2529,'2yka','RRM DOMAIN OF MRNA EXPORT ADAPTOR REF2-I BOUND TO HVS ORF57 PEPTIDE','SOLUTION NMR',NULL,'RNA BINDING PROTEIN/TRANSCRIPTION',1,1,1),(2530,'2ykt','CRYSTAL STRUCTURE OF THE I-BAR DOMAIN OF IRSP53 (BAIAP2) IN COMPLEX WITH AN EHEC DERIVED TIR PEPTIDE','X-RAY DIFFRACTION',2.110,'SIGNALING PROTEIN',1,1,1),(2531,'2yle','CRYSTAL STRUCTURE OF THE HUMAN SPIR-1 KIND FSI DOMAIN IN COMPLEX WITH THE FSI PEPTIDE','X-RAY DIFFRACTION',1.800,'ACTIN-BINDING PROTEIN',1,1,1),(2532,'2ymt','GAMMA 2 ADAPTIN EAR DOMAIN CRYSTAL STRUCTURE WITH PHAGE PEPTIDE GEEWGPWV','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT',1,1,1),(2533,'2ynn','YEAST BETAPRIME COP 1-304 WITH KTKTN MOTIF','X-RAY DIFFRACTION',1.780,'PROTEIN TRANSPORT',1,1,1),(2534,'2yno','YEAST BETAPRIME COP 1-304H6','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT',1,1,1),(2535,'2ynr','MIMP_ALPHADIBB_B54NLS','X-RAY DIFFRACTION',2.300,'TRANSPORT PROTEIN',2,1,1),(2536,'2yns','RIMP_ALPHA_B54NLS','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN',2,2,1),(2537,'2ypk','STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,1,1),(2538,'2ypl','STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM/VIRAL PROTEIN',1,3,1),(2539,'2yq6','STRUCTURE OF BCL-XL BOUND TO BIMSAHB','X-RAY DIFFRACTION',1.800,'APOPTOSIS',1,1,1),(2540,'2yq7','STRUCTURE OF BCL-XL BOUND TO BIMLOCK','X-RAY DIFFRACTION',1.900,'APOPTOSIS',1,1,1),(2541,'2ys5','SOLUTION STRUCTURE OF THE COMPLEX OF THE PTB DOMAIN OF SNT-2 AND 19- RESIDUE PEPTIDE (AA 1571-1589) OF HALK','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(2542,'2yu7','SOLUTION STRUCTURE OF THE SHP-1 C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM NKG2A','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(2543,'2yyr','STRUCTURAL ANALYSIS OF PHD DOMAIN OF PYGOPUS COMPLEXED WITH TRIMETHYLATED HISTONE H3 PEPTIDE','X-RAY DIFFRACTION',2.500,'METAL BINDING PROTEIN',1,1,1),(2544,'2z23','CRYSTAL STRUCTURE OF Y.PESTIS OLIGO PEPTIDE BINDING PROTEIN OPPA WITH TRI-LYSINE LIGAND','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(2545,'2z32','CRYSTAL STRUCTURE OF KEAP1 COMPLEXED WITH PROTHYMOSIN ALPHA','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(2546,'2z34','CRYSTAL STRUCTURE OF SPCIA1/ASF1 COMPLEX WITH HIP1','X-RAY DIFFRACTION',2.400,'CHAPERONE',2,2,1),(2547,'2z3c','A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2548,'2z3d','A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2549,'2z3e','A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE','X-RAY DIFFRACTION',2.320,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2550,'2z3n','COMPLEX STRUCTURE OF LF-TRANSFERASE AND PEPTIDE B','X-RAY DIFFRACTION',2.500,'TRANSFERASE',2,2,1),(2551,'2z5s','MOLECULAR BASIS FOR THE INHIBITION OF P53 BY MDMX','X-RAY DIFFRACTION',2.300,'CELL CYCLE',3,3,1),(2552,'2z5t','MOLECULAR BASIS FOR THE INHIBITION OF P53 BY MDMX','X-RAY DIFFRACTION',2.300,'CELL CYCLE',3,3,1),(2553,'2z6w','CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH CYCLOSPORIN A','X-RAY DIFFRACTION',0.960,'ISOMERASE/IMMUNOSUPPRESSANT',2,2,1),(2554,'2z7f','CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN NEUTROPHIL ELASTASE WITH 1/2SLPI','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2555,'2z7x','CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TRI-ACYLATED LIPOPEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(2556,'2z8p','STRUCTURAL BASIS FOR THE CATALYTIC MECHANISM OF PHOSPHOTHREONINE LYASE','X-RAY DIFFRACTION',1.800,'LYASE',1,1,1),(2557,'2z9i','CRYSTAL STRUCTURE OF RV0983 FROM MYCOBACTERIUM TUBERCULOSIS- PROTEOLYTICALLY ACTIVE FORM','X-RAY DIFFRACTION',2.000,'HYDROLASE',6,3,1),(2558,'2zc9','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.580,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2559,'2zda','EXPLORING THROMBIN S1 POCKET','X-RAY DIFFRACTION',1.730,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2560,'2zdv','EXPLORING THROMBIN S1 POCKET','X-RAY DIFFRACTION',1.720,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2561,'2zf0','EXPLORING THROMBIN S1 POCKET','X-RAY DIFFRACTION',2.200,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2562,'2zff','EXPLORING THROMBIN S1-POCKET','X-RAY DIFFRACTION',1.470,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2563,'2zfp','THROMBIN INIBITION','X-RAY DIFFRACTION',2.250,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2564,'2zfq','EXPLORING THROMBIN S3 POCKET','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2565,'2zfr','EXPLORING THROMBIN S3 POCKET','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2566,'2zfx','CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH YR301 AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',1.990,'TRANSCRIPTION',1,1,1),(2567,'2zg0','EXPLORING THROMBIN S3 POCKET','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2568,'2zgb','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2569,'2zgh','CRYSTAL STRUCTURE OF ACTIVE GRANZYME M BOUND TO ITS PRODUCT','X-RAY DIFFRACTION',2.170,'HYDROLASE',1,1,1),(2570,'2zgj','CRYSTAL STRUCTURE OF D86N-GZMM COMPLEXED WITH ITS OPTIMAL SYNTHESIZED SUBSTRATE','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(2571,'2zgx','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2572,'2zhe','EXPLORING THROMBIN S3 POCKET','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2573,'2zhf','EXPLORING THROMBIN S3 POCKET','X-RAY DIFFRACTION',1.980,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2574,'2zhq','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.960,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2575,'2zhr','CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH OM99-2 AT PH 5.0','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2576,'2zhw','EXPLORING THROMBIN S3 POCKET','X-RAY DIFFRACTION',2.020,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2577,'2zi2','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2578,'2ziq','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2579,'2zjd','CRYSTAL STRUCTURE OF LC3-P62 COMPLEX','X-RAY DIFFRACTION',1.560,'APOPTOSIS INHIBITOR/APOPTOSIS',2,2,1),(2580,'2zl2','CRYSTAL STRUCTURE OF H.PYLORI CLPP IN COMPLEX WITH THE PEPTIDE NVLGFTQ','X-RAY DIFFRACTION',2.500,'HYDROLASE',8,10,1),(2581,'2zl4','CRYSTAL STRUCTURE OF H.PYLORI CLPP S99A IN COMPLEX WITH THE PEPTIDE AAAA','X-RAY DIFFRACTION',2.500,'HYDROLASE',14,14,1),(2582,'2zl9','2-SUBSTITUTED-16-ENE-22-THIA-1ALPHA,25-DIHYDROXY-26,27- DIMETHYL-19-NORVITAMIN D3 ANALOGS: SYNTHESIS, BIOLOGICAL EVALUATION AND CRYSTAL STRUCTURE','X-RAY DIFFRACTION',1.900,'HORMONE',1,1,1),(2583,'2zla','2-SUBSTITUTED-16-ENE-22-THIA-1ALPHA,25-DIHYDROXY-26,27- DIMETHYL-19-NORVITAMIN D3 ANALOGS: SYNTHESIS, BIOLOGICAL EVALUATION AND CRYSTAL STRUCTURE','X-RAY DIFFRACTION',2.000,'HORMONE',1,1,1),(2584,'2zlc','2-SUBSTITUTED-16-ENE-22-THIA-1ALPHA,25-DIHYDROXY-26,27- DIMETHYL-19-NORVITAMIN D3 ANALOGS: SYNTHESIS, BIOLOGICAL EVALUATION AND CRYSTAL STRUCTURE','X-RAY DIFFRACTION',2.000,'HORMONE',1,1,1),(2585,'2zmh','CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(2586,'2zmi','CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',1,1,1),(2587,'2zmj','CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION',1,1,1),(2588,'2zne','CRYSTAL STRUCTURE OF ZN2+-BOUND FORM OF DES3-23ALG-2 COMPLEXED WITH ALIX ABS PEPTIDE','X-RAY DIFFRACTION',2.200,'APOPTOSIS',2,2,1),(2589,'2znk','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2590,'2znl','CRYSTAL STRUCTURE OF PA-PB1 COMPLEX FORM INFLUENZA VIRUS RNA POLYMERASE','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(2591,'2zo3','BISPHENYLIC THROMBIN INHIBITORS','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2592,'2zok','CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',4,4,1),(2593,'2zpk','CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,4,1),(2594,'2zpy','CRYSTAL STRUCTURE OF THE MOUSE RADXIN FERM DOMAIN COMPLEXED WITH THE MOUSE CD44 CYTOPLASMIC PEPTIDE','X-RAY DIFFRACTION',2.100,'CELL ADHESION',1,1,1),(2595,'2zsv','CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(2596,'2ztt','CRYSTAL STRUCTURE OF RNA POLYMERASE PB1-PB2 SUBUNITS FROM INFLUENZA A VIRUS','X-RAY DIFFRACTION',2.100,'TRANSFERASE',2,2,1),(2597,'2zu0','CRYSTAL STRUCTURE OF SUFC-SUFD COMPLEX INVOLVED IN THE IRON- SULFUR CLUSTER BIOSYNTHESIS','X-RAY DIFFRACTION',2.200,'BIOSYNTHETIC PROTEIN/PROTEIN BINDING',1,1,1),(2598,'2zvl','CRYSTAL STRUCTURE OF PCNA IN COMPLEX WITH DNA POLYMERASE KAPPA FRAGMENT','X-RAY DIFFRACTION',2.500,'TRANSFERASE',6,6,1),(2599,'2zvm','CRYSTAL STRUCTURE OF PCNA IN COMPLEX WITH DNA POLYMERASE IOTA FRAGMENT','X-RAY DIFFRACTION',2.300,'TRANSFERASE',3,3,1),(2600,'2zvv','CRYSTAL STRUCTURE OF PROLIFERATING CELLULAR NUCLEAR ANTIGEN 1 AND SHORT PEPTIDE FROM HUMAN P21','X-RAY DIFFRACTION',2.000,'DNA BINDING PROTEIN',2,2,1),(2601,'2zvw','CRYSTAL STRUCTURE OF PROLIFERATING CELL NUCLEAR ANTIGEN 2 AND SHORT PEPTIDE FROM HUMAN P21','X-RAY DIFFRACTION',2.500,'DNA BINDING PROTEIN',8,8,1),(2602,'2zxe','CRYSTAL STRUCTURE OF THE SODIUM - POTASSIUM PUMP IN THE E2.2K+.PI STATE','X-RAY DIFFRACTION',2.400,'HYDROLASE/TRANSPORT PROTEIN',1,2,1),(2603,'2zxn','A NEW CLASS OF VITAMIN D RECEPTOR LIGANDS THAT INDUCE STRUCTURAL REARRANGEMENT OF THE LIGAND-BINDING POCKET','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(2604,'2zxw','BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE',6,10,1),(2605,'3a1g','HIGH-RESOLUTION CRYSTAL STRUCTURE OF RNA POLYMERASE PB1-PB2 SUBUNITS FROM INFLUENZA A VIRUS','X-RAY DIFFRACTION',1.700,'TRANSFERASE',2,2,1),(2606,'3a1q','CRYSTAL STRUCTURE OF THE MOUSE RAP80 UIMS IN COMPLEX WITH LYS63-LINKED DI-UBIQUITIN','X-RAY DIFFRACTION',2.200,'GENE REGULATION/SIGNALING PROTEIN',2,4,1),(2607,'3a2h','CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH TEI-9647 AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',2.500,'HORMONE RECEPTOR, TRANSCRIPTION',1,1,1),(2608,'3a9j','CRYSTAL STRUCTURE OF THE MOUSE TAB2-NZF IN COMPLEX WITH LYS63-LINKED DI-UBIQUITIN','X-RAY DIFFRACTION',1.180,'SIGNALING PROTEIN/METAL BINDING PROTE',1,2,1),(2609,'3a9k','CRYSTAL STRUCTURE OF THE MOUSE TAB3-NZF IN COMPLEX WITH LYS63-LINKED DI-UBIQUITIN','X-RAY DIFFRACTION',1.400,'SIGNALING PROTEIN/METAL BINDING PROTE',1,2,1),(2610,'3aa0','CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH THE CP- BINDING MOTIF DERIVED FROM CARMIL','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING',1,2,1),(2611,'3aa1','CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH THE CP- BINDING MOTIF DERIVED FROM CKIP-1','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING',1,2,1),(2612,'3aa6','CRYSTAL STRUCTURE OF ACTIN CAPPING PROTEIN IN COMPLEX WITH THE CP- BINDING MOTIF DERIVED FROM CD2AP','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING',1,2,1),(2613,'3abd','STRUCTURE OF HUMAN REV7 IN COMPLEX WITH A HUMAN REV3 FRAGMENT IN A MONOCLINIC CRYSTAL','X-RAY DIFFRACTION',1.900,'CELL CYCLE/REPLICATION',2,2,1),(2614,'3abk','BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',6,10,1),(2615,'3abl','BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',6,10,1),(2616,'3abm','BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)','X-RAY DIFFRACTION',1.950,'OXIDOREDUCTASE',6,10,1),(2617,'3afr','CRYSTAL STRUCTURE OF VDR-LBD/22S-BUTYL-1A,24R-DIHYDROXYVITAMIN D3 COMPLEX','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(2618,'3ag1','BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE',6,10,1),(2619,'3ag2','BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',6,10,1),(2620,'3ag3','BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',6,10,1),(2621,'3ag4','BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K','X-RAY DIFFRACTION',2.050,'OXIDOREDUCTASE',6,10,1),(2622,'3agy','CRYSTAL STRUCTURE OF HUMAN HSP40 HDJ1 PEPTIDE-BINDING DOMAIN COMPLEXED WITH A C-TERMINAL PEPTIDE OF HSP70','X-RAY DIFFRACTION',1.850,'CHAPERONE',3,2,1),(2623,'3ajb','CRYSTAL STRUCTURE OF HUMAN PEX3P IN COMPLEX WITH N-TERMINAL PEX19P PEPTIDE','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT',1,1,1),(2624,'3al3','CRYSTAL STRUCTURE OF TOPBP1 BRCT7/8-BACH1 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.150,'DNA BINDING PROTEIN/PROTEIN BINDING',1,1,1),(2625,'3am7','CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF EIF4E-M7GTP-4EBP2 PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSLATION/PROTEIN BINDING',1,1,1),(2626,'3ama','PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR JNJ- 7706621','X-RAY DIFFRACTION',1.750,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(2627,'3amb','PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR VX- 680','X-RAY DIFFRACTION',2.250,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(2628,'3ap1','CRYSTAL STRUCTURE OF HUMAN TYROSYLPROTEIN SULFOTRANSFERASE-2 COMPLEXED WITH PAP AND C4 PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',2,2,1),(2629,'3ap2','CRYSTAL STRUCTURE OF HUMAN TYROSYLPROTEIN SULFOTRANSFERASE-2 COMPLEXED WITH PAP,C4 PEPTIDE, AND PHOSPHATE ION','X-RAY DIFFRACTION',2.400,'TRANSFERASE',2,2,1),(2630,'3apr','BINDING OF A REDUCED PEPTIDE INHIBITOR TO THE ASPARTIC PROTEINASE FROM RHIZOPUS CHINENSIS. IMPLICATIONS FOR A MECHANISM OF ACTION','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2631,'3asl','STRUCTURE OF UHRF1 IN COMPLEX WITH HISTONE TAIL','X-RAY DIFFRACTION',1.410,'LIGASE/DNA BINDING PROTEIN',1,1,1),(2632,'3aso','BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',6,10,1),(2633,'3at0','STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS','X-RAY DIFFRACTION',2.500,'CELL ADHESION/BLOOD CLOTTING',1,1,1),(2634,'3atw','STRUCTURE-BASED DESIGN, SYNTHESIS, EVALUATION OF PEPTIDE-MIMETIC SARS 3CL PROTEASE INHIBITORS','X-RAY DIFFRACTION',2.360,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2635,'3au4','STRUCTURE OF THE HUMAN MYOSIN-X MYTH4-FERM CASSETTE BOUND TO ITS SPECIFIC CARGO, DCC','X-RAY DIFFRACTION',1.900,'MOTOR PROTEIN/APOPTOSIS',1,1,1),(2636,'3aun','CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH YR335 AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205','X-RAY DIFFRACTION',1.810,'TRANSCRIPTION',1,1,1),(2637,'3av9','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.700,'RECOMBINATION/INHIBITOR',2,2,1),(2638,'3ava','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.700,'RECOMBINATION/INHIBITOR',2,2,1),(2639,'3avb','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.850,'RECOMBINATION/INHIBITOR',2,2,1),(2640,'3avc','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.770,'RECOMBINATION/INHIBITOR',2,2,1),(2641,'3avf','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.700,'RECOMBINATION/INHIBITOR',2,2,1),(2642,'3avg','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.700,'RECOMBINATION/INHIBITOR',2,2,1),(2643,'3avh','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.880,'RECOMBINATION/INHIBITOR',2,2,1),(2644,'3avi','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.700,'RECOMBINATION/INHIBITOR',2,2,1),(2645,'3avj','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.700,'RECOMBINATION/INHIBITOR',2,2,1),(2646,'3avk','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.750,'RECOMBINATION/INHIBITOR',2,2,1),(2647,'3avl','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.880,'RECOMBINATION/INHIBITOR',2,2,1),(2648,'3avm','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',1.880,'RECOMBINATION/INHIBITOR',2,2,1),(2649,'3avn','CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE','X-RAY DIFFRACTION',2.100,'RECOMBINATION/INHIBITOR',2,2,1),(2650,'3avr','CATALYTIC FRAGMENT OF UTX/KDM6A BOUND WITH HISTONE H3K27ME3 PEPTIDE, N-OXYALYLGLYCINE, AND NI(II)','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE/STRUCTURAL PROTEIN',1,1,1),(2651,'3avz','STRUCTURE OF SARS 3CL PROTEASE WITH PEPTIDIC ALDEHYDE INHIBITOR CONTAINING CYCLOHEXYL SIDE CHAIN','X-RAY DIFFRACTION',2.460,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2652,'3aw0','STRUCTURE OF SARS 3CL PROTEASE WITH PEPTIDIC ALDEHYDE INHIBITOR','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2653,'3awr','CRYSTAL STRUCTURE OF RAT TOM20-ALDH PRESEQUENCE COMPLEX: THE INTERMOLECULAR DISULFIDE BOND WAS CLEAVED IN THE CRYSTAL OF A DISULFIDE-TETHERED COMPLEX.','X-RAY DIFFRACTION',2.000,'MEMBRANE PROTEIN/TRANSPORT PROTEIN',2,2,1),(2654,'3ax2','CRYSTAL STRUCTURE OF RAT TOM20-ALDH PRESEQUENCE COMPLEX: A DISULFIDE- TETHERED COMPLEX WITH A NON-OPTIMIZED, LONG LINKER','X-RAY DIFFRACTION',1.900,'MEMBRANE PROTEIN/TRANSPORT PROTEIN',4,4,1),(2655,'3ax3','CRYSTAL STRUCTURE OF RAT TOM20-ALDH PRESEQUENCE COMPLEX: A COMPLEX (FORM2) BETWEEN TOM20 AND A DISULFIDE-BRIDGED PRESEQUENCE PEPTIDE CONTAINING D-CYS AND L-CYS AT THE I AND I+3 POSITIONS.','X-RAY DIFFRACTION',2.100,'MEMBRANE PROTEIN/TRANSPORT PROTEIN',4,4,1),(2656,'3ax5','CRYSTAL STRUCTURE OF RAT TOM20-ALDH PRESEQUENCE COMPLEX: A COMPLEX (FORM1) BETWEEN TOM20 AND A DISULFIDE-BRIDGED PRESEQUENCE PEPTIDE CONTAINING D-CYS AND L-CYS AT THE I AND I+3 POSITIONS.','X-RAY DIFFRACTION',2.200,'MEMBRANE PROTEIN/TRANSPORT PROTEIN',2,2,1),(2657,'3axy','STRUCTURE OF FLORIGEN ACTIVATION COMPLEX CONSISTING OF RICE FLORIGEN HD3A, 14-3-3 PROTEIN GF14 AND RICE FD HOMOLOG OSFD1','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN/PROTEIN BINDING',4,4,1),(2658,'3ayu','CRYSTAL STRUCTURE OF MMP-2 ACTIVE SITE MUTANT IN COMPLEX WITH APP- DRIVED DECAPEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2659,'3b0z','CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAIN OF FLHB FROM SALMONELLA TYPHIMURIUM','X-RAY DIFFRACTION',2.450,'PROTEIN TRANSPORT',1,1,1),(2660,'3b1j','CRYSTAL STRUCTURE OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE COMPLEXED WITH CP12 IN THE PRESENCE OF COPPER FROM SYNECHOCOCCUS ELONGATUS','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE/PROTEIN BINDING',2,2,1),(2661,'3b1m','CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR CERCO-A','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',1,1,1),(2662,'3b23','CRYSTAL STRUCTURE OF THROMBIN-VARIEGIN COMPLEX: INSIGHTS OF A NOVEL MECHANISM OF INHIBITION AND DESIGN OF TUNABLE THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2663,'3b3i','CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES','X-RAY DIFFRACTION',1.860,'IMMUNE SYSTEM',1,1,1),(2664,'3b6s','CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(2665,'3b7s','[E296Q]LTA4H IN COMPLEX WITH RSR SUBSTRATE','X-RAY DIFFRACTION',1.470,'HYDROLASE',1,1,1),(2666,'3b7t','[E296Q]LTA4H IN COMPLEX WITH ARG-ALA-ARG SUBSTRATE','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(2667,'3b7v','HIV-1 PROTEASE COMPLEXED WITH GEM-DIOL-AMINE TETRAHEDRAL INTERMEDIATE NLLTQI','X-RAY DIFFRACTION',1.460,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(2668,'3b80','HIV-1 PROTEASE MUTANT I54V COMPLEXED WITH GEM-DIOL-AMINE INTERMEDIATE NLLTQI','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(2669,'3b9f','1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2670,'3bae','CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)','X-RAY DIFFRACTION',1.590,'IMMUNE SYSTEM',1,2,1),(2671,'3bef','CRYSTAL STRUCTURE OF THROMBIN BOUND TO THE EXTRACELLULAR FRAGMENT OF PAR1','X-RAY DIFFRACTION',2.200,'HYDROLASE',4,2,1),(2672,'3bei','CRYSTAL STRUCTURE OF THE SLOW FORM OF THROMBIN IN A SELF_INHIBITED CONFORMATION','X-RAY DIFFRACTION',1.550,'HYDROLASE',1,1,1),(2673,'3bej','STRUCTURE OF HUMAN FXR IN COMPLEX WITH MFA-1 AND CO-ACTIVATOR PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION REGULATOR',2,2,1),(2674,'3bev','11MER STRUCTURE OF AN MHC CLASS I MOLECULE FROM B21 CHICKENS ILLUSTRATE PROMISCUOUS PEPTIDE BINDING','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(2675,'3bf6','THROMBIN:SURAMIN COMPLEX','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,1,1),(2676,'3bfq','CRYSTAL STRUCTURE OF TRUNCATED FIMG (FIMGT) IN COMPLEX WITH THE DONOR STRAND PEPTIDE OF FIMF (DSF)','X-RAY DIFFRACTION',1.340,'STRUCTURAL PROTEIN/STRUCTURAL PROTEIN',1,1,1),(2677,'3bfw','CRYSTAL STRUCTURE OF TRUNCATED FIMG (FIMGT) IN COMPLEX WITH THE DONOR STRAND PEPTIDE OF FIMF (DSF)','X-RAY DIFFRACTION',1.800,'STRUCTURAL PROTEIN/STRUCTURAL PROTEIN',2,2,1),(2678,'3bg4','THE CRYSTAL STRUCTURE OF GUAMERIN IN COMPLEX WITH CHYMOTRYPSIN AND THE DEVELOPMENT OF AN ELASTASE-SPECIFIC INHIBITOR','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2679,'3bgm','CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(2680,'3bh8','CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,1,1),(2681,'3bh9','CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(2682,'3bhb','CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(2683,'3bin','STRUCTURE OF THE DAL-1 AND TSLC1 (372-383) COMPLEX','X-RAY DIFFRACTION',2.300,'CELL ADHESION',1,1,1),(2684,'3biu','HUMAN THROMBIN-IN COMPLEX WITH UB-THR10','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2685,'3biv','HUMAN THROMBIN-IN COMPLEX WITH UB-THR11','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2686,'3bkj','CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)','X-RAY DIFFRACTION',1.590,'IMMUNE SYSTEM',1,2,1),(2687,'3bl2','CRYSTAL STRUCTURE OF M11, THE BCL-2 HOMOLOG OF MURINE GAMMA- HERPESVIRUS 68, COMPLEXED WITH MOUSE BECLIN1 (RESIDUES 106-124)','X-RAY DIFFRACTION',2.300,'VIRAL PROTEIN/APOPTOSIS',2,2,1),(2688,'3bo7','CRYSTAL STRUCTURE OF TOXOPLASMA GONDII PEPTIDYL-PROLYL CIS-TRANS ISOMERASE, 541.M00136','X-RAY DIFFRACTION',2.350,'ISOMERASE/IMMUNOSUPPRESSANT',4,4,1),(2689,'3bo8','THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(2690,'3boo','STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A WITH AN INHIBITORY PEPTIDE BOUND','X-RAY DIFFRACTION',1.400,'TOXIN/TOXIN INHIBITOR',1,1,1),(2691,'3bp4','THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(2692,'3bp7','THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(2693,'3bpm','CRYSTAL STRUCTURE OF FALCIPAIN-3 WITH ITS INHIBITOR, LEUPEPTIN','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2694,'3bpq','CRYSTAL STRUCTURE OF RELB-RELE ANTITOXIN-TOXIN COMPLEX FROM METHANOCOCCUS JANNASCHII','X-RAY DIFFRACTION',2.200,'TOXIN',2,2,1),(2695,'3bps','PCSK9:EGF-A COMPLEX','X-RAY DIFFRACTION',2.410,'HYDROLASE/LIPID TRANSPORT',1,1,1),(2696,'3bqd','DOUBLING THE SIZE OF THE GLUCOCORTICOID RECEPTOR LIGAND BINDING POCKET BY DEACYLCORTIVAZOL','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING',1,1,1),(2697,'3bqo','CRYSTAL STRUCTURE OF TRF1 TRFH DOMAIN AND TIN2 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.000,'DNA BINDING PROTEIN',1,1,1),(2698,'3brd','CSL (LAG-1) BOUND TO DNA WITH LIN-12 RAM PEPTIDE, P212121','X-RAY DIFFRACTION',2.210,'DNA BINDING PROTEIN/DNA',1,1,1),(2699,'3brf','CSL (LAG-1) BOUND TO DNA WITH LIN-12 RAM PEPTIDE, C2221','X-RAY DIFFRACTION',2.470,'DNA BINDING PROTEIN/DNA',1,1,1),(2700,'3brh','PROTEIN TYROSINE PHOSPHATASE PTPN-22 (LYP) BOUND TO THE MONO- PHOSPHORYLATED LCK ACTIVE SITE PEPTIDE','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(2701,'3brl','CRYSTAL STRUCTURE OF LC8 S88E / SWA','X-RAY DIFFRACTION',1.900,'MOTOR PROTEIN',1,1,1),(2702,'3brt','NEMO/IKK ASSOCIATION DOMAIN STRUCTURE','X-RAY DIFFRACTION',2.250,'TRANSFERASE/TRANSCRIPTION',2,2,1),(2703,'3brv','NEMO/IKKB ASSOCIATION DOMAIN STRUCTURE','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSCRIPTION',2,2,1),(2704,'3bs4','CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN PH0321 FROM PYROCOCCUS HORIKOSHII IN COMPLEX WITH AN UNKNOWN PEPTIDE','X-RAY DIFFRACTION',1.600,'STRUCTURAL GENOMICS, UNKNOWN FUNCTION',1,1,1),(2705,'3bt2','STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(2706,'3btp','CRYSTAL STRUCTURE OF AGROBACTERIUM TUMEFACIENS VIRE2 IN COMPLEX WITH ITS CHAPERONE VIRE1: A NOVEL FOLD AND IMPLICATIONS FOR DNA BINDING','X-RAY DIFFRACTION',2.300,'DNA BINDING PROTEIN, CHAPERONE',1,1,1),(2707,'3bu3','CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE','X-RAY DIFFRACTION',1.650,'TRANSFERASE',1,1,1),(2708,'3bu5','CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(2709,'3bu6','CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.950,'TRANSFERASE',1,1,1),(2710,'3bu8','CRYSTAL STRUCTURE OF TRF2 TRFH DOMAIN AND TIN2 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.150,'DNA BINDING PROTEIN',2,2,1),(2711,'3bua','CRYSTAL STRUCTURE OF TRF2 TRFH DOMAIN AND APOLLO PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.500,'DNA BINDING PROTEIN',4,4,1),(2712,'3bum','CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SPROUTY2','X-RAY DIFFRACTION',2.000,'LIGASE',1,1,1),(2713,'3bun','CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SPROUTY4','X-RAY DIFFRACTION',2.000,'LIGASE/SIGNALING PROTEIN',1,1,1),(2714,'3buw','CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN SYK','X-RAY DIFFRACTION',1.450,'LIGASE/SIGNALING PROTEIN',2,2,1),(2715,'3bux','CRYSTAL STRUCTURE OF C-CBL-TKB DOMAIN COMPLEXED WITH ITS BINDING MOTIF IN C-MET','X-RAY DIFFRACTION',1.350,'LIGASE/SIGNALING PROTEIN',2,2,1),(2716,'3bv9','STRUCTURE OF THROMBIN BOUND TO THE INHIBITOR FM19','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2717,'3bw9','CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12-MER PEPTIDE FROM THE PP65 PROTEIN','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,1,1),(2718,'3bwa','CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8-MER PEPTIDE FROM THE PP65 PROTEIN','X-RAY DIFFRACTION',1.300,'IMMUNE SYSTEM',1,1,1),(2719,'3bxl','CRYSTAL STRUCTURE OF THE R-TYPE CALCIUM CHANNEL (CAV2.3) IQ DOMAIN AND CA2+CALMODULIN COMPLEX','X-RAY DIFFRACTION',2.300,'MEMBRANE PROTEIN, SIGNALING PROTEIN',1,1,1),(2720,'3bxm','STRUCTURE OF AN INACTIVE MUTANT OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II [GCPII(E424A)] IN COMPLEX WITH N-ACETYL-ASP-GLU (NAAG)','X-RAY DIFFRACTION',1.710,'HYDROLASE',1,1,1),(2721,'3bxn','THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA','X-RAY DIFFRACTION',1.860,'IMMUNE SYSTEM',1,1,1),(2722,'3bya','STRUCTURE OF A CALMODULIN COMPLEX','X-RAY DIFFRACTION',1.850,'METAL BINDING PROTEIN',1,1,1),(2723,'3bze','THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- E','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',4,4,1),(2724,'3bzf','THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(2725,'3bzi','MOLECULAR AND STRUCTURAL BASIS OF POLO-LIKE KINASE 1 SUBSTRATE RECOGNITION: IMPLICATIONS IN CENTROSOMAL LOCALIZATION','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(2726,'3bzl','CRYSTAL STRUCTURAL OF NATIVE ESCU C-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.710,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',2,2,1),(2727,'3bzo','CRYSTAL STRUCTURAL OF NATIVE ESCU C-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.500,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',1,1,1),(2728,'3bzv','CRYSTAL STRUCTURAL OF THE MUTATED T264A ESCU C-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.940,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',1,1,1),(2729,'3bzx','CRYSTAL STRUCTURE OF THE MUTATED H265A ESCU C-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.600,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',1,1,1),(2730,'3bzy','CRYSTAL STRUCTURE OF THE MUTATED Y316D ESCU C-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.200,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',1,1,1),(2731,'3bzz','CRYSTAL STRUCTURAL OF THE MUTATED R313T ESCU/SPAS C-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.410,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',1,1,1),(2732,'3c00','CRYSTAL STRUCTURAL OF THE MUTATED G247T ESCU/SPAS C-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.410,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',1,1,1),(2733,'3c03','CRYSTAL STRUCTURE OF THE ESCU C-TERMINAL DOMAIN WITH P263A MUTATION, SPACE GROUP P 1 21 1','X-RAY DIFFRACTION',1.900,'MEMBRANE PROTEIN, PROTEIN TRANSPORT',1,2,1),(2734,'3c0t','STRUCTURE OF THE SCHIZOSACCHAROMYCES POMBE MEDIATOR SUBCOMPLEX MED8C/18','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(2735,'3c1k','CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH INHIBITOR 15','X-RAY DIFFRACTION',1.840,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2736,'3c27','CYANOFLUOROPHENYLACETAMIDES AS ORALLY EFFICACIOUS THROMBIN INHIBITORS','X-RAY DIFFRACTION',2.180,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2737,'3c2a','ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,4,1),(2738,'3c2g','CRYSTAL COMPLEX OF SYS-1/POP-1 AT 2.5A RESOLUTION','X-RAY DIFFRACTION',2.500,'CELL ADHESION/TRANSCRIPTION',2,2,1),(2739,'3c3o','ALIX BRO1-DOMAIN:CHMIP4A CO-CRYSTAL STRUCTURE','X-RAY DIFFRACTION',2.150,'TRANSPORT PROTEIN',1,1,1),(2740,'3c3q','ALIX BRO1-DOMAIN:CHMIP4B CO-CRYSTAL STRUCTURE','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN',1,1,1),(2741,'3c3r','ALIX BRO1 CHMP4C COMPLEX','X-RAY DIFFRACTION',2.020,'TRANSPORT PROTEIN',1,1,1),(2742,'3c4m','STRUCTURE OF HUMAN PARATHYROID HORMONE IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF ITS G-PROTEIN-COUPLED RECEPTOR (PTH1R)','X-RAY DIFFRACTION',1.950,'MEMBRANE PROTEIN',2,2,1),(2743,'3c59','CRYSTAL STRUCTURE OF THE LIGAND-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN/SIGNALING PROTEIN',1,1,1),(2744,'3c5i','CRYSTAL STRUCTURE OF PLASMODIUM KNOWLESI CHOLINE KINASE, PKH_134520','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(2745,'3c5j','CRYSTAL STRUCTURE OF HLA DR52C','X-RAY DIFFRACTION',1.800,'MEMBRANE PROTEIN',1,2,1),(2746,'3c5l','POLO-LIKE KINASE 1 POLO BOX DOMAIN IN COMPLEX WITH PPHSPT PEPTIDE','X-RAY DIFFRACTION',2.330,'TRANSFERASE',1,1,1),(2747,'3c5t','CRYSTAL STRUCTURE OF THE LIGAND-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN/SIGNALING PROTEIN',1,1,1),(2748,'3c88','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGC','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2749,'3c89','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGM','X-RAY DIFFRACTION',1.580,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2750,'3c8a','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGL','X-RAY DIFFRACTION',1.520,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2751,'3c8b','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGI','X-RAY DIFFRACTION',1.470,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2752,'3c9a','HIGH RESOLUTION CRYSTAL STRUCTURE OF ARGOS BOUND TO THE EGF DOMAIN OF SPITZ','X-RAY DIFFRACTION',1.600,'HORMONE/SIGNALING PROTEIN',2,2,1),(2753,'3c9n','CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501','X-RAY DIFFRACTION',1.870,'IMMUNE SYSTEM',1,1,1),(2754,'3c9q','CRYSTAL STRUCTURE OF THE UNCHARACTERIZED HUMAN PROTEIN C8ORF32 WITH BOUND PEPTIDE','X-RAY DIFFRACTION',1.500,'STRUCTURAL GENOMICS, UNKNOWN FUNCTION',1,1,1),(2755,'3caa','CLEAVED ANTICHYMOTRYPSIN A347R','X-RAY DIFFRACTION',2.400,'SERPIN',1,1,1),(2756,'3cal','CRYSTAL STRUCTURE OF THE SECOND AND THIRD FIBRONECTIN F1 MODULES IN COMPLEX WITH A FRAGMENT OF STAPHYLOCOCCUS AUREUS FNBPA-5','X-RAY DIFFRACTION',1.700,'CELL ADHESION',2,2,1),(2757,'3cbl','CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE','X-RAY DIFFRACTION',1.750,'TRANSFERASE',1,1,1),(2758,'3cbm','SET7/9-ER-ADOMET COMPLEX','X-RAY DIFFRACTION',1.690,'TRANSFERASE/TRANSFERASE RECEPTOR',1,1,1),(2759,'3cbo','SET7/9-ER-ADOHCY COMPLEX','X-RAY DIFFRACTION',1.650,'TRANSFERASE/TRANSFERASE RECEPTOR',1,1,1),(2760,'3cbp','SET7/9-ER-SINEFUNGIN COMPLEX','X-RAY DIFFRACTION',1.420,'TRANSFERASE/TRANSFERASE RECEPTOR',1,1,1),(2761,'3cc2','THE REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION WITH RRNA SEQUENCE FOR THE 23S RRNA AND GENOME-DERIVED SEQUENCES FOR R-PROTEINS','X-RAY DIFFRACTION',2.400,'RIBOSOME',1,1,1),(2762,'3cc5','H-2DB COMPLEX WITH HUMAN GP100','X-RAY DIFFRACTION',1.910,'IMMUNE SYSTEM',2,2,1),(2763,'3cd3','CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE','X-RAY DIFFRACTION',1.980,'TRANSFERASE',1,1,1),(2764,'3cdw','CRYSTAL STRUCTURE OF COXSACKIEVIRUS B3 RNA-DEPENDENT RNA POLYMERASE (3DPOL) IN COMPLEX WITH PROTEIN PRIMER VPG AND A PYROPHOSPHATE','X-RAY DIFFRACTION',2.500,'TRANSFERASE/VIRAL PROTEIN',1,1,1),(2765,'3cfs','STRUCTURAL BASIS OF THE INTERACTION OF RBAP46/RBAP48 WITH HISTONE H4','X-RAY DIFFRACTION',2.400,'HISTONE/CHAPERONE',1,1,1),(2766,'3ch1','CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',4,4,1),(2767,'3ch5','THE CRYSTAL STRUCTURE OF THE RANGDP-NUP153ZNF2 COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN',1,1,1),(2768,'3ch8','THE CRYSTAL STRUCTURE OF PDZ-FIBRONECTIN FUSION PROTEIN','X-RAY DIFFRACTION',1.900,'STRUCTURAL PROTEIN',1,1,1),(2769,'3che','CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH TRIPEPTIDE','X-RAY DIFFRACTION',2.050,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2770,'3chf','CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH TETRAPEPTIDE','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2771,'3chw','COMPLEX OF DICTYOSTELIUM DISCOIDEUM ACTIN WITH PROFILIN AND THE LAST POLY-PRO OF HUMAN VASP','X-RAY DIFFRACTION',2.300,'STRUCTURAL PROTEIN',1,2,1),(2772,'3cji','STRUCTURE OF SENECA VALLEY VIRUS-001','X-RAY DIFFRACTION',2.300,'VIRUS',1,3,1),(2773,'3cpl','CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(2774,'3cqu','CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(2775,'3cqw','CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(2776,'3cs8','STRUCTURAL AND BIOCHEMICAL BASIS FOR THE BINDING SELECTIVITY OF PPARG TO PGC-1A','X-RAY DIFFRACTION',2.300,'NUCLEAR PROTEIN',1,1,1),(2777,'3cu8','IMPAIRED BINDING OF 14-3-3 TO RAF1 IS LINKED TO NOONAN AND LEOPARD SYNDROME','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING, SIGNALING PROTEIN',2,2,1),(2778,'3cv0','STRUCTURE OF PEROXISOMAL TARGETING SIGNAL 1 (PTS1) BINDING DOMAIN OF TRYPANOSOMA BRUCEI PEROXIN 5 (TBPEX5)COMPLEXED TO T. BRUCEI PHOSPHOGLUCOISOMERASE (PGI) PTS1 PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(2779,'3cvl','STRUCTURE OF PEROXISOMAL TARGETING SIGNAL 1 (PTS1) BINDING DOMAIN OF TRYPANOSOMA BRUCEI PEROXIN 5 (TBPEX5)COMPLEXED TO T. BRUCEI PHOSPHOFRUCTOKINASE (PFK) PTS1 PEPTIDE','X-RAY DIFFRACTION',2.150,'TRANSPORT PROTEIN',1,1,1),(2780,'3cvn','STRUCTURE OF PEROXISOMAL TARGETING SIGNAL 1 (PTS1) BINDING DOMAIN OF TRYPANOSOMA BRUCEI PEROXIN 5 (TBPEX5)COMPLEXED TO T. BRUCEI GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPDH) PTS1 PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(2781,'3cvp','STRUCTURE OF PEROXISOMAL TARGETING SIGNAL 1 (PTS1) BINDING DOMAIN OF TRYPANOSOMA BRUCEI PEROXIN 5 (TBPEX5)COMPLEXED TO PTS1 PEPTIDE (10- SKL)','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(2782,'3cwd','MOLECULAR RECOGNITION OF NITRO-FATTY ACIDS BY PPAR GAMMA','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(2783,'3cww','CRYSTAL STRUCTURE OF IDE-BRADYKININ COMPLEX','X-RAY DIFFRACTION',1.960,'HYDROLASE',2,2,1),(2784,'3cxw','CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND I','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(2785,'3cy2','CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A BETA CARBOLINE LIGAND II','X-RAY DIFFRACTION',2.010,'TRANSFERASE',1,1,1),(2786,'3cy3','CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND THE JNK INHIBITOR V','X-RAY DIFFRACTION',2.150,'TRANSFERASE',1,1,1),(2787,'3cys','DETERMINATION OF THE NMR SOLUTION STRUCTURE OF THE CYCLOPHILIN A- CYCLOSPORIN A COMPLEX','SOLUTION NMR',NULL,'ISOMERASE/IMMUNOSUPPRESSANT',1,1,1),(2788,'3cyy','THE CRYSTAL STRUCTURE OF ZO-1 PDZ2 IN COMPLEX WITH THE CX43 PEPTIDE','X-RAY DIFFRACTION',2.400,'PEPTIDE BINDING PROTEIN',2,2,1),(2789,'3czf','CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)','X-RAY DIFFRACTION',1.200,'IMMUNE SYSTEM',1,1,1),(2790,'3d0l','CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',1,2,1),(2791,'3d0v','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW','X-RAY DIFFRACTION',2.050,'IMMUNE SYSTEM',1,2,1),(2792,'3d18','CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS','X-RAY DIFFRACTION',1.740,'IMMUNE SYSTEM',1,1,1),(2793,'3d1e','CRYSTAL STRUCTURE OF E. COLI SLIDING CLAMP (BETA) BOUND TO A POLYMERASE II PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSFERASE, TRANSCRIPTION',1,1,1),(2794,'3d1f','CRYSTAL STRUCTURE OF E. COLI SLIDING CLAMP (BETA) BOUND TO A POLYMERASE III PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSFERASE, TRANSCRIPTION',2,2,1),(2795,'3d23','MAIN PROTEASE OF HCOV-HKU1','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(2796,'3d24','CRYSTAL STRUCTURE OF LIGAND-BINDING DOMAIN OF ESTROGEN- RELATED RECEPTOR ALPHA (ERRALPHA) IN COMPLEX WITH THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR COACTIVATOR- 1ALPHA BOX3 PEPTIDE (PGC-1ALPHA)','X-RAY DIFFRACTION',2.110,'TRANSCRIPTION',2,2,1),(2797,'3d25','CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',1.300,'IMMUNE SYSTEM',1,1,1),(2798,'3d2u','STRUCTURE OF UL18, A PEPTIDE-BINDING VIRAL MHC MIMIC, BOUND TO A HOST INHIBITORY RECEPTOR','X-RAY DIFFRACTION',2.210,'IMMUNE SYSTEM',2,2,1),(2799,'3d2y','COMPLEX OF THE N-ACETYLMURAMYL-L-ALANINE AMIDASE AMID FROM E.COLI WITH THE SUBSTRATE ANHYDRO-N-ACETYLMURAMIC ACID-L-ALA-D-GAMMA-GLU-L-LYS','X-RAY DIFFRACTION',1.750,'HYDROLASE',1,1,1),(2800,'3d32','COMPLEX OF GABA(A) RECEPTOR-ASSOCIATED PROTEIN (GABARAP) WITH A SYNTHETIC PEPTIDE','X-RAY DIFFRACTION',1.300,'TRANSPORT PROTEIN',2,2,1),(2801,'3d36','HOW TO SWITCH OFF A HISTIDINE KINASE: CRYSTAL STRUCTURE OF GEOBACILLUS STEAROTHERMOPHILUS KINB WITH THE INHIBITOR SDA','X-RAY DIFFRACTION',2.030,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(2802,'3d3x','CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE E CATALYTIC DOMAIN IN COMPLEX WITH SNAP-25 SUBSTRATE PEPTIDE','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE SUBSTRATE',2,2,1),(2803,'3d42','CRYSTAL STRUCTURE OF HEPTP IN COMPLEX WITH A MONOPHOSPHORYLATED ERK2 PEPTIDE','X-RAY DIFFRACTION',2.460,'HYDROLASE',1,1,1),(2804,'3d44','CRYSTAL STRUCTURE OF HEPTP IN COMPLEX WITH A DUALLY PHOSPHORYLATED ERK2 PEPTIDE MIMETIC','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(2805,'3d49','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.500,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2806,'3d4b','CRYSTAL STRUCTURE OF SIR2TM IN COMPLEX WITH ACETYL P53 PEPTIDE AND DADME-NAD+','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(2807,'3d6f','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING ARG240->GLN SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(2808,'3d6h','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING ASN263->SER SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(2809,'3d6m','CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING LYS319->ARG SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(2810,'3d7v','CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH AN MCL-1 SELECTIVE BH3 LIGAND','X-RAY DIFFRACTION',2.030,'APOPTOSIS',1,1,1),(2811,'3d81','SIR2-S-ALKYLAMIDATE COMPLEX CRYSTAL STRUCTURE','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(2812,'3d8c','FACTOR INHIBITING HIF-1 ALPHA D201G MUTANT IN COMPLEX WITH ZN(II), ALPHA-KETOGLUTARATE AND HIF-1 ALPHA 19MER','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION REGULATOR, OXIDOREDUCTA',1,1,1),(2813,'3d9k','SNAPSHOTS OF THE RNA PROCESSING FACTOR SCAF8 BOUND TO DIFFERENT PHOSPHORYLATED FORMS OF THE CARBOXY-TERMINAL DOMAIN OF RNA-POLYMERASE II','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(2814,'3d9l','SNAPSHOTS OF THE RNA PROCESSING FACTOR SCAF8 BOUND TO DIFFERENT PHOSPHORYLATED FORMS OF THE CARBOXY-TERMINAL DOMAIN OF RNA-POLYMERASE II','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION/PEPTIDE',2,2,1),(2815,'3d9m','SNAPSHOTS OF THE RNA PROCESSING FACTOR SCAF8 BOUND TO DIFFERENT PHOSPHORYLATED FORMS OF THE CARBOXY-TERMINAL DOMAIN OF RNA-POLYMERASE II','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION',2,2,1),(2816,'3d9n','SNAPSHOTS OF THE RNA PROCESSING FACTOR SCAF8 BOUND TO DIFFERENT PHOSPHORYLATED FORMS OF THE CARBOXY-TERMINAL DOMAIN OF RNA-POLYMERASE II','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',2,2,1),(2817,'3d9o','SNAPSHOTS OF THE RNA PROCESSING FACTOR SCAF8 BOUND TO DIFFERENT PHOSPHORYLATED FORMS OF THE CARBOXY-TERMINAL DOMAIN OF RNA-POLYMERASE II','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(2818,'3d9p','SNAPSHOTS OF THE RNA PROCESSING FACTOR SCAF8 BOUND TO DIFFERENT PHOSPHORYLATED FORMS OF THE CARBOXY-TERMINAL DOMAIN OF RNA-POLYMERASE II','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(2819,'3d9t','CIAP1-BIR3 IN COMPLEX WITH N-TERMINAL PEPTIDE FROM CASPASE- 9 (ATPFQE)','X-RAY DIFFRACTION',1.500,'APOPTOSIS',2,2,1),(2820,'3d9u','THE BIR3 DOMAIN OF CIAP1 IN COMPLEX WITH THE N TERMINAL PEPTIDE FROM SMAC/DIABLO (AVPIAQ).','X-RAY DIFFRACTION',2.300,'APOPTOSIS',1,1,1),(2821,'3da9','CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.800,'HYDROLASE',2,1,1),(2822,'3dab','STRUCTURE OF THE HUMAN MDMX PROTEIN BOUND TO THE P53 TUMOR SUPPRESSOR TRANSACTIVATION DOMAIN','X-RAY DIFFRACTION',1.900,'CELL CYCLE',4,4,1),(2823,'3dac','STRUCTURE OF THE HUMAN MDMX PROTEIN BOUND TO THE P53 TUMOR SUPPRESSOR TRANSACTIVATION DOMAIN','X-RAY DIFFRACTION',1.800,'CELL CYCLE',2,2,1),(2824,'3db3','CRYSTAL STRUCTURE OF THE TANDEM TUDOR DOMAINS OF THE E3 UBIQUITIN- PROTEIN LIGASE UHRF1 IN COMPLEX WITH TRIMETHYLATED HISTONE H3-K9 PEPTIDE','X-RAY DIFFRACTION',2.400,'LIGASE',1,1,1),(2825,'3dbo','CRYSTAL STRUCTURE OF A MEMBER OF THE VAPBC FAMILY OF TOXIN-ANTITOXIN SYSTEMS, VAPBC-5, FROM MYCOBACTERIUM TUBERCULOSIS','X-RAY DIFFRACTION',1.760,'TOXIN/ANTITOXIN',1,1,1),(2826,'3dcg','CRYSTAL STRUCTURE OF THE HIV VIF BC-BOX IN COMPLEX WITH HUMAN ELONGINB AND ELONGINC','X-RAY DIFFRACTION',2.400,'LIGASE/VIRAL PROTEIN',2,3,1),(2827,'3dct','FXR WITH SRC1 AND GW4064','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/TRANSCRIPTION ACTIVATOR',1,1,1),(2828,'3dd2','CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO HUMAN THROMBIN','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR/RNA',1,1,1),(2829,'3dd7','STRUCTURE OF DOCH66Y IN COMPLEX WITH THE C-TERMINAL DOMAIN OF PHD','X-RAY DIFFRACTION',1.700,'RIBOSOME INHIBITOR',2,2,1),(2830,'3dda','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A SNAP-25 PEPTIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,1,1),(2831,'3ddb','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A SUBSTRATE ANALOG PEPTIDE','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(2832,'3dhk','BISPHENYLIC THROMBIN INHIBITORS','X-RAY DIFFRACTION',1.730,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2833,'3diw','C-TERMINAL BETA-CATENIN BOUND TIP-1 STRUCTURE','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN/CELL ADHESION',2,2,1),(2834,'3dks','DSBA SUBSTRATE COMPLEX','X-RAY DIFFRACTION',1.900,'OXIDOREDUCTASE',2,4,1),(2835,'3dnd','CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24','X-RAY DIFFRACTION',2.260,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(2836,'3dne','CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(2837,'3dnj','THE STRUCTURE OF THE CAULOBACTER CRESCENTUS CLPS PROTEASE ADAPTOR PROTEIN IN COMPLEX WITH A N-END RULE PEPTIDE','X-RAY DIFFRACTION',1.150,'PEPTIDE BINDING PROTEIN',2,2,1),(2838,'3dow','COMPLEX STRUCTURE OF GABA TYPE A RECEPTOR ASSOCIATED PROTEIN AND ITS BINDING EPITOPE ON CALRETICULIN','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',1,1,1),(2839,'3dox','X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,1,1),(2840,'3dpc','STRUCTURE OF E.COLI ALKALINE PHOSPHATASE MUTANT IN COMPLEX WITH A PHOSPHORYLATED PEPTIDE','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(2841,'3dpo','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E. COLI DNAK IN COMPLEX WITH A SHORT PYRRHOCORICIN-DERIVED INHIBITOR PEPTIDE','X-RAY DIFFRACTION',2.100,'CHAPERONE, PEPTIDE BINDING PROTEIN',2,2,1),(2842,'3dpp','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E. COLI DNAK IN COMPLEX WITH A LONG PYRRHOCORICIN-DERIVED INHIBITOR PEPTIDE (FORM A)','X-RAY DIFFRACTION',2.500,'CHAPERONE, PEPTIDE BINDING PROTEIN',2,2,1),(2843,'3drf','LACTOCOCCAL OPPA COMPLEXED WITH AN ENDOGENOUS PEPTIDE IN THE CLOSED CONFORMATION','X-RAY DIFFRACTION',1.300,'PEPTIDE BINDING PROTEIN',1,1,1),(2844,'3drg','LACTOCOCCAL OPPA COMPLEXED WITH BRADYKININ IN THE CLOSED CONFORMATION','X-RAY DIFFRACTION',2.500,'PEPTIDE BINDING PROTEIN',1,1,1),(2845,'3drh','CRYSTAL STRUCTURE OF LACTOCOCCAL OPPA CO-CRYSTALLIZED WITH LEU- ENKEPHALIN IN AN OPEN CONFORMATION','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN',1,1,1),(2846,'3dri','CRYSTAL STRUCTURE OF LACTOCOCCAL OPPA CO-CRYSTALLIZED WITH AN OCTAMER PEPTIDE IN AN OPEN CONFORMATION','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(2847,'3drj','CRYSTAL STRUCTURE OF LACTOCOCCAL OPPA CO-CRYSTALLIZED WITH PTH-RELATED PEPTIDE IN AN OPEN CONFORMATION','X-RAY DIFFRACTION',1.500,'PEPTIDE BINDING PROTEIN',1,1,1),(2848,'3drk','CRYSTAL STRUCTURE OF LACTOCOCCAL OPPA CO-CRYSTALLIZED WITH NEUROPEPTIDE S IN AN OPEN CONFORMATION','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(2849,'3drq','CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(2850,'3ds0','HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (N183A) IN COMPLEX WITH AN INHIBITOR OF PARTICLE ASSEMBLY (CAI)','X-RAY DIFFRACTION',1.600,'VIRAL PROTEIN',1,1,1),(2851,'3ds1','HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (E187A) IN COMPLEX WITH AN INHIBITOR OF PARTICLE ASSEMBLY (CAI)','X-RAY DIFFRACTION',1.600,'VIRAL PROTEIN',1,1,1),(2852,'3ds4','HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S) IN COMPLEX WITH AN INHIBITOR OF PARTICLE ASSEMBLY (CAI)','X-RAY DIFFRACTION',1.120,'VIRAL PROTEIN',1,1,1),(2853,'3ds9','A POTENT PEPTIDOMIMETIC INHIBITOR OF BOTULINUM NEUROTOXIN SEROTYPE A HAS A VERY DIFFERENT CONFORMATION THAN SNAP-25 SUBSTRATE','X-RAY DIFFRACTION',1.760,'HYDROLASE, TOXIN',1,1,1),(2854,'3dt0','UNDERSTANDING THROMBIN INHIBITION','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2855,'3dtx','CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(2856,'3duf','SNAPSHOTS OF CATALYSIS IN THE E1 SUBUNIT OF THE PYRUVATE DEHYDROGENASE MULTI-ENZYME COMPLEX','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE/TRANSFERASE',2,4,1),(2857,'3dux','UNDERSTANDING THROMBIN INHIBITION','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2858,'3dv0','SNAPSHOTS OF CATALYSIS IN THE E1 SUBUNIT OF THE PYRUVATE DEHYDROGENASE MULTI-ENZYME COMPLEX','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE/TRANSFERASE',2,4,1),(2859,'3dva','SNAPSHOTS OF CATALYSIS IN THE E1 SUBUNIT OF THE PYRUVATE DEHYDROGENASE MULTI-ENZYME COMPLEX','X-RAY DIFFRACTION',2.350,'OXIDOREDUCTASE/TRANSFERASE',2,4,1),(2860,'3dve','CRYSTAL STRUCTURE OF CA2+/CAM-CAV2.2 IQ DOMAIN COMPLEX','X-RAY DIFFRACTION',2.350,'MEMBRANE PROTEIN',1,1,1),(2861,'3dvk','CRYSTAL STRUCTURE OF CA2+/CAM-CAV2.3 IQ DOMAIN COMPLEX','X-RAY DIFFRACTION',2.300,'MEMBRANE PROTEIN',1,1,1),(2862,'3dvp','PAK1 PEPTIDE BOUND LC8','X-RAY DIFFRACTION',2.500,'STRUCTURAL PROTEIN, MOTOR PROTEIN',2,2,1),(2863,'3dvu','CRYSTAL STRUCTURE OF THE COMPLEX OF MURINE GAMMA-HERPESVIRUS 68 BCL-2 HOMOLOG M11 AND THE BECLIN 1 BH3 DOMAIN','X-RAY DIFFRACTION',2.500,'VIRAL PROTEIN/APOPTOSIS',2,2,1),(2864,'3dx6','CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(2865,'3dx7','CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(2866,'3dx8','CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(2867,'3dxc','CRYSTAL STRUCTURE OF THE INTRACELLULAR DOMAIN OF HUMAN APP IN COMPLEX WITH FE65-PTB2','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING',2,2,1),(2868,'3dxd','CRYSTAL STRUCTURE OF THE INTRACELLULAR DOMAIN OF HUMAN APP (T668E MUTANT) IN COMPLEX WITH FE65-PTB2','X-RAY DIFFRACTION',2.200,'PROTEIN BINDING',2,2,1),(2869,'3dxe','CRYSTAL STRUCTURE OF THE INTRACELLULAR DOMAIN OF HUMAN APP (T668A MUTANT) IN COMPLEX WITH FE65-PTB2','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',2,2,1),(2870,'3dy0','CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN','X-RAY DIFFRACTION',1.550,'BLOOD CLOTTING, HYDROLASE INHIBITOR',1,1,1),(2871,'3e0m','CRYSTAL STRUCTURE OF FUSION PROTEIN OF MSRA AND MSRB','X-RAY DIFFRACTION',2.400,'OXIDOREDUCTASE',3,3,1),(2872,'3e1i','CRYSTAL STRUCTURE OF BBETAD432A VARIANT FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE','X-RAY DIFFRACTION',2.300,'BLOOD CLOTTING',2,2,1),(2873,'3e2b','CRYSTAL STRUCTURE OF DYNEIN LIGHT CHAIN LC8 IN COMPLEX WITH A PEPTIDE DERIVED FROM SWALLOW','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(2874,'3e4z','CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH INSULIN-LIKE GROWTH FACTOR II','X-RAY DIFFRACTION',2.280,'HYDROLASE/HORMONE',2,2,1),(2875,'3e50','CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-ALPHA','X-RAY DIFFRACTION',2.300,'HYDROLASE/HORMONE',2,2,1),(2876,'3e5a','CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH VX-680 AND TPX2','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(2877,'3e6f','MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PA9, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',1,1,1),(2878,'3e6h','MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PI10, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(2879,'3e6y','STRUCTURE OF 14-3-3 IN COMPLEX WITH THE DIFFERENTIATION-INDUCING AGENT COTYLENIN A','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',2,2,1),(2880,'3e7a','CRYSTAL STRUCTURE OF PROTEIN PHOSPHATASE-1 BOUND TO THE NATURAL TOXIN NODULARIN-R','X-RAY DIFFRACTION',1.630,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2881,'3e7c','GLUCOCORTICOID RECEPTOR LBD BOUND TO GSK866','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',2,2,1),(2882,'3e87','CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS','X-RAY DIFFRACTION',2.300,'TRANSFERASE',2,2,1),(2883,'3e88','CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS','X-RAY DIFFRACTION',2.500,'TRANSFERASE',2,2,1),(2884,'3e8c','CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS','X-RAY DIFFRACTION',2.200,'TRANSFERASE',6,6,1),(2885,'3e8e','CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS','X-RAY DIFFRACTION',2.000,'TRANSFERASE',6,6,1),(2886,'3e8u','CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(2887,'3e90','WEST NILE VI RUS NS2B-NS3PROTEASE IN COMPLEXED WITH INHIBITOR NAPH-KKR-H','X-RAY DIFFRACTION',2.450,'HYDROLASE',2,2,1),(2888,'3e94','CRYSTAL STRUCTURE OF RXRALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIBUTYLTIN AND A COACTIVATOR FRAGMENT','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(2889,'3eab','CRYSTAL STRUCTURE OF SPASTIN MIT IN COMPLEX WITH ESCRT III','X-RAY DIFFRACTION',2.500,'CELL CYCLE',6,6,1),(2890,'3ear','NOVEL DIMERIZATION MOTIF IN THE DEAD BOX RNA HELICASE HERA: FORM 1, PARTIAL DIMER','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(2891,'3ebb','PLAP/P97 COMPLEX','X-RAY DIFFRACTION',1.900,'CHAPERONE',4,4,1),(2892,'3ecb','CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(2893,'3ech','THE MARR-FAMILY REPRESSOR MEXR IN COMPLEX WITH ITS ANTIREPRESSOR ARMR','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION, TRANSCRIPTION REGULATI',1,2,1),(2894,'3edq','CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-LDESD-CHO','X-RAY DIFFRACTION',1.610,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(2895,'3edr','THE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-LDESD-CHO','X-RAY DIFFRACTION',2.450,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(2896,'3edx','CRYSTAL STRUCTURE OF THE W215A/E217A MUTANT OF MURINE THROMBIN','X-RAY DIFFRACTION',2.400,'HYDROLASE',3,3,1),(2897,'3eg6','STRUCTURE OF WDR5 BOUND TO MLL1 PEPTIDE','X-RAY DIFFRACTION',1.720,'PROTEIN BINDING',1,1,1),(2898,'3egh','CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PROTEIN PHOSPHATASE 1 ALPHA (PP1), THE PP1 BINDING AND PDZ DOMAINS OF SPINOPHILIN AND THE SMALL NATURAL MOLECULAR TOXIN NODULARIN-R','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(2899,'3egk','KNOBLE INHIBITOR','X-RAY DIFFRACTION',2.200,'BLOOD CLOTTING/HYDROLASE INHIBITOR',2,1,1),(2900,'3ehu','CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CORTICOTROPIN RELEASING FACTOR RECEPTOR TYPE 1 (CRFR1) IN COMPLEX WITH CRF','X-RAY DIFFRACTION',1.960,'MEMBRANE PROTEIN',2,2,1),(2901,'3ejh','CRYSTAL STRUCTURE OF THE FIBRONECTIN 8-9FNI DOMAIN PAIR IN COMPLEX WITH A TYPE-I COLLAGEN PEPTIDE','X-RAY DIFFRACTION',2.100,'CELL ADHESION',2,2,1),(2902,'3emh','STRUCTURAL BASIS OF WDR5-MLL INTERACTION','X-RAY DIFFRACTION',1.370,'GENE REGULATION',1,1,1),(2903,'3emw','CRYSTAL STRUCTURE OF HUMAN SPLA/RYANODINE RECEPTOR DOMAIN AND SOCS BOX CONTAINING 2 (SPSB2) IN COMPLEX WITH A 20-RESIDUE VASA PEPTIDE','X-RAY DIFFRACTION',1.800,'APOPTOSIS',1,1,1),(2904,'3emy','CRYSTAL STRUCTURE OF TRICHODERMA REESEI ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN A','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2905,'3eq0','THROMBIN INHIBITOR','X-RAY DIFFRACTION',1.530,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2906,'3eqs','CRYSTAL STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH A 12-MER PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.650,'LIGASE',1,1,1),(2907,'3eqy','CRYSTAL STRUCTURE OF HUMAN MDMX IN COMPLEX WITH A 12-MER PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.630,'ONCOPROTEIN',2,2,1),(2908,'3er5','THE ACTIVE SITE OF ASPARTIC PROTEINASES','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2909,'3erd','HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',2.030,'NUCLEAR RECEPTOR',2,2,1),(2910,'3ery','DIFFERENT THERMODYNAMIC BINDING MECHANISMS AND PEPTIDE FINE SPECIFICITIES ASSOCIATED WITH A PANEL OF STRUCTURALLY SIMILAR HIGH-AFFINITY T CELL RECEPTORS','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',2,2,1),(2911,'3esk','STRUCTURE OF HOP TPR2A DOMAIN IN COMPLEX WITH THE NON-COGNATE HSC70 PEPTIDE LIGAND','X-RAY DIFFRACTION',2.050,'CHAPERONE',1,1,1),(2912,'3et1','STRUCTURE OF PPARALPHA WITH 3-[5-METHOXY-1-(4-METHOXY- BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/TRANSFERASE',2,2,1),(2913,'3et3','STRUCTURE OF PPARGAMMA WITH 3-[5-METHOXY-1-(4-METHOXY- BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',1,1,1),(2914,'3eu7','CRYSTAL STRUCTURE OF A PALB2 / BRCA2 COMPLEX','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION/ANTITUMOR PROTEIN',1,1,1),(2915,'3ewf','CRYSTAL STRUCTURE ANALYSIS OF HUMAN HDAC8 H143A VARIANT COMPLEXED WITH SUBSTRATE.','X-RAY DIFFRACTION',2.500,'HYDROLASE',4,4,1),(2916,'3ewt','CRYSTAL STRUCTURE OF CALMODULIN COMPLEXED WITH A PEPTIDE','X-RAY DIFFRACTION',2.400,'CALCIUM BINDING PROTEIN',1,1,1),(2917,'3exb','CRYSTAL STRUCTURE OF CYTOCHROME C PEROXIDASE WITH A PROPOSED ELECTRON PATHWAY EXCISED IN A COMPLEX WITH A PEPTIDE WIRE','X-RAY DIFFRACTION',1.600,'OXIDOREDUCTASE/PEPTIDE',1,1,1),(2918,'3eyd','STRUCTURE OF HCV NS3-4A PROTEASE WITH AN INHIBITOR DERIVED FROM A BORONIC ACID','X-RAY DIFFRACTION',2.300,'VIRAL PROTEIN',2,2,1),(2919,'3eyf','CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,4,1),(2920,'3eys','PFA1 FAB FRAGMENT COMPLEXED WITH PYRO-GLU3-A-BETA (3-8)','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,2,1),(2921,'3f02','CLEAVED HUMAN NEUROSERPIN','X-RAY DIFFRACTION',1.800,'HYDROLASE INHIBITOR',2,2,1),(2922,'3f1i','HUMAN ESCRT-0 CORE COMPLEX','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING',1,2,1),(2923,'3f2k','STRUCTURE OF THE TRANSPOSASE DOMAIN OF HUMAN HISTONE-LYSINE N-METHYLTRANSFERASE SETMAR','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(2924,'3f2o','CRYSTAL STRUCTURE OF HUMAN SPLA/RYANODINE RECEPTOR DOMAIN AND SOCS BOX CONTAINING 1 (SPSB1) IN COMPLEX WITH A 20-RESIDUE VASA PEPTIDE','X-RAY DIFFRACTION',2.050,'APOPTOSIS/HYDROLASE',2,2,1),(2925,'3f68','THROMBIN INHIBITION','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2926,'3f6k','CRYSTAL STRUCTURE OF THE VPS10P DOMAIN OF HUMAN SORTILIN/NTS3 IN COMPLEX WITH NEUROTENSIN','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',1,1,1),(2927,'3f7d','SF-1 LBD BOUND BY PHOSPHATIDYLCHOLINE','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(2928,'3f7o','CRYSTAL STRUCTURE OF CUTICLE-DEGRADING PROTEASE FROM PAECILOMYCES LILACINUS (PL646)','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(2929,'3f9w','STRUCTURAL INSIGHTS INTO LYSINE MULTIPLE METHYLATION BY SET DOMAIN METHYLTRANSFERASES, SET8-Y334F / H4-LYS20 / ADOHCY','X-RAY DIFFRACTION',1.600,'TRANSFERASE',4,4,1),(2930,'3f9x','STRUCTURAL INSIGHTS INTO LYSINE MULTIPLE METHYLATION BY SET DOMAIN METHYLTRANSFERASES, SET8-Y334F / H4-LYS20ME2 / ADOHCY','X-RAY DIFFRACTION',1.250,'TRANSFERASE',4,4,1),(2931,'3f9y','STRUCTURAL INSIGHTS INTO LYSINE MULTIPLE METHYLATION BY SET DOMAIN METHYLTRANSFERASES, SET8-Y334F / H4-LYS20ME1 / ADOHCY','X-RAY DIFFRACTION',1.500,'TRANSFERASE',2,2,1),(2932,'3f9z','STRUCTURAL INSIGHTS INTO LYSINE MULTIPLE METHYLATION BY SET DOMAIN METHYLTRANSFERASES, SET8-Y245F / H4-LYS20 / ADOHCY','X-RAY DIFFRACTION',1.600,'TRANSFERASE',4,4,1),(2933,'3fdl','BIM BH3 PEPTIDE IN COMPLEX WITH BCL-XL','X-RAY DIFFRACTION',1.780,'APOPTOSIS',1,1,1),(2934,'3fdm','ALPHA/BETA FOLDAMER IN COMPLEX WITH BCL-XL','X-RAY DIFFRACTION',2.260,'APOPTOSIS',3,3,1),(2935,'3fdo','STRUCTURE OF HUMAN MDMX IN COMPLEX WITH HIGH AFFINITY PEPTIDE','X-RAY DIFFRACTION',1.400,'CELL CYCLE',1,1,1),(2936,'3fe7','CRYSTAL STRUCTURE OF HDMX BOUND TO THE P53-PEPTIDOMIMETIC AC-PHE-MET- AIB-PMP-TRP-GLU-AC3C-LEU-NH2 AT 1.35A','X-RAY DIFFRACTION',1.350,'CELL CYCLE',1,1,1),(2937,'3fea','CRYSTAL STRUCTURE OF HDMX BOUND TO THE P53-PEPTIDOMIMETIC AC-PHE-MET- AIB-PMP-6-CL-TRP-GLU-AC3C-LEU-NH2 AT 1.33A','X-RAY DIFFRACTION',1.330,'CELL CYCLE',2,1,1),(2938,'3fei','DESIGN AND BIOLOGICAL EVALUATION OF NOVEL, BALANCED DUAL PPARA/G AGONISTS','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(2939,'3fej','DESIGN AND BIOLOGICAL EVALUATION OF NOVEL, BALANCED DUAL PPARA/G AGONISTS','X-RAY DIFFRACTION',2.010,'TRANSCRIPTION',1,1,1),(2940,'3ffd','STRUCTURE OF PARATHYROID HORMONE-RELATED PROTEIN COMPLEXED TO A NEUTRALIZING MONOCLONAL ANTIBODY','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/HORMONE',1,2,1),(2941,'3fg5','CRYSTAL STRUCTURE DETERMINATION OF A TERNARY COMPLEX OF PHOSPHOLIPASE A2 WITH A PENTAPETIDE FLSYK AND AJMALINE AT 2.5 A RESOLUTION','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(2942,'3fhv','STRUCTURAL BASIS OF SALMONELLA TYPHI TYPE IVB PILS AND CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INTERACTION','X-RAY DIFFRACTION',1.900,'CELL ADHESION/MEMBRANE PROTEIN',1,2,1),(2943,'3fie','CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH1)','X-RAY DIFFRACTION',2.100,'HYDROLASE, TOXIN/PROTEIN TRANSPORT',2,2,1),(2944,'3fii','CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH2)','X-RAY DIFFRACTION',2.170,'HYDROLASE, TOXIN/PROTEIN TRANSPORT',1,1,1),(2945,'3fiv','CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(2946,'3fjq','CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA IN COMPLEX WITH PEPTIDE INHIBITOR PKI ALPHA (6-25)','X-RAY DIFFRACTION',1.600,'TRANSFERASE',1,1,1),(2947,'3fma','CRYSTAL STRUCTURE OF THE GYF DOMAIN OF SMY2 IN COMPLEX WITH A PROLINE- RICH PEPTIDE FROM BBP/SCSF1','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING',5,5,1),(2948,'3fn0','CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB Z13E1 IN COMPLEX WITH A 12-RESIDUE PEPTIDE CONTAINING THE Z13E1 EPITOPE ON GP41','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,2,1),(2949,'3fol','CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFERI','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(2950,'3fom','CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE IQQSIERL','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(2951,'3fon','CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI','X-RAY DIFFRACTION',2.030,'IMMUNE SYSTEM',2,2,1),(2952,'3fp2','CRYSTAL STRUCTURE OF TOM71 COMPLEXED WITH HSP82 C-TERMINAL FRAGMENT','X-RAY DIFFRACTION',1.980,'TRANSPORT PROTEIN',1,1,1),(2953,'3fp4','CRYSTAL STRUCTURE OF TOM71 COMPLEXED WITH SSA1 C-TERMINAL FRAGMENT','X-RAY DIFFRACTION',2.140,'TRANSPORT PROTEIN',1,1,1),(2954,'3fp7','ANIONIC TRYPSIN VARIANT S195A IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) CLEAVED AT THE SCISSILE BOND (LYS15-ALA16) DETERMINED TO THE 1.46 A RESOLUTION LIMIT','X-RAY DIFFRACTION',1.460,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(2955,'3fqn','PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,1,1),(2956,'3fqr','PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(2957,'3fqt','PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(2958,'3fqu','PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(2959,'3fqw','PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES','X-RAY DIFFRACTION',1.930,'IMMUNE SYSTEM',1,1,1),(2960,'3fqx','PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(2961,'3fs1','CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR PGC-1A FRAGMENT','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(2962,'3ft2','CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA- A2','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(2963,'3ft3','CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1HIS IN COMPLEX WITH HLA-A2','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,1,1),(2964,'3ft4','CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(2965,'3fug','CRYSTAL STRUCTURE OF THE RETINOID X RECEPTOR LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST 3-[4-HYDROXY-3-(3,5, 5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)- PHENYL]ACRYLIC ACID','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(2966,'3fur','CRYSTAL STRUCTURE OF PPARG IN COMPLEX WITH INT131','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(2967,'3fv3','SECRETED ASPARTIC PROTEASE 1 FROM CANDIDA PARAPSILOSIS IN COMPLEX WITH PEPSTATIN A','X-RAY DIFFRACTION',1.850,'HYDROLASE',8,8,1),(2968,'3fvh','POLO-LIKE KINASE 1 POLO BOX DOMAIN IN COMPLEX WITH AC-LHSPTA-NH2 PEPTIDE','X-RAY DIFFRACTION',1.580,'CELL CYCLE, PEPTIDE BINDING PROTEIN',1,1,1),(2969,'3fwv','CRYSTAL STRUCTURE OF A REDESIGNED TPR PROTEIN, T-MOD(VMY), IN COMPLEX WITH MEEVF PEPTIDE','X-RAY DIFFRACTION',2.200,'CHAPERONE',2,2,1),(2970,'3fxv','IDENTIFICATION OF AN N-OXIDE PYRIDINE GW4064 ANALOGUE AS A POTENT FXR AGONIST','X-RAY DIFFRACTION',2.260,'HORMONE RECEPTOR',1,1,1),(2971,'3fxx','HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYE[PTYR]IW','X-RAY DIFFRACTION',1.700,'TRANSFERASE',1,1,1),(2972,'3fy2','HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYEFIW','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(2973,'3g03','STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH HIGH AFFINITY PEPTIDE','X-RAY DIFFRACTION',1.800,'CELL CYCLE',2,2,1),(2974,'3g19','THE STRUCTURE OF THE CAULOBACTER CRESCENTUS CLPS PROTEASE ADAPTOR PROTEIN IN COMPLEX WITH LLL TRIPEPTIDE','X-RAY DIFFRACTION',1.850,'PEPTIDE BINDING PROTEIN',1,1,1),(2975,'3g1b','THE STRUCTURE OF THE M53A MUTANT OF CAULOBACTER CRESCENTUS CLPS PROTEASE ADAPTOR PROTEIN IN COMPLEX WITH WLFVQRDSKE PEPTIDE','X-RAY DIFFRACTION',1.450,'PEPTIDE BINDING PROTEIN',2,2,1),(2976,'3g2s','VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH SORLA C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',1.700,'PROTEIN TRANSPORT',2,2,1),(2977,'3g2t','VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH SORLA C-TERMINAL PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT',2,2,1),(2978,'3g2u','VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH SOTILIN C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',2,2,1),(2979,'3g2v','VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH SOTILIN C-TERMINAL PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT',2,2,1),(2980,'3g2w','VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH A DXXLL HINGE PEPTIDE','X-RAY DIFFRACTION',2.400,'PROTEIN TRANSPORT',2,2,1),(2981,'3g3p','THE STRUCTURE OF THE M53A MUTANT OF THE CAULOBACTER CRESCENTUS CLPS IN COMPLEX WITH A PEPTIDE CONTAINING AN AMINO-TERMINAL NORLEUCINE RESIDUE','X-RAY DIFFRACTION',1.480,'PEPTIDE BINDING PROTEIN',1,1,1),(2982,'3g43','CRYSTAL STRUCTURE OF THE CALMODULIN-BOUND CAV1.2 C-TERMINAL REGULATORY DOMAIN DIMER','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN',1,3,1),(2983,'3g5v','ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(2984,'3g5y','ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR','X-RAY DIFFRACTION',1.590,'IMMUNE SYSTEM',1,2,1),(2985,'3g6n','CRYSTAL STRUCTURE OF AN EFPDF COMPLEX WITH MET-ALA-SER','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(2986,'3g7l','CHROMODOMAIN OF CHP1 IN COMPLEX WITH HISTONE H3K9ME3 PEPTIDE','X-RAY DIFFRACTION',2.200,'NUCLEAR PROTEIN',1,1,1),(2987,'3g7z','CCDB DIMER IN COMPLEX WITH TWO C-TERMINAL CCDA DOMAINS','X-RAY DIFFRACTION',2.350,'TOXIN/TOXIN REPRESSOR',2,2,1),(2988,'3g8f','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II PHOSPHOLIPASE A2 AND DESIGNED PEPTIDE INHIBITOR CARBOBENZOXY-DEHYDRO- VAL-ALA-ARG-SER AT 1.2 A RESOLUTION','X-RAY DIFFRACTION',1.250,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(2989,'3g8i','ALEGLITAZAR, A NEW, POTENT, AND BALANCED PPAR ALPHA/GAMMA AGONIST FOR THE TREATMENT OF TYPE II DIABETES','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION/TRANSFERASE',1,1,1),(2990,'3g9e','ALEGLITAAR. A NEW. POTENT, AND BALANCED DUAL PPARA/G AGONIST FOR THE TREATMENT OF TYPE II DIABETES','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION/TRANSFERASE',1,1,1),(2991,'3g9w','CRYSTAL STRUCTURE OF TALIN2 F2-F3 IN COMPLEX WITH THE INTEGRIN BETA1D CYTOPLASMIC TAIL','X-RAY DIFFRACTION',2.170,'CELL ADHESION',2,2,1),(2992,'3gch','CHEMISTRY OF CAGED ENZYMES. BINDING OF PHOTOREVERSIBLE CINNAMATES TO CHYMOTRYPSIN','X-RAY DIFFRACTION',1.900,'HYDROLASE (SERINE PROTEINASE)',1,2,1),(2993,'3gci','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A NEW ISOFORM OF PHOSPHOLIPASE A2 WITH C-TERMINAL AMYLOID BETA HEPTAPEPTIDE AT 2 A RESOLUTION','X-RAY DIFFRACTION',2.040,'HYDROLASE',1,1,1),(2994,'3gcm','CRYSTAL STRUCTURE OF E. COLI POLYNUCLEOTIDE PHOSPHORYLASE BOUND TO RNA AND RNASE E','X-RAY DIFFRACTION',2.500,'TRANSFERASE / PROTEIN BINDING',3,3,1),(2995,'3gct','STRUCTURE OF GAMMA-*CHYMOTRYPSIN IN THE RANGE $P*H 2.0 TO $P*H 10.5 SUGGESTS THAT GAMMA-CHYMOTRYPSIN IS A COVALENT ACYL-ENZYME ADDUCT AT LOW $P*H','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',2,2,1),(2996,'3gdv','CRYSTAL STRUCTURE OF DEGS H198P/D320A MUTANT MODIFIED BY DFP AND IN COMPLEX WITH YQF PEPTIDE','X-RAY DIFFRACTION',2.490,'HYDROLASE/HYDROLASE ACTIVATOR',3,3,1),(2997,'3ggw','CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',2,4,1),(2998,'3ghb','CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',2,4,1),(2999,'3ghe','CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 537-10D IN COMPLEX WITH V3 PEPTIDE MN','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(3000,'3gi0','CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID \'COVALENT DIMER\' [L-ALA51,D-ALA51\'] HIV-1 PROTEASE MOLECULE COMPLEXED WITH JG- 365 INHIBITOR','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3001,'3gic','STRUCTURE OF THROMBIN MUTANT DELTA(146-149E) IN THE FREE FORM','X-RAY DIFFRACTION',1.550,'HYDROLASE',1,1,1),(3002,'3gis','CRYSTAL STRUCTURE OF NA-FREE THROMBIN IN COMPLEX WITH THROMBOMODULIN','X-RAY DIFFRACTION',2.400,'BLOOD CLOTTING',3,4,1),(3003,'3giv','ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(3004,'3gj3','CRYSTAL STRUCTURE OF HUMAN RANGDP-NUP153ZNF2 COMPLEX','X-RAY DIFFRACTION',1.790,'TRANSPORT PROTEIN',1,1,1),(3005,'3gj4','CRYSTAL STRUCTURE OF HUMAN RANGDP-NUP153ZNF3 COMPLEX','X-RAY DIFFRACTION',2.150,'TRANSPORT PROTEIN',2,2,1),(3006,'3gj5','CRYSTAL STRUCTURE OF HUMAN RANGDP-NUP153ZNF4 COMPLEX','X-RAY DIFFRACTION',1.790,'TRANSPORT PROTEIN',2,2,1),(3007,'3gj7','CRYSTAL STRUCTURE OF HUMAN RANGDP-NUP153ZNF12 COMPLEX','X-RAY DIFFRACTION',1.930,'TRANSPORT PROTEIN',2,2,1),(3008,'3gj8','CRYSTAL STRUCTURE OF HUMAN RANGDP-NUP153ZNF34 COMPLEX','X-RAY DIFFRACTION',1.820,'TRANSPORT PROTEIN',2,2,1),(3009,'3gjf','RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,6,1),(3010,'3gjo','CRYSTAL STRUCTURE OF HUMAN EB1 IN COMPLEX WITH MICROTUBULE TIP LOCALIZATION SIGNAL PEPTIDE OF MACF','X-RAY DIFFRACTION',2.500,'STRUCTURAL PROTEIN',4,3,1),(3011,'3gjs','CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES','X-RAY DIFFRACTION',1.900,'APOPTOSIS',2,4,1),(3012,'3gjt','CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES','X-RAY DIFFRACTION',2.200,'APOPTOSIS',2,4,1),(3013,'3gkr','CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMX:UDP-MURNAC-HEXAPEPTIDE COMPLEX','X-RAY DIFFRACTION',1.600,'TRANSFERASE/TRANSFERASE PRODUCT',1,1,1),(3014,'3glr','CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ACETYL-LYSINE ACECS2 PEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE REGULATOR',1,1,1),(3015,'3glt','CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ADPR BOUND TO THE ACECS2 PEPTIDE CONTAINING A THIOACETYL LYSINE','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE REGULATOR',1,1,1),(3016,'3glu','CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ACECS2 PEPTIDE','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE REGULATOR',1,1,1),(3017,'3gme','CRYSTAL STRUCTURE OF POLYNUCLEOTIDE PHOSPHORYLASE IN COMPLEX WITH RNASE E AND MANGANESE','X-RAY DIFFRACTION',2.400,'TRANSFERASE / PROTEIN BINDING',1,1,1),(3018,'3gn8','X-RAY CRYSTAL STRUCTURE OF ANCGR2 IN COMPLEX WITH DEXAMETHASONE','X-RAY DIFFRACTION',2.500,'HORMONE/HORMONE ACTIVATOR',2,2,1),(3019,'3go1','CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN','X-RAY DIFFRACTION',1.890,'IMMUNE SYSTEM',1,2,1),(3020,'3gof','CALMODULIN BOUND TO PEPTIDE FROM MACROPHAGE NITRIC OXIDE SYNTHASE','X-RAY DIFFRACTION',1.450,'METAL BINDING PROTEIN/OXIDOREDUCTASE',2,2,1),(3021,'3gp2','CALMODULIN BOUND TO PEPTIDE FROM CALMODULIN KINASE II (CAMKII)','X-RAY DIFFRACTION',1.460,'METAL BINDING PROTEIN/TRANSFERASE',1,1,1),(3022,'3gq1','THE STRUCTURE OF THE CAULOBACTER CRESCENTUS CLPS PROTEASE ADAPTOR PROTEIN IN COMPLEX WITH A WLFVQRDSKE DECAPEPTIDE','X-RAY DIFFRACTION',1.500,'PEPTIDE BINDING PROTEIN',2,2,1),(3023,'3gs2','RING1B C-TERMINAL DOMAIN/CBX7 CBOX COMPLEX','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',2,2,1),(3024,'3gso','CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(3025,'3gsq','CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT','X-RAY DIFFRACTION',2.120,'IMMUNE SYSTEM',1,1,1),(3026,'3gsr','CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,1,1),(3027,'3gsu','CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3028,'3gsv','CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3029,'3gsw','CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT','X-RAY DIFFRACTION',1.810,'IMMUNE SYSTEM',1,1,1),(3030,'3gsx','CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(3031,'3gv4','CRYSTAL STRUCTURE OF HUMAN HDAC6 ZINC FINGER DOMAIN AND UBIQUITIN C- TERMINAL PEPTIDE RLRGG','X-RAY DIFFRACTION',1.720,'HYDROLASE',1,1,1),(3032,'3gw1','THE STRUCTURE OF THE CAULOBACTER CRESCENTUS CLPS PROTEASE ADAPTOR PROTEIN IN COMPLEX WITH FGG TRIPEPTIDE','X-RAY DIFFRACTION',2.360,'PEPTIDE BINDING PROTEIN',2,2,1),(3033,'3gxv','THREE-DIMENSIONAL STRUCTURE OF N-TERMINAL DOMAIN OF DNAB HELICASE FROM HELICOBACTER PYLORI AND ITS INTERACTIONS WITH PRIMASE','X-RAY DIFFRACTION',2.200,'HYDROLASE/REPLICATION',2,2,1),(3034,'3gyt','NUCLEAR RECEPTOR DAF-12 FROM PARASITIC NEMATODE STRONGYLOIDES STERCORALIS IN COMPLEX WITH ITS PHYSIOLOGICAL LIGAND DAFACHRONIC ACID DELTA 4','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(3035,'3gyu','NUCLEAR RECEPTOR DAF-12 FROM PARASITIC NEMATODE STRONGYLOIDES STERCORALIS IN COMPLEX WITH ITS PHYSIOLOGICAL LIGAND DAFACHRONIC ACID DELTA 7','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(3036,'3gz1','CRYSTAL STRUCTURE OF IPGC IN COMPLEX WITH THE CHAPERONE BINDING REGION OF IPAB','X-RAY DIFFRACTION',2.150,'CHAPERONE',2,2,1),(3037,'3gze','ALGAL PROLYL 4-HYDROXYLASE COMPLEXED WITH ZINC AND (SER-PRO)5 PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.980,'HYDROLASE',2,2,1),(3038,'3h0a','CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) AND RETINOIC ACID RECEPTOR ALPHA (RXRA) IN COMPLEX WITH 9-CIS RETINOIC ACID, CO-ACTIVATOR PEPTIDE, AND A PARTIAL AGONIST','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(3039,'3h0t','HEPCIDIN-FAB COMPLEX','X-RAY DIFFRACTION',1.890,'IMMUNE SYSTEM/ANTIMICROBIAL PROTEIN',1,2,1),(3040,'3h11','ZYMOGEN CASPASE-8:C-FLIPL PROTEASE DOMAIN COMPLEX','X-RAY DIFFRACTION',1.900,'APOPTOSIS',1,1,1),(3041,'3h1z','MOLECULAR BASIS FOR THE ASSOCIATION OF PIPKIGAMMA -P90 WITH THE CLATHRIN ADAPTOR AP-2','X-RAY DIFFRACTION',1.830,'ENDOCYTOSIS',1,1,1),(3042,'3h3g','CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE HUMAN PARATHYROID HORMONE RECEPTOR (PTH1R) IN COMPLEX WITH PARATHYROID HORMONE-RELATED PROTEIN (PTHRP)','X-RAY DIFFRACTION',1.940,'MEMBRANE PROTEIN',1,1,1),(3043,'3h5r','CRYSTAL STRUCTURE OF E. COLI MCCB + SUCCINIMIDE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/ANTIBIOTIC',2,2,1),(3044,'3h7b','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE','X-RAY DIFFRACTION',1.880,'IMMUNE SYSTEM',2,2,1),(3045,'3h8a','CRYSTAL STRUCTURE OF E. COLI ENOLASE BOUND TO ITS COGNATE RNASE E RECOGNITION DOMAIN','X-RAY DIFFRACTION',1.900,'LYASE/PROTEIN BINDING',2,4,1),(3046,'3h8d','CRYSTAL STRUCTURE OF MYOSIN VI IN COMPLEX WITH DAB2 PEPTIDE','X-RAY DIFFRACTION',2.200,'MOTOR PROTEIN/SIGNALING PROTEIN',4,4,1),(3047,'3h8k','CRYSTAL STRUCTURE OF UBE2G2 COMPLXED WITH THE G2BR DOMAIN OF GP78 AT 1.8-A RESOLUTION','X-RAY DIFFRACTION',1.800,'LIGASE',1,1,1),(3048,'3h9g','CRYSTAL STRUCTURE OF E. COLI MCCB + MCCA-N7ISOASN','X-RAY DIFFRACTION',2.200,'TRANSFERASE/ANTIBIOTIC',4,4,1),(3049,'3h9h','HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(3050,'3h9j','CRYSTAL STRUCTURE OF E. COLI MCCB + AMPCPP + SEMET MCCA','X-RAY DIFFRACTION',2.300,'TRANSFERASE/ANTIBIOTIC',1,2,1),(3051,'3ha6','CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10','X-RAY DIFFRACTION',2.360,'TRANSFERASE',1,1,1),(3052,'3hat','ACTIVE SITE MIMETIC INHIBITION OF THROMBIN','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(3053,'3hbu','PRTC METHIONINE MUTANTS: M226H DESY','X-RAY DIFFRACTION',1.770,'HYDROLASE',1,1,1),(3054,'3hbv','PRTC METHIONINE MUTANTS: M226A IN-HOUSE','X-RAY DIFFRACTION',1.950,'HYDROLASE',1,1,1),(3055,'3hcv','CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,1,1),(3056,'3hda','PRTC METHIONINE MUTANTS: M226A_DESY','X-RAY DIFFRACTION',2.130,'HYDROLASE',1,1,1),(3057,'3hdb','CRYSTAL STRUCTURE OF AAHIV, A METALLOPROTEINASE FROM VENOM OF AGKISTRODON ACUTUS','X-RAY DIFFRACTION',2.310,'HYDROLASE',1,1,1),(3058,'3hds','CRYSTAL STRUCTURE OF 4-METHYLMUCONOLACTONE METHYLISOMERASE IN COMPLEX WITH MES','X-RAY DIFFRACTION',1.450,'ISOMERASE',2,4,1),(3059,'3hik','STRUCTURE OF HUMAN PLK1-PBD IN COMPLEX WITH PLHSPT','X-RAY DIFFRACTION',1.770,'TRANSFERASE',1,1,1),(3060,'3hk3','CRYSTAL STRUCTURE OF MURINE THROMBIN MUTANT W215A/E217A (ONE MOLECULE IN THE ASYMMETRIC UNIT)','X-RAY DIFFRACTION',1.940,'HYDROLASE',1,1,1),(3061,'3hki','CRYSTAL STRUCTURE OF MURINE THROMBIN MUTANT W215A/E217A IN COMPLEX WITH THE EXTRACELLULAR FRAGMENT OF HUMAN PAR1','X-RAY DIFFRACTION',2.200,'HYDROLASE',4,2,1),(3062,'3hm1','CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTRONE ((8R,9S,13S,14S)-3-HYDROXY-13-METHYL- 7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE)','X-RAY DIFFRACTION',2.330,'TRANSCRIPTION',2,2,1),(3063,'3hna','CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN EUCHROMATIC HISTONE METHYLTRANSFERASE 1 IN COMPLEX WITH SAH AND MONO-METHYLATED H3K9 PEPTIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE REGULATOR',2,2,1),(3064,'3hpj','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(3065,'3hpw','CCDB DIMER IN COMPLEX WITH ONE C-TERMINAL CCDA DOMAIN','X-RAY DIFFRACTION',1.450,'TOXIN/TOXIN REPRESSOR',1,2,1),(3066,'3hqh','STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX- MACROH2ASBCPEP1','X-RAY DIFFRACTION',2.300,'LIGASE',1,1,1),(3067,'3hql','STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES:SPOPMATHX-PUCSBC1_PEP2','X-RAY DIFFRACTION',1.660,'PROTEIN BINDING, LIGASE/HYDROLASE',2,2,1),(3068,'3hqm','STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX-CISBC2','X-RAY DIFFRACTION',1.740,'PROTEIN BINDING, LIGASE',2,2,1),(3069,'3hqr','PHD2:MN:NOG:HIF1-ALPHA SUBSTRATE COMPLEX','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE/TRANSCRIPTION',1,1,1),(3070,'3hqu','PHD2:FE:UN9:PARTIAL HIF1-ALPHA SUBSTRATE COMPLEX','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE/TRANSCRIPTION',1,1,1),(3071,'3hr5','M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',4,8,1),(3072,'3hry','CRYSTAL STRUCTURE OF PHD IN A TRIGONAL SPACE GROUP AND PARTIALLY DISORDERED','X-RAY DIFFRACTION',2.250,'ANTITOXIN',1,1,1),(3073,'3hs8','INTERSECTIN 1-PEPTIDE-AP2 ALPHA EAR COMPLEX','X-RAY DIFFRACTION',1.900,'ENDOCYTOSIS',1,1,1),(3074,'3hs9','INTERSECTIN 1-PEPTIDE-AP2 BETA EAR COMPLEX','X-RAY DIFFRACTION',2.150,'ENDOCYTOSIS',1,1,1),(3075,'3hsv','STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATHX- MACROH2ASBCPEP2','X-RAY DIFFRACTION',1.430,'PROTEIN BINDING, LIGASE',1,2,1),(3076,'3htu','CRYSTAL STRUCTURE OF THE HUMAN VPS25-VPS20 SUBCOMPLEX','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT',4,4,1),(3077,'3huf','STRUCTURE OF THE S. POMBE NBS1-CTP1 COMPLEX','X-RAY DIFFRACTION',2.150,'CELL CYCLE',1,1,1),(3078,'3hxg','CRYSTAL STRUCTURE OF SCHISTSOME EIF4E COMPLEXED WITH M7GPPPA AND 4E-BP','X-RAY DIFFRACTION',2.100,'TRANSLATION',1,1,1),(3079,'3hxi','CRYSTAL STRUCTURE OF SCHISTOSOME EIF4E COMPLEXED WITH M7GPPPG AND 4E-BP','X-RAY DIFFRACTION',1.800,'TRANSLATION',1,1,1),(3080,'3i1h','CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITH BAK BH3 PEPTIDE','X-RAY DIFFRACTION',2.200,'APOPTOSIS',1,1,1),(3081,'3i5r','PI3K SH3 DOMAIN IN COMPLEX WITH A PEPTIDE LIGAND','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING',1,1,1),(3082,'3i6g','NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,2,1),(3083,'3i6l','NEWLY IDENTIFIED EPITOPE N1 DERIVED FROM SARS-COV N PROTEIN COMPLEXED WITH HLA-A*2402','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(3084,'3i7z','PROTEIN TYROSINE PHOSPHATASE 1B - TRANSITION STATE ANALOG FOR THE FIRST CATALYTIC STEP','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(3085,'3ici','CRYSTAL STRUCTURE OF CYCLOPHILIN B IN COMPLEX WITH CALMEGIN FRAGMENT','X-RAY DIFFRACTION',1.700,'ISOMERASE',1,1,1),(3086,'3idg','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD','X-RAY DIFFRACTION',1.860,'IMMUNE SYSTEM',1,2,1),(3087,'3idi','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB\' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(3088,'3idj','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB\' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(3089,'3idm','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB\' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',1,2,1),(3090,'3idn','CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB\' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',1,2,1),(3091,'3iec','HELICOBACTER PYLORI CAGA INHIBITS PAR1/MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN/TOXIN',4,4,1),(3092,'3iet','CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,4,1),(3093,'3ifl','X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,2,1),(3094,'3ifn','X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,2,1),(3095,'3ifo','X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',2,4,1),(3096,'3ig6','LOW MOLECULAR WEIGTH HUMAN UROKINASE TYPE PLASMINOGEN ACTIVATOR 2-[6- (3\'-AMINOMETHYL-BIPHENYL-3-YLOXY)-4-(3-DIMETHYLAMINO-PYRROLIDIN-1- YL)-3,5-DIFLUORO-PYRIDIN-2-YLOXY]-4-DIMETHYLAMINO-BENZOIC ACID COMPLEX','X-RAY DIFFRACTION',1.830,'HYDROLASE',2,2,1),(3097,'3iiq','CRYSTALLOGRAPHIC ANALYSIS OF BACTERIAL SIGNAL PEPTIDASE IN TERNARY COMPLEX WITH ARYLOMYCIN A2 AND A BETA-SULTAM INHIBITOR','X-RAY DIFFRACTION',2.000,'HYDROLASE/ANTIBIOTIC/INHIBITOR',2,2,1),(3098,'3iiw','CRYSTAL STRUCTURE OF EED IN COMPLEX WITH A TRIMETHYLATED HISTONE H3K27 PEPTIDE','X-RAY DIFFRACTION',1.800,'GENE REGULATION',1,1,1),(3099,'3ij0','CRYSTAL STRUCTURE OF EED IN COMPLEX WITH A TRIMETHYLATED HISTONE H3K9 PEPTIDE','X-RAY DIFFRACTION',2.450,'GENE REGULATION',1,1,1),(3100,'3ij1','CRYSTAL STRUCTURE OF EED IN COMPLEX WITH A TRIMETHYLATED HISTONE H4K20 PEPTIDE','X-RAY DIFFRACTION',2.100,'GENE REGULATION',1,1,1),(3101,'3ik5','SIVMAC239 NEF IN COMPLEX WITH TCR ZETA ITAM 1 POLYPEPTIDE (A63-R80)','X-RAY DIFFRACTION',2.050,'VIRAL PROTEIN/SIGNALING PROTEIN',2,2,1),(3102,'3io8','BIML12F IN COMPLEX WITH BCL-XL','X-RAY DIFFRACTION',2.300,'APOPTOSIS',2,2,1),(3103,'3io9','BIML12Y IN COMPLEX WITH MCL-1','X-RAY DIFFRACTION',2.400,'APOPTOSIS',1,1,1),(3104,'3iol','CRYSTAL STRUCTURE OF GLUCAGON-LIKE PEPTIDE-1 IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN/SIGNALING PROTEIN',1,1,1),(3105,'3ipq','X-RAY STRUCTURE OF GW3965 SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(3106,'3ips','X-RAY STRUCTURE OF BENZISOXAZOLE SYNTHETIC AGONIST BOUND TO THE LXR- ALPHA','X-RAY DIFFRACTION',2.260,'TRANSCRIPTION',2,2,1),(3107,'3ipu','X-RAY STRUCTURE OF BENZISOXAZOLE UREA SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(3108,'3iqg','STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE IN COMPLEX WITH PEPTIDE MNWNI','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(3109,'3iqh','STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE IN COMPLEX WITH PEPTIDE MNYDI','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(3110,'3iqi','STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE IN COMPLEX WITH PEPTIDE MNENI','X-RAY DIFFRACTION',1.700,'TRANSFERASE',1,1,1),(3111,'3iqj','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH RAF1 PEPTIDE (10MER)','X-RAY DIFFRACTION',1.150,'PROTEIN BINDING, SIGNALING PROTEIN',1,1,1),(3112,'3iqq','X-RAY STRUCTURE OF BOVINE TRTK12-CA(2+)-S100B','X-RAY DIFFRACTION',2.010,'METAL BINDING PROTEIN',1,1,1),(3113,'3iqu','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH RAF1 PEPTIDE (6MER)','X-RAY DIFFRACTION',1.050,'PROTEIN BINDING, SIGNALING PROTEIN',1,1,1),(3114,'3iqv','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH RAF1 PEPTIDE (6MER) AND STABILISATOR FUSICOCCIN','X-RAY DIFFRACTION',1.200,'PROTEIN BINDING, SIGNALING PROTEIN',1,1,1),(3115,'3itb','CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 6 (PBP6) FROM E. COLI IN COMPLEX WITH A SUBSTRATE FRAGMENT','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,2,1),(3116,'3itn','CRYSTAL STRUCTURE OF PSEUDO-ACTIVATED PROCASPASE-3','X-RAY DIFFRACTION',1.630,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3117,'3iur','APPEP_D266NX+H2H3 OPENED STATE','X-RAY DIFFRACTION',2.050,'HYDROLASE',2,1,1),(3118,'3iux','CRYSTAL STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH A POTENT MINIATURE PROTEIN INHIBITOR (18-RESIDUES)','X-RAY DIFFRACTION',1.650,'LIGASE',2,2,1),(3119,'3ivb','STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATH- MACROH2ASBCPEP1','X-RAY DIFFRACTION',1.750,'PROTEIN BINDING, LIGASE',1,1,1),(3120,'3ivq','STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATH-CISBC2','X-RAY DIFFRACTION',2.100,'LIGASE',2,2,1),(3121,'3ivv','STRUCTURES OF SPOP-SUBSTRATE COMPLEXES: INSIGHTS INTO MOLECULAR ARCHITECTURES OF BTB-CUL3 UBIQUITIN LIGASES: SPOPMATH-PUCSBC1_PEP1','X-RAY DIFFRACTION',1.250,'LIGASE',1,1,1),(3122,'3ixa','HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,2,1),(3123,'3ixs','RING1B C-TERMINAL DOMAIN/RYBP C-TERMINAL DOMAIN COMPLEX','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING',6,6,1),(3124,'3jpv','CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A PYRROLO[2,3- A]CARBAZOLE LIGAND','X-RAY DIFFRACTION',2.350,'TRANSFERASE / TRANSFERASE INHIBITOR',1,1,1),(3125,'3jpx','EED: A NOVEL HISTONE TRIMETHYLLYSINE BINDER WITHIN THE EED-EZH2 POLYCOMB COMPLEX','X-RAY DIFFRACTION',2.050,'GENE REGULATION',1,1,1),(3126,'3jq5','PHOSPHOLIPASE A2 PREVENTS THE AGGREGATION OF AMYLOID BETA PEPTIDES: CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH OCTAPEPTIDE FRAGMENT OF AMYLOID BETA PEPTIDE, ASP- ALA-GLU-PHE-ARG-HIS-ASP-SER AT 2 A RESOLUTION','X-RAY DIFFRACTION',2.030,'HYDROLASE',1,1,1),(3127,'3jql','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A HEXAPEPTIDE FRAGMENT OF AMYLOID BETA PEPTIDE, LYS-LEU-VAL-PHE-PHE-ALA AT 1.2 A RESOLUTION','X-RAY DIFFRACTION',1.200,'HYDROLASE',1,1,1),(3128,'3jr3','SIR2 BOUND TO ACETYLATED PEPTIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,1,1),(3129,'3jrv','STRUCTURE OF POXVIRUS K7 PROTEIN IN COMPLEX WITH RNA HELICASE DDX3','X-RAY DIFFRACTION',1.600,'VIRAL PROTEIN/PROTEIN BINDING',3,2,1),(3130,'3jtc','IMPORTANCE OF MG2+ IN THE CA2+-DEPENDENT FOLDING OF THE GAMMA- CARBOXYGLUTAMIC ACID DOMAINS OF VITAMIN K-DEPENDENT CLOTTING AND ANTICLOTTING PROTEINS','X-RAY DIFFRACTION',1.600,'BLOOD CLOTTING',2,2,1),(3131,'3jti','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 WITH BETA-AMYLOID FRAGMENT, LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET AT 1.8 A RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(3132,'3jvk','CRYSTAL STRUCTURE OF BROMODOMAIN 1 OF MOUSE BRD4 IN COMPLEX WITH HISTONE H3-K(AC)14','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(3133,'3jxt','CRYSTAL STRUCTURE OF THE THIRD PDZ DOMAIN OF SAP-102 IN COMPLEX WITH A FLUOROGENIC PEPTIDE-BASED LIGAND','X-RAY DIFFRACTION',1.500,'SIGNALING PROTEIN',2,2,1),(3134,'3jz1','CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT N143P IN E:NA+ FORM','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(3135,'3jz2','CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT N143P IN E* FORM','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(3136,'3jzg','STRUCTURE OF EED IN COMPLEX WITH H3K27ME3','X-RAY DIFFRACTION',2.100,'GENE REGULATION',1,1,1),(3137,'3jzh','EED-H3K79ME3','X-RAY DIFFRACTION',2.050,'GENE REGULATION',1,1,1),(3138,'3jzo','HUMAN MDMX LIGANDED WITH A 12MER PEPTIDE (PDI)','X-RAY DIFFRACTION',1.800,'CELL CYCLE',1,1,1),(3139,'3jzp','HUMAN MDMX LIGANDED WITH A 12MER PEPTIDE INHIBITOR (PDI6W)','X-RAY DIFFRACTION',1.740,'CELL CYCLE',1,1,1),(3140,'3jzq','HUMAN MDMX LIGANDED WITH A 12MER PEPTIDE INHIBITOR (PDIQ)','X-RAY DIFFRACTION',1.800,'CELL CYCLE',2,2,1),(3141,'3jzr','HUMAN MDM2 LIGANDED WITH A 12MER PEPTIDE INHIBITOR (PDI6W)','X-RAY DIFFRACTION',2.100,'LIGASE',1,1,1),(3142,'3jzs','HUMAN MDM2 LIGANDED WITH A 12MER PEPTIDE INHIBITOR (PDIQ)','X-RAY DIFFRACTION',1.780,'LIGASE',1,1,1),(3143,'3k05','THE CRYSTAL STRUCTURE OF MDC1 BRCT T2067D IN COMPLEX WITH A MINIMAL RECOGNITION TETRAPEPTIDE WITH AN AMIDATED C-TERMINUS','X-RAY DIFFRACTION',1.330,'PROTEIN BINDING',2,2,1),(3144,'3k22','GLUCOCORTICOID RECEPTOR WITH BOUND ALANINAMIDE 10 WITH TIF2 PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(3145,'3k24','CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT IN COMPLEX WITH GLN-LEU-ALA PEPTIDE','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(3146,'3k26','COMPLEX STRUCTURE OF EED AND TRIMETHYLATED H3K4','X-RAY DIFFRACTION',1.580,'GENE REGULATION',1,1,1),(3147,'3k27','COMPLEX STRUCTURE OF EED AND TRIMETHYLATED H3K9','X-RAY DIFFRACTION',1.760,'GENE REGULATION',1,1,1),(3148,'3k2u','CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40','X-RAY DIFFRACTION',2.350,'HYDROLASE/IMMUNE SYSTEM',1,1,1),(3149,'3k6g','CRYSTAL STRUCTURE OF RAP1 AND TRF2 COMPLEX','X-RAY DIFFRACTION',1.950,'PROTEIN BINDING',3,3,1),(3150,'3kee','HCV NS3/NS4A COMPLEXED WITH NON-COVALENT MACROCYCLIC COMPOUND TMC435','X-RAY DIFFRACTION',2.400,'HYDROLASE',4,4,1),(3151,'3kf2','THE HCV NS3/NS4A PROTEASE APO STRUCTURE','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(3152,'3kik','SGF11:SUS1 COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',4,4,1),(3153,'3kj0','MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DY','X-RAY DIFFRACTION',1.700,'APOPTOSIS',1,1,1),(3154,'3kj1','MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DA','X-RAY DIFFRACTION',1.950,'APOPTOSIS',1,1,1),(3155,'3kj2','MCL-1 IN COMPLEX WITH BIM BH3 MUTANT F4AE','X-RAY DIFFRACTION',2.350,'APOPTOSIS',1,1,1),(3156,'3kkv','STRUCTURE OF PKA WITH A PROTEIN KINASE B-SELECTIVE INHIBITOR.','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3157,'3kl6','DISCOVERY OF TETRAHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVE TAK-442: A POTENT, SELECTIVE AND ORALLY ACTIVE FACTOR XA INHIBITOR','X-RAY DIFFRACTION',1.450,'HYDROLASE',1,1,1),(3158,'3kla','CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',2,2,1),(3159,'3kmg','THE X-RAY CRYSTAL STRUCTURE OF PPAR-GAMMA IN COMPLEX WITH AN INDOLE DERIVATIVE MODULATOR, GSK538, AND AN SRC-1 PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(3160,'3kmr','CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH AN AGONIST LIGAND (AM580) AND A COACTIVATOR FRAGMENT','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(3161,'3kmt','CRYSTAL STRUCTURE OF VSET/SAH/H3 TERNARY COMPLEX','X-RAY DIFFRACTION',1.780,'VIRAL PROTEIN',3,3,1),(3162,'3kmz','CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH THE INVERSE AGONIST BMS493 AND A COREPRESSOR FRAGMENT','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(3163,'3kn2','HCV NS3 PROTEASE DOMAIN WITH KETOAMIDE INHIBITOR','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(3164,'3knd','TPX2:IMPORTIN-ALPHA COMPLEX','X-RAY DIFFRACTION',2.150,'PROTEIN TRANSPORT',1,1,1),(3165,'3kpl','CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN','X-RAY DIFFRACTION',1.960,'IMMUNE SYSTEM',1,1,1),(3166,'3kpm','CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(3167,'3kpn','CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(3168,'3kpo','CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(3169,'3kpp','CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3170,'3kpq','CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE','X-RAY DIFFRACTION',1.840,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(3171,'3kqi','CRYSTAL STRUCTURE OF PHF2 PHD DOMAIN COMPLEXED WITH H3K4ME3 PEPTIDE','X-RAY DIFFRACTION',1.780,'NUCLEAR PROTEIN',1,1,1),(3172,'3kti','STRUCTURE OF CLPP IN COMPLEX WITH ADEP1','X-RAY DIFFRACTION',2.000,'HYDROLASE/ANTIBIOTIC',7,7,1),(3173,'3ktp','STRUCTURAL BASIS OF GW182 RECOGNITION BY POLY(A)-BINDING PROTEIN','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',1,1,1),(3174,'3ktr','STRUCTURAL BASIS OF ATAXIN-2 RECOGNITION BY POLY(A)-BINDING PROTEIN','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING',1,1,1),(3175,'3kui','CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF PABPC1 IN COMPLEX WITH BINDING REGION OF ERF3A','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING',1,1,1),(3176,'3kuj','CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF PABPC1 IN COMPLEX WITH BINDING REGION OF ERF3A','X-RAY DIFFRACTION',1.400,'PROTEIN BINDING',1,1,1),(3177,'3kus','CRYSTAL STRUCTURE OF THE MLLE DOMAIN OF POLY(A)-BINDING PROTEIN IN COMPLEX WITH THE BINDING REGION OF PAIP2','X-RAY DIFFRACTION',1.400,'PROTEIN BINDING',2,2,1),(3178,'3kut','CRYSTAL STRUCTURE OF THE MLLE DOMAIN OF POLY(A)-BINDING PROTEIN IN COMPLEX WITH THE BINDING REGION OF PAIP2','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',2,2,1),(3179,'3kv4','STRUCTURE OF PHF8 IN COMPLEX WITH HISTONE H3','X-RAY DIFFRACTION',2.190,'H3K4ME3 BINDING PROTEIN, TRANSFERASE',1,1,1),(3180,'3kww','CRYSTAL STRUCTURE OF THE \'RESTRICTION TRIAD\' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE','X-RAY DIFFRACTION',2.180,'IMMUNE SYSTEM',1,1,1),(3181,'3kwy','CRYSTAL STRUCTURE OF RXRALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIPHENYLTIN AND A COACTIVATOR FRAGMENT','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(3182,'3kyn','CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(3183,'3kyo','CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',2,2,1),(3184,'3kyt','CRYSTAL STRUCTURE OF ORPHAN NUCLEAR RECEPTOR RORGAMMA IN COMPLEX WITH NATURAL LIGAND','X-RAY DIFFRACTION',2.350,'LIPID BINDING PROTEIN',1,1,1),(3185,'3kz0','MCL-1 COMPLEX WITH MCL-1-SPECIFIC SELECTED PEPTIDE','X-RAY DIFFRACTION',2.350,'APOPTOSIS',2,2,1),(3186,'3kze','CRYSTAL STRUCTURE OF T-CELL LYMPHOMA INVASION AND METASTASIS-1 PDZ IN COMPLEX WITH SSRKEYYA PEPTIDE','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',2,3,1),(3187,'3l03','CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTETROL (ESTRA-1,3,5(10)-TRIENE-3,15 ALPHA, 16ALPHA,17BETA-TETROL)','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(3188,'3l0e','X-RAY CRYSTAL STRUCTURE OF A POTENT LIVER X RECEPTOR MODULATOR','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(3189,'3l0j','CRYSTAL STRUCTURE OF ORPHAN NUCLEAR RECEPTOR RORGAMMA IN COMPLEX WITH NATURAL LIGAND','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(3190,'3l0l','CRYSTAL STRUCTURE OF ORPHAN NUCLEAR RECEPTOR RORGAMMA IN COMPLEX WITH NATURAL LIGAND','X-RAY DIFFRACTION',1.740,'TRANSCRIPTION',2,2,1),(3191,'3l3d','CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3192,'3l3g','CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(3193,'3l3i','CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(3194,'3l3j','CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(3195,'3l3q','MOUSE IMPORTIN ALPHA-PEPTM NLS PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',2,1,1),(3196,'3l3x','CRYSTAL STRUCTURE OF DHT-BOUND ANDROGEN RECEPTOR IN COMPLEX WITH THE FIRST MOTIF OF STEROID RECEPTOR COACTIVATOR 3','X-RAY DIFFRACTION',1.550,'PROTEIN BINDING',1,1,1),(3197,'3l3z','CRYSTAL STRUCTURE OF DHT-BOUND ANDROGEN RECEPTOR IN COMPLEX WITH THE THIRD MOTIF OF STEROID RECEPTOR COACTIVATOR 3','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',1,1,1),(3198,'3l41','CRYSTAL STRUCTURE OF S. POMBE BRC1 BRCT5-BRCT6 DOMAINS IN COMPLEX WITH PHOSPHORYLATED H2A','X-RAY DIFFRACTION',1.450,'CELL CYCLE',1,1,1),(3199,'3l6f','STRUCTURE OF MHC CLASS II MOLECULE HLA-DR1 COMPLEXED WITH PHOSPHOPEPTIDE MART-1','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM/PEPTIDE BINDING PROTEIN',1,2,1),(3200,'3l6x','CRYSTAL STRUCTURE OF P120 CATENIN IN COMPLEX WITH E-CADHERIN','X-RAY DIFFRACTION',2.400,'CELL ADHESION',1,1,1),(3201,'3l81','CRYSTAL STRUCTURE OF ADAPTOR PROTEIN COMPLEX 4 (AP-4) MU4 SUBUNIT C- TERMINAL DOMAIN, IN COMPLEX WITH A SORTING PEPTIDE FROM THE AMYLOID PRECURSOR PROTEIN (APP)','X-RAY DIFFRACTION',1.600,'TRANSPORT PROTEIN',1,1,1),(3202,'3l9l','CRYSTAL STRUCTURE OF PKA WITH COMPOUND 36','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(3203,'3l9m','CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A, L173M, Q181K) WITH COMPOUND 18','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(3204,'3l9n','CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A, L173M, Q181K) WITH COMPOUND 27','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3205,'3lae','THE CRYSTAL STRUCTURE OF A FUNCTIONALLY UNKNOWN CONSERVED PROTEIN FROM HAEMOPHILUS INFLUENZAE RD KW20','X-RAY DIFFRACTION',1.450,'MEMBRANE PROTEIN',1,1,1),(3206,'3lca','STRUCTURE OF TOM71 COMPLEXED WITH HSP70 SSA1 C TERMINAL TAIL INDICATING CONFORMATIONAL PLASTICITY','X-RAY DIFFRACTION',2.190,'TRANSPORT PROTEIN',1,1,1),(3207,'3lcn','NAB2:GFD1 COMPLEX','X-RAY DIFFRACTION',2.000,'NUCLEAR PROTEIN',2,2,1),(3208,'3ldx','DISCOVERY AND CLINICAL EVALUATION OF RWJ-671818, A THROMBIN INHIBITOR WITH AN OXYGUANIDINE P1 MOTIF','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3209,'3lex','2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41','X-RAY DIFFRACTION',1.970,'IMMUNE SYSTEM',2,4,1),(3210,'3ley','2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 6A7 IN COMPLEX WITH HIV-1 GP41','X-RAY DIFFRACTION',1.990,'IMMUNE SYSTEM',1,2,1),(3211,'3lge','CRYSTAL STRUCTURE OF RABBIT MUSCLE ALDOLASE-SNX9 LC4 COMPLEX','X-RAY DIFFRACTION',2.200,'LYASE/PROTEIN BINDING',4,4,1),(3212,'3liy','CRYSTAL STRUCTURE OF HTLV PROTEASE COMPLEXED WITH STATINE-CONTAINING PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.860,'HYDROLASE/HYDROLASE INHIBITOR',3,6,1),(3213,'3lk2','CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CARMIL','X-RAY DIFFRACTION',2.200,'PROTEIN BINDING',1,2,1),(3214,'3lk4','CRYSTAL STRUCTURE OF CAPZ BOUND TO THE UNCAPPING MOTIF FROM CD2AP','X-RAY DIFFRACTION',1.990,'PROTEIN BINDING',12,24,1),(3215,'3lkn','CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(3216,'3lko','CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3217,'3lkp','CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3218,'3lkq','CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3219,'3lkr','CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),